<SEC-DOCUMENT>0001193125-22-105019.txt : 20220414
<SEC-HEADER>0001193125-22-105019.hdr.sgml : 20220414
<ACCEPTANCE-DATETIME>20220414084803
ACCESSION NUMBER:		0001193125-22-105019
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		24
CONFORMED PERIOD OF REPORT:	20220525
FILED AS OF DATE:		20220414
DATE AS OF CHANGE:		20220414

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXELIXIS, INC.
		CENTRAL INDEX KEY:			0000939767
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				043257395
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30235
		FILM NUMBER:		22826113

	BUSINESS ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502
		BUSINESS PHONE:		6508377000

	MAIL ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS INC
		DATE OF NAME CHANGE:	20000207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20000106
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d282574ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #3f3f3f">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #3f3f3f">&nbsp;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>UNITED STATES
</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f;width:27%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>SCHEDULE 14A </B></FONT></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT
 COLOR="#3f3f3f"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Securities Exchange Act of 1934
(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;) </B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f;width:27%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Filed by the
Registrant&nbsp;&nbsp;<FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#3f3f3f">&#9746;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a Party other than the Registrant&nbsp;&nbsp;<FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#3f3f3f">&#9744;</FONT> </FONT></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Check the appropriate box: </FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Preliminary Proxy Statement</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Confidential, for Use of the Commission Only (as permitted by Rule <FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9746;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Definitive Proxy Statement</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Definitive Additional Materials</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Soliciting Material Pursuant to <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT></FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g87b92.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:22pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>EXELIXIS, INC. </B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>(Exact name of registrant as specified in its charter) </B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>(Name of Person(s) Filing Proxy Statement, if other than
the Registrant) </B></FONT></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Payment of Filing Fee (Check all boxes that apply): </FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9746;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT COLOR="#3f3f3f">No fee required.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT COLOR="#3f3f3f">Fee paid previously with preliminary materials.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT COLOR="#3f3f3f">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules <FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT></FONT></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #3f3f3f">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #3f3f3f">&nbsp;</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g282574g87b92.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">DEAR FELLOW STOCKHOLDERS, </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In 2021, Exelixis made substantial progress on its mission to help cancer patients recover stronger and live longer. Against the backdrop of the
continuing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the Exelixis team secured new regulatory approvals for CABOMETYX<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (cabozantinib), delivered strong commercial and
financial growth, and achieved numerous discovery and clinical development milestones integral to the buildout and rapid maturation of the company&#146;s pipeline. We, along with the rest of the Board at Exelixis, are incredibly proud of the entire
team&#146;s dedication and hard work throughout the year to continue upholding the company&#146;s core values&nbsp;&#150; to <I>Be Exceptional, Excel for Patients</I> and <I>Exceed Together</I>&nbsp;&#150; for themselves and for our patients, while
advancing the company&#146;s business objectives. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Exelixis team&#146;s accomplishments in 2021 included: </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:9pt"><FONT COLOR="#3f3f3f">Securing two new regulatory approvals from the U.S. Food and Drug Administration (FDA) for our
franchise molecule CABOMETYX as a treatment for forms of kidney and thyroid cancer;</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:9pt"><FONT COLOR="#3f3f3f">Driving continued commercial success, including a 45% year-over-year increase in cabozantinib
franchise net product revenues, a 50% year-over-year increase in CABOMETYX total prescription (TRx) growth, and an increase in CABOMETYX TRx market share for tyrosine kinase inhibitors (TKIs) in renal cell carcinoma to 35% at <FONT
STYLE="white-space:nowrap">year-end</FONT> (up from 30% at the start of 2021); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:9pt"><FONT COLOR="#3f3f3f">Completing or advanced enrollment in multiple potentially label-enabling
trials;</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:9pt"><FONT COLOR="#3f3f3f">Executing eight new or amended business development transactions, including two clinical trial
collaboration and supply agreements focused on XL092, our next-generation oral TKI;</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:9pt"><FONT COLOR="#3f3f3f">Progressing our product pipeline by initiating phase 1 trials for XB002 and XL102, <FONT
STYLE="white-space:nowrap">in-licensing</FONT> XL114 and receiving clearance from the FDA to move the compound into clinical development, and designating XB010 as a Development Candidate; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:9pt"><FONT COLOR="#3f3f3f">Expanding our team by 23%, adding the skill and experience required to support the future growth of
our pipeline and infrastructure, including our campus in Alameda and East Coast expansion. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">During 2021, we also made
important enhancements to our business and governance infrastructure, including critical investments to reinforce our cybersecurity policies and practices to keep pace with the increasingly digital nature of our operations and the mounting volume of
threats in the external cyber environment. In addition, having taken note of important trends related to environmental, social and governance (ESG) initiatives, we built up our capacity to evaluate and record metrics concerned with these aspects of
our business, and we plan to publish more detailed annual corporate sustainability reports beginning in 2022. Finally in December 2021, we appointed Jacqueline (Jacky) Wright to our Board of Directors. Jacky brings formidable experience working in
large, multinational corporations and has already made an impact on the Board&#146;s stewardship, especially in the critical area of digital transformation.</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Exelixis team&#146;s dedication and collective ability to maintain the company&#146;s culture of resilience continued to be critical components to our success in 2021 as we transitioned back to an
<FONT STYLE="white-space:nowrap">in-person</FONT> work environment. As a socially responsible company, it was also important for us to focus on our human capital management strategy and equity, diversity and inclusion (DEI) initiatives by
implementing a number of programs, hosting several DEI trainings, and hiring a new director of DEI. While there is still work to be done, we are proud of the progress we made in 2021 and remain committed to fostering a culture where each and every
employee feels a sense of belonging to the Exelixis team and our mission.</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In closing, Exelixis&#146; accomplishments in 2021 have
created the potential for additional eligible cancer patient communities to benefit from CABOMETYX and the investigational products in our growing pipeline, while also putting us in a solid position to deliver long-term revenue and earnings growth.
We remain committed to delivering exceptional results not just for our stockholders, but for all of our stakeholders&nbsp;&#150; including the broader oncology community and, most critically, patients and their families. We thank you for your
continued support.</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We hope you will join us for the Exelixis 2022 Annual Meeting of Stockholders, which will be held in a virtual
format on Wednesday, May&nbsp;25, 2022, beginning at 9:00 a.m. Pacific Time. Due to the ongoing public health impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and to support the health and well-being of our stockholders and
employees, we determined it would be appropriate to maintain the virtual format we used for last year&#146;s meeting. You will be able to view the meeting, submit questions and vote online at <I>www.virtualshareholdermeeting.com/EXEL2022</I>. The
following notice of our Annual Meeting </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">
contains details of the business to be conducted at the Annual Meeting, as well as information regarding how and when to vote.</FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">On a personal note, the current proxy process will be Dr.&nbsp;Charles Cohen&#146;s last as a member of the Exelixis Board of Directors: following
more than 26 years of service, he has decided not to stand for <FONT STYLE="white-space:nowrap">re-election</FONT> at the Annual Meeting. Dr.&nbsp;Cohen&#146;s contributions during his long tenure with Exelixis have been invaluable. The Board and
Exelixis alike have benefited from his experience, counsel, and passion for the company&#146;s mission. We are grateful for his decades of service and partnership, and wish him the very best. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Very truly yours, </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g282574g77n77.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;


<IMG SRC="g282574g74j57.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos, PhD</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Chair of the Board</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Charles Cohen, PhD</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Chair of the Compensation Committee</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g282574g87b92.jpg" ALT="LOGO">
</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1851 Harbor Bay Parkway </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Alameda, CA 94502 </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:22pt; font-family:Calibri"><FONT
 COLOR="#6d6d6d">N<SMALL>OTICE</SMALL> <SMALL>OF</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:22pt; font-family:Calibri"><FONT COLOR="#6d6d6d"><SMALL>OF</SMALL>
S<SMALL>TOCKHOLDERS</SMALL> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02">T<SMALL>O</SMALL> B<SMALL>E</SMALL> H<SMALL>ELD</SMALL> <SMALL>ON</SMALL> M<SMALL>AY</SMALL>&nbsp;25,
2022 </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To the Stockholders of Exelixis, Inc.: </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>NOTICE IS HEREBY GIVEN</B> that the 2022 Annual Meeting of Stockholders (Annual Meeting) of Exelixis, Inc., a Delaware corporation (Exelixis),
will be held on Wednesday, May&nbsp;25, 2022, at&nbsp;9:00 a.m., Pacific Time. The Annual Meeting will be a completely virtual meeting of stockholders, which will be conducted via live webcast. You will be able to attend the virtual
Annual&nbsp;Meeting, view our list of stockholders as of the record date, submit your questions and vote your shares online during the meeting by visiting <I>www.virtualshareholdermeeting.com/EXEL2022</I> and using your <FONT
STYLE="white-space:nowrap">16-digit</FONT> control number to enter the Annual Meeting. In addition, you may submit your questions and vote your shares online in advance of the Annual Meeting by visiting <I>www.proxyvote.com</I> and using your <FONT
STYLE="white-space:nowrap">16-digit</FONT> control number. The Annual Meeting will be held for the following purposes: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#fc7841">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To elect the eleven nominees for director named in the Proxy Statement accompanying this Notice of
Annual Meeting to hold office until the next annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#fc7841">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To ratify the selection by the Audit Committee of the Board of Directors of Ernst&nbsp;&amp; Young
LLP as Exelixis&#146; independent registered public accounting firm for the fiscal year ending December&nbsp;30, 2022. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#fc7841">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To amend and restate the Exelixis, Inc. 2017 Equity Incentive Plan to, among other things,
increase the number of shares authorized for issuance by 28,500,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#fc7841">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To approve, on an advisory basis, the compensation of Exelixis&#146; named executive officers, as
disclosed in the Proxy Statement accompanying this Notice of Annual Meeting. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#fc7841">5.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To conduct any other business properly brought before the meeting. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">These items of business are more fully described in the Proxy Statement accompanying this Notice of Annual Meeting. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">You will only be able to attend the virtual Annual Meeting by using your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided
on your Notice of Internet Availability of Proxy Materials (Notice of Availability), your proxy card<B> </B>or your voting instruction form in order to gain access to the virtual Annual Meeting. Therefore, it is important to retain your Notice of
Internet Availability of Proxy Materials or a copy of your proxy card or voting instruction form to enable you to gain access to the virtual Annual Meeting. If you are a beneficial owner of shares held in &#147;street name&#148; who did not receive
a <FONT STYLE="white-space:nowrap">16-digit</FONT> control number via email or on your Notice of Availability or voting instruction form, and you wish to attend the Annual Meeting, please follow the specific instructions from your broker, bank or
other stockholder of record, including any requirement to obtain a valid legal proxy. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The list of stockholders of record entitled to
vote at the virtual Annual Meeting will be available for 10 days prior to the Annual Meeting for any purpose germane to the Annual Meeting, between the hours of 9:00 a.m. and 5:00 p.m., Pacific Time, at our principal executive offices located at
1851 Harbor Bay Parkway, Alameda, California 94502 by contacting our Corporate Secretary. Due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, registered stockholders must make an appointment and must comply with our <FONT
STYLE="white-space:nowrap">COVID-19</FONT> protocols. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We are mailing to most of our stockholders a Notice of Availability instead of a
paper copy of our Proxy Statement and our Annual Report for the fiscal year ended December&nbsp;31, 2021 (Annual Report). The Notice of Availability contains instructions on how to access those documents over the Internet. The Notice of Availability
also contains instructions on how to request a paper copy of our proxy materials, including this Proxy Statement, our Annual Report and a form of proxy card or voting instruction form. All stockholders who do not receive a Notice of Availability
will receive a paper copy of the proxy materials by mail. We believe that this process will allow us to provide our stockholders with the information they need in a more timely manner, while reducing the environmental impact and lowering the costs
of printing and distributing our proxy materials. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The record date for the Annual Meeting is March&nbsp;28, 2022. Only stockholders of
record at the close of business on that date may vote at the meeting or any postponement or adjournment thereof. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="99%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER:1px solid #fc4c02; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.56em; margin-right:0.56em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Important
notice regarding the availability of proxy materials for the 2022 Annual Meeting of Stockholders to be held on May&nbsp;25, 2022, at 9:00 a.m., Pacific Time, via live webcast at </B><B><I>www.virtualshareholdermeeting.com/EXEL2022</I></B><B>. You
will need your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided on your Notice of Internet Availability of Proxy Materials, your proxy card or your voting instruction form in order to gain access to the virtual Annual
Meeting.</B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.56em; margin-right:0.56em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>The
Proxy Statement and Annual Report to stockholders are available at </B><B><I>www.exel-annualstockholdermeeting.com</I></B><B>.</B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.56em; margin-right:0.56em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>The Board of Directors recommends that you vote &#147;FOR&#148; Proposal Nos. <FONT
STYLE="white-space:nowrap">1-4</FONT> identified above.</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">By Order of the Board of Directors </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g282574g99m98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">JEFFREY J. HESSEKIEL </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Executive Vice President, General Counsel and Secretary </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alameda, California </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">April&nbsp;14, 2022 </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>YOUR VOTE IS IMPORTANT </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">WHETHER OR NOT YOU PLAN TO ATTEND THE VIRTUAL ANNUAL MEETING, TO ENSURE THAT YOU ARE REPRESENTED AT THE MEETING AND TO ENSURE THAT A QUORUM IS
PRESENT, WE URGE YOU TO VOTE YOUR PROXY ONLINE, BY TELEPHONE OR BY RETURNING A PROXY CARD BY MAIL AS INSTRUCTED IN THE PROXY MATERIALS. EVEN IF YOU HAVE VOTED BY PROXY, YOU MAY STILL VOTE IF YOU ATTEND THE VIRTUAL ANNUAL MEETING. PLEASE NOTE,
HOWEVER, THAT IF YOU HOLD YOUR SHARES THROUGH A BROKER, BANK OR OTHER NOMINEE, THEN THAT ENTITY IS THE STOCKHOLDER OF RECORD, AND YOU WILL NEED TO FOLLOW THE INSTRUCTIONS ON THE VOTING INSTRUCTION FORM THEY SEND TO YOU, AND THEY WILL VOTE YOUR
SHARES AS YOU DIRECT. </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1851 Harbor Bay Parkway </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Alameda, CA 94502 </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:22pt; font-family:Calibri"><FONT
 COLOR="#6d6d6d">P<SMALL>ROXY</SMALL> S<SMALL>TATEMENT</SMALL> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:21pt; font-family:Calibri"><FONT COLOR="#fc4c02">F<SMALL>OR</SMALL> <SMALL>THE</SMALL> 2022 A<SMALL>NNUAL</SMALL>
M<SMALL>EETING</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCKHOLDERS</SMALL> </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02">May&nbsp;25, 2022 </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Proposals to be voted on at the 2022 Annual Meeting of Stockholders </FONT></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-TOP:1px solid #fc4c02" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:1px solid #fc4c02" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#fc7841">&nbsp;&nbsp;1.</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">To elect the eleven nominees for director named in the Proxy Statement accompanying this Notice of Annual Meeting to hold office
until the next annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her death, resignation or removal.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#fc7841">&nbsp;&nbsp;2.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">To ratify the selection by the Audit Committee of the Board of Directors of Ernst&nbsp;&amp; Young LLP as Exelixis&#146; independent registered public
accounting firm for the fiscal year ending December&nbsp;30, 2022.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#fc7841">&nbsp;&nbsp;3.</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">To amend and restate the Exelixis, Inc. 2017 Equity Incentive Plan to, among other things, increase the number of shares authorized
for issuance by 28,500,000 shares.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#fc7841">&nbsp;&nbsp;4.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">To approve, on an advisory basis, the compensation of Exelixis&#146; named executive officers, as disclosed in the Proxy Statement accompanying this
Notice of Annual Meeting.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #fc4c02" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#fc7841">&nbsp;&nbsp;5.</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #fc4c02" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">To conduct any other business properly brought before the meeting.</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="99%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #fc4c02; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; margin-right:0.50em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Important
notice regarding the availability of proxy materials for the 2022 Annual Meeting of Stockholders to be held on May&nbsp;25, 2022, at 9:00 a.m., Pacific Time, via live webcast at </B><B><I>www.virtualshareholdermeeting.com/EXEL2022</I></B><B>. You
will need your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided on your Notice of Internet Availability of Proxy Materials, your proxy card or your voting instruction form in order to gain access to the virtual Annual
Meeting.</B></FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>The Proxy Statement and
Annual Report to stockholders are available at </B><B><I>www.exel-annualstockholdermeeting.com</I></B><B>.</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We intend to mail the Notice of Internet Availability of Proxy Materials relating to the Annual
Meeting on or about April&nbsp;14, 2022 to all stockholders of record entitled to vote at the Annual Meeting. </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Table of Contents </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc"></A>TABLE OF CONTENTS </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_1">Questions and Answers about these Proxy Materials and Voting</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>1</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_2">Proposal 1: Election of Directors</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>8</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_3">Corporate Governance</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_4">Board Committees and Meetings</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_5">Annual Meeting; Attendance</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_6">Compensation of Directors </A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>27</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_7">Director Compensation Table </A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_8">Proposal 2: Ratification of Selection of Independent Registered Public Accounting Firm</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>31</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_9">Report of the Audit Committee</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>33</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_10">Proposal 3: Amendment and Restatement of the Exelixis, Inc. 2017 Equity Incentive Plan</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>34</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_11">Proposal 4: Advisory Vote on the Compensation of the Named Executive Officers</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>50</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_12">Required Vote and Board of Directors Recommendation
</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_13">Security Ownership of Certain Beneficial Owners and Management</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>51</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_14">Information about our Executive Officers</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>54</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_15">Compensation of Executive Officers</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>56</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_16">Compensation Discussion and Analysis</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">56</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_17">Executive Summary</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">56</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_18">Objectives of the Compensation Program</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_19">How We Determine Executive Compensation</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_20">Compensation Elements</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_21">Compensation Mix</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_22">2021 Compensation Decisions</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_23">Other Compensation Information</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">77</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_24">Compensation Policies and Practices as They Relate to Risk Management
</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_25">Summary of Compensation</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_26">Grants of Plan-Based Awards</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">82</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_27">Compensation Arrangements</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">83</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_28">Outstanding Equity Awards at Fiscal <FONT
STYLE="white-space:nowrap">Year-End</FONT></A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_29">Option Exercises and Stock Vested</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">88</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_30">Potential Payments Upon Termination or Change in
Control</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">89</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc282574_31">CEO Pay Ratio</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">92</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_32">Compensation Committee Report</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>94</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_33">Compensation Committee Interlocks and Insider Participation</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>94</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_34">Delinquent Section&nbsp;16(a) Reports</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>94</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_35">Certain Relationships and Related Party Transactions</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>95</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_36">Householding of Proxy Materials</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>95</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_37">Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT></A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>95</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc282574_38">Other Matters</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>96</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">i</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proxy Statement&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Questions and Answers about these Proxy Materials and Voting </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_1"></A>QUESTIONS AND ANSWERS ABOUT THESE PROXY
MATERIALS AND VOTING </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Why am I receiving these materials? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We have made these materials available to you on the Internet or, upon your request, have delivered printed versions of these materials to you by
mail because the Board of Directors (the Board), of Exelixis, Inc. (sometimes referred to as &#147;we,&#148; &#147;us,&#148; the &#147;company&#148; or &#147;Exelixis&#148;) is soliciting your proxy to vote at the 2022 Annual Meeting of Stockholders
(Annual Meeting), including at any adjournments or postponements of the meeting. The virtual Annual Meeting will be held on Wednesday, May&nbsp;25, 2022, at 9:00 a.m., Pacific Time, via live webcast at
<I>www.virtualshareholdermeeting.com/EXEL2022</I>. We invite you to attend the virtual Annual Meeting to vote on the proposals described in this Proxy Statement, and you will need your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number
provided on your Notice of Internet Availability of Proxy Materials (described below), your proxy card or your voting instruction form in order to gain access to the virtual Annual Meeting. Therefore, it is important to retain your Notice of
Internet Availability of Proxy Materials or a copy of your proxy card or voting instruction form to enable you to gain access to the virtual Annual Meeting. However, you do not need to attend the virtual Annual Meeting to vote your shares. Instead,
you may simply complete, sign and return a proxy card, or follow the instructions below to vote your shares over the telephone or on the Internet. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">We intend to send or make available these materials to stockholders on April&nbsp;14, 2022. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Why is the Annual
Meeting being held as a virtual Annual Meeting? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Due to concerns regarding the <FONT STYLE="white-space:nowrap">COVID-19</FONT>
pandemic and to assist in protecting the health and well-being of our stockholders and employees, the Annual Meeting will be held virtually via live webcast on the Internet. After utilizing a virtual format for our 2020 Annual Meeting of
Stockholders and 2021 Annual Meeting of Stockholders, we have designed a similar virtual format for the Annual Meeting to ensure that our stockholders who attend virtually will be afforded the same rights and opportunities to participate as they
would at an <FONT STYLE="white-space:nowrap">in-person</FONT> meeting. Accordingly, as stockholders from any location in the world and at no cost, you will be able to listen, submit your questions and vote your shares online at
<I>www.virtualshareholdermeeting.com/EXEL2022</I> by using your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided on your Notice of Internet Availability of Proxy Materials, your proxy card or your voting instruction form that
accompanied your proxy materials. In addition, you may submit your questions and vote your shares online in advance of the meeting by visiting <I>www.proxyvote.com</I> and using your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The live webcast will begin promptly at 9:00 a.m., Pacific Time. We encourage you to access the meeting prior to the start time, as
you should allow ample time for the <FONT STYLE="white-space:nowrap">check-in</FONT> procedures. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What is included in these proxy
materials? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">These proxy materials include: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The Notice of Annual Meeting; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The Proxy Statement for the Annual Meeting; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended
December&nbsp;31, 2021, as filed with to the Securities and Exchange Commission (SEC) on February&nbsp;18, 2022 (Annual Report). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">If you requested printed versions by mail, these proxy materials also include the proxy card or voting instruction form for the virtual Annual Meeting. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Why did I receive a notice in the mail regarding Internet availability of proxy materials instead of a full set of printed proxy materials?
</B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Pursuant to rules adopted by the SEC, we have elected to use the Internet as the primary means of furnishing proxy materials to
our stockholders this year. This method allows us to deliver the proxy materials to you more quickly, lowers our costs significantly and helps to conserve natural resources. Accordingly, we are sending a Notice of Internet Availability of Proxy
Materials (Notice of Availability) to our stockholders who have not asked us to provide proxy materials in printed form. All stockholders receiving a Notice of Availability can request a printed set of proxy materials. Moreover, all stockholders can
access the proxy materials at <I>www.exel-annualstockholdermeeting.com</I>, irrespective of whether they receive a Notice of Availability or a printed copy of the proxy materials. Instructions on how to access the proxy materials on the Internet or
how to request a printed copy may be found in the Notice of Availability and in this Proxy Statement. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">1</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In addition, a
stockholder may ask to receive proxy materials in printed form by mail or electronically by email on an ongoing basis. We encourage stockholders to take advantage of the option to receive proxy materials electronically by email to help reduce the
environmental impact of our annual meeting and to reduce costs associated with the physical printing and mailing of materials. If you choose to receive future proxy materials by email, you will receive an email message next year with instructions
containing a link to those materials and a link to the proxy voting website. Your election to receive proxy materials by email will remain in effect until you terminate it. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How can I access the list of stockholders of record? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The list of stockholders of record entitled to vote at the virtual Annual Meeting will be available for 10 days prior to the Annual Meeting for
any purpose germane to the Annual Meeting, between the hours of 9:00 a.m. and 5:00 p.m., Pacific Time, at our principal executive offices located at 1851 Harbor Bay Parkway, Alameda, California 94502 by contacting our Corporate Secretary. Due to the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, registered stockholders must make an appointment and must comply with our <FONT STYLE="white-space:nowrap">COVID-19</FONT> protocols. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The list of stockholders of record will also be available at and through the conclusion of the Annual Meeting via the virtual meeting website at
<I>www.virtualshareholdermeeting.com/EXEL2022</I>. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Who may vote at the Annual Meeting? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Only stockholders of record at the close of business on March&nbsp;28, 2022 (the Record Date) will be entitled to vote at the virtual Annual
Meeting. On the Record Date, there were 320,182,340 shares of common stock outstanding and entitled to vote. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02">Stockholder of Record:
Shares Registered in Your Name </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If on March&nbsp;28, 2022, your shares were registered directly in your name with our transfer agent,
Computershare Trust Company, N.A., then you are a stockholder of record. As a stockholder of record, you may vote at the virtual Annual Meeting or vote by proxy. Whether or not you plan to attend the virtual Annual Meeting, we urge you to vote by
proxy over the telephone or on the Internet as instructed below, or complete and mail the proxy card if you received printed materials. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#fc4c02">Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Stockholder of Record (<I>i.e.</I>, &#147;Street Name&#148;) </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">If on March&nbsp;28, 2022, your shares were held in an account at a brokerage firm, bank, dealer, or other similar organization, then you are the beneficial owner of shares held in &#147;street name,&#148; and these proxy materials
are being forwarded to you by that organization. The organization holding your shares is considered to be the stockholder of record for purposes of voting at the virtual Annual Meeting. As a beneficial owner, you have the right to direct your
broker, bank or other stockholder of record regarding how to vote the shares in your account, and we invite you to attend the virtual Annual Meeting. Many stockholders of record will provide you with a
<FONT STYLE="white-space:nowrap">16-digit</FONT> control number via email or in your Notice of Availability or voting instruction form in order to attend and vote your shares at the virtual Annual Meeting. If you did not receive a <FONT
STYLE="white-space:nowrap">16-digit</FONT> control number via email or on your Notice of Availability or voting instruction form, you will be provided with other instructions from your broker, bank or other stockholder of record that must be
followed, including any requirement to obtain a valid legal proxy, in order for your broker, bank or other stockholder of record to vote your shares per your instructions or to attend and vote your shares at the Annual Meeting. Many brokers, banks
or other stockholders of record allow a stockholder to obtain a valid legal proxy either online or by mail, and we recommend that you contact your broker, bank or other stockholder of record to do so. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What am I voting on? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">There are four matters scheduled for a vote at the virtual Annual Meeting. They are as follows: </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Election of the eleven nominees for director named herein to hold office until the next annual
meeting of stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Ratification of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm
for the fiscal year ending December&nbsp;30, 2022; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Approval of the amendment and restatement of the Exelixis, Inc. 2017 Equity Incentive Plan (2017
Plan) to, among other things, increase the number of shares authorized for issuance by 28,500,000 shares; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Advisory approval of the compensation of our named executive officers, as disclosed in this Proxy
Statement. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">2</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proxy Statement&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Questions and Answers about these Proxy Materials and Voting </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How do I vote? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Whether or not you plan to attend the virtual Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend
the virtual Annual Meeting and vote even if you have already voted by proxy. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02">Stockholder of Record: Shares Registered in Your Name
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a stockholder of record, you have four ways to vote. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g59s99.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>At&nbsp;Virtual&nbsp;Meeting</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc7841">&#155;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">To vote at the virtual Annual Meeting, follow the instructions at<I> www.virtualshareholdermeeting.com/EXEL2022</I>. You will need your
<FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided on your Notice of Availability, your proxy card or your voting instruction form in order to gain access to the virtual Annual Meeting.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g01w73.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Via&nbsp;Internet</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc7841">&#155;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To vote on the Internet, go to <I>www.proxyvote.com</I>
and follow the instructions provided in the Notice of Availability. You will need your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided on your Notice of Availability, your proxy card or your voting instruction form in order
to vote your shares in advance of the meeting. Your vote must be received by 11:59 p.m., Eastern Time, on May&nbsp;24, 2022, to be counted.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g28x28.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>By&nbsp;Telephone</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc7841">&#155;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To vote by telephone, follow the instructions and call
the number provided in the proxy materials to transmit your voting instructions. Your vote must be received by 11:59 p.m. Eastern Time, on May&nbsp;24, 2022, to be counted.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g90v60.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>By Mail</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc7841">&#155;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To vote by mail, follow the instructions provided in the
proxy materials, request a paper copy of the proxy materials and then complete, sign and date the proxy card enclosed with the paper copy of the proxy materials and return it promptly in the envelope that will be provided. If you return your signed
proxy card to us before the Annual Meeting, we will vote your shares as you direct.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc7841">Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Stockholder of Record </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a beneficial owner of shares registered in the name of your broker, bank, or other stockholder of record, you should have received the
Notice of Availability containing voting instructions from that organization rather than from us. You must follow these instructions for your bank, broker or other stockholder of record to vote your shares per your instructions. Alternatively, many
brokers and banks provide the means to grant proxies or otherwise instruct them to vote your shares by telephone and via the Internet, including by providing you with a <FONT STYLE="white-space:nowrap">16-digit</FONT> control number via email or on
your Notice of Availability or your voting instruction form. If your shares are held in an account with a broker, bank or other stockholder of record providing such a service, you may instruct them to vote your shares by telephone (by calling the
number provided in the proxy materials) or over the Internet as instructed by your broker, bank or other stockholder of record. If you did not receive a <FONT STYLE="white-space:nowrap">16-digit</FONT> control number via email or on your Notice of
Availability or voting instruction form, and you wish to vote prior to or at the virtual Annual Meeting, you must follow the instructions from your broker, bank or other stockholder of record, including any requirement to obtain a valid legal proxy.
Many brokers, banks and other stockholders of record allow a beneficial owner to obtain a valid legal proxy either online or by mail, and we recommend that you contact your broker, bank or other stockholder of record to do so. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="99%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #fc4c02; padding-left:8pt; padding-right:2pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.30em; margin-right:0.50em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>We provide
Internet proxy voting to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your Internet
access, such as usage charges from Internet access providers and telephone companies.</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How many votes do I have? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">On each matter to be voted upon, you have one vote for each share of common stock you own as of the Record Date, March&nbsp;28, 2022. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How are proxies voted? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All shares represented by valid proxies received prior to the taking of the vote at the Annual Meeting will be voted and, where a stockholder
specifies by means of a proxy a choice with respect to any matter to be acted upon, the shares will be voted in accordance with the stockholder&#146;s instructions. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">3</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>If I am a
stockholder of record, what happens if I return a proxy card but do not make specific choices? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a stockholder of record
and you return a signed and dated proxy card without marking any voting selections, your shares will be voted on the proposals as follows: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;For&#148; the election of Drs. Freire, Garber, Marchesi, Morrissey, Papadopoulos, Poste and
Willsey, Messrs. Feldbaum and Wyszomierski and Mses. Smith and Wright, as described in Proposal 1; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;For&#148; the ratification of our selection of Ernst&nbsp;&amp; Young LLP as our
independent registered public accounting firm for the fiscal year ending December&nbsp;30, 2022, as described in Proposal 2; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;For&#148; the approval of the amendment and restatement of the 2017 Plan to, among other
things, increase the number of shares authorized for issuance by 28,500,000 shares, as described in Proposal 3; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;For&#148; the advisory approval of the compensation of our named executive officers, as
described in Proposal 4. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If any other matter is properly presented at the Annual Meeting, your proxyholder (one of
the individuals named on your proxy card), if permitted, will vote your shares using his best judgment. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>If I am a holder of
record and I do not vote, what happens? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a holder of record and do not vote, then your shares will not be voted at the
Annual Meeting. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx282574_1601"></A>If I am a beneficial owner of shares held in street name and I do not provide my
broker or bank with voting instructions, what happens? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a beneficial owner of shares registered in the name of your
broker, bank or other stockholder of record and you do not provide the broker, bank or other stockholder of record holding your shares with voting instructions, and your broker or bank has not provided you with the means vote your shares at the
Annual Meeting, including by providing you with a <FONT STYLE="white-space:nowrap">16-digit</FONT> control number via email or on your Notice of Availability or your voting instruction form, your broker, bank or other stockholder of record will
determine if it has the discretionary authority to vote on the particular matter. If you are a beneficial owner whose shares are held of record by a broker and you do not provide voting instructions and you are unable to vote your shares at the
Annual Meeting, your shares will not be voted on any proposal on which the broker does not have discretionary authority to vote. This is called a &#147;broker <FONT STYLE="white-space:nowrap">non-vote.&#148;</FONT> In these cases, the broker can
register your shares as being present at the Annual Meeting for purposes of determining the presence of a quorum, but will not be able to vote on those matters for which specific authorization is required under the rules of the New York Stock
Exchange. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a beneficial owner whose shares are held of record by a broker, your broker has discretionary voting authority
under the rules of the New York Stock Exchange to vote your shares on Proposal No.&nbsp;2 (the ratification of the appointment of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending
December&nbsp;30, 2022), even if your broker does not receive voting instructions from you. However, your broker does not have discretionary authority to vote on Proposal No.&nbsp;1, Proposal No.&nbsp;3 or Proposal No.&nbsp;4 without voting
instructions from you, in which case a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will occur, and your shares will not be voted on Proposal No.&nbsp;1, Proposal No.&nbsp;3 or Proposal No.&nbsp;4. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Who is paying for this proxy solicitation? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">We are soliciting proxies and will bear the entire cost of soliciting proxies, including the preparation, printing and mailing of the Notice of Availability, the Notice of Annual Meeting, the Proxy Statement, the proxy card and any
additional information furnished to stockholders. We have engaged Morrow&nbsp;Sodali LLC, located at 470 West Ave, Stamford, Connecticut&nbsp;06902, to assist in the solicitation of proxies from shareholders for a fee of $13,000 plus reimbursement
of customary <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses. Copies of solicitation materials will be furnished to banks, brokerage houses, fiduciaries and custodians holding in their names
shares of our common stock beneficially owned by others to forward to such beneficial owners. We may reimburse persons representing beneficial owners of our common stock for their costs of forwarding solicitation materials to such beneficial owners.
Original solicitation of proxies by mail may be supplemented by telephone, telegram or personal solicitation by our directors, officers or other regular employees. No additional compensation will be paid to directors, officers or other regular
employees for such services. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What does it mean if I receive more than one Notice of Availability or proxy card? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you receive more than one Notice of Availability or proxy card, your shares are registered in more than one name or are registered in
different accounts. Please follow the instructions on each Notice of Availability or proxy card to ensure that all of your shares are voted. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">4</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proxy Statement&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Questions and Answers about these Proxy Materials and Voting </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Can I change my vote after submitting my proxy? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. You may revoke your proxy in the following ways:
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc7841">Stockholder of Record: Shares Registered in Your Name </FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Your proxy may be revoked by filing with the Secretary of Exelixis at our principal executive
office, Exelixis, Inc., 1851&nbsp;Harbor Bay Parkway, Alameda, California 94502, either (1)&nbsp;a written notice of revocation or (2)&nbsp;a duly executed proxy card bearing a later date. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Your proxy may also be revoked by granting a subsequent proxy by telephone or on the Internet
(your latest telephone or Internet proxy is the one that is counted). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Your proxy may also be revoked by attending the virtual Annual Meeting and voting online via the
live webcast. Attendance at the Annual Meeting will not, by itself, revoke your proxy. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc7841">Beneficial Owner: Shares
Registered in the Name of Broker, Bank or Other Stockholder of Record </FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">If your shares are held by your broker or bank as nominee or agent, you should follow the
instructions provided by your broker or bank to revoke any prior voting instructions, which may include attending the virtual Annual Meeting and voting online via the live webcast. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What is the quorum requirement for the Annual Meeting? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">A majority of the outstanding shares entitled to vote at the virtual Annual Meeting must be present or represented by proxy at the Annual Meeting
to hold a valid meeting. This is called a &#147;quorum.&#148; As this is a virtual Annual Meeting, holders of record attending via the live webcast will be deemed to be present at the virtual Annual Meeting. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a stockholder of record, your shares will be counted towards the quorum only if you vote at the virtual Annual Meeting or have
properly voted by proxy on the Internet, by telephone or by submitting a proxy card by mail. You may vote &#147;For,&#148; &#147;Against&#148; or &#147;Abstain&#148; with respect to Proposal Nos. 1, 2, 3 and 4. Abstentions will be counted towards
the number of shares considered to be present at the meeting for purposes of determining whether a quorum is present. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a
beneficial owner holding your shares in &#147;street name&#148; then only the broker, bank or other stockholder of record can vote your shares unless you obtain a valid legal proxy from the broker, bank or other stockholder of record, or are
otherwise provided with a separate means to vote your shares (such as a <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided via email or on your Notice of Availability or voting instruction form). See &#147;<A HREF="#tx282574_1601">If
 I am a beneficial owner of shares held in street name and I do not provide my broker or bank with voting instructions, what happens?</A>&#148; above. Shares represented by &#147;broker <FONT STYLE="white-space:nowrap">non-votes&#148;</FONT> will be
counted in determining whether there is a quorum present. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Votes will be counted by the inspector of election appointed for the Annual
Meeting. If there is no quorum, either the chairperson of the Annual Meeting or the holders of a majority of shares present or represented by proxy at the Annual Meeting may adjourn the Annual Meeting to another date. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How many votes are needed to approve each proposal, how are votes counted, and how are abstentions and broker
<FONT STYLE="white-space:nowrap">non-votes</FONT> treated? </B></FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><B><I>Proposal <FONT STYLE="white-space:nowrap">1-Election</FONT> of Directors:</I></B> Directors
in an uncontested election, such as this one, are elected by a majority of the votes cast. Accordingly, each of the eleven nominees must receive &#147;For&#148; votes from the holders of a majority of the votes cast with respect to such director
(i.e., the number of shares voted &#147;For&#148; a director must exceed the number of shares voted &#147;Against&#148; that director). Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are not counted for purposes of electing
directors and will have no effect on the results of this vote. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><B><I>Proposal <FONT STYLE="white-space:nowrap">2-Ratification</FONT> of
Ernst</I></B><B><I></I></B><B><I>&nbsp;&amp; Young LLP: </I></B>The affirmative vote of a majority of shares present or represented by proxy at the Annual Meeting and entitled to vote on the proposal is required to ratify the selection of
Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;30, 2022. Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the same effect as votes
against the proposal. Broker <FONT STYLE="white-space:nowrap">non-votes,</FONT> if any, will have no effect and will not be counted towards the vote total. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><B><I>Proposal <FONT STYLE="white-space:nowrap">3-Approval</FONT> of the Amendment and
Restatement of the. 2017 Plan: </I></B>The affirmative vote of a majority of shares present or represented by proxy at the Annual Meeting and entitled to vote on the proposal is required to
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">5</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">amend and restate the 2017 Plan to, among other things, increase the number of shares authorized for issuance by 28,500,000 shares. Abstentions will be counted toward the tabulation of votes cast
on the proposal and will have the same effect as votes against this proposal. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect and will not be counted towards the vote total. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><B><I>Proposal <FONT STYLE="white-space:nowrap">4-Advisory</FONT> Vote on Executive
Compensation:</I></B> The affirmative vote of a majority of shares present or by represented proxy at the Annual Meeting and entitled to vote on the proposal is required to approve the <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory
vote on executive compensation. Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the same effect as votes against this proposal. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no
effect and will not be counted towards the vote total. Since the vote is advisory, it is not binding on the Board or on us. Nevertheless, the views expressed by our stockholders, whether through this vote or otherwise, are very important to the
Board and the management team and, accordingly, the Compensation Committee and Board intend to consider the results of this vote in making determinations in the future regarding executive compensation arrangements. Your vote will serve as an
additional tool to guide the Compensation Committee and Board as they continue to improve the alignment of our executive compensation programs with business objectives and performance and with the interests of our stockholders.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Do I have dissenters&#146; rights? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">No. We are organized as a corporation under Delaware law. Under the Delaware General Corporation Law, our stockholders are not entitled to
dissenters&#146; rights with respect to any of the proposals set forth in this Proxy Statement and we will not independently provide the stockholders with any such rights. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How can I find out the results of the voting at the Annual Meeting? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We expect to announce preliminary voting results at the Annual Meeting. In addition, final voting results will be published in a current report
on Form <FONT STYLE="white-space:nowrap">8-K</FONT> that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a Form <FONT STYLE="white-space:nowrap">8-K</FONT> within
four business days after the Annual Meeting, we intend to file a <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> to publish preliminary results and, within four business days after the final results are known to us, file an additional Form <FONT
STYLE="white-space:nowrap">8-K</FONT> to publish the final results. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Will other matters be voted on at the Annual Meeting?
</B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We are not aware of any matters to be presented at the Annual Meeting other than those described in this Proxy Statement. If any
other matters not described in the Proxy Statement are properly presented at the meeting, proxies will be voted in accordance with the best judgment of the proxyholders. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What proxy materials are available on the Internet? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">This Proxy Statement and our Annual Report are available at <I>www.exel-annualstockholdermeeting.com</I>. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What is the deadline for submitting stockholder proposals for the 2023 Annual Meeting? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To be considered for inclusion in the 2023 proxy materials, your proposal must be submitted in writing by December&nbsp;15, 2022, to
Exelixis&#146; Secretary at Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, California 94502, and you must comply with all applicable requirements of Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> promulgated under the Securities Exchange Act
of 1934, as amended (Exchange Act). However, if our 2023 Annual Meeting of Stockholders is held before April&nbsp;25, 2023, or after June&nbsp;24, 2023, then the deadline will be a reasonable time prior to the time that we make our proxy materials
available to our stockholders, either online or in printed form. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you wish to submit a proposal or nominate a director at the 2023
Annual Meeting of Stockholders, but you are not requesting that your proposal or nomination be included in next year&#146;s proxy materials, you must submit your proposal in writing, in the manner set forth in our Bylaws, to Exelixis&#146; Secretary
at Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, California 94502, to be received no earlier than the close of business on February&nbsp;24, 2023, and no later than the close of business on March&nbsp;26, 2023. However, if our 2023 Annual
Meeting of Stockholders is held before April&nbsp;25, 2023, or after June&nbsp;24, 2023, then you must notify Exelixis&#146; Secretary, in writing, not earlier than the close of business on the 90th day prior to the date of the 2023 Annual Meeting
of Stockholders and not later than the close of business on the later of (i)&nbsp;the 60th day prior to the date of the 2023 Annual Meeting of Stockholders or (ii)&nbsp;if we publicly announce the date of the 2023 Annual Meeting of Stockholders
fewer than 70 days prior to the date of the 2023 Annual Meeting of Stockholders, the 10th day </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">6</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proxy Statement&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Questions and Answers about these Proxy Materials and Voting </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">following the day that we first make such public announcement of the date
of the 2023 Annual Meeting of Stockholders. We also advise you to review our Bylaws, which contain additional requirements about advance notice of stockholder proposals and director nominations. The chairperson of the 2023 Annual Meeting of
Stockholders may determine, if the facts warrant, that a matter has not been properly brought before the meeting and, therefore, may not be considered at the meeting. In addition, unless prohibited by Rule
<FONT STYLE="white-space:nowrap">14a-4(c)</FONT> promulgated under the Exchange Act, our management will have discretionary authority to vote all shares for which it has proxies for any such stockholder proposal or director nomination, including in
opposition to such stockholder proposal or director nomination. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How may I obtain a printed copy of the Proxy Materials?
</B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Instructions on how to obtain a printed copy of the proxy materials are set forth in the Notice of Availability. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc7841"><B>Forward-Looking Statements </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">This Proxy Statement contains forward-looking statements, including, without limitation, statements related to: Exelixis&#146; plans for future growth of its pipeline and infrastructure, including at the Alameda campus and East
Coast expansion; Exelixis&#146; plans to publish annual corporate sustainability reports beginning in 2022; Exelixis&#146; commitment to fostering a culture of inclusion and belonging; Exelixis&#146; belief that its 2021 accomplishments have created
the potential for additional eligible cancer patient communities to benefit from CABOMETYX and the investigational products in Exelixis&#146; growing pipeline, while also putting the company in a solid position to deliver long-term revenue and
earnings growth; Exelixis&#146; expectations that its employees and partners will commit to the highest standards of ethical behavior and maintain values and principles that reflect both global awareness and sustainability; Exelixis&#146; dedication
of financial resources to offer patients high-quality cancer treatments and commitment to providing patients with access to Exelixis medicines; Exelixis&#146; strategies for quality monitoring and compliance in developing its products;
Exelixis&#146; potential to attain future environmental stability; Exelixis&#146; ongoing efforts towards the achievement of key priorities and anticipated milestones for 2022 and beyond; Exelixis&#146; ability to execute on potential future
strategic initiatives; Exelixis&#146; plans for the continued buildout of its Digital Transformation function to further enhance its information technology infrastructure; potential shifts in healthcare regulations applicable to Exelixis&#146;
business; Exelixis&#146; plans for continued development of cabozantinib, XL092, XB002, XL102 and other current and future development candidates, as well for the evaluation and development of new INDs and collaboration management; and other
statements that are not historical fact. Any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and are based upon Exelixis&#146; current plans, assumptions,
beliefs, expectations, estimates and projections. Forward-looking statements involve risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in the forward-looking statements as a result of
these risks and uncertainties, which include, without limitation: the degree of market acceptance of CABOMETYX and other Exelixis products in the indications for which they are approved and in the territories where they are approved, and Exelixis
and its partners&#146; ability to obtain or maintain coverage and reimbursement for these products; the effectiveness of CABOMETYX and other Exelixis products in comparison to competing products; the level of costs associated with Exelixis&#146;
commercialization, research and development, in-licensing or acquisition of product candidates, and other activities; Exelixis&#146; ability to maintain and scale adequate sales, marketing, market access and product distribution capabilities for its
products or to enter into and maintain agreements with third parties to do so; the availability of data at the referenced times; the potential failure of cabozantinib and other Exelixis product candidates, both alone and in combination with other
therapies, to demonstrate safety and/or efficacy in clinical testing; uncertainties inherent in the drug discovery and product development process; Exelixis&#146; dependence on its relationships with its collaboration partners, including their
pursuit of regulatory approvals for partnered compounds in new indications, their adherence to their obligations under relevant collaboration agreements and the level of their investment in the resources necessary to complete clinical trials or
successfully commercialize partnered compounds in the territories where they are approved; complexities and the unpredictability of regulatory review and approval processes in the U.S. and elsewhere; Exelixis&#146; continuing compliance with
applicable legal and regulatory requirements; unexpected concerns that may arise as a result of the occurrence of adverse safety events or additional data analyses of clinical trials evaluating cabozantinib and other Exelixis products;
Exelixis&#146; dependence on third-party vendors for the development, manufacture and supply of its products and product candidates; Exelixis&#146; ability to protect its intellectual property rights; market competition, including the potential for
competitors to obtain approval for generic versions of Exelixis&#146; marketed products; changes in economic and business conditions; and other factors discussed under the caption &#147;Risk Factors&#148; in Exelixis&#146; Annual Report on Form 10-K
filed with the SEC on February 18, 2022, and in Exelixis&#146; future filings with the SEC. All forward-looking statements in this Proxy Statement are based on information available to Exelixis as of the date of this Proxy Statement, and Exelixis
undertakes no obligation to update or revise any forward-looking statements contained herein, except as required by law. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">7</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_2"></A>P<SMALL>ROPOSAL</SMALL> 1 </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#6d6d6d">E<SMALL>LECTION</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our Certificate of Incorporation and Bylaws provide for the annual election of each director. There are currently twelve directors on the Board,
and eleven directors have been nominated and are standing for <FONT STYLE="white-space:nowrap">re-election</FONT> this year. Dr.&nbsp;Cohen is not standing <FONT STYLE="white-space:nowrap">for&nbsp;re-election&nbsp;at</FONT> the Annual Meeting. As a
result, effective at the Annual Meeting, the number of directors constituting the Board will be reduced from twelve to eleven. We acknowledge with gratitude Dr.&nbsp;Cohen&#146;s long-term service on the Board and his invaluable contributions to
Exelixis. The Board&#146;s nominees for director are: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5" STYLE="BORDER-TOP:2.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Director Nominees</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Age</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Position</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Director<BR>Since</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Carl B. Feldbaum,
Esq.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">78</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2007</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Maria C. Freire,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">67</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2018</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alan M. Garber, M.D.,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">66</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2005</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent T. Marchesi,
M.D., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">86</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2001</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">61</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">President&nbsp;and Chief&nbsp;Executive&nbsp;Officer</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2010</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">73</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Chair&nbsp;of&nbsp;the&nbsp;Board</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1994</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George Poste, DVM,
Ph.D., FRS</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">77</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2004</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie Anne
Smith</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">51</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Lance Willsey,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">60</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1997</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jacqueline
Wright</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">62</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2021</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jack L.
Wyszomierski</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">66</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2004</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If elected at the Annual Meeting, each of these director nominees would serve until the next annual meeting of
stockholders and until the director&#146;s successor is elected and has qualified, or, if sooner, until the director&#146;s death, resignation or removal. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">As this is an uncontested election, each director will be elected by a majority of the votes cast with respect to that director. A majority of the votes cast means that the number of shares voted &#147;for&#148; a director must
exceed the number of votes cast &#147;against&#148; that director. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the election of directors. If any nominee becomes unavailable for election as a result
of an unexpected occurrence, your shares will be voted for the election of such substitute nominee as the Board, after receiving the recommendation of the Nominating and Corporate Governance Committee of the Board, may propose. Each person nominated
for election has agreed to serve if elected, and we have no reason to believe that any nominee will be unable to serve. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Majority
Voting Standard and Resignation Policy </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our Corporate Governance Guidelines require that all director nominees set forth in this Proxy
Statement have tendered an irrevocable resignation as a director conditioned upon: (i)&nbsp;such director failing to receive a majority of the votes cast at the Annual Meeting; and (ii)&nbsp;acceptance by the Board of such resignation. If a director
nominee who is serving as a director at the time of the election does not receive a majority of the votes cast at the Annual Meeting, then the Board will take the following actions: </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f">The Nominating and Corporate Governance Committee will act to determine whether to recommend to the
Board that it accept the director&#146;s conditional resignation. In making their respective decisions, the Nominating and Corporate Governance Committee and the Board will evaluate the best interests of Exelixis and its stockholders and shall
consider all factors and information deemed relevant by the respective body. The director who tenders his or her conditional resignation shall not participate in the Nominating and Corporate Governance Committee&#146;s recommendation or Board action
regarding whether to accept the conditional resignation of such director. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f">The Board will act on the Nominating and Corporate Governance Committee&#146;s recommendation
within ninety days following certification of the stockholder vote. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f">If the Board determines not to accept the conditional resignation of a director, the Board will
promptly disclose its decision-making process and decision to reject the conditional resignation in a Form <FONT STYLE="white-space:nowrap">8-K</FONT> furnished to the SEC. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">8</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Election of Directors </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Board Independence, Diversity and Skills </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Board regularly evaluates the skills and experiences that it believes are desirable to be represented on the Board and best align with our strategic vision and business and operations. Below are certain qualifications, skills
and experiences of our current directors that contribute the Board&#146;s effectiveness as a whole. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g03a55.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In addition, set forth below is biographical information for each nominee for election to our Board at the
Annual Meeting. Incorporated within each biography is a description of the specific qualifications, skills and experiences of each nominee that led our Board to conclude that the individual should serve as a director as of the date of this Proxy
Statement. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">9</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="tx282574_1007"></A>Director Nominees </FONT></P>
<P STYLE="line-height:3.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Carl B. Feldbaum, Esq.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>President Emeritus, Biotechnology Innovation Organization</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2007</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 78</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Mr.&nbsp;Feldbaum should continue to serve as a director of Exelixis due to his training as an attorney, his knowledge and experience with respect to the biotechnology, pharmaceutical and healthcare
industries, his broad leadership experience resulting from service on various boards and as an executive officer and his knowledge and experience with policymaking, regulatory issues and other governmental matters.</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Nominating and Corporate Governance Committee</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Risk
Committee (chair)</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company
Boards:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Carl B. Feldbaum, Esq., has been a director since
February 2007. Mr.&nbsp;Feldbaum serves as a member emeritus of the board of directors of BIO Ventures for Global Health, a <FONT STYLE="white-space:nowrap">non-profit</FONT> organization, and is president emeritus of the Biotechnology Innovation
Organization (BIO), which is the world&#146;s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
Mr.&nbsp;Feldbaum served as president of BIO from 1993 until his retirement in 2005. Prior to joining BIO, Mr.&nbsp;Feldbaum was chief of staff to Senator Arlen Specter of Pennsylvania. He also was president and founder of Palomar Corporation, a
national security &#147;think tank&#148; in Washington, D.C. Before founding Palomar Corporation, Mr.&nbsp;Feldbaum was Assistant to the Secretary of Energy and served as the Inspector General for defense intelligence in the U.S. Department of
Defense. Mr.&nbsp;Feldbaum served as a member of the board of directors of the following publicly held companies: Actelion, Ltd, a biopharmaceutical company focused on the discovery, development and commercialization of innovative drugs for diseases
with significant unmet medical needs (acquired by Johnson&nbsp;&amp; Johnson in 2017), from 2005 to 2015; Trovagene, Inc., a precision medicine biotechnology company focused on the development of oncology therapeutics for improved cancer care, from
2014 to 2015; and Connetics Corporation, a specialty pharmaceutical company focused on the development and commercialization of innovative therapeutics for the dermatology market, from 2005 until its acquisition by Stiefel Laboratories, Inc. in
2006. Mr.&nbsp;Feldbaum holds an A.B. in Biology from Princeton University and a J.D. from the University of Pennsylvania Law School.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Maria C. Freire, Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Former President and Executive Director, Foundation for the National Institutes of Health</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2018</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 67</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Freire should continue to serve as a director of Exelixis due to her training as a scientist, her knowledge and experience with respect to medical research, the pharmaceutical industry and
government healthcare policymaking, as well as her leadership experience in the public sector.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Nominating and Corporate Governance Committee</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Risk
Committee</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company
Boards:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Alexandria Real Estate Equities, serving on the Nominating&nbsp;&amp;
Corporate Governance Committee and the Science&nbsp;&amp; Technology Committee (chair)</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Biogen Inc., serving on the Compensation and Management Development
Committee</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Maria C. Freire, Ph.D., has been a director since April
2018. From November 2012 to September 2021, Dr.&nbsp;Freire served as President and Executive Director and as a member of the board of directors of the Foundation for the National Institutes of Health. Previously, she served as President and as a
member of the board of directors of the Albert and Mary Lasker Foundation from 2008 to 2012, as President and Chief Executive Officer of the Global Alliance for TB Drug Development from 2001 to 2008 and as Director of the Office of Technology
Transfer at the National Institutes of Health from 1995 to 2001. Dr.&nbsp;Freire has served on the board of directors of Biogen Inc., a publicly held biopharmaceutical company focused on the treatment of serious diseases, since June 2021, and on the
board of directors of Alexandria Real Estate Equities, Inc. a publicly held urban office real estate investment trust uniquely focused on collaborative life science and technology campuses, since April 2012. She has previously served on the boards
of numerous national and international organizations, including the Science Board of the U.S. Food and Drug Administration, the World Health Organization Commission on Intellectual Property Rights, Innovation and Public Health and the United Nations
Secretary General&#146;s High Level Panel on Access to Medicines. Dr.&nbsp;Freire is also a member of the National Academy of Medicine and the Council on Foreign Relations, and she is the recipient of numerous awards, including a 2017 Gold Stevie
Award for &#147;Woman of the Year,&#148; the U.S. Department of Health and Human Services Secretary&#146;s Award for Distinguished Service, the Arthur S. Fleming Award and the Bayh-Dole Award. Dr.&nbsp;Freire holds a Ph.D. in Biophysics from the
University of Virginia and a B.S. from the Universidad Peruana Cayetano Heredia in Lima, Peru.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">10</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Director Nominees </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Alan M. Garber, M.D., Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Provost of Harvard University</B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2005</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 66</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Garber should continue to serve as a director of Exelixis due to his training as a physician and economist, his knowledge and experience with respect to the life sciences, healthcare and
pharmaceutical industries, and his knowledge and experience with policymaking, regulatory issues and other governmental matters.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Nominating and Corporate Governance Committee (chair)</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Vertex
Pharmaceuticals Incorporated, serving on the Audit&nbsp;&amp; Finance Committee and the Scientific&nbsp;&amp; Technology Committee</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:Calibri; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alan M. Garber, M.D., Ph.D., has been a director since
January 2005. He became Provost of Harvard University, Mallinckrodt Professor of Health Care Policy at Harvard Medical School, and a Professor in the Harvard Kennedy School of Government and in the Department of Economics at Harvard in September
2011. Before moving to Harvard, from 1998 until August 2011, he was the Henry J. Kaiser Jr. Professor, a Professor of Medicine, and a Professor (by courtesy) of Economics, Health Research and Policy, and of Economics in the Graduate School of
Business at Stanford University. Dr.&nbsp;Garber also served as the Director of the Center for Primary Care and Outcomes Research and the Center for Health Policy at Stanford. During his tenure at Stanford University, Dr.&nbsp;Garber also served as
a Senior Fellow at the Freeman Spogli Institute for International Studies and as a staff physician at the VA Palo Alto Health Care System. Dr.&nbsp;Garber has served as a member of the board of directors of Vertex Pharmaceuticals Incorporated, a
publicly held biotechnology company focused on developing and commercializing therapies for the treatment of cystic fibrosis, since June 2017. In addition, Dr.&nbsp;Garber is a one of several <FONT STYLE="white-space:nowrap">co-founders</FONT> and
serves as the chair of the board of directors for Landmark Bio, PBLLC (f/k/a the Center for Advanced Biological Innovation and Manufacturing), a public benefit limited liability company in the Boston metro area created to encourage collaboration
among multiple institutions, with the ultimate aim of promoting the development and production of cell and gene therapies, biologics, immunotherapies and other emerging technologies that can benefit patients. Dr.&nbsp;Garber is a member of the
National Academy of Medicine, the American Society of Clinical Investigation, the Association of American Physicians and the American Academy of Arts and Sciences. He is a Fellow of the American College of Physicians, the Royal College of Physicians
and the American Association for the Advancement of Science. Dr.&nbsp;Garber is also a Research Associate with the National Bureau of Economic Research and served as founding Director of its Health Care Program for nineteen years. He has also served
as a member of the National Advisory Council on Aging at the National Institutes of Health, as a member of the Board of Health Advisers of the Congressional Budget Office and as Chair of the Medicare Evidence Development and Coverage Advisory
Committee at the Centers for Medicare and Medicaid Services. Dr.&nbsp;Garber previously served on the editorial board of a number of acclaimed scientific journals and has received numerous awards and honors. Dr.&nbsp;Garber holds an A.B. summa cum
laude, an A.M. and a Ph.D., all in Economics, from Harvard University, and an M.D. with research honors from Stanford University.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Vincent T. Marchesi, M.D., Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Professor of Pathology and Cell Biology, Yale University</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="8">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="8"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2001</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 86</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Marchesi should continue to serve as a director of Exelixis due to his training as a physician and scientist and his research and experience in the fields of healthcare and life sciences, with a
particular focus on biotechnology.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee
Assignments:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Compensation Committee</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent T. Marchesi, M.D., Ph.D., has been a director
since May 2001. Since 1973, Dr.&nbsp;Marchesi has been a Professor of Pathology and Cell Biology at Yale University and, since 1991, the Director of the Boyer Center for Molecular Medicine at Yale University until his retirement. In 1982,
Dr.&nbsp;Marchesi <FONT STYLE="white-space:nowrap">co-founded</FONT> Molecular Diagnostics, Inc., a diagnostic development company. Dr.&nbsp;Marchesi was formerly Chair of Pathology at the <FONT STYLE="white-space:nowrap">Yale-New</FONT> Haven
Hospital. Dr.&nbsp;Marchesi holds an M.D. from Yale University and a Ph.D. from Oxford University, and is a member of the National Academy of Sciences and the National Academy of Medicine.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">11</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Michael M. Morrissey, Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>President and Chief Executive Officer, Exelixis, Inc.</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="7">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="7"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2010</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 61</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Morrissey should continue to serve as a director of Exelixis due to his leadership role as the President and Chief Executive Officer of Exelixis. Beyond his role as Exelixis&#146; principal
executive officer, the Board also considered Dr.&nbsp;Morrissey&#146;s extensive qualifications, including his training as a scientist, his significant knowledge and experience with respect to the biotechnology, healthcare and pharmaceutical
industries, comprehensive leadership background resulting from service as an executive in the biotechnology industry, and his ability to bring historic knowledge and continuity to the Board.</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Vera
Therapeutics, Inc. (chair), serving on the Audit Committee and the Nominating and Corporate Governance Committee</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D., has served as a director and
as Exelixis&#146; President and Chief Executive Officer since July 2010. Dr.&nbsp;Morrissey has held positions of increasing responsibility at Exelixis since he joined the company in February 2000, including serving as President of Research and
Development from January 2007 until July 2010. From 1991 to 2000, Dr.&nbsp;Morrissey held several positions at Berlex Biosciences, last holding the position of Vice President, Discovery Research. Earlier in his career, Dr.&nbsp;Morrissey served as a
Senior Scientist and Project Team Leader in Medicinal Chemistry at CIBA-Geigy Corporation. Dr.&nbsp;Morrissey has served as chair of the board of directors of Vera Therapeutics, Inc., a publicly held, clinical-stage biotechnology company focused on
developing and commercializing transformative treatments for patients with serious immunological diseases, since April 2022, as a member of the board of directors of XWPharma Ltd., a privately held, clinical-stage biopharmaceutical company dedicated
to the discovery and development of novel therapeutics, since December 2020, and as a member of the board of directors of CERo Therapeutics, Inc., a privately held biopharmaceutical company focused on next-generation cell-based therapies for cancer,
since January, 2022. He is the author of numerous scientific publications in medicinal chemistry and drug discovery and an inventor on 70 issued U.S. patents and 25&nbsp;additional published U.S. patent applications. Dr.&nbsp;Morrissey holds a B.S.
(Honors) in Chemistry from the University of Wisconsin and a Ph.D. in Chemistry from Harvard&nbsp;University.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:6pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Stelios Papadopoulos, Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><FONT STYLE="white-space:nowrap">Co-Founder</FONT> and Chair of the Board, Exelixis, Inc.</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 1994</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 73</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Papadopoulos should continue to serve as a director of Exelixis due to his training as a scientist, his knowledge and experience with respect to the biotechnology, healthcare and pharmaceutical
industries, his broad leadership experience resulting from extensive service on various boards, his knowledge and experience with respect to finance matters, and his ability to bring historic knowledge and continuity to the Board.</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Audit
Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Biogen
Inc. (chair), serving on the Corporate Governance Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Regulus Therapeutics, Inc. (chair), serving on the Audit Committee and the
Nominating and Governance Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Eucrates Biomedical Acquisition Corp. (chair)</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:Calibri; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos, Ph.D., a <FONT
STYLE="white-space:nowrap">co-founder</FONT> of Exelixis, has been a director since December 1994 and the Chair of the Board since January 1998. Dr.&nbsp;Papadopoulos retired as Vice Chairman of Cowen&nbsp;&amp; Co., LLC in August 2006 after six
years as an investment banker with the firm, where he focused on the biotechnology and pharmaceutical sectors. Prior to joining Cowen&nbsp;&amp; Co., he spent 13 years as an investment banker at PaineWebber, Incorporated, where he was most recently
Chairman of PaineWebber Development Corp., a PaineWebber subsidiary focusing on biotechnology. He joined PaineWebber in April 1987 from Drexel Burnham Lambert, where he was a Vice President in the Equity Research Department covering the
biotechnology industry. Prior to Drexel, he was a biotechnology analyst at Donaldson, Lufkin&nbsp;&amp; Jenrette. Before coming to Wall&nbsp;Street in 1985, Dr.&nbsp;Papadopoulos was on the faculty of the Department of Cell Biology at New&nbsp;York
University Medical Center. Dr.&nbsp;Papadopoulos was a <FONT STYLE="white-space:nowrap">co-founder</FONT> of Anadys Pharmaceuticals, Inc., a publicly held biopharmaceutical company dedicated to improving patient care by developing novel medicines
for the treatment of hepatitis C, acquired by <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche Inc. in November 2011. Dr.&nbsp;Papadopoulos served as a member of the board of directors of Anadys Pharmaceuticals from 2000 to 2011 and as its
chairman in 2011, prior to its acquisition. Dr.&nbsp;Papadopoulos has also served as a member of the board of directors of four other publicly held companies: Biogen, Inc., a biopharmaceutical company focused on the treatment of serious diseases,
since 2008 and as its chairman since 2014; Regulus Therapeutics Inc., a biopharmaceutical company focused on the development of medicines targeting microRNAs, since 2008, and as its chairman since 2013; Eucrates Biomedical Acquisition Corp., a
special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, and as its chairman, since 2020;
and BG Medicine, Inc., a diagnostics company focused on the development and commercialization of cardiovascular diagnostic tests, from 2003 until 2018. Dr.&nbsp;Papadopoulos was also <FONT STYLE="white-space:nowrap">co-founder</FONT> and member of
the board of directors of Cellzome Inc., a privately held drug discovery company acquired by GlaxoSmithKline in May 2012. In the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> sector,
Dr.&nbsp;Papadopoulos is a <FONT STYLE="white-space:nowrap">co-founder</FONT> and Chairman of Fondation Sant&eacute;, a member of the board of visitors of Duke Medicine, and a member of the Global Advisory Board of the Duke Institute for Health
Innovation. Dr.&nbsp;Papadopoulos holds an M.S. in Physics, a Ph.D. in Biophysics and an M.B.A. in Finance, all from New York University.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">12</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Director Nominees </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>George Poste, DVM, Ph.D., FRS</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Chief Scientist, Complex Adaptive Systems Initiative</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2004</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 77</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Poste should continue to serve as a director of Exelixis due to his training as a scientist, his knowledge and experience with respect to the life sciences, healthcare and pharmaceutical industries,
his broad leadership experience resulting from service on various boards, and his knowledge and experience with policymaking, regulatory issues and other governmental matters.</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee (chair)</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Risk
Committee</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company
Boards:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:Calibri; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George Poste, DVM, Ph.D., FRS, has been a director since
August 2004. Since February 2009, Dr.&nbsp;Poste has been the Chief Scientist at Complex Adaptive Systems Initiative and Regents&#146; Professor and Del E. Webb Professor of Health Innovation at Arizona State University. From May&nbsp;2003 to
February 2009, Dr.&nbsp;Poste served as the director of the Biodesign Institute at Arizona State University. Dr.&nbsp;Poste has served as the Chief Executive Officer of Health Technology Networks, a consulting company that specializes in the
application of genomic technologies and computing in healthcare, since 2000. From 1992 to 1999, he was the Chief Science and Technology Officer and President, R&amp;D, of SmithKline Beecham Corporation, a pharmaceutical company (later merged into
GlaxoSmithKline plc). Dr.&nbsp;Poste served on the Defense Science Board of the U.S. Department of Defense from 2001 to 2010 and is a member of other organizations dedicated to advancing defenses against bioweapons and biowarfare. Dr.&nbsp;Poste has
served as a member of the board of directors of Caris Life Sciences, a privately held medical diagnostics company, since 2009, and as a member of the board of directors of INanoBio, Inc., a privately held biotechnology company, since 2021.
Previously, Dr.&nbsp;Poste served as a member of the board of directors of Monsanto Company, a publicly held provider of agricultural products and solutions, from February 2003 until its acquisition by Bayer Aktiengesellschaft in June 2018, and as
the <FONT STYLE="white-space:nowrap">Non-Executive</FONT> Chairman of Orchid Cellmark, Inc., a publicly held DNA forensics company, from April 2000 until its acquisition by the Laboratory Corporation of America in August&nbsp;2009. Dr.&nbsp;Poste is
a Fellow of the Royal Society, the UK Academy of Medical Sciences, Hoover Institution, Stanford&nbsp;University, and various other prestigious organizations and has been awarded honorary doctorates from several universities. Dr.&nbsp;Poste holds a
DVM in veterinary medicine and a Ph.D. in Virology from the University of Bristol, England and Board Certification in Pathology from the Royal College of Pathologists.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Julie Anne Smith</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>President and Chief Executive Officer, ESCAPE Bio Inc.</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2016</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 51</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Ms.&nbsp;Smith should continue to serve as a director of Exelixis due to her knowledge and experience with respect to biotechnology, healthcare and pharmaceutical industries and her broad leadership
experience resulting from service as an executive in the pharmaceutical industry.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Audit Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Compensation Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Stoke
Therapeutics, Inc., serving on the Compensation Committee</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie Anne Smith has been a director since September
2016. Since August 2018, Ms.&nbsp;Smith has served as President and Chief Executive Officer and as a member of the board of directors of ESCAPE Bio Inc., a privately held, clinical-stage biopharmaceutical company developing novel, precisely targeted
therapeutics for genetically defined neurodegenerative diseases. From July 2017 until June 2018, Ms.&nbsp;Smith served as President and Chief Executive Officer and as a member of the board of directors of Nuredis, Inc., a privately held
biotechnology company. Prior to Nuredis, she served as President and Chief Executive Officer of Raptor Pharmaceutical Corp., a publicly held biopharmaceutical company focused on developing and commercializing transformative treatments for people
affected by rare and debilitating diseases, from January 2015 until the company&#146;s acquisition by Horizon Pharma plc in October 2016, where she also served as Executive Vice President and Chief Operating Officer from 2012 to 2014. From 2008 to
2012, Ms.&nbsp;Smith served as Chief Commercial Officer of Enobia Pharmaceuticals prior to the company&#146;s acquisition by Alexion Pharmaceuticals, Inc. Previously, Ms.&nbsp;Smith served as Vice&nbsp;President of Commercial at Jazz Pharmaceuticals
plc from 2006 to 2008, as Vice President, Global Marketing at Genzyme General from 2001 to 2005, and helped to establish the operations and business development function for the biotech <FONT STYLE="white-space:nowrap">start-up,</FONT> Novazyme
Pharmaceuticals, from 2000 to 2001. Ms.&nbsp;Smith began her industry career at Bristol-Myers Squibb Company in 1996. Ms.&nbsp;Smith has served as a member of the board of directors of Stoke Therapeutics, Inc., a publicly held biotechnology company
pioneering a new way to treat the underlying cause of genetic diseases by precisely unregulating protein expression, since June 2020. Previously, Ms.&nbsp;Smith served as a member of the board of directors of Audentes Therapeutics, Inc. a publicly
held, clinical-stage biotechnology company focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects, from December 2016 until its acquisition by
Astellas Pharma Inc. in January 2020, and as a Director on the Health and Emerging Companies Sections of the BIO board. Ms.&nbsp;Smith holds a B.S. in biological and nutritional sciences from Cornell University.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">13</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Lance Willsey, M.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Founding Partner, DCF Capital</B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="4"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 1997</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 60</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Willsey should continue to serve as a director of Exelixis due to his skill as a physician, his knowledge and experience with respect to the life sciences and healthcare industries, and his
knowledge and experience with respect to finance matters.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Compensation Committee</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Lance Willsey, M.D., has been a director since April
1997. Dr.&nbsp;Willsey was a founding partner of DCF Capital, a hedge fund focused on investing in the life sciences, from July 1998 to March 2002, and currently is a consultant to institutional investors in the field of oncology. Since 2000,
Dr.&nbsp;Willsey has served on the Visiting Committee of the Department of Genitourinary Oncology at the Dana-Farber Cancer Institute at Harvard Medical School. From July 1997 to July 1998, Dr.&nbsp;Willsey served on the Staff Department of Urologic
Oncology at the Dana-Farber Cancer Institute. From July 1996 to July 1997, Dr.&nbsp;Willsey served on the Staff Department of Urology at Massachusetts General Hospital at Harvard University School of Medicine, where he was a urology resident from
July 1992 to July 1996. From 2000 to 2010, Dr.&nbsp;Willsey served a member of the board of directors of Exact Sciences Corporation, a publicly held molecular diagnostics company focused on the early detection and prevention of the deadliest forms
of cancer. Dr.&nbsp;Willsey holds a B.S. in Physiology from Michigan State University and an M.S. in Biology and an M.D., both from Wayne State University.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Jacqueline (Jacky) Wright</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Corporate Vice President&nbsp;&amp; Chief Digital Officer, U.S. Business, Microsoft Corporation</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="4"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2021</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 62</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Ms.&nbsp;Wright should continue to serve as a director of Exelixis due to her extensive experience in digital transformation, as well as her broad business and leadership experience in both the private and
public sectors.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Nominating and Corporate Governance Committee</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Risk
Committee</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company
Boards:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;nVent Electric plc, serving on the Compensation and Human Capital Committee
and the Governance and Social Responsibility Committee</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jacqueline Wright has been a director since December
2021. Since November 2019, Ms. Wright has served as Corporate Vice President &amp; Chief Digital Officer, U.S. Business, of Microsoft Corporation, a multinational technology company. Previously, she served as Chief Digital &amp; Information Officer
for HM Revenue &amp; Customs, the tax department of the United Kingdom Government, under a secondment arrangement from October 2017 to November 2019, and served in various roles at Microsoft Corporation from September 2011 to October 2017, including
Corporate Vice President, IT Strategic Enterprise Services and Corporate Vice President, Core Services Engineering Platform. Before joining Microsoft, Ms. Wright served in chief information officer roles for multiple large companies, including BP
plc and General Electric Company. Ms.&nbsp;Wright has served as a member of the board of directors of nVent Electric plc, a publicly held provider of electrical connection and protection solutions, since March 2020, and as a member of the board of
directors of Russell Reynolds Associates, Inc., a privately held global leadership advisory and search firm, since June 2021. In the not-for-profit sector, she is a member of the board of directors of the MxD Manufacturing Council, the board of
councilors of the Center for Global Health Innovation, the Industry Advisory Board for the Institute of Coding (UK) and the data analytics advisory board of Bernard M. Baruch College, City University of New York, having previously served on the
board of trustees of Harvey Mudd College and the board of trustees of Prostate Cancer UK. Ms. Wright holds a B.B.A. in Computer Information Systems &amp; Accounting from Bernard M. Baruch College, City University of New York.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">14</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Director Nominees </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Jack L. Wyszomierski</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Former Executive Vice President and Chief Financial Officer,</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>VWR&nbsp;International, LLC</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="10">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="10"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2004</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 66</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Mr.&nbsp;Wyszomierski should continue to serve as a director of Exelixis due to his extensive financial reporting, accounting and finance experience, as well as his experience in the healthcare and life
sciences industries. These qualities have also formed the basis for the Board&#146;s decision to appoint Mr.&nbsp;Wyszomierski as a member and Chair of the Audit Committee.</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Audit
Committee (chair)</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Nominating and Corporate Governance Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;XOMA
Corporation, serving on the Audit Committee and the Compensation Committee (chair)</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Athersys, Inc., serving on the Audit Committee and the Nominations
Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.12em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;SiteOne Landscape Supply, Inc., serving on the Audit Committee and the
Nominating&nbsp;&amp; Corporate Governance Committee (chair)</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:Calibri; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jack L. Wyszomierski has been a director since February
2004. From June 2004 to June 2009, Mr.&nbsp;Wyszomierski served as the Executive Vice President and Chief Financial Officer of VWR International, LLC, a supplier of laboratory supplies, equipment and supply chain solutions to the global research
laboratory industry. From 1982 to 2003, Mr.&nbsp;Wyszomierski held positions of increasing responsibility within the finance group at Schering-Plough Corporation, a health care company, culminating with his appointment as Executive Vice President
and Chief Financial Officer in 1996. Prior to joining Schering-Plough, he was responsible for capitalization planning at Joy Manufacturing Company, a producer of mining equipment, and was a management consultant at Data Resources, Inc.
Mr.&nbsp;Wyszomierski has served: as a member of the board of directors of XOMA Corporation, a publicly held biotech royalty aggregator, since August 2010; as a member of the board of directors of Athersys, Inc., a publicly held company engaged in
the discovery and development of therapeutic product candidates, since June 2010; and as a member of the board of directors of SiteOne Landscape Supply, Inc., a publicly held company that distributes landscape supply products, since April 2016.
Mr.&nbsp;Wyszomierski previously served as a member of the board of directors of: Unigene Laboratories, Inc., a publicly held biopharmaceutical company, from April 2010 to July 2013; AssuraMed Holding, Inc., a privately held distributor of home
healthcare products, from January 2011 until its acquisition by Cardinal Health Inc. in March 2013; and Solenis, Inc., a privately held chemicals producer from August 2014 until its acquisition by Platinum Equity in November 2021.
Mr.&nbsp;Wyszomierski holds a M.S. in Industrial Administration and a B.S. in Administration, Management Science and Economics from Carnegie Mellon University.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:6pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:6pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:6pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;background-color:#e5e5e5;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#fc4c02"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; EACH NAMED NOMINEE. </B></FONT></P></div>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">15</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_3"></A>Corporate Governance </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Please note that information found
on, or accessible through, our website is not a part of, and is not incorporated into, this Proxy Statement. </I></FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Corporate
Governance Guidelines </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We have adopted written Corporate Governance Guidelines, which may be viewed at <I>www.exelixis.com</I> under
the caption &#147;Investors&nbsp;&amp; Media&#151;Corporate Governance&#151;Corporate Governance Documents.&#148; This document covers, among other topics, director independence, board composition, structure and functioning, director selection
criteria, committees of the board, board and board committee evaluations, overboarding guidelines and our majority voting policy. Our Board regularly reviews, and modifies from time to time, our Corporate Governance Guidelines, Board committee
charters and Board practices. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Corporate Code of Conduct </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We have adopted a Corporate Code of Conduct, which functions as our Code of Ethics under the SEC rules and applies to all directors, officers and
employees, including the principal executive officer and principal financial/accounting officer. The Corporate Code of Conduct is posted on our website at <I>www.exelixis.com</I> under the caption &#147;Investors&nbsp;&amp; Media&#151;Corporate
Governance&#151;Corporate Governance Documents.&#148; We intend to satisfy the disclosure requirement under Item&nbsp;5.05 of <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> regarding an amendment to, or waiver from, a provision of this
Corporate Code of Conduct by posting such information on our website, at the address and location specified above and, to the extent required by the listing standards of the Nasdaq Stock Market, by filing a Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> with the SEC, disclosing such information. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our Corporate Code of Conduct reflects our corporate
values and describes how our officers, directors, employees and contractors are expected to conduct themselves when representing Exelixis. It also underscores our commitment to strive to comply with laws that regulate our business activities as a
biotechnology company. Our employees receive regular training on our Corporate Code of Conduct, which includes consequences of taking actions that would constitute a violation of our Corporate Code of Conduct. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Included in our Corporate Code of Conduct are procedures for employees to report potential violations to our Ethics Committee, which is chaired
by our Chief Executive Officer and includes other members of our senior management team. To ensure our employees feel comfortable raising good faith questions or concerns with respect to our Corporate Code of Conduct or our other policies, these
reports can be made confidentially (or anonymously) via our Ethics Helpline, and we maintain a strict policy against any retaliation or discrimination towards an employee who makes such a report. The Board, through the Audit Committee, regularly
receives reports of disclosures made through the Ethics Helpline, as well as any concerns raised to the Ethics Committee or otherwise submitted through our internal compliance reporting system. The Audit Committee is responsible for the oversight of
such matters, or as appropriate, will assign such oversight to another committee of the Board. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Director Independence </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We have adopted standards for director independence pursuant to Nasdaq listing standards, which require that a majority of the members of a
listed company&#146;s board of directors qualify as &#147;independent,&#148; as affirmatively determined by the board of directors. An &#147;independent director&#148; means a person other than an officer or employee of Exelixis or one of our
subsidiaries, or another individual having a relationship that, in the opinion of the Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Consistent with these considerations, after
review of all relevant transactions or relationships between each director, or any of his or her family members, and Exelixis, its senior management or its independent registered public accounting firm, the Board has affirmatively determined that
Drs. Cohen, Freire, Garber, Marchesi, Papadopoulos, Poste and Willsey, Messrs.&nbsp;Wyszomierski and Feldbaum and Mses.&nbsp;Smith and Wright, who are eleven of the twelve members of the Board, represent a majority of the Board and are independent
under applicable SEC rules and the Nasdaq listing standards. Dr.&nbsp;Morrissey, our President and Chief Executive Officer, is not independent by virtue of his employment with Exelixis. In addition, the Board has also determined that: (i)&nbsp;all
directors who serve on the Audit, Compensation and Nominating and Corporate Governance Committees are independent under applicable Nasdaq listing standards; and (ii)&nbsp;all members of the Audit Committee meet the independence requirements under
the Exchange Act. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#fc7841"><B><I>Special Note Regarding Independence of Dr.&nbsp;Papadopoulos.</I></B></FONT><FONT
STYLE="font-family:Calibri" COLOR="#3f3f3f"> Dr.&nbsp;Papadopoulos is considered a <FONT STYLE="white-space:nowrap">&#147;co-founder&#148;</FONT> of Exelixis as a result of financial contributions he made during the earliest part of its history and
his role in assembling and advising the </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">16</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Corporate Governance </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">scientists who ultimately served as the company&#146;s earliest management team. However, he has never been employed by us or otherwise involved
with any daily business operations and, moreover, Exelixis&#146; management team today is composed of entirely different individuals from the company&#146;s earliest management team. Accordingly, the Board has determined that Dr.&nbsp;Papadopoulos
is independent under applicable SEC rules and the Nasdaq listing standards and is qualified to serve as our Chair and on our Audit Committee, as the Board believes that he has no interest, business or other relationship (including no family
relationships) that could, or could reasonably be perceived to, materially interfere with his ability to act in the best interests of Exelixis. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT
 COLOR="#fc4c02">Board Leadership Structure </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board does not have a formal policy on whether the role of Chair and Chief Executive
Officer should be separate or combined. Our Corporate Governance Guidelines provide that the Board will select its Chair and the Chief Executive Officer in the manner it considers to be in the best interests of our company. Currently, we have an
independent Chair of the Board separate from the Chief Executive Officer. The Board believes this bifurcated structure provides for independent oversight of management and strong Board leadership, while allowing for the effective management of
company affairs. The Board believes that if the positions of Chair and Chief Executive Officer are combined, the appointment of a lead independent director would be necessary for effective governance. Accordingly, our Corporate Governance Guidelines
provide that if the roles are combined, the independent directors of the Board must appoint a lead independent director. Our Corporate Governance Guidelines further provide that the lead independent director would: (i)&nbsp;preside at all meetings
of the Board at which the Chair is not present, including executive sessions of the independent directors; (ii)&nbsp;have the authority to call meetings of the independent directors; (iii)&nbsp;serve as the principal liaison on Board-wide issues
between the independent directors and the Chair; and (iv)&nbsp;have such other authority and duties as the Board may from time to time determine. The Board believes that this flexible approach provides it with the ability to establish a leadership
structure that, based upon its judgment, is in the best interests of our company and those of our stockholders at any given time. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Role of the Board in Risk Oversight </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Management is responsible for assessing, managing and mitigating the various risks associated with our business and operational activities, including, without limitation, strategic, operational, financial, regulatory and
cybersecurity risks that may exist from time to time. Management has implemented appropriate risk management structures, policies and procedures, and manages our risk exposure on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> basis. In accordance with our Corporate Governance Guidelines, the Board, both directly and through its committees (including the Risk Committee formed in
December 2019), oversees the proper functioning of our internal risk management processes. In their specific risk oversight roles, the Board and the Risk Committee evaluate whether management has reasonable controls in place to address material
risks currently facing our company and those we may face in the future. The Board, the Risk Committee and other committees meet at regularly scheduled and special meetings throughout the year at which management reports to the Board concerning the
results of its risk management activities, as well as external changes that may change the levels of business risk to which we are exposed. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Board delegates certain of its risk oversight responsibilities to its various committees as follows: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our </FONT><FONT COLOR="#fc7841">Audit Committee</FONT><FONT COLOR="#3f3f3f"> oversees the
management of risks relating to financial reporting or fraud, securities trading and tax matters. Our Audit Committee also reviews any proposed related party transactions to ensure we do not engage in transactions that would create a conflict of
interest or result in harm to us. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our </FONT><FONT COLOR="#fc7841">Compensation Committee</FONT><FONT COLOR="#3f3f3f"> periodically
assesses our compensation policies and practices, including structuring and reviewing our executive compensation programs, in order to determine whether any such policies or practices are reasonably likely to have a material adverse effect on us.
Our Compensation Committee also assists the Board in its oversight of our human capital management function. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our </FONT><FONT COLOR="#fc7841">Nominating and Corporate Governance Committee</FONT><FONT
 COLOR="#3f3f3f"> oversees our governance practices and the management of related risks, including director independence and Board composition and succession of both the Board and CEO, and the development and administration of our Code of Conduct.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our </FONT><FONT COLOR="#fc7841">Research&nbsp;&amp; Development Committee</FONT><FONT
 COLOR="#3f3f3f"> evaluates risks associated with the scientific discovery process, preclinical and clinical development programs, to the extent not within the purview of the Risk Committee&#146;s oversight of our compliance programs.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our </FONT><FONT COLOR="#fc7841">Risk Committee</FONT><FONT COLOR="#3f3f3f"> assists the Board
with oversight of our internal risk management framework, policies, guidelines and infrastructure, and, if called for, its administration of government and other investigations and
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">17</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">material litigation matters. The Risk Committee receives reports from management&#146;s Ethics Committee and also oversees management in the dispatch of its responsibility to administer our various
compliance programs, including, but not limited to, data privacy (including cybersecurity), drug safety, healthcare compliance and quality management. Finally, the Risk Committee oversees our business and operational risks that are not specifically
allocated to the Board or another committee of the Board. The Risk Committee provides periodic reports to the full Board. </FONT></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Senior management presents the full Board with frequent business updates during monthly teleconferences, at which time the Board provides management with feedback, makes recommendations and, as needed, issues directives to address
our risk exposure. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Prohibitions on Derivative, Hedging, Monetization and Other Transactions </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We maintain an insider trading policy that applies to directors and employees, including our executive officers, which prohibits certain
transactions in our stock, including short sales, puts, calls or other transactions involving derivative securities, hedging or monetization transactions, purchases of Exelixis securities on margin or borrowing against an account in which Exelixis
securities are held, or, subject to the following exception, pledging Exelixis stock as collateral for a loan. There are no exceptions to these prohibitions, other than the pledging of Exelixis stock as collateral for a loan, which requires prior
approval of Exelixis&#146; Securities Compliance Committee (comprising senior members of our legal and finance teams). Before granting the exception, the Securities Compliance Committee will require such director or employee to establish his or her
financial capacity to repay the loan without resort to the pledged securities, and the pledged securities may not be sold without the advance written consent of the Securities Compliance Committee. As of the date of this Proxy Statement, no shares
of Exelixis stock are pledged by any of our directors or executive officers. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Corporate Responsibility and Sustainability </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Exelixis&#146; mission is to help cancer patients recover stronger and live longer. As we strive to extend and improve cancer patients&#146;
lives, we recognize the need also to contribute positively to society as a whole. To that end, Exelixis expects that its employees will commit to the highest standards of ethical behavior and maintain values and principles that reflect both global
awareness and sustainability. This entails integrating environmental, social and governance (ESG) considerations directly into our research and development projects, business operations and investment processes as we strive to create sustained value
for all our stakeholders by translating science into impact for patients and all those we serve. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">18</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Corporate Governance </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We seek to achieve these commitments through a number of initiatives, including those listed below: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Our Governance and Compliance </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g282574g41k86.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>At Exelixis, we recognize that good governance, corporate responsibility and accountability are critical to
our quest to treat and defeat cancer. We embed strong compliance practices and oversight into our scientific and business activities with the goal that these business activities be conducted in a legal and ethical manner and in the best interests of
all Exelixis&#146; stakeholders, in particular, the patients we serve.
</I></FONT></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Program Highlights: </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Strong internal governance structure relies upon the management-level Ethics Committee and its subcommittees, overseen by the Board-level Risk Committee </FONT></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Requirement for systematic and periodic reporting to senior management and our Board of Directors on matters relating to our Corporate Code of Conduct, including responding to and escalating key
issues and concerns as needed </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Commitment to high standards and ethics across all departments and company stakeholders, as reflected by our internal policies, including our <I>Policy for Recoupment of Variable Compensation
(Clawback Policy)</I> </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Comprehensive training programs covering various compliance matters and utilizing both live <FONT STYLE="white-space:nowrap">(in-person</FONT> or virtual) classroom sessions and interactive online
modules.<I> </I> </FONT></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Access to Health </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g282574g48v36.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>At Exelixis, we value being exceptional in what we do and how we lead, excelling for patients by going the
extra mile to care for them and exceeding together as a business and contributor to the scientific community. We dedicate substantial financial resources and work tirelessly in our efforts to offer patients high-quality, safe and effective cancer
treatments. Moreover, once our products are available, our goal is to ensure that no patient prescribed an Exelixis medicine will go without it due to lack of insurance or inability to pay.
</I></FONT></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Program Highlights: </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Long history of dedicated research and development efforts, focused on creating better treatments for patients </FONT></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Thoughtful pricing decisions that account for patient access (including discounting and rebates for certain group purchases), reinvestment designed to improve our drugs and production costs
</FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Exelixis Access Services (EASE), a comprehensive resource that provides <FONT STYLE="white-space:nowrap">co-pay</FONT> assistance, allows qualifying uninsured or underinsured patients to receive
medication free of charge and connects patients with healthcare providers to assist with their treatment </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Launch of <I>Inclusiveness Initiative </I>to improve representation of diverse communities in Exelixis-sponsored clinical trials
</FONT></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">19</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Taking Responsibility
for Our Products </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g282574g97h93.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>The well-being of patients is a top priority for us. Our Corporate Code of Conduct holds every Exelixis
employee accountable to safe and ethical standards of work and behavior, and is designed to ensure our products are developed in compliance with Good Practice quality guidelines. As a core reflection of Exelixis values, product responsibility is
monitored by teams with a direct chain of reporting to our Ethics Committee and overseen by our Board of Directors. This process is designed to allow us to escalate and address issues quickly and holistically. </I></FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Program Highlights: </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Quality assurance program designed to ensure safe and ethical development and manufacturing practices </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Initiatives designed to provide transparency to clinical patients regarding important study considerations and pseudonymization of all patient data designed to protect sensitive personal
information </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Anticounterfeiting and serialization practices designed to safeguard product integrity in our supply chain and system to manage product recalls (should one become necessary)
</FONT></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Environmental </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g282574g97o48.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Exelixis is committed to conducting business in a way that respects our environment and the Earth&#146;s
changing climate, and that is also consistent with serving the well-being of our patients, employees and all our stakeholders. We have already incorporated many environmentally sustainable practices into our facilities and operations, and we plan to
incorporate more of these practices as we continue to grow.
</I></FONT></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Program Highlights: </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Continued implementation of more energy-efficient systems in our headquarters and use of renewable energy sources, including for additional office space currently under construction
</FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Employee commuter programs designed to take cars off the road, as well as electric vehicle charging stations, which together reduce emission of greenhouse gases </FONT></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Waste reduction practices with an emphasis on recycling by employees and a commitment to adherence to applicable laws and regulations that govern the handling and disposal of hazardous materials
</FONT></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Human Capital Management and
Workforce Diversity </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g282574g06f64.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Our mission to help cancer patients recover stronger and live longer depends on the talent and dedication
of our employees. We therefore invest in building their collective strength as a team by hiring the best qualified candidates available and fostering growth opportunities for individuals. At Exelixis, we
value</I><B><I></I></B><I></I><B><I>&nbsp;being exceptional</I></B><I>&nbsp;in what we do and how we lead,</I><B><I></I></B><I></I><B><I>&nbsp;excelling for patients</I></B><I>&nbsp;by going the extra mile to care for them
and</I><B><I></I></B><I></I><B><I>&nbsp;exceeding together</I></B><I>&nbsp;as a business and contributor to the scientific community.
</I></FONT></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Program Highlights: </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Integrate our strong corporate values into our new hire interview process, performance evaluations and promotion criteria </FONT></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Support of diversity in our workforce (with 48% and 46% of managerial roles held by <FONT STYLE="white-space:nowrap">non-whites</FONT> and women, respectively, as of the end of fiscal 2020) and
insistence upon anti-discrimination in hiring and promotion practices </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Comprehensive safety measures in response to <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, combined with regular inspections and training to promote general workplace safety and low
rate of accidents </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Competitive benefits programs to recruit and retain talented employees and a collaborative workplace culture that fosters individual development while embodying our corporate values
</FONT></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">20</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Corporate Governance </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Further information about our ESG programs and sustainability efforts is available on our website at <I>www.exelixis.com</I> under the caption
&#147;Impact&#151;Environmental, Social and Governance.&#148; In addition, we plan to issue our first annual corporate sustainability report during 2022, which will address the ESG programs and sustainability efforts in more detail. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Stockholder Communications with the Board </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Board welcomes communications from Exelixis&#146; stockholders. Stockholders may communicate with the Board by sending a written communication to &#147;Exelixis, Inc., Board of Directors c/o Corporate Secretary, 1851 Harbor Bay
Parkway, Alameda, California 94502.&#148; Stockholders may also communicate with the Board by facsimile at <FONT STYLE="white-space:nowrap">(650)&nbsp;837-7951</FONT> or by <FONT STYLE="white-space:nowrap">e-mail</FONT> at info@exelixis.com, with
each of the foregoing sent with &#147;Attn: Board of Directors&#148; in the &#147;Subject&#148; line. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Each communication must set
forth the name and address of the stockholder as it appears in the Exelixis&#146; records (and, if the stock is held by a nominee, the name and address of the beneficial owner of the stock). After confirming the stock ownership of the author of the
communication, the Corporate Secretary will review and evaluate the communication, and shall have the authority to and will screen out communications from stockholders that are not directly related to the duties and responsibilities of the Board.
The Corporate Secretary may also disregard duplicative communications. If deemed directly related to the duties and responsibilities of the Board, the Corporate Secretary will forward the communication, depending on the subject matter, to the Chair
of the Nominating and Corporate Governance Committee, the Chair of the Audit Committee, the Chair of the Board, the independent directors, or the full Board, as deemed appropriate. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Stockholder Outreach </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We
maintain a robust program for stockholder outreach to elicit a better understanding of the concerns and perspectives of our stockholder base, and we have implemented the feedback received from our stockholders into our executive compensation
program, human capital management practices, diversity, equity and inclusion programs and initiatives, governance practices, ESG disclosures and other areas of our business. For additional details about our stockholder outreach efforts during fiscal
2021, please see &#147;<A HREF="#tx282574_1001">Compensation Discussion and Analysis&#151;How We Determine Executive Compensation&#151;Stockholder Outreach</A>.&#148; </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Stock Ownership Guidelines for <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We maintain Stock Ownership Guidelines for our directors and Named Executive Officers (as defined below) to further align their financial
interests with those of our stockholders, as well as to promote sound corporate governance. For our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, we amended our Stock Ownership Guidelines in February 2021 to provide an ownership
target of the value equivalent to 5 times the annual cash Board retainer, an increase from the prior target of the lesser of the value equivalent to 3 times the annual cash Board retainer or 3,000 shares. All
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors are expected to achieve their stock ownership targets within five years of becoming subject to these guidelines. The policy includes procedures for granting exemptions in the case of
severe financial hardship. Ownership targets for our Named Executive Officers (including those serving on our Board) are described below under<I></I><I>&nbsp;
&#147;</I><A HREF="#tx282574_1501">Compensation Discussion and Analysis&#151;Other Compensation Information&#151;Stock Ownership Guidelines for Named Executive Officers</A>.&#148; </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In determining ownership levels for each <FONT STYLE="white-space:nowrap">non-employee</FONT> director under our Stock Ownership Guidelines,
credit is provided for&nbsp;shares held outright (including shares owned through trusts, the Amended and Restated Exelixis, Inc. 401(k) Plan (401(k)&nbsp;Plan), or by a spouse), as well as 50% of the number of vested, but unexercised, stock options.
No credit is provided for RSUs (as defined below) until they vest. The values for all shares determined to be held by our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and Named Executive Officers are based on the <FONT
STYLE="white-space:nowrap">200-day</FONT> average stock price as of the measurement date. As of February&nbsp;28, 2022, all of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors had met the required ownership targets, with the
exception of Ms.&nbsp;Wright, who joined the Board in December 2021 and is not required to achieve her stock ownership target until December 2026. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><A NAME="toc282574_4"></A>Board Committees and Meetings </FONT></P> <P STYLE="line-height:3.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board held four meetings during 2021, and all of our directors attended at least 75% of the total meetings of the Board and of the
committees on which they served. The independent directors met four times in regularly scheduled executive sessions. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">During 2021, the
Board had five standing committees: the Audit Committee; the Compensation Committee; the Nominating and Corporate Governance Committee; the Research&nbsp;&amp; Development Committee; and the Risk Committee. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">21</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Committee membership in
2021 was as follows: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">


<TR STYLE="visibility:hidden; line-height:0pt; color:white">

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD nowrap STYLE="font-size:8pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD nowrap STYLE="font-size:8pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD nowrap STYLE="font-size:8pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD nowrap STYLE="font-size:8pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD nowrap STYLE="font-size:8pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Board Member</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f"><B>Audit<BR>Committee</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Compensation</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Committee</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f"><B>Nominating<BR>and&nbsp;Corporate<BR>Governance<BR>Committee</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Research &amp;</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Development<BR>Committee</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f"><B>Risk<BR>Committee</B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Charles Cohen,
Ph.D.&#094;</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member*</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Chair</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Carl B. Feldbaum,
Esq.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Chair</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Maria C. Freire,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alan M. Garber, M.D.,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Chair</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent T. Marchesi,
M.D., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member*</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George Poste, DVM,
Ph.D., FRS</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Chair</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie A.
Smith</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member*</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Lance Willsey,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jacqueline
Wright**</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jack L.
Wyszomierski</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Chair*</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Number of Meetings Held
in Fiscal 2021</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#fc4c02"><B>4</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#fc4c02"><B>16</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#fc4c02"><B>3</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#fc4c02"><B>4</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#fc4c02"><B>2</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#094;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Dr.&nbsp;Cohen is not standing for <FONT STYLE="white-space:nowrap">re-election</FONT> at the
Annual Meeting. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Designated by the Board as an &#147;audit committee financial expert.&#148;
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">**</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Ms.&nbsp;Wright became a director on December&nbsp;16, 2021, and was also appointed to the
Nominating and Corporate Governance Committee and Risk Committee on December&nbsp;16, 2021. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Audit Committee
</FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Audit Committee
assists the Board in overseeing our financial reporting process and ensuring the integrity of our financial statements. The Audit Committee is composed entirely of independent directors and performs several functions, including: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Evaluating the performance, qualifications, compensation and
continued engagement of the independent registered public accounting firm, as well as resolving any disagreements between the independent registered public accounting firm and management</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing our tax strategy, the status of any material tax
audits and proceedings and any other material tax matters</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing, providing oversight of, and approving related person
transactions</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing the financial statements for inclusion in our Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and preparing the Audit Committee&#146;s report for inclusion in our Proxy Statement or Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT></FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Establishing procedures to receive and address complaints
regarding accounting, internal accounting controls or auditing matters</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing the results of the annual audit and the results of our
quarterly financial statement reviews with management and the independent registered public accounting firm</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing our management of risks relating to financial
reporting or fraud, securities trading and tax matters</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Serving as the Qualified Legal Compliance Committee within the
meaning of Rule 205.2(k) of Title 17, Chapter II of the Code of Federal Regulations</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Maintaining compliance with SEC and Nasdaq rules applicable to
audit committees</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing and approving our decisions to enter into certain
swaps and other derivatives transactions, as well as our overall hedging strategy</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">22</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Board Committees and Meetings </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board has determined that each member of the Audit Committee is an
&#147;audit committee financial expert&#148; as defined in applicable SEC rules. Although Mr.&nbsp;Wyszomierski, the Chair of our Audit Committee, also serves as a director and a member of the audit committee for three other publicly traded
companies, he attended all Exelixis Board and Audit Committee meetings during 2021 and makes himself generally available to assist or advise Exelixis management.</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Audit Committee&#146;s report is set forth in &#147;<A HREF="#toc282574_9">Report of the Audit Committee</A>&#148; below. The Audit
Committee has a written charter, which is available on our website at <I>www.exelixis.com</I> under the caption &#147;Investors&nbsp;&amp; Media&#151;Corporate Governance&#151;Committee Composition and Charters.&#148; </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Compensation Committee </FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee assists the Board in overseeing our compensation policies, plans and programs. The Compensation Committee is composed
entirely of independent directors and performs several functions, including: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing and determining the compensation to be paid to
executive officers</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing our Compensation Discussion and Analysis and preparing
the Compensation Committee&#146;s report for inclusion in our Proxy Statement</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Addressing any conflict of interest with any compensation
adviser engaged by management or the Compensation Committee</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Establishing general policies relating to compensation and
benefits of employees, including executive officers</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Evaluating director compensation and recommending any changes to
the Board for approval</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Administering the issuance of equity awards under our stock
plans</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Assisting the Board in its oversight of our policies and
strategies relating to our human capital management function, including recruiting, retention, career development and progression, <FONT STYLE="white-space:nowrap">non-CEO</FONT> management succession, diversity and employment
practices</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Assessing compensation policies and practices in order to
determine whether they are reasonably likely to have a material adverse effect on us.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee&#146;s report is set forth in &#147;<A HREF="#toc282574_32">Compensation Committee Report
</A> &#148; below. Information on the Compensation Committee&#146;s processes and procedures for consideration of executive compensation are addressed in &#147;<A HREF="#tx282574_1003">Compensation Discussion and Analysis</A>&#148; below. For
information regarding our processes and procedures for the consideration and determination of director compensation, please see &#147;<A HREF="#toc282574_6">Compensation of Directors</A>&#148; below. The Compensation Committee has a written charter,
which is available on our website at <I>www.exelixis.com</I> under the caption &#147;Investors&nbsp;&amp; Media&#151;Corporate Governance&#151;Committee Composition and Charters.&#148; In accordance with its charter, the Compensation Committee also
may delegate any of its authority or responsibility to the Chair of the Compensation Committee or to a subcommittee composed of one or more members of the Compensation Committee and/or other members of the Board and/or officers of Exelixis.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#fc7841"><I>Compensation Consultants. </I></FONT><FONT STYLE="font-family:Calibri" COLOR="#3f3f3f">The
Compensation Committee retained Aon&#146;s Human Capital Solutions practice a division of Aon plc (Aon), a compensation consulting firm serving technology and life sciences companies, as its external compensation consultant to assist the
Compensation Committee in its duties related to executive and <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation during 2021. In this capacity, Aon reported directly to the Compensation Committee or through its Chair. In
addition, at the direction of the Compensation Committee, management retained Aon, principally to provide benchmark and industry compensation data for executive and broad-based compensation analyses. In consideration for compensation related
services provided during 2021 we paid Aon an aggregate of $184,842. Aon&#146;s affiliate Radford provided our management with access to the Radford Global Life Sciences Survey, Radford Global Technology Survey, Radford Global Sales Survey, Radford
U.S. Benefits Survey and similar materials, for which we paid Radford an aggregate of $32,695 in 2021. Aon is also an affiliate of Aon Risk Services, which provided insurance brokerage services to us during 2021 at a total cost of $240,000. See
&#147;<A HREF="#tx282574_1003">Compensation Discussion and Analysis</A>&#148; for more information regarding the Compensation Committee&#146;s engagement of Radford. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">23</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Nominating and
Corporate Governance Committee </FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Nominating and Corporate Governance Committee oversees all aspects of our corporate governance functions on behalf of the Board. The Nominating and Corporate Governance Committee is composed entirely of independent directors and
performs several functions, including: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing our governance practices, including reviewing and
recommending to the Board for approval any changes to our corporate governance framework</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Ensuring effective communication between the Board, its
committees and management, as well developing and administering policies and procedures for stockholders&#146; communications to the Board</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Conducting periodic assessments of the performance of the Board
and its committees and compliance with SEC and Nasdaq requirements for independence and expertise</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Facilitating our CEO Succession Plan in the event our Chief
Executive Officer is no longer able to serve in that position</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Identifying, reviewing and evaluating candidates to serve as
directors and recommending qualified candidates to the Board</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Developing a set of Corporate Governance Guidelines, as well as
administering our Corporate Code of Conduct</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Conducting periodic assessments of sustainability strategy and
policies (including ESG matters), and overseeing management in their implementation and the preparation of public disclosures pertaining to ESG programs and sustainability efforts</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Nominating and Corporate Governance Committee has a written charter, which is available on our website at
<I>www.exelixis.com</I> under the caption &#147;Investors&nbsp;&amp; Media&#151;Corporate Governance&#151;Committee Composition and Charters.&#148; </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
STYLE="font-family:Calibri" COLOR="#fc7841"><I>Director Qualifications; Diversity.</I></FONT><FONT STYLE="font-family:Calibri" COLOR="#3f3f3f"> The Nominating and Corporate Governance Committee does not have a fixed set of minimum qualifications for
candidates for membership on the Board. Instead, in considering candidates for directorship, the Nominating and Corporate Governance Committee will generally consider all relevant factors, including the candidate&#146;s applicable expertise and
demonstrated excellence in his or her field, the usefulness of such expertise to us, the availability of the candidate to devote sufficient time and attention to the affairs of Exelixis, the existence of any relationship that would interfere with
the exercise of the candidate&#146;s independent judgment, and the candidate&#146;s demonstrated character and judgment. In addition, the Board believes that its members should reflect a diversity of viewpoints, background, experience and other
characteristics such as gender and race. Accordingly, when evaluating candidates for nomination as new directors, the Nominating and Corporate Governance Committee considers (and will ask any search firm that it engages to provide) candidates who
would contribute to Board diversity, including women and individuals from historically underrepresented communities who meet the relevant business and search criteria. Both the Nominating and Corporate Governance Committee and full Board evaluate
the effectiveness of this diversity policy as part of their periodic performance assessments. In the director candidate review process, the Nominating and Corporate Governance Committee evaluates prospective candidates for directorship in the
context of the existing membership of the Board (including the qualities and skills of the existing directors), our operating requirements and the long-term interests of our stockholders. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Nominating and Corporate Governance Committee regularly evaluates the needs of the Board with respect to skills and experiences that may be
filled by a new director candidate. In addition, the Nominating and Corporate Governance Committee is authorized to access external resources as it deems necessary or appropriate to fulfill its defined responsibilities, including engagement of
executive search firms to help identify director candidates. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#fc7841"><I>Director Nominations. </I></FONT><FONT
STYLE="font-family:Calibri" COLOR="#3f3f3f">The Nominating and Corporate Governance Committee considers and assesses all candidates recommended by our directors, officers and stockholders. Evaluations of candidates generally involve a review of
background materials, internal discussions and interviews with selected candidates as appropriate. If, after its review, the Nominating and Corporate Governance Committee supports a candidate, it would recommend the candidate for consideration by
the full Board. The Nominating and Corporate Governance Committee considers stockholder recommendations for directors using the same criteria as potential nominees recommended by the members of the
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">24</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Board Committees and Meetings </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Nominating and Corporate Governance Committee or others. The Nominating
and Corporate Governance Committee has not received any recommended nominations from any stockholder holding 5% or more of our common stock in connection with the Annual Meeting. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stockholders who wish to recommend individuals for consideration by the Nominating and Corporate Governance Committee to become nominees for
election to the Board may do so by delivering a written recommendation to the Nominating and Corporate Governance Committee within the timeframe specified in our Bylaws that is applicable to matters to be brought before an annual meeting of
stockholders as set forth under &#147;<A HREF="#toc282574_1">Questions and Answers About These Proxy Materials and Voting</A>&#148; above. Such communications should be sent to the following address: Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda,
California 94502, Attn: Nominating and Corporate Governance Committee of the Board. Submissions must include (a)&nbsp;the name, age, business address and residence address of such person, (b)&nbsp;the principal occupation or employment of such
person, (c)&nbsp;the class and number of shares of the corporation which are beneficially owned by such person, (d)&nbsp;a description of all arrangements or understandings between the stockholder and each nominee and any other person or persons
(naming such person or persons) pursuant to which the nominations are to be made by the stockholder, (e)&nbsp;a statement whether such person, if elected, intends to comply with our Corporate Governance Guidelines, including with respect to matters
relating to the election of directors, and (f)&nbsp;any other information relating to such person that is required to be disclosed in solicitations of proxies for election of directors, or is otherwise required, in each case pursuant to
Regulation&nbsp;14A under the 1934 Act (including without limitation such person&#146;s written consent to being named in the proxy statement, if any, as a nominee and to serving as a director if elected). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#fc7841"><I>Performance Assessments.</I></FONT><FONT STYLE="font-family:Calibri" COLOR="#3f3f3f"> The Nominating and Corporate
Governance Committee performs periodic assessments of the performance of the Board and its committees. As part of this process, each director, under the direction of the Nominating and Corporate Governance Committee, completes an annual assessment
questionnaire for the full Board and each committee on which such director serves to evaluate, anonymously, the overall performance of the Board and its committees and identify areas for improvement. The factors considered in the annual assessment
questionnaires include, but are not limited to: the appropriateness of the size of the Board; whether the directors possess the skills and expertise appropriate for the company; the effectiveness of the Board&#146;s selection criteria for new
director candidates (including with respect to the Board&#146;s diversity policy); the overall effectiveness of and efficient use of time at Board and committee meetings; and the process for management to report important information to committees
or the full Board, as appropriate. The annual assessment questionnaires also provide each director with an opportunity to provide open-ended responses with respect to ways to improve Board and/or committee performance. In addition, as part of the
performance assessment process during certain years, each director will interview with an independent legal counsel to the Board to discuss his or her perspectives about the Board&#146;s performance, as well as corporate governance goals and
potential risks facing the company, and summaries of these interviews are then reported to the Board. The Nominating and Corporate Governance Committee and the full Board also seek input from management and external advisors as part of the
performance assessment process. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Research&nbsp;&amp; Development Committee </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Research&nbsp;&amp; Development
Committee assists the Board in overseeing various scientific matters related to our drug discovery and preclinical and clinical development programs. The Research&nbsp;&amp; Development Committee is composed entirely of independent directors and
performs several functions, including: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing our clinical development program and internal drug
discovery activities</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Evaluating and discussing trends in the oncology treatment
landscape and potential effects on our pipeline strategy and other business needs</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing the progress of preclinical assets that we have <FONT
STYLE="white-space:nowrap">in-licensed</FONT> or acquired and evaluating potential future business development opportunities</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Advising the Board on other matters of scientific importance
as the Board, in consultation with management, may designate from time to time</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">25</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Risk Committee
</FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Risk Committee of the
Board assists the Board in overseeing management&#146;s responsibility to assess, manage and mitigate risks associated with our business and operational activities. The Risk Committee is composed entirely of independent directors and performs
several functions, including: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing our overall risk management framework and
infrastructure designed to identify, assess, manage and mitigate our material risks</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing management&#146;s administration of our various
compliance programs, including, but not limited to, those relating to data privacy (including cybersecurity), drug safety, healthcare compliance and quality management</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing the policies, guidelines and practices aimed at the
management of business and operational risks</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing management&#146;s administration of government and
other investigations and material litigation matters</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing management&#146;s identification, assessment and
management of our business and operational risks not specifically allocated to the Board or another committee of the Board, and obtaining periodic reports from our Ethics Committee</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Evaluating and discussing trends in the relevant areas of
risk management and advising the Board on best practices with respect to risk management strategy and implementation</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_5"></A>Annual Meeting; Attendance </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board does not have a formal
policy with respect to the attendance of its members at Annual Meetings of Stockholders. Drs. Papadopoulos, Cohen and&nbsp;Morrissey were in attendance at the 2021 Annual Meeting of Stockholders. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">26</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Directors </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_6"></A>COMPENSATION OF DIRECTORS </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Overview of Director Compensation </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The compensation program for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors is intended to be competitive and fair so that we can attract optimal talent to our Board and recognize the time and effort required of
a director given the size and complexity of our operations. In accordance with its charter, our Compensation Committee is responsible for recommending to the Board for approval the annual compensation for our
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors and acts on behalf of the Board in discharging the Board&#146;s responsibilities with respect to overseeing our compensation policies for
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors. To assist with the Compensation Committee&#146;s and the Board&#146;s review, the Compensation Committee&#146;s external compensation consultant prepares a comprehensive annual
assessment of our <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation program. The assessment includes benchmarking director compensation against the same 2021 peer group used for executive compensation purposes, an update in
recent trends in director compensation and a review of related corporate governance best practices. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Cash Compensation
Arrangements </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Each <FONT STYLE="white-space:nowrap">non-employee</FONT> director receives an annual cash retainer for his or her
service on the Board, as well as an additional annual cash retainer if he or she serves as the Chair of the Board, on a committee or as the chair of a committee. In addition, our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors receive
meeting fees for attendance at each Board meeting or at each of their respective committee meetings in excess of the <FONT STYLE="white-space:nowrap">pre-determined</FONT> number of meetings for the fiscal year, which is included in the full
description of the 2021 cash compensation arrangements for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in the table below. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The table below provides information regarding the cash compensation arrangements for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for 2021. Dr.&nbsp;Morrissey receives no compensation in his capacity as a
member of the Board. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD style="width:41pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:41pt"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Service</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02"><B>Fee Type</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#fc4c02"><B>Cash&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#fc4c02"><B>Compensation&nbsp;($)&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Board</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">31,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(2)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,500&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Audit Committee</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">12,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">13,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(3)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Compensation Committee</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(3)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Nominating&nbsp;&amp; Corporate Governance Committee</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Research&nbsp;&amp; Development Committee</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Risk Committee</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(4)</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Meeting for which minutes are generated count toward the meeting threshold to determine when
Meeting Fees are to be paid. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Meeting Fee paid for all meetings in excess of eight meetings. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Meeting Fee paid for all meetings in excess of seven meetings. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Meeting Fee paid for all meetings in excess of four meetings. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All cash compensation is paid to each director in arrears on a quarterly basis for services performed during the prior fiscal quarter.
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">27</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx282574_1006"></A>Equity Compensation Arrangements </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors are also eligible to receive equity as part of their Board service, including
an initial award upon joining the Board and an annual award on the day following each annual meeting of stockholders. Grants to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors are made under our 2017 Equity Incentive Plan (2017
Plan), pursuant to the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Equity Compensation Policy, as amended (Directors&#146; Policy), as adopted by the Board.&nbsp;To address changes in the trading price of our common stock, we
utilize a value-based approach for determining the number of shares subject to <FONT STYLE="white-space:nowrap">non-employee</FONT> director equity awards. Under the terms of the Directors&#146; Policy, the aggregate value of each <FONT
STYLE="white-space:nowrap">one-time</FONT> initial award is $680,000, and the aggregate value of each annual award is $400,000. The value of each initial award and annual award is then divided approximately evenly between a nonstatutory stock option
and a restricted stock unit (RSU) award. However, each <FONT STYLE="white-space:nowrap">non-employee</FONT> director may instead elect to receive the full value of his or her annual award in the form of either RSUs or nonstatutory stock options.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Under the Directors&#146; Policy, the total number of options and RSUs granted as part of each initial award and annual award is
determined using a formula based upon the Black-Scholes Merton option pricing model and the average of the daily closing sale prices of our common stock for the trading days during the <FONT STYLE="white-space:nowrap">30-day</FONT> calendar period
ending on (and including) the last calendar day immediately prior to the relevant grant date. The value of each award, as determined in accordance with the Directors&#146; Policy, may be greater or lesser than the grant date fair value computed for
financial reporting purposes and reflected in the &#147;<A HREF="#toc282574_7">Director Compensation Table</A>&#148; below. This is a result of the different calculation employed to determine the grant date fair value, which uses a formula based
upon the Black-Scholes Merton option pricing model and the closing sale price of our common stock on the grant date. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Options granted
under the 2017 Plan in accordance with the Directors&#146; Policy are not incentive stock options under the Internal Revenue Code of 1986, as amended (the Code). The exercise price of each initial and annual stock option granted under the 2017 Plan
is equal to 100% of the fair market value of a share of common stock on the grant date. Under the terms of the Directors&#146; Policy, the <FONT STYLE="white-space:nowrap">one-time</FONT> initial options are immediately exercisable, but shares
issued upon early exercise are subject to a repurchase right and will vest at the rate of 25% of the underlying shares on the first anniversary of the grant date and monthly thereafter over the next three years. The annual options are immediately
exercisable, but shares issued upon early exercise are subject to a repurchase right and will vest at the rate of 100% of the underlying shares on the first anniversary of the grant date. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">As long as the <FONT STYLE="white-space:nowrap">non-employee</FONT> director continues to serve with us or with an affiliate of ours, the options
continue to vest and be exercisable during their terms, and shares issued upon early exercise continue to vest. When the option holder&#146;s service terminates, we have the right to repurchase any unvested shares acquired upon exercise of the
option at the original exercise price without interest. The post-termination exercise period for the vested portion of options granted to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors is generally set to terminate the earlier of
three years after a <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s service terminates or the remainder of the term of the option, as described in the form of option agreement for
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors under the 2017 Plan (not to exceed seven years from the date of grant). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The initial RSU awards vest at the rate of 25% of the underlying shares on each of the first four anniversaries of the grant date, and the annual
RSU awards vest at the rate of 100% of the underlying shares on the first anniversary of the grant date, in each case so long as the <FONT STYLE="white-space:nowrap">non-employee</FONT> director continues to serve with us or with an affiliate of
ours. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In the event of a change in control, 100% of the <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s
outstanding and unvested equity awards will immediately vest, and any applicable repurchase rights we may have will terminate. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">On
December&nbsp;16, 2021, Ms.&nbsp;Wright joined the Board and became eligible to receive an initial equity award having an aggregate value equal to approximately $680,000, pursuant to the terms of the Directors&#146; Policy. Accordingly, on
December&nbsp;16, 2021, the Board granted Ms.&nbsp;Wright a <FONT STYLE="white-space:nowrap">one-time</FONT> initial award, the value of which was divided approximately evenly between a nonstatutory stock option and an RSU award consisting of
(i)&nbsp;an option to purchase 41,717 shares of our common stock and (ii)&nbsp;an RSU award representing 20,858 shares of our common stock. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>Reimbursement of Expenses </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The members of the Board are eligible for reimbursement of certain expenses
incurred in connection with their attendance at Board meetings and their service on the Board in accordance with our policy. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">28</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Directors </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Meaningful Limits on Director Compensation </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The aggregate value of all compensation granted or paid to any individual solely for service as a
<FONT STYLE="white-space:nowrap">non-employee</FONT> director may not exceed (a) $750,000 in total value with respect to any calendar year after a <FONT STYLE="white-space:nowrap">non-employee</FONT> director is first appointed or elected to the
Board or (b) $1,500,000 in total value with respect to the calendar year during which a <FONT STYLE="white-space:nowrap">non-employee</FONT> director is first appointed or elected to the Board, in each case calculating the value of any stock awards
based on the grant date fair value of such awards for financial reporting purposes. These limits on <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation were approved by our stockholders and are included in our 2017 Plan.
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_7"></A>Director Compensation Table </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table shows
compensation information for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for the fiscal year ended December&nbsp;31, 2021. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Director Compensation for Fiscal 2021 </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Fees&nbsp;Earned&nbsp;or<BR>Paid&nbsp;in&nbsp;
Cash<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock&nbsp;Awards<BR>($)(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option&nbsp;Awards<BR>($)(2)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Total</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Charles Cohen,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">96,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">353,120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">449,120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Carl B. Feldbaum,
Esq.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">353,120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">423,120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Maria C. Freire,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">65,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">186,562</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">174,702</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">426,264</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alan M. Garber, M.D.,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">353,120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">423,120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent T. Marchesi,
M.D., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">74,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">186,562</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">174,702</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">435,264</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">98,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">369,212</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">467,212</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George Poste, DVM,
Ph.D., FRS</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">369,212</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">439,212</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie A.
Smith</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">369,212</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">449,212</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Lance Willsey,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">72,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">353,120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">425,120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jacqueline Wright
(3)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">367,727</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">336,193</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">703,920</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jack L.
Wyszomierski</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">186,562</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">174,702</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">441,264</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">On May&nbsp;27, 2021, each of Drs. Freire, Marchesi, Papadopoulos and Poste, Ms.&nbsp;Smith, and
Mr.&nbsp;Wyszomierski were granted an RSU award pursuant to the Directors&#146; Policy. Each of Drs. Papadopoulos and Poste, and Ms.&nbsp;Smith elected to receive 100% of their annual award in the form of RSU awards, while each of Drs. Freire and
Marchesi, and Mr.&nbsp;Wyszomierski elected to receive approximately 50% of their annual award in the form of an RSU award and 50% of their annual award in the form of options to purchase our common stock. Amounts shown in this column reflect the
grant date fair value of the RSU award as computed in accordance with Financial Accounting Standards Board, Accounting Standards Codification Topic 718 (ASC 718). See &#147;<A HREF="#tx282574_1006">Equity Compensation Arrangements</A>&#148; above
for a description of the RSU awards made to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors on May&nbsp;27, 2021. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Only one RSU award was granted to each of Drs. Freire, Marchesi, Papadopoulos and Poste,
Mses.&nbsp;Smith and Wright and Mr.&nbsp;Wyszomierski during fiscal 2021 and, accordingly, the grant date fair value of that RSU award is reflected in the table. The aggregate number of shares subject to all RSUs held by each of these <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors as of December&nbsp;31, 2021, is as follows: Dr.&nbsp;Freire&#151;11,829 Dr.&nbsp;Marchesi&#151;8,299; Dr.&nbsp;Papadopoulos&#151;16,424; Dr.&nbsp;Poste&#151;16,424;
Ms.&nbsp;Smith&#151;16,424; Ms.&nbsp;Wright&#151;20,858 and Mr.&nbsp;Wyszomierski&#151;8,299. None of the other <FONT STYLE="white-space:nowrap">non-employee</FONT> directors received any RSU awards during fiscal 2021, and none of the other <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors held any outstanding RSU or other stock awards as of December&nbsp;31, 2021. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">On May&nbsp;27, 2021, seven of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors
were granted an option to purchase our common stock pursuant to the Directors&#146; Policy. Each of Drs. Cohen, Garber and Willsey, and Mr.&nbsp;Feldbaum elected to receive 100% of their annual award in the form of options to purchase our common
stock, while each of Drs. Freire and Marchesi, and Mr.&nbsp;Wyszomierski elected to receive approximately 50% of their annual award in the form of options to purchase our common stock and approximately 50% of their annual award in the form of an RSU
award. Amounts shown in this column reflect the aggregate grant date fair value for the option awards granted in fiscal 2021 as computed in </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">29</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">accordance with ASC 718. The assumptions used to calculate the value of option awards are set forth in Note 8 of the Notes to Consolidated Financial Statements included in our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021, filed with the SEC on February&nbsp;18, 2022. There can be no assurance that the options will ever be exercised (in which case no value will actually be
realized by the director) or that the value on exercise of stock options will be equal to the grant date fair value shown in this column. See &#147;<A HREF="#tx282574_1006">Equity Compensation Arrangements</A>&#148; above for a description of the
option grants made to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors on May&nbsp;27, 2020. </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Only one stock option award was granted to each of Drs. Cohen, Freire, Garber, Marchesi and
Willsey, Ms.&nbsp;Wright, and Messrs.&nbsp;Feldbaum and Wyszomierski during fiscal 2021 and, accordingly, the grant date fair value of that stock option is reflected in the table. The aggregate number of shares subject to all stock options held by
each of our current <FONT STYLE="white-space:nowrap">non-employee</FONT> directors as of December&nbsp;31, 2021, is as follows: Dr.&nbsp;Cohen&#151;161,598; Mr.&nbsp;Feldbaum&#151;221,598; Dr.&nbsp;Freire&#151;96,802; Dr.&nbsp;Garber&#151;241,598;
Dr.&nbsp;Marchesi&#151;80,248; Dr.&nbsp;Papadopoulos&#151;48,194; Dr.&nbsp;Poste&#151;88,194; Ms.&nbsp;Smith&#151;139,919; Dr.&nbsp;Willsey&#151;241,598; Ms.&nbsp;Wright&#151;41,717; and Mr.&nbsp;Wyszomierski&#151;160,248.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">On December&nbsp;16, 2021, Ms.&nbsp;Wright was granted an RSU award representing 20,858 shares of
our common stock and an option to purchase 41,717 shares or our common stock, together comprising her initial award in connection with her joining the Board. The grant date fair value of the RSU component of her initial award was $367,727, and the
grant date fair value of the option component of her initial award was $336,193, in each case as computed in accordance with ASC 718. The assumptions used to calculate the value of this option award are set forth in Note 8 of the Notes to
Consolidated Financial Statements included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021, filed with the SEC on February&nbsp;18, 2022. There can be no assurance that the
option will ever be exercised (in which case no value will actually be realized by Ms.&nbsp;
Wright) or that the value on exercise of the stock option will be equal to the grant date fair value described above. See &#147;<A HREF="#tx282574_1006">Equity Compensation Arrangements</A>&#148; above for a description of the initial award granted
to Ms.&nbsp;Wright on December&nbsp;16, 2021. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">30</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 2&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Ratification of Selection of Independent Registered Public Accounting Firm </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_8"></A>P<SMALL>ROPOSAL</SMALL> 2 </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#6d6d6d">R<SMALL>ATIFICATION</SMALL> <SMALL>OF</SMALL> S<SMALL>ELECTION</SMALL> <SMALL>OF</SMALL> I<SMALL>NDEPENDENT</SMALL> R<SMALL>EGISTERED</SMALL>
P<SMALL>UBLIC</SMALL> A<SMALL>CCOUNTING</SMALL> F<SMALL>IRM</SMALL> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Audit Committee of the Board has selected Ernst&nbsp;&amp;
Young LLP as Exelixis&#146; independent registered public accounting firm for the fiscal year ending December&nbsp;30, 2022. The Board, on behalf of the Audit Committee, has further directed that management submit the selection of the independent
registered public accounting firm for ratification by the stockholders at the Annual Meeting. Ernst&nbsp;&amp; Young LLP has audited our financial statements for each of the <FONT STYLE="white-space:nowrap">twenty-one</FONT> fiscal years in the
period ended December&nbsp;31, 2021. Representatives of Ernst&nbsp;&amp; Young LLP are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate
questions. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Neither our Bylaws nor other governing documents or law require stockholder ratification of the selection of
Ernst&nbsp;&amp; Young LLP as Exelixis&#146; independent registered public accounting firm. However, the Board is submitting the selection of Ernst&nbsp;&amp; Young LLP to the stockholders for ratification as a matter of good corporate governance.
If the stockholders fail to ratify the selection, the Audit Committee of the Board will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee of the Board in its discretion may direct the appointment
of a different independent registered public accounting firm at any time during the year if they determine that such a change would be in the best interests of Exelixis and its stockholders. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The affirmative vote of the holders of a majority of the shares present or represented by proxy at the Annual Meeting and entitled to vote on
this proposal is required to ratify the selection of Ernst&nbsp;&amp; Young LLP. Abstentions will be counted toward the tabulation of votes cast on this proposal and will have the same effect as votes against this proposal. Broker <FONT
STYLE="white-space:nowrap">non-votes,</FONT> if any, will have no effect. </FONT></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;background-color:#e5e5e5;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#fc4c02"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; PROPOSAL 2. </B></FONT></P></div>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Principal Accountant Fees and Services </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The aggregate fees billed by Ernst&nbsp;&amp; Young LLP for the last two fiscal years (fiscal 2021, which ended on December 31, 2021, and fiscal 2020, which ended on January 1, 2021) for the services described below are as follows:
</FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Fiscal Year Ended</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:1pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">December&nbsp;31,<BR>2021</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">January&nbsp;1,<BR>2021</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Audit fees (1)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,567,500</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,076,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Audit-related fees (2)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">22,500</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Tax fees:</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">660,068</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">477,736</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax compliance fees (3)</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>211,150</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>132,200</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other tax fees (4)</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>448,918</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>345,536</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All other fees (5)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3,360</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">6,010</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>&nbsp;&nbsp;&nbsp;&nbsp;Total
Fees</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>$</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>3,253,428</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B></B>&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>$</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>2,639,746</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B></B>&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Audit fees&#148; consist of fees billed for professional services rendered for the audit of
our consolidated financial statements and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided by Ernst&nbsp;&amp; Young LLP in connection with statutory and regulatory filings
and other engagements such as consents and review of documents filed with the SEC. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Audit-related fees&#148; consist of fees billed for assurance and related services that are
reasonably related to the performance of the audit or review of our consolidated financial statements and are not reported under &#147;Audit fees.&#148; During fiscal 2021 and 2020 these services included consultations relating to various
transactions. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">31</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Tax compliance fees&#148; consist of fees for tax compliance and tax preparation.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Other tax fees&#148; consist of fees for tax advice and tax planning.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;All other fees&#148; consist of fees for products and services other than the services
described above. During fiscal 2021 and 2020, these fees related to an <FONT STYLE="white-space:nowrap">on-line</FONT> subscription to an Ernst&nbsp;&amp; Young LLP database. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All fees described above were <FONT STYLE="white-space:nowrap">pre-approved</FONT> by the Audit Committee. The Audit Committee has determined
that the rendering of the services other than audit services by Ernst&nbsp;&amp; Young LLP is compatible with maintaining the independence of the independent registered public accounting firm. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><FONT STYLE="white-space:nowrap">Pre-Approval</FONT> of Services </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">During 2021 and 2020, the Audit Committee of the Board <FONT STYLE="white-space:nowrap">pre-approved</FONT> the audit and <FONT
STYLE="white-space:nowrap">non-audit</FONT> services to be performed by Exelixis&#146; independent registered public accounting firm, Ernst&nbsp;&amp; Young LLP. <FONT STYLE="white-space:nowrap">Non-audit</FONT> services are defined as services
other than those provided in connection with an audit or a review of our financial statements. The Audit Committee <FONT STYLE="white-space:nowrap">pre-approves</FONT> all audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services rendered
by Ernst&nbsp;&amp; Young LLP. The Audit Committee generally <FONT STYLE="white-space:nowrap">pre-approves</FONT> specified services in the defined categories of audit services, audit-related services, tax services and all other services up to
specified amounts. <FONT STYLE="white-space:nowrap">Pre-approval</FONT> may also be given as part of the Audit Committee&#146;s approval of the scope of the engagement of the independent registered public accounting firm or on an individual explicit
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis before the independent auditor is engaged to provide each service. The Audit Committee or its Chair, whom the Audit Committee has designated as a <FONT
STYLE="white-space:nowrap">one-person</FONT> subcommittee with <FONT STYLE="white-space:nowrap">pre-approval</FONT> authority, <FONT STYLE="white-space:nowrap">pre-approved</FONT> all audit fees, audit-related fees, tax fees and other fees in 2021
and 2020. Any <FONT STYLE="white-space:nowrap">pre-approvals</FONT> by the subcommittee must be and were presented to the Audit Committee at its next scheduled meeting. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">32</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Report of the Audit Committee </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_9"></A>R<SMALL>EPORT</SMALL> <SMALL>OF</SMALL>
<SMALL>THE</SMALL> A<SMALL>UDIT</SMALL> C<SMALL>OMMITTEE</SMALL> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>The material in this report is not &#147;soliciting
material,&#148; is not deemed &#147;filed&#148; with the Securities and Exchange Commission and is not deemed to be incorporated by reference in any filing of Exelixis under the Securities Act of 1933, as amended, or the Securities Exchange Act of
1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing. </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">In connection with the audited consolidated financial statements for the fiscal year ended December&nbsp;31, 2021, of Exelixis, Inc. (&#147;Exelixis&#148;), the Audit Committee of the Board of Directors of Exelixis has: </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(1) reviewed and discussed the audited financial statements for the fiscal year ended December&nbsp;31, 2021, with management of
Exelixis; </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(2) discussed with Ernst&nbsp;&amp; Young LLP, Exelixis&#146; independent registered public accounting firm
(&#147;Ernst&nbsp;&amp; Young&#148;), the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (&#147;PCAOB&#148;) and the SEC; and </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(3)&nbsp;received the written disclosures and the letter from Ernst&nbsp;&amp; Young required by the applicable requirements of
the PCAOB regarding Ernst&nbsp;&amp; Young&#146;s communications with the Audit Committee concerning independence, and has discussed with Ernst&nbsp;&amp; Young that accounting firm&#146;s independence. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Based on the foregoing, the Audit Committee has recommended to the Board of Directors that the audited financial statements be included in
Exelixis&#146; Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Audit Committee: </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Jack L.
Wyszomierski, Chair </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Charles Cohen </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Stelios Papadopoulos </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Julie A. Smith </I></FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">33</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_10"></A>P<SMALL>ROPOSAL</SMALL> 3 </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#6d6d6d">A<SMALL>MENDMENT</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATEMENT</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> E<SMALL>XELIXIS</SMALL>,
I<SMALL>NC</SMALL>. 2017 E<SMALL>QUITY</SMALL> I<SMALL>NCENTIVE</SMALL> P<SMALL>LAN</SMALL> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board approved an amendment and
restatement of the 2017 Plan in April 2022, subject to approval by our stockholders. For purposes of this Proposal 3, we refer to the 2017 Plan, as amended and restated by the Board in April 2022, as the &#147;Amended 2017 Plan.&#148; We are asking
our stockholders to approve the Amended 2017 Plan at the Annual Meeting. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Amended 2017 Plan contains the following material
changes from the 2017 Plan: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f">Subject to adjustment for certain changes in our capitalization, the aggregate number of shares of
our common stock that may be issued under the 2017 Plan has been increased by 28,500,000 shares under the Amended 2017 Plan. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f">The multiplier used in the &#147;fungible share counting&#148; structure further described below
was increased from 1.5 under the 2017 Plan to 2 under the Amended 2017 Plan. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Why We Are Asking Our Stockholders
to Approve the Amended 2017 Plan </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We are seeking stockholder approval of the Amended 2017 Plan to increase the number of shares
available for the grant of stock options, RSU awards and other awards of company equity to our employees and directors. By adding additional shares to our equity incentive program, we will be able to continue competing for key talent in our highly
competitive industry. The Compensation Committee is closely involved in the determination of what type and value of equity compensation is necessary and appropriate to attract and incentivize the services of key employees and directors, and to
provide long-term incentives that align the interests of our employees and directors with the interests of our stockholders. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Requested Share Increase </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Subject to adjustment for certain changes in our capitalization, if this Proposal 3 is approved by our stockholders, we will have 28,500,000 new shares available for grant under the Amended 2017 Plan after the Annual Meeting.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The rate at which we utilize and exhaust the shares available in our equity incentive program is determined by many factors,
including changes in our stock price and the rate of growth of our employee headcount. We are not presently able to forecast how long the new pool of shares will last, permitting us to attract and retain top talent. However, based on historic
utilization and other factors, the Board determined that our request for 28,500,000 new shares under the Amended 2017 Plan is an appropriate amount that we believe a majority of our institutional investors would support. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Why You Should Vote to Approve the Amended 2017 Plan </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Equity Awards Are an Important Part of Our Compensation Philosophy </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board believes that our future success depends, in large part, on our ability to maintain a competitive position in attracting, retaining and
motivating employees and directors. The Board believes that the grant of equity awards is a key element underlying our ability to attract, retain and motivate employees and directors, and better aligns the interests of our employees and directors
with those of our stockholders. The Amended 2017 Plan will allow us to continue to provide equity-based incentives to our employees and directors. Therefore, the Board believes that the Amended 2017 Plan is in the best interests of Exelixis and our
stockholders and recommends a vote in favor of this Proposal 3. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>We Have Experienced and Expect to Continue to Experience
Substantial Growth in Our Business </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Recent progress in our product development programs has driven growth in the number of our
employees. As of January&nbsp;1, 2021, we had 773 employees, compared to 954 employees as of December&nbsp;31, 2021, and 986 employees as of the Record Date (in each case, including full-time and part-time employees). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board believes that the Amended 2017 Plan is necessary to ensure that the number of shares available for issuance pursuant to equity awards
will be sufficient to allow us to continue to attract, retain and motivate the services of talented individuals essential to our long-term growth and financial success. The Board strongly believes that the grant of equity
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">34</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 3&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Amendment and Restatement of 2017 Equity Incentive Plan </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">awards is a key element underlying our ability to attract, retain and
motivate our employees, including our executives, and our directors, and is a substantial contributing factor to our success and the growth of our business. We have relied significantly on equity awards in the form of stock options and RSU awards to
attract, retain and motivate key employees, and we believe that equity awards are necessary for us to remain competitive in the marketplace for executive talent and other employees. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>We Manage Our Equity Award Use Carefully and Dilution Is Reasonable </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We believe that equity awards such as stock options and RSU awards are a vital part of our overall compensation program, and we grant awards to
substantially all of our employees. However, we recognize that this compensation philosophy dilutes existing stockholders, and, therefore, we must responsibly manage the growth of our equity compensation program. We are committed to monitoring our
equity compensation share reserve carefully, including our &#147;burn rate,&#148; to ensure that we maximize stockholders&#146; value by granting the appropriate number of equity awards necessary to attract, retain and motivate our employees and
directors. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>The Size of Our Share Reserve Increase Request Is Reasonable </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Subject to adjustment for certain changes in our capitalization, if this Proposal 3 is approved by our stockholders, we will have 28,500,000 new
shares available for grant under the Amended 2017 Plan after the Annual Meeting (for a total of approximately 32,526,530 shares available for grant under the Amended 2017 Plan after the Annual Meeting (based on the number of shares available for
grant under the 2017 Plan as of the Record Date) (plus the Prior Plans&#146; Returning Shares (as defined below), as such shares become available from time to time)). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board believes that our request for 28,500,000 new shares under the Amended 2017 Plan is necessary to provide an appropriate amount of equity
awards for attracting, retaining, and motivating our employees and directors in accordance with our business plans, and is an amount that we believe a majority of our institutional investors would support. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>The Amended 2017 Plan Combines Compensation and Governance Best Practices </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Amended 2017 Plan includes provisions that are designed to protect our stockholders&#146; interests and to reflect corporate governance best
practices including: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>No liberal share counting or recycling</I>. The following shares will not become available again
for issuance under the Amended 2017 Plan: (i)&nbsp;shares that are reacquired or withheld (or not issued) by us to satisfy the exercise or purchase price of a stock award; (ii)&nbsp;shares that are reacquired or withheld (or not issued) by us to
satisfy a tax withholding obligation in connection with stock options or stock appreciation rights; (iii)&nbsp;shares repurchased by us on the open market with the proceeds of the exercise price of a stock option or stock appreciation right; and
(iv)&nbsp;the gross number of shares subject to a stock appreciation right in the event that such stock appreciation right is settled in shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Fungible share counting</I>. The Amended 2017 Plan contains a fungible share counting structure,
whereby the number of shares of our common stock available for issuance under the Amended 2017 Plan will be reduced by: (i)&nbsp;1 share for each share issued pursuant to an &#147;appreciation award&#148; (which is a stock option or a stock
appreciation right with respect to which the exercise or strike price is at least 100% of the fair market value of our common stock on the date of grant) granted under the Amended 2017 Plan; (ii) 1.5 shares for each share issued pursuant to a
&#147;full value award&#148; (which is a stock award that is not an appreciation award) granted under the Amended 2017 Plan prior to May&nbsp;25, 2022; and (iii)&nbsp;2 shares for each share issued pursuant to a full value award granted under the
Amended 2017 Plan on or after May&nbsp;25, 2022. As part of such fungible share counting structure, the number of shares of our common stock available for issuance under the Amended 2017 Plan will be increased by: (i)&nbsp;1 share for each share
that becomes available again for issuance under the terms of the Amended 2017 Plan subject to an appreciation award; (ii) 1.5 shares for each share that becomes available again for issuance under the terms of the Amended 2017 Plan subject to a full
value award prior to May&nbsp;25, 2022; and (iii)&nbsp;2 shares for each share that becomes available again for issuance under the terms of the Amended 2017 Plan subject to a full value award on or after May&nbsp;25, 2022.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Minimum vesting requirements</I>. The Amended 2017 Plan provides that no award may vest until at
least 12 months following the date of grant of the award;<I></I><I>&nbsp;provided, however</I>, that shares up to 5% of the aggregate number of shares that may be issued under the Amended 2017 Plan may be issued pursuant to awards which do not meet
such vesting requirements. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">35</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Maximum 7-year term for stock options and stock appreciation rights</I>.&nbsp;The Amended 2017
Plan provides that no stock option or stock appreciation right may have a term longer than 7 years. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Restrictions on dividends</I>.&nbsp;The Amended 2017 Plan provides that (i)&nbsp;no dividends or
dividend equivalents may be paid with respect to any shares subject to an award before the date such shares have vested, (ii)&nbsp;any dividends or dividend equivalents that are credited with respect to any such shares will be subject to all of the
terms and conditions applicable to such shares under the terms of the applicable award agreement (including any vesting conditions), and (iii)&nbsp;any dividends or dividend equivalents that are credited with respect to any such shares will be
forfeited to us on the date such shares are forfeited to or repurchased by us due to a failure to vest. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Awards subject to forfeiture/clawback</I>. Awards granted under the Amended 2017 Plan will be
subject to recoupment in accordance with (i)&nbsp;the Clawback Policy and (ii)&nbsp;any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are
listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, the Board may impose other clawback, recovery or recoupment provisions in an award agreement, including a
reacquisition right in respect of previously acquired shares or other cash or property upon the occurrence of cause. For additional information on the Clawback Policy, please see &#147;<A HREF="#tx282574_r36">Compensation Discussion and Analysis&#151;Other
 Compensation Information&#151;Clawback Policy</A>.&#148; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Repricing not allowed</I>. The Amended 2017 Plan prohibits the repricing of outstanding stock
options and stock appreciation rights and the cancellation of any outstanding stock options or stock appreciation rights that have an exercise price greater than the then-current fair market value of our common stock in exchange for cash or other
awards under the Amended 2017 Plan without prior stockholder approval. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>No liberal change in control definition</I>. The change in control definition in the Amended
2017 Plan is not a &#147;liberal&#148; definition. A change in control transaction must actually occur in order for the change in control provisions in the Amended 2017 Plan to be triggered. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Limit
on</I><I></I><I><FONT STYLE="white-space:nowrap">&nbsp;non-employee</FONT></I><I></I><I>&nbsp;director compensation</I>. The maximum number of shares subject to stock awards granted during any calendar year to any of
<FONT STYLE="white-space:nowrap">our&nbsp;non-employee&nbsp;directors,</FONT> taken together with any cash fees paid by Exelixis to <FONT STYLE="white-space:nowrap">such&nbsp;non-employee&nbsp;director</FONT> during such calendar year, may not
exceed $750,000 in total value, or $1,500,000 in total value with respect to the calendar year in which the individual is first appointed or elected to the Board (calculating the value of any such stock awards based on the grant date fair value of
such stock awards for financial reporting purposes). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Overhang </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table provides certain additional information regarding our equity incentive program. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">As&nbsp;of&nbsp;Record&nbsp;Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Total number of shares of
common stock subject to outstanding stock options</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">12,734,196</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Weighted-average exercise
price of outstanding stock options</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$16.74</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Weighted-average
remaining term of outstanding stock options</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3.34 years</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Total number of shares of
common stock subject to outstanding full value awards</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">17,409,112</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Total number of shares of
common stock available for grant under the 2017 Plan (1)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,026,530</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Total number of shares of
common stock outstanding</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">320,182,340</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><FONT
STYLE="white-space:nowrap">Per-share&nbsp;closing</FONT> price of common stock as reported on Nasdaq Global Select Market</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$21.75</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">As of the Record Date, there were no shares of common stock available for grant under any of our
equity incentive plans other than the 2017 Plan, as described in this table. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">36</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 3&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Amendment and Restatement of 2017 Equity Incentive Plan </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Burn Rate </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table provides detailed information regarding the activity related to our equity incentive plans for fiscal years 2021, 2020 and
2019. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Fiscal Year<BR>2021</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Fiscal Year<BR>2020</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Fiscal Year<BR>2019</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Total number of shares
of common stock subject to appreciation awards granted</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,573,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,637,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,311,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Total number of shares
of common stock subject to full value awards granted</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">6,276,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7,709,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,842,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Weighted-average number
of shares of common stock outstanding</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">314,884,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">308,271,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">302,584,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Adjusted Burn Rate
(1)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4.80%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5.53%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4.29%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Unadjusted Burn Rate
(2)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2.81%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3.03%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2.36%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Adjusted Burn Rate is calculated as: (shares subject to appreciation awards granted + 2 (shares
subject to full value awards granted))/weighted average common stock outstanding. For purposes of this calculation, shares subject to full value awards granted are increased by a 2.0x volatility multiplier for each of fiscal years 2019-2021. The
share reserve under the 2017 Plan is reduced by 1.5 shares for each share issued pursuant to a full value award.</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Unadjusted Burn Rate is calculated as: (shares subject to appreciation awards granted + shares
subject to full value awards granted)/weighted average common stock outstanding. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Stockholder Approval
</B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If this Proposal 3 is approved by our stockholders, the Amended 2017 Plan will become effective as of the date of the Annual
Meeting. In the event that our stockholders do not approve this Proposal 3, the Amended 2017 Plan will not become effective and the 2017 Plan will continue to be effective in accordance with its terms. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Description of the Amended 2017 Plan </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The material features of the Amended 2017 Plan are described below. The following description of the Amended 2017 Plan is a summary only and is qualified in its entirety by reference to the complete text of the Amended 2017 Plan.
Stockholders are urged to read the actual text of the Amended 2017 Plan in its entirety. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Purpose </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Amended 2017 Plan is designed to secure and retain the services of our employees, directors and consultants, provide incentives for our
employees, directors and consultants to exert maximum efforts for the success of Exelixis and our affiliates, and provide a means by which our employees, directors and consultants may be given an opportunity to benefit from increases in the value of
our common stock. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Successor to 2014 Plan </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Amended 2017 Plan is intended to be the successor to the Exelixis, Inc. 2014 Equity Incentive Plan (2014 Plan). </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Types of Awards </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The
terms of the Amended 2017 Plan provide for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, RSU awards, other stock awards, and performance awards that may be settled in cash,
stock, or other property. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Shares Available for Awards </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Subject to adjustment for certain changes in our capitalization, the aggregate number of shares of our common stock that may be issued under the
Amended 2017 Plan (Share Reserve) will not exceed the sum of (i)&nbsp;453,064 shares (the number of unallocated shares that were available for grant under the 2014 Plan as of the effective date of the 2017 Plan), (ii) 24,000,000 additional shares
that were reserved as of the effective date of the 2017 Plan, (iii)&nbsp;21,000,000 additional shares that were approved at the 2020 Annual Meeting, and (iv) 28,500,000 newly requested shares, plus the Prior Plans&#146; Returning Shares, as such
shares become available from time to time. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">37</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The &#147;Prior
Plans&#146; Returning Shares&#148; are shares subject to outstanding stock awards granted under any of the following plans (which we refer to as the &#147;Prior Plans&#148; for purposes of this Proposal 3): the 2014 Plan, the Exelixis, Inc. 2000
Equity Incentive Plan, the Exelixis, Inc. <FONT STYLE="white-space:nowrap">2000&nbsp;Non-Employee&nbsp;Directors&#146;</FONT> Stock Option Plan, the Exelixis, Inc. 2011 Equity Incentive Plan, and the Exelixis, Inc. 2016 Inducement Award Plan, in
each case that, from and after the effective date of the 2017 Plan, (i)&nbsp;expire or terminate for any reason prior to exercise or settlement, (ii)&nbsp;are forfeited, cancelled or otherwise returned to us because of the failure to meet a
contingency or condition required for the vesting of such shares, or (iii)&nbsp;other than with respect to outstanding appreciation awards granted under the Prior Plans, are reacquired or withheld (or not issued) by us to satisfy a tax withholding
obligation in connection with a stock award. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The number of shares of our common stock available for issuance under the Amended 2017
Plan will be reduced by (i)&nbsp;1&nbsp;share for each share of common stock issued pursuant to an appreciation award granted under the Amended 2017 Plan, (ii)&nbsp;1.5 shares for each share of common stock issued pursuant to a full value award
granted under the Amended 2017 Plan prior to May&nbsp;25, 2022, and (iii)&nbsp;2&nbsp;shares for each share of common stock issued pursuant to a full value award granted under the Amended 2017 Plan on or after May&nbsp;25, 2022. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If (i)&nbsp;any shares of common stock subject to a stock award granted under the Amended 2017 Plan are not issued because the stock award
expires or otherwise terminates without all of the shares covered by the stock award having been issued or is settled in cash, (ii)&nbsp;any shares of common stock issued pursuant to a stock award granted under the Amended 2017 Plan are forfeited
back to or repurchased by us because of the failure to meet a contingency or condition required for the vesting of such shares, or (iii)&nbsp;with respect to a full value award granted under the Amended 2017 Plan, any shares of common stock are
reacquired or withheld (or not issued) by us to satisfy a tax withholding obligation in connection with the award, then such shares (which we refer to as the &#147;Amended 2017 Plan Returning Shares&#148; for purposes of this Proposal 3) will again
become available for issuance under the Amended 2017 Plan. For each Amended 2017 Plan Returning Share or Prior Plans&#146; Returning Share subject to a full value award, the number of shares of common stock available for issuance under the Amended
2017 Plan will increase by (i) 1.5 shares for each such Amended 2017 Plan Returning Share or Prior Plans&#146; Returning Share that returns to the Amended 2017 Plan prior to May&nbsp;25, 2022 and (ii)&nbsp;2&nbsp;shares for each such Amended 2017
Plan Returning Share or Prior Plans&#146; Returning Share that returns to the Amended 2017 Plan on or after May&nbsp;25, 2022. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Any
shares of common stock reacquired or withheld (or not issued) by us to satisfy the exercise or purchase price of a stock award granted under the Amended 2017 Plan or a Prior Plan will no longer be available for issuance under the Amended 2017 Plan,
including any shares subject to a stock award that are not delivered to a participant because the stock award is exercised through a reduction of shares subject to the stock award. Any shares reacquired or withheld (or not issued) by us to satisfy a
tax withholding obligation in connection with an appreciation award granted under the Amended 2017 Plan or a Prior Plan, or any shares repurchased by us on the open market with the proceeds of the exercise price of an appreciation award granted
under the Amended 2017 Plan or a Prior Plan will no longer be available for issuance under the Amended 2017 Plan. In the event that a stock appreciation right granted under the Amended 2017 Plan or a Prior Plan is settled in shares of common stock,
the gross number of shares subject to such stock appreciation right will no longer be available for issuance under the Amended 2017 Plan. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><I>Eligibility </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All of our (including our affiliates&#146;)
<FONT STYLE="white-space:nowrap">employees,&nbsp;non-employee&nbsp;directors</FONT> and consultants are eligible to participate in the Amended 2017 Plan and may receive all types of awards other than incentive stock options. Incentive stock options
may be granted under the Amended 2017 Plan only to our (including our affiliates&#146;) employees. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">As of the Record Date, we
(including our affiliates) had 986 employees (including full-time and part-time employees), 11 <FONT STYLE="white-space:nowrap">non-employee&nbsp;directors</FONT> and approximately 60 consultants. However, Dr.&nbsp;Cohen, who is not standing for <FONT
STYLE="white-space:nowrap">re-election</FONT> at the Annual Meeting, will not be eligible to receive awards as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director under the Amended 2017 Plan. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Individual Award Limits </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Under the Amended 2017 Plan, subject to adjustment for certain changes in our capitalization, no participant will be eligible to be granted during any calendar year more than: (i)&nbsp;a maximum of 5,000,000 shares of our common
stock subject to stock options, stock appreciation rights and other stock awards whose value is determined by reference to an increase over an exercise or strike price of at least 100% of the fair market value of our common stock on the date of
grant; (ii)&nbsp;a maximum of 5,000,000 shares of our common stock subject to performance stock awards; and (iii)&nbsp;a maximum of $10,000,000 subject to performance cash awards. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">38</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 3&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Amendment and Restatement of 2017 Equity Incentive Plan </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I><FONT STYLE="white-space:nowrap">Non-Employee&nbsp;Director</FONT>
Compensation Limit </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The maximum number of shares of our common stock subject to stock awards granted during any calendar year to
any of <FONT STYLE="white-space:nowrap">our&nbsp;non-employee&nbsp;directors,</FONT> taken together with any cash fees paid by Exelixis to <FONT STYLE="white-space:nowrap">such&nbsp;non-employee</FONT> director during such calendar year, will not
exceed $750,000 in total value, or $1,500,000 in total value with respect to the calendar year in which the individual is first appointed or elected to the Board (calculating the value of any such stock awards based on the grant date fair value of
such stock awards for financial reporting purposes). </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Administration </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Amended 2017 Plan will be administered by the Board, which may in turn delegate authority to administer the Amended 2017 Plan to a committee.
The Board has delegated concurrent authority to administer the Amended 2017 Plan to the Compensation Committee, but may, at any time, revest in itself some or all of the power delegated to the Compensation Committee. The Board and the Compensation
Committee are each considered to be a Plan Administrator for purposes of this Proposal 3. Subject to the terms of the Amended 2017 Plan (including certain minimum vesting requirements (see &#147;<A HREF="#tx282574_1502">Minimum Vesting
Requirements</A>&#148; below)), the Plan Administrator may determine the recipients, the types of awards to be granted, the number of shares of our common stock subject to or the cash value of awards, and the terms and conditions of awards granted
under the Amended 2017 Plan, including the period of their exercisability and vesting. The Plan Administrator also has the authority to provide for accelerated exercisability and vesting of awards. Subject to the limitations set forth below, the
Plan Administrator also determines the fair market value applicable to a stock award and the exercise or strike price of stock options and stock appreciation rights granted under the Amended 2017 Plan. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Plan Administrator may also delegate to one or more officers the authority to designate employees who are not officers to be recipients of
certain stock awards and the number of shares of our common stock subject to such stock awards. Under any such delegation, the Plan Administrator will specify the total number of shares of our common stock that may be subject to the stock awards
granted by such officer. The officer may not grant a stock award to himself or herself. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Repricing; Cancellation <FONT
STYLE="white-space:nowrap">and&nbsp;Re-Grant&nbsp;of</FONT> Awards </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Under the Amended 2017 Plan, the Plan Administrator does not
have the authority to reprice any outstanding stock option or stock appreciation right by reducing the exercise or strike price of the stock option or stock appreciation right or to cancel any outstanding stock option or stock appreciation right
that has an exercise or strike price greater than the then-current fair market value of our common stock in exchange for cash or other awards without obtaining the approval of our stockholders. Such approval must be obtained within 12 months prior
to such an event. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I><A NAME="tx282574_1502"></A>Minimum Vesting Requirements </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Under the Amended 2017 Plan, no award may vest until at least 12 months following the date of grant of the award;<I></I><I> provided,
however</I>, that shares up to 5% of the Share Reserve may be issued pursuant to awards which do not meet such vesting requirements. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Dividends and Dividend Equivalents </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Amended 2017 Plan provides that dividends or dividend equivalents may be paid or credited with respect to any shares of our common stock subject to an award, as determined by the Board and contained in the applicable award
agreement;<I></I><I> provided, however</I>, that (i)&nbsp;no dividends or dividend equivalents may be paid with respect to any such shares before the date such shares have vested, (ii)&nbsp;any dividends or dividend equivalents that are credited
with respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of the applicable award agreement (including any vesting conditions), and (iii)&nbsp;any dividends or dividend equivalents
that are credited with respect to any such shares will be forfeited to us on the date such shares are forfeited to or repurchased by us due to a failure to vest. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Section&nbsp;162(m) Transition Relief for Performance-Based Compensation </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Under Section&nbsp;162(m) of the Code, compensation paid to any publicly held corporation&#146;s &#147;covered employees&#148; (as defined under
Section&nbsp;162(m) of the Code) that exceeds $1&nbsp;million per taxable year for any covered employee is generally <FONT STYLE="white-space:nowrap">non-deductible.</FONT> Certain provisions in the Amended 2017 Plan refer to the
&#147;performance-based compensation&#148; exception to the $1&nbsp;million deductibility limit under Section&nbsp;162(m) of the Code. Pursuant to the Tax Cuts and Jobs Act, this exception was repealed with respect to taxable years beginning after
December&nbsp;31, 2017. However, an award may still be eligible for this </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">39</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">exception if, among
other requirements, it is intended to qualify, and is eligible to qualify, as &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code pursuant to the transition relief provided by the Tax Cuts and Jobs Act for remuneration
provided pursuant to a written binding contract which was in effect on November&nbsp;2, 2017 and which was not modified in any material respect on or after such date. For purposes of this Proposal 3, the term &#147;Section&nbsp;162(m) Transition
Relief&#148; refers to such transition relief. Accordingly, the provisions in the Amended 2017 Plan which refer to the &#147;performance-based compensation&#148; exception under Section&nbsp;162(m) of the Code will only apply to any award that is
intended to qualify, and is eligible to qualify, as &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code pursuant to the Section&nbsp;162(m) Transition Relief and, therefore, such provisions are not applicable to any
other awards granted under the Amended 2017 Plan. However, even if an award is intended to qualify as &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code, no assurance can be given that the award will in fact qualify for
the Section&nbsp;162(m) Transition Relief or the &#147;performance-based compensation&#148; exception under Section&nbsp;162(m) of the Code. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><I>Stock Options </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stock options may be granted under the Amended 2017 Plan pursuant to stock option agreements.
The Amended 2017 Plan permits the grant of stock options that are intended to qualify as incentive stock options, or ISOs, and nonstatutory stock options, or NSOs. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The exercise price of a stock option granted under the Amended 2017 Plan may not be less than 100% of the fair market value of the common stock
subject to the stock option on the date of grant and, in some cases (see &#147;<A HREF="#tx282574_1503">Limitations on Incentive Stock Options</A>&#148;&nbsp;below), may not be less than 110% of such fair market value. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The term of stock options granted under the Amended 2017 Plan may not exceed 7&nbsp;
years and, in some cases (see &#147;<A HREF="#tx282574_1503">Limitations on Incentive Stock Options</A>&#148; below), may not exceed 5&nbsp;years. Except as otherwise provided in a participant&#146;s stock option agreement or other agreement with us
or one of our affiliates, if a participant&#146;s service relationship with us or any of our affiliates (referred to in this Proposal 3 as &#147;continuous service&#148;) terminates (other than for cause and other than upon the participant&#146;s
death or disability), the participant may exercise any vested stock options for up to 3&nbsp;months following the participant&#146;s termination of continuous service. Except as otherwise provided in a participant&#146;s stock option agreement or
other agreement with us or one of our affiliates, if a participant&#146;s continuous service terminates due to the participant&#146;s disability or death (or the participant dies within a specified period, if any, following termination of continuous
service), the participant, or his or her beneficiary, as applicable, may exercise any vested stock options for up to 12&nbsp;months following the participant&#146;s termination due to the participant&#146;s disability or for up to 18 months
following the participant&#146;s death. Except as explicitly provided otherwise in a participant&#146;s stock option agreement or other written agreement with us or one of our affiliates, if a participant&#146;s continuous service is terminated for
cause (as defined in the Amended 2017 Plan), all stock options held by the participant will terminate upon the participant&#146;s termination of continuous service and the participant will be prohibited from exercising any stock option from and
after such termination date. Except as otherwise provided in a participant&#146;s stock option agreement or other agreement with us or one of our affiliates, the term of a stock option may be extended if the exercise of the stock option following
the participant&#146;s termination of continuous service (other than for cause and other than upon the participant&#146;s death or disability) would be prohibited by applicable securities laws or if the sale of any common stock received upon
exercise of the stock option following the participant&#146;s termination of continuous service (other than for cause) would violate our insider trading policy. In no event, however, may a stock option be exercised after its original expiration
date. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Acceptable forms of consideration for the purchase of our common stock pursuant to the exercise of a stock option under the
Amended 2017 Plan will be determined by the Plan Administrator and may include payment: (i)&nbsp;by cash, check, bank draft or money order payable to us; (ii)&nbsp;pursuant to a program developed under Regulation T as promulgated by the Federal
Reserve Board; (iii)&nbsp;by delivery to us of shares of our common stock (either by actual delivery or attestation); (iv) by a net exercise arrangement (for NSOs only); or (v)&nbsp;in other legal consideration approved by the Plan Administrator.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Subject to certain minimum vesting requirements (see &#147;<A HREF="#tx282574_1502">Minimum Vesting Requirements</A>&#148; above),
stock options granted under the Amended 2017 Plan may become exercisable in cumulative increments, or &#147;vest,&#148; as determined by the Plan Administrator at the rate specified in the stock option agreement. Shares covered by different stock
options granted under the Amended 2017 Plan may be subject to different vesting schedules as the Plan Administrator may determine. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">40</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 3&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Amendment and Restatement of 2017 Equity Incentive Plan </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Plan Administrator may impose limitations on the transferability of
stock options granted under the Amended 2017 Plan in its discretion. Generally, a participant may not transfer a stock option granted under the Amended 2017 Plan other than by will or the laws of descent and distribution or, subject to approval by
the Plan Administrator, pursuant to a domestic relations order or an official marital settlement agreement. However, the Plan Administrator may permit transfer of a stock option in a manner that is not prohibited by applicable tax and securities
laws. In addition, subject to approval by the Plan Administrator, a participant may designate a beneficiary who may exercise the stock option following the participant&#146;s death. Notwithstanding the foregoing, no stock option may be transferred
to any financial institution without prior stockholder approval. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I><A NAME="tx282574_1503"></A>Limitations on Incentive Stock
Options </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The aggregate fair market value, determined at the time of grant, of shares of our common stock with respect to ISOs that
are exercisable for the first time by a participant during any calendar year under all of our stock plans may not exceed $100,000. The stock options or portions of stock options that exceed this limit or otherwise fail to qualify as ISOs are treated
as NSOs. No ISO may be granted to any person who, at the time of grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any affiliate unless the following conditions are satisfied: </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f">the exercise price of the ISO must be at least 110% of the fair market value of the common stock
subject to the ISO on the date of grant; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f">the term of the ISO must not exceed 5&nbsp;years from the date of grant.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Subject to adjustment for certain changes in our capitalization, the aggregate maximum number of shares of our
common stock that may be issued pursuant to the exercise of ISOs under the Amended 2017 Plan is 50,000,000 shares. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Stock
Appreciation Rights </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stock appreciation rights may be granted under the Amended 2017 Plan pursuant to stock appreciation right
agreements. Each stock appreciation right is denominated in common stock share equivalents. The strike price of each stock appreciation right will be determined by the Plan Administrator, but will in no event be less than 100% of the fair market
value of the common stock subject to the stock appreciation right on the date of grant. Subject to certain minimum vesting requirements (see &#147;<A HREF="#tx282574_1502">Minimum Vesting Requirements</A>&#148; above), the Plan Administrator may
also impose restrictions or conditions upon the vesting of stock appreciation rights that it deems appropriate. The appreciation distribution payable upon exercise of a stock appreciation right may be paid in shares of our common stock, in cash, in
a combination of cash and stock, or in any other form of consideration determined by the Plan Administrator and set forth in the stock appreciation right agreement. The term of stock appreciation rights granted under the Amended 2017 Plan may not
exceed 7&nbsp;years. Stock appreciation rights will be subject to the same conditions upon termination of continuous service and restrictions on transfer as stock options under the Amended 2017 Plan. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Restricted Stock Awards </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Restricted stock awards may be granted under the Amended 2017 Plan pursuant to restricted stock award agreements. A restricted stock award may be granted in consideration for cash, check, bank draft or money order payable to us, the
participant&#146;s services performed for us or any of our affiliates, or any other form of legal consideration acceptable to the Plan Administrator. Subject to certain minimum vesting requirements (see &#147;<A HREF="#tx282574_1502">Minimum Vesting Requirements
</A>&nbsp;&#148; above), shares of our common stock acquired under a restricted stock award may be subject to forfeiture to or repurchase by us in accordance with a vesting schedule to be determined by the Plan Administrator. Rights to acquire
shares of our common stock under a restricted stock award may be transferred only upon such terms and conditions as are set forth in the restricted stock award agreement;<I></I><I>&nbsp;provided, however</I>, that no restricted stock award may be
transferred to any financial institution without prior stockholder approval. Upon a participant&#146;s termination of continuous service for any reason, any shares subject to restricted stock awards held by the participant that have not vested as of
such termination date may be forfeited to or repurchased by us. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>RSU Awards </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">RSU awards may be granted under the Amended 2017 Plan pursuant to RSU award agreements. Payment of any purchase price may be made in any form of
legal consideration acceptable to the Plan Administrator. A RSU award may be settled by the delivery of shares of our common stock, in cash, in a combination of cash and stock, or in any other form of consideration
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">41</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">determined by the Plan
Administrator and set forth in the RSU award agreement. Subject to certain minimum vesting requirements (see &#147;<A HREF="#tx282574_1502">Minimum Vesting Requirements</A>&#148; above), RSU awards may be subject to vesting in accordance with a
vesting schedule to be determined by the Plan Administrator. Except as otherwise provided in a participant&#146;s RSU award agreement, RSUs that have not vested will be forfeited upon the participant&#146;s termination of continuous service for any
reason. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Performance Awards </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Amended 2017 Plan allows us to grant performance stock and cash awards. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">A performance stock award is a stock
award that is payable (including that may be granted, may vest, or may be exercised) contingent upon the attainment <FONT STYLE="white-space:nowrap">of&nbsp;pre-determined&nbsp;performance</FONT> goals during a performance period. A performance
stock award may require the completion of a specified period of continuous service. Subject to certain minimum vesting requirements (see &#147;<A HREF="#tx282574_1502">Minimum Vesting Requirements</A>&#148; above), the length of any performance
period, the performance goals to be achieved during the performance period, and the measure of whether and to what degree such performance goals have been attained will be determined by the Compensation Committee, except that the Plan Administrator
also may make any such determinations to the extent that the award is not intended to qualify as performance-based compensation under Section&nbsp;162(m) of the Code. In addition, to the extent permitted by applicable law and the performance stock
award agreement, the Plan Administrator may determine that cash may be used in payment of performance stock awards. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">A performance
cash award is a cash award that is payable contingent upon the attainment <FONT STYLE="white-space:nowrap">of&nbsp;pre-determined&nbsp;performance</FONT> goals during a performance period. A performance cash award may require the completion of a
specified period of continuous service. Subject to certain minimum vesting requirements (see &#147;<A HREF="#tx282574_1502">Minimum Vesting Requirements</A>&#148; above), the length of any performance period, the performance goals to be achieved
during the performance period, and the measure of whether and to what degree such performance goals have been attained will be determined by the Compensation Committee, except that the Plan Administrator also may make any such determinations to the
extent that the award is not intended to qualify as performance-based compensation under Section&nbsp;162(m) of the Code. The Plan Administrator may specify the form of payment of performance cash awards, which may be cash or other property, or may
provide for a participant to have the option for his or her performance cash award to be paid in cash or other property. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Performance
goals under the Amended 2017 Plan will be based on any one or more of the following performance criteria: (1)&nbsp;earnings (including earnings per share and net earnings); (2) earnings before interest, taxes and depreciation; (3)&nbsp;earnings
before interest, taxes, depreciation and amortization; (4)&nbsp;total stockholder return; (5)&nbsp;return on equity or average stockholder&#146;s equity; (6)&nbsp;return on assets, investment, or capital employed; (7)&nbsp;stock price;
(8)&nbsp;margin (including gross margin); (9) income (before or after taxes); (10) operating income; (11)&nbsp;operating income after <FONT STYLE="white-space:nowrap">taxes;&nbsp;(12)&nbsp;pre-tax&nbsp;profit;</FONT> (13)&nbsp;operating cash flow;
(14)&nbsp;sales or revenue targets; (15)&nbsp;increases in revenues or product revenues; (16)&nbsp;expenses and cost reduction goals; (17)&nbsp;improvement in or attainment of working capital levels; (18)&nbsp;economic value added (or an equivalent
metric); (19) market share; (20)&nbsp;cash flow; (21)&nbsp;cash flow per share; (22)&nbsp;share price performance; (23)&nbsp;debt reduction; (24)&nbsp;implementation or completion of projects or processes; (25)&nbsp;customer satisfaction;
(26)&nbsp;stockholders&#146; equity; (27)&nbsp;capital expenditures; (28)&nbsp;debt levels; (29)&nbsp;operating profit or net operating profit; (30)&nbsp;workforce diversity; (31)&nbsp;growth of net income or operating income; (32)&nbsp;billings;
and (33)&nbsp;to the extent that an award is not intended to comply with Section&nbsp;162(m) of the Code, other measures of performance selected by the Plan Administrator. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Performance goals may be based on a company-wide basis, with respect to one or more business units, divisions, affiliates or business segments,
and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Under the Amended 2017 Plan, unless specified otherwise by the Compensation Committee (or, if not
required for compliance with Section&nbsp;162(m) of the Code, the Plan Administrator)&nbsp;(i) in the award agreement at the time the award is granted or (ii)&nbsp;in such other document setting forth the performance goals at the time the
performance goals are established, the Compensation Committee (or, if not required for compliance with Section&nbsp;162(m) of the Code, the Plan Administrator) will appropriately make adjustments in the method of calculating the attainment of
performance goals for a performance period: (1)&nbsp;to exclude restructuring and/or other nonrecurring charges; (2)&nbsp;to exclude exchange rate effects, as applicable, <FONT STYLE="white-space:nowrap">for&nbsp;non-U.S.&nbsp;dollar</FONT>
denominated performance goals; (3)&nbsp;to exclude the effects of changes to generally accepted accounting principles; (4)&nbsp;to exclude the effects of any statutory adjustments to corporate tax rates; and (5)&nbsp;to exclude the effects of any
items that are &#147;unusual&#148; in nature or occur &#147;infrequently&#148; as determined under generally accepted accounting principles. In addition, the Compensation Committee (or, if not required for compliance with Section&nbsp;162(m) of the
Code, the Plan Administrator) retains the discretion to reduce or eliminate the </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">42</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 3&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Amendment and Restatement of 2017 Equity Incentive Plan </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">compensation or economic benefit due upon the attainment of any
performance goals and to define the manner of calculating the performance criteria it selects to use for a performance period. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Other Stock Awards </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Other forms of stock awards valued in whole or in part by reference to, or otherwise based on, our common stock may be granted either alone or in
addition to other stock awards under the Amended 2017 Plan. Subject to the terms of the Amended 2017 Plan (including certain minimum vesting requirements (see &#147;<A HREF="#tx282574_1502">Minimum Vesting Requirements</A>&#148; above)), the Plan
Administrator will have sole and complete authority to determine the persons to whom and the time or times at which such other stock awards will be granted, the number of shares of our common stock to be granted and all other terms and conditions of
such other stock awards. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Clawback Policy </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Awards granted under the Amended 2017 Plan will be subject to recoupment in accordance with (i)&nbsp;the Clawback Policy and (ii)&nbsp;any
clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer
Protection Act or other applicable law. In addition, the Plan Administrator may impose other clawback, recovery or recoupment provisions in an award agreement as the Plan Administrator determines necessary or appropriate, including a reacquisition
right in respect of previously acquired shares of our common stock or other cash or property upon the occurrence of cause. For additional information on the Clawback Policy, please see &#147;<A HREF="#tx282574_r36">Compensation Discussion and Analysis&#151;Other
 Compensation Information&#151;Clawback Policy</A>.&#148; </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Changes to Capital Structure </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In the event of certain capitalization adjustments, the Plan Administrator will appropriately adjust: (i)&nbsp;the class(es) and maximum number
of securities subject to the Amended 2017 Plan; (ii)&nbsp;the class(es) and maximum number of securities that may be issued pursuant to the exercise of ISOs; (iii)&nbsp;the class(es) and maximum number of securities that may be awarded to any
participant pursuant to the individual award limits under the Amended 2017 Plan; and (iv)&nbsp;the class(es) and number of securities and price per share of stock subject to outstanding stock awards. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Corporate Transaction and Change in Control </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following applies to stock awards under the Amended 2017 Plan in the event of a corporate transaction (as defined in the Amended 2017 Plan)
or a change in control (as defined in the Amended 2017 Plan) (each of which we refer to as a &#147;Transaction&#148; for purposes of this Proposal 3), unless otherwise provided in a participant&#146;s stock award agreement or other written
arrangement with us or one of our affiliates or in any director compensation policy. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In the event of a Transaction, any stock awards
outstanding under the Amended 2017 Plan may be assumed, continued or substituted for by any surviving or acquiring corporation (or its parent company), and any reacquisition or repurchase rights held by us with respect to the stock award may be
assigned to the successor (or its parent company). If the surviving or acquiring corporation (or its parent company) does not assume, continue or substitute for such stock awards, then (i)&nbsp;with respect to any such stock awards that are held by
participants whose continuous service has not terminated prior to the effective time of the Transaction (Current Participants), the vesting (and exercisability, if applicable) of such stock awards will be accelerated in full (and with respect to any
such stock awards that are subject to performance-based vesting conditions or requirements, vesting will be deemed to be satisfied at the target level of performance) to a date prior to the effective time of the Transaction (contingent upon the
effectiveness of the Transaction), and such stock awards will terminate if not exercised (if applicable) at or prior to the effective time of the Transaction, and any reacquisition or repurchase rights held by us with respect to such stock awards
will lapse (contingent upon the effectiveness of the Transaction), and (ii)&nbsp;any such stock awards that are held by persons other than Current Participants will terminate if not exercised (if applicable) prior to the effective time of the
Transaction, except that any reacquisition or repurchase rights held by us with respect to such stock awards will not terminate and may continue to be exercised notwithstanding the Transaction. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In the event a stock award will terminate if not exercised prior to the effective time of a Transaction, the Plan Administrator may provide that
the holder of such stock award may not exercise such stock award but instead will receive a payment equal in value to the excess (if any) of (i)&nbsp;the value of the property the participant would have received upon exercise of such stock award
immediately prior to the effective time of the Transaction over (ii)&nbsp;any exercise price payable in connection with such exercise. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">43</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">For purposes of the
Amended 2017 Plan, a corporate transaction generally will be deemed to occur in the event of the consummation of: (i)&nbsp;a sale, lease or other disposition of all or substantially all of our assets; (ii)&nbsp;an acquisition by a person, entity or
group of the beneficial ownership of our securities representing at least 50% of the combined voting power entitled to vote in the election of our directors; (iii)&nbsp;a merger, consolidation or similar transaction in which we are not the surviving
corporation; or (iv)&nbsp;a reverse merger, consolidation or similar transaction in which we are the surviving corporation but shares of our outstanding common stock are converted into other property by virtue of the transaction. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">For purposes of the Amended 2017 Plan, a change in control generally will be deemed to occur in the event of the consummation of: (i)&nbsp;a
sale, lease or other disposition of all or substantially all of our assets; (ii)&nbsp;an acquisition by a person, entity or group of the beneficial ownership of our securities representing at least 50% of the combined voting power entitled to vote
in the election of our directors other than by virtue of a merger, consolidation or similar transaction; (iii)&nbsp;a merger, consolidation or similar transaction in which we are not the surviving corporation; or (iv)&nbsp;a reverse merger,
consolidation or similar transaction in which we are the surviving corporation but shares of our outstanding common stock are converted into other property by virtue of the transaction. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Control Acquisition </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following applies to stock awards under the Amended 2017 Plan in the event of a control acquisition (as defined in the Amended 2017 Plan),
unless otherwise provided in a participant&#146;s stock award agreement or other written arrangement with us or one of our affiliates or in any director compensation policy. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In the event of a control acquisition that was not approved by the Plan Administrator prior to the consummation of such transaction, the vesting
(and exercisability, if applicable) of any stock awards that are held by Current Participants will be accelerated in full (and with respect to any such stock awards that are subject to performance-based vesting conditions or requirements, vesting
will be deemed to be satisfied at the target level of performance) to a date prior to the effective time of the control acquisition (contingent upon the effectiveness of the control acquisition), and any reacquisition or repurchase rights held by us
with respect to such stock awards will lapse (contingent upon the effectiveness of the control acquisition). </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">For purposes of the
Amended 2017 Plan, a control acquisition generally will be deemed to occur in the event of the consummation of an acquisition by a person, entity or group of the beneficial ownership of our securities representing at least 50% of the combined voting
power entitled to vote in the election of our directors. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Change in Control </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following applies to stock awards under the Amended 2017 Plan in the event of a change in control (as defined in the Amended 2017 Plan),
unless otherwise provided in a participant&#146;s stock award agreement or other written arrangement with us or one of our affiliates or in any director compensation policy. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If a change in control occurs and within 1&nbsp;month before, as of, or within 13 months after, the effective time of such change in control, a
participant&#146;s continuous service terminates due to an involuntary termination (not including death or disability) without cause (as defined in the Amended 2017 Plan) or due to a voluntary termination with good reason (as defined in the Amended
2017 Plan), then the vesting (and exercisability, if applicable) of such participant&#146;s stock awards will be accelerated in accordance with the vesting schedule applicable to such stock awards as if (i)&nbsp;with respect to any such stock awards
that are subject to vesting conditions or requirements based solely on such participant&#146;s continuous service, such participant&#146;s continuous service had continued for 12 months following the date of termination, and (ii)&nbsp;with respect
to any such stock awards that are subject to performance-based vesting conditions or requirements, vesting has been satisfied at the target level of performance. Any such acceleration will occur on the date of termination, or if later, the effective
date of the change in control. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Plan Amendments and Termination </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Plan Administrator will have the authority to amend or terminate the Amended 2017 Plan at any time. However, except as otherwise provided in
the Amended 2017 Plan or an award agreement, no amendment or termination of the Amended 2017 Plan may materially impair a participant&#146;s rights under his or her outstanding awards without the participant&#146;s consent. We will obtain
stockholder approval of any amendment to the Amended 2017 Plan as required by applicable law and listing requirements. No incentive stock options may be granted under the Amended 2017 Plan after the tenth anniversary of the date the 2017 Plan was
adopted by our Board. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">44</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 3&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Amendment and Restatement of 2017 Equity Incentive Plan </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>U.S. Federal Income Tax Consequences </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following is a summary of the principal United States federal income tax consequences to participants and us with respect to participation in
the Amended 2017 Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or foreign jurisdiction in which a participant may reside. The information is based upon current federal income tax
rules and therefore is subject to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each participant should consult the participant&#146;s tax adviser regarding the
federal, state, local and other tax consequences of the grant or exercise of an award or the disposition of stock acquired under the Amended 2017 Plan. The Amended 2017 Plan is not qualified under the provisions of Section&nbsp;401(a) of the Code
and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974. Our ability to realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement of
reasonableness, the provisions of Section&nbsp;162(m) of the Code and the satisfaction of our tax reporting obligations. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Nonstatutory Stock Options </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Generally, there is no taxation upon the grant of an NSO if the stock option is granted with an exercise price equal to the fair market value of the underlying stock on the grant date. Upon exercise, a participant will recognize
ordinary income equal to the excess, if any, of the fair market value of the underlying stock on the date of exercise of the stock option over the exercise price. If the participant is employed by us or one of our affiliates, that income will be
subject to withholding taxes. The participant&#146;s tax basis in those shares will be equal to their fair market value on the date of exercise of the stock option, and the participant&#146;s capital gain holding period for those shares will begin
on that date. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m) of the Code and the satisfaction of
a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><I>Incentive Stock Options </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Amended 2017 Plan provides for the grant of stock options that are intended to
qualify as &#147;incentive stock options,&#148; as defined in Section&nbsp;422 of the Code. Under the Code, a participant generally is not subject to ordinary income tax upon the grant or exercise of an ISO. If the participant holds a share received
upon exercise of an ISO for more than 2&nbsp;years from the date the stock option was granted and more than 1&nbsp;year from the date the stock option was exercised, which is referred to as the required holding period, the difference, if any,
between the amount realized on a sale or other taxable disposition of that share and the participant&#146;s tax basis in that share will be long-term capital gain or loss. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If, however, a participant disposes of a share acquired upon exercise of an ISO before the end of the required holding period, which is referred
to as a disqualifying disposition, the participant generally will recognize ordinary income in the year of the disqualifying disposition equal to the excess, if any, of the fair market value of the share on the date of exercise of the stock option
over the exercise price. However, if the sales proceeds are less than the fair market value of the share on the date of exercise of the stock option, the amount of ordinary income recognized by the participant will not exceed the gain, if any,
realized on the sale. If the amount realized on a disqualifying disposition exceeds the fair market value of the share on the date of exercise of the stock option, that excess will be short-term or long-term capital gain, depending on whether the
holding period for the share exceeds 1&nbsp;year. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">For purposes of the alternative minimum tax, the amount by which the fair market
value of a share of stock acquired upon exercise of an ISO exceeds the exercise price of the stock option generally will be an adjustment included in the participant&#146;s alternative minimum taxable income for the year in which the stock option is
exercised. If, however, there is a disqualifying disposition of the share in the year in which the stock option is exercised, there will be no adjustment for alternative minimum tax purposes with respect to that share. In computing alternative
minimum taxable income, the tax basis of a share acquired upon exercise of an ISO is increased by the amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the stock option is
exercised. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We are not allowed a tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired
upon exercise of an ISO after the required holding period. If there is a disqualifying disposition of a share, however, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant, subject to the
requirement of reasonableness and the provisions of Section&nbsp;162(m) of the Code, and provided that either the employee includes that amount in income or we timely satisfy our reporting requirements with respect to that amount. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">45</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Restricted Stock
Awards </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Generally, the recipient of a restricted stock award will recognize ordinary income at the time the stock is received
equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock is not vested when it is received (for example, if the employee is required to work
for a period of time in order to have the right to sell the stock), the recipient generally will not recognize income until the stock becomes vested, at which time the recipient will recognize ordinary income equal to the excess, if any, of the fair
market value of the stock on the date it becomes vested over any amount paid by the recipient in exchange for the stock. A recipient may, however, file an election with the Internal Revenue Service, within 30&nbsp;days following his or her receipt
of the stock award, to recognize ordinary income, as of the date the recipient receives the award, equal to the excess, if any, of the fair market value of the stock on the date the award is granted over any amount paid by the recipient for the
stock. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The recipient&#146;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a
restricted stock award will be the amount paid for such shares plus any ordinary income recognized either when the stock is received or when the stock becomes vested. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m) of the Code and the satisfaction of a tax reporting
obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock award. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>RSU Awards </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Generally,
the recipient of an RSU award structured to comply with the requirements of Section&nbsp;409A of the Code or an exemption from Section&nbsp;409A of the Code will recognize ordinary income at the time the stock is delivered equal to the excess, if
any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. To comply with the requirements of Section&nbsp;409A of the Code, the stock subject to a restricted stock unit award may generally
only be delivered upon one of the following events: a fixed calendar date (or dates), separation from service, death, disability or a change in control. If delivery occurs on another date, unless the restricted stock unit award otherwise complies
with or qualifies for an exemption from the requirements of Section&nbsp;409A of the Code, in addition to the tax treatment described above, the recipient will owe an additional 20% federal tax and interest on any taxes owed. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The recipient&#146;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from an RSU award will be the
amount paid for such shares plus any ordinary income recognized when the stock is delivered. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Subject to the requirement of
reasonableness, the provisions of Section&nbsp;162(m) of the Code and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the RSU award.
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Stock Appreciation Rights </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Generally, if a stock appreciation right is granted with an exercise price equal to the fair market value of the underlying stock on the grant date, the recipient will recognize ordinary income equal to the fair market value of the
stock or cash received upon such exercise. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m) of the
Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock appreciation right. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Section&nbsp;162(m) of the Code </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Under Section&nbsp;162(m) of the Code, compensation paid to any publicly held corporation&#146;s &#147;covered employees&#148; (as defined under Section&nbsp;162(m) of the Code) that exceeds $1&nbsp;million per taxable year for any
covered employee is generally <FONT STYLE="white-space:nowrap">non-deductible.</FONT> Prior to the enactment of the Tax Cuts and Jobs Act, compensation that qualified as &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the
Code was not subject to this deduction limitation. Pursuant to the Tax Cuts and Jobs Act, this exception for &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code was repealed with respect to taxable years beginning after
December&nbsp;31, 2017, except that certain transition relief is provided for remuneration provided pursuant to a written binding contract which was in effect on November&nbsp;2, 2017 and which was not modified in any material respect on or after
such date. As a result, compensation paid to any of our &#147;covered employees&#148; in excess of $1&nbsp;million per taxable year generally will not be deductible unless, among other requirements, it is intended to qualify, and is
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">46</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 3&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Amendment and Restatement of 2017 Equity Incentive Plan </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">eligible to qualify, as &#147;performance-based compensation&#148; under
Section&nbsp;162(m) of the Code pursuant to the transition relief described above. Because of certain ambiguities and uncertainties as to the application and interpretation of Section&nbsp;162(m) of the Code, as well as other factors beyond the
control of the Compensation Committee, no assurance can be given that any award granted under the Amended 2017 Plan will be eligible for such transition relief and, therefore, eligible for the &#147;performance-based compensation&#148; exception
under Section&nbsp;162(m) of the Code. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>New Plan Benefits under Amended 2017 Plan </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Amended 2017 Plan </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name and position</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Dollar&nbsp;value</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;shares</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D. <BR><I>President
and Chief Executive Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner <BR><I>Executive Vice
President and Chief Financial Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley <BR><I>Executive Vice
President, Commercial</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D. <BR><I>Executive
Vice President, General Counsel and Secretary</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D. <BR><I>Executive Vice
President, Scientific Strategy and Chief Scientific Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D. <BR><I>Former
President, Product Development and Medical Affairs and Chief Medical Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(2</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(2</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All current executive officers as a
group</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All current directors who are not executive
officers as a group</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$<BR>&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,000,000&nbsp;per<BR>calendar year</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><BR>&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(3</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All employees, including all current
officers who are not executive officers, as a group</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">)&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Awards granted under the Amended 2017 Plan to our executive officers and other employees are
discretionary and are not subject to set benefits or amounts under the terms of the Amended 2017 Plan, and the Board and the Compensation Committee have not granted any awards under the Amended 2017 Plan subject to stockholder approval of this
Proposal 3. Accordingly, the benefits or amounts that will be received by or allocated to our executive officers and other employees under the Amended 2017 Plan are not determinable. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Dr.&nbsp;Schwab passed away in September 2021. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Awards granted under the Amended 2017 Plan to
<FONT STYLE="white-space:nowrap">our&nbsp;non-employee&nbsp;directors</FONT> are discretionary and are not subject to set benefits or amounts under the terms of the Amended 2017 Plan. However, pursuant to our equity compensation policy <FONT
STYLE="white-space:nowrap">for&nbsp;non-employee&nbsp;directors,</FONT> each of our <FONT STYLE="white-space:nowrap">current&nbsp;non-employee&nbsp;directors</FONT> (except Dr.&nbsp;Cohen, who is not standing for
<FONT STYLE="white-space:nowrap">re-election</FONT> at the Annual Meeting) automatically will be granted annual awards in the form of a stock option and RSU award (or in the form of a stock option or RSU award only, if elected by such individual) on
the day following each of our annual meetings of stockholders, provided that such individual is <FONT STYLE="white-space:nowrap">a&nbsp;non-employee&nbsp;director</FONT> on such date. The total dollar value of each
<FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s annual awards will be $400,000. The number of shares of our common stock subject to each such award will be based on the valuation methodology established by the Board, which is in
part based on the fair market value of our common stock during <FONT STYLE="white-space:nowrap">the&nbsp;30-calendar&nbsp;day</FONT> period prior to the grant date and, therefore, is not determinable at this time. On and after the date of the Annual
Meeting, any such awards will be granted under the Amended 2017 Plan if this Proposal 3 is approved by our stockholders. For additional information regarding our equity compensation policy
<FONT STYLE="white-space:nowrap">for&nbsp;non-employee&nbsp;directors,</FONT> see the &#147;<A HREF="#toc282574_6">Compensation of Directors</A>&#148; section above. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">47</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Plan Benefits under
2017 Plan </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table sets forth, for each of the individuals and the various groups indicated, the total number of
shares of our common stock subject to awards that have been granted (even if not currently outstanding) under the 2017 Plan since its approval by our stockholders in 2017 through the Record Date. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name and position</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;shares</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D. <BR><I>President
and Chief Executive Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,311,397</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner <BR><I>Executive Vice
President and Chief Financial Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,281,373</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley <BR><I>Executive Vice
President, Commercial</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,175,285</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D. <BR><I>Executive
Vice President, General Counsel and Secretary</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,141,600</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D. <BR><I>Executive Vice
President, Scientific Strategy and Chief Scientific Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,180,365</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D. <BR><I>Former
President, Product Development and Medical Affairs and Chief Medical Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,183,649</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All current executive officers as a
group</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">9,340,020</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All current directors who are not executive
officers as a group</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,271,083</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Each nominee for election as a director</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Carl B. Feldbaum,
Esq.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">161,598</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Maria C. Freire,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">145,203</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Alan M. Garber,
M.D., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">161,598</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Vincent T. Marchesi,
M.D., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120,372</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Michael M.
Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,311,397</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Stelios
Papadopoulos, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">104,253</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;George Poste, DVM,
Ph.D., FRS</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">104,253</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Julie Anne
Smith</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">129,261</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Lance Willsey,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">161,598</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Jacqueline
Wright</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">62,575</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Jack L.
Wyszomierski</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120,372</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Each associate of any executive officers,
current directors or director nominees</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Each other person who received or is to
receive 5% of awards</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All employees, including all current
officers who are not executive officers, as a group</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">23,215,338</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">48</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 3&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Amendment and Restatement of 2017 Equity Incentive Plan </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Equity Compensation Plan Information </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table provides certain information about our common stock that may be issued upon the exercise of stock options and other rights
under all of our existing equity compensation plans as of December&nbsp;31, 2021, which consists of our 2000 Employee Stock Purchase Plan (the ESPP), the 2014 Plan, our 2016 Inducement Award Plan (the 2016 Plan) and the 2017 Plan: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Plan Category</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;securities<BR>to&nbsp;be&nbsp;issued&nbsp;
upon<BR>exercise&nbsp;of&nbsp;outstanding</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">options,
warrants and<BR>rights (a)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Weighted-average<BR>exercise&nbsp;price of<BR>outstanding</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">options,&nbsp;warrants&nbsp;and</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">rights&nbsp;(b)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;securities&nbsp;remaining<BR>available&nbsp;for&nbsp;future&nbsp;issuance<BR>under equity
compensation<BR>plans (excluding securities<BR>reflected in column (a)) (c)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Equity compensation plans approved by
stockholders&nbsp;(1)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">26,658,364</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;8.50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">14,172,938</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Equity compensation plans not approved by
stockholders&nbsp;(3)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">150,700</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">19.72</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Total</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">26,809,064</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;8.56</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">14,172,938</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Equity plans approved by our stockholders include the 2014 Plan, the 2017 Plan and the ESPP. As
of December&nbsp;31, 2021, a total of 3,168,354 shares of our common stock remained available for issuance under the ESPP, and up to a maximum of 534,037 shares of our common stock may be purchased in the current purchase period. The shares issuable
pursuant to our ESPP are not included in the number of shares to be issued pursuant to rights outstanding or and the weighted-average exercise price of such rights as of December&nbsp;31, 2021, as those numbers are not known.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The weighted-average exercise price takes into account the shares subject to outstanding RSU
awards, including such awards with performance conditions, which have no exercise price. The weighted-average exercise price, excluding such outstanding RSU awards, is $16.76. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Represents shares of our common stock issuable pursuant to the 2016 Plan. As of December&nbsp;31,
2021, no shares of our common stock remained available for additional grants under the 2016 Plan. In November 2016, the Board adopted the 2016 Plan pursuant to which we reserved 1,500,000 shares of our common stock for issuance under the 2016 Plan.
The only persons eligible to receive grants of Awards under the 2016 Plan are individuals who satisfy the standards for inducement grants under Nasdaq Marketplace Rule 5635(c)(4) and the related guidance under Nasdaq IM <FONT
STYLE="white-space:nowrap">5635-1&#151;that</FONT> is, generally, a person not previously an employee or director of Exelixis, or following a bona fide period of <FONT STYLE="white-space:nowrap">non-employment,</FONT> as an inducement material to
the individual&#146;s entering into employment with Exelixis. An &#147;Award&#148; is any right to receive Exelixis common stock pursuant to the 2016 Plan, consisting of NSOs, stock appreciation rights, restricted stock awards, RSU awards, or any
other stock award. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Required Vote and Board of Directors Recommendation </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The affirmative vote of the holders of a majority of the shares present or represented by proxy and entitled to vote at the Annual Meeting is
required to approve the Amended 2017 Plan. Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the same effect as votes against this proposal.
<FONT STYLE="white-space:nowrap">Broker&nbsp;non-votes&nbsp;will</FONT> have no effect and will not be counted towards the vote total. </FONT></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;background-color:#e5e5e5;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#fc4c02"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; PROPOSAL 3. </B></FONT></P></div>
<P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">49</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_11"></A>P<SMALL>ROPOSAL</SMALL> 4 </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#6d6d6d">A<SMALL>DVISORY</SMALL> V<SMALL>OTE</SMALL> O<SMALL>N</SMALL> T<SMALL>HE</SMALL> C<SMALL>OMPENSATION</SMALL> O<SMALL>F</SMALL> T<SMALL>HE</SMALL>
N<SMALL>AMED</SMALL> E<SMALL>XECUTIVE</SMALL> O<SMALL>FFICERS</SMALL> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our stockholders are entitled to vote to approve, on an
advisory basis, the compensation, as disclosed in this Proxy Statement, of our Chief Executive Officer, Chief Financial Officer and the other executive officers appearing in the table titled &#147;<A HREF="#tx282574_500">Summary Compensation
Table</A>&#148; later in this Proxy Statement (collectively, the Named Executive Officers). This vote is not intended to address any specific item of compensation, but rather the overall compensation of our Named Executive Officers and the
philosophy, policies and practices described in this Proxy Statement. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board encourages our stockholders to review the
compensation tables and read the disclosures set forth in the &#147;<A HREF="#tx282574_1003">Compensation Discussion and Analysis</A>&#148; section of this Proxy Statement that describe our executive compensation program and the compensation of our
Named Executive Officers for fiscal 2021. For the reasons described in this Proxy Statement, the Board believes that our executive compensation program strongly aligns with the interests of our stockholders, effectively ties executive compensation
with our performance and results in the attraction and retention of highly talented executives. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Accordingly, the Board recommends
that our stockholders vote FOR the following resolution: </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; margin-right:8%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#147;<B>RESOLVED,</B> that the
compensation paid to the Named Executive Officers, as disclosed pursuant to Item&nbsp;402 of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> including the Compensation Discussion and Analysis, compensation tables and narrative discussion, is
hereby APPROVED.&#148; </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_12"></A>Required Vote and Board of Directors Recommendation </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Advisory approval of Proposal 4
requires the affirmative vote of a majority of the shares present or represented by proxy at the Annual Meeting and entitled to vote on this proposal. Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the
same effect as votes against this proposal. Broker <FONT STYLE="white-space:nowrap">non-votes,</FONT> if any, will have no effect. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our stockholders have expressed a preference, and our Board has determined, to hold an advisory vote on executive compensation annually. We are
presenting this Proposal 4 as required by Section&nbsp;14A of the Exchange Act. Our Board believes that approval of Proposal 4 is in our best interests and the best interests of our stockholders for the reasons stated above. Because the vote is
advisory, it is not binding on the Board or on us. Nevertheless, the views expressed by our stockholders, whether through this vote or otherwise, are very important to the Board and the management team and, accordingly, the Compensation Committee
and Board intend to consider the results of this vote in making determinations in the future regarding executive compensation arrangements. Your vote will serve as an additional tool to guide the Compensation Committee and Board as they continue to
improve the alignment of our executive compensation programs with business objectives and performance and with the interests of our stockholders. Unless our Board changes the frequency of future advisory votes on executive compensation, the next
advisory vote on executive compensation will be held at the 2023 Annual Meeting of Stockholders. </FONT></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;background-color:#e5e5e5;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#fc4c02"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; PROPOSAL 4. </B></FONT></P></div>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">50</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Security Ownership of Certain Beneficial Owners and Management </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_13"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table sets forth certain information regarding the ownership of our common stock as of
February&nbsp;28, 2022, (except as noted) by: (i)&nbsp;each director and nominee for director; (ii)&nbsp;each of the executive officers named in the <A HREF="#tx282574_500">Summary Compensation Table</A>; (iii)&nbsp;all current executive officers
and directors of Exelixis as a group; and (iv)&nbsp;all those known by us to be beneficial owners of more than five percent of our common stock. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Beneficially&nbsp;Owned&nbsp;(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;Name of Beneficial
Owner</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Shares&nbsp;of<BR>Common&nbsp;Stock</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Percentage<BR>of&nbsp;Total</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Executive Officers and
Directors</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D. (2)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,672,884</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner
(3)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">852,234</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley
(4)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">467,129</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D. (5)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">793,096</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D.
(6)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">645,747</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Charles Cohen, Ph.D.
(7)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">403,884</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Carl B. Feldbaum, Esq.
(8)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">210,119</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Maria C. Freire, Ph.D.
(9)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">128,629</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alan M. Garber, M.D.,
Ph.D. (10)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">254,316</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent T. Marchesi,
M.D., Ph.D. (11)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">146,363</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos,
Ph.D. (12)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,251,806</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George Poste, DVM, Ph.D.,
FRS (13)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">245,384</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie A. Smith
(14)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">156,220</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Lance Willsey, M.D.
(15)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">666,013</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jacqueline Wright
(16)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">41,717</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jack L. Wyszomierski
(17)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">391,837</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All current directors,
executive officers as a group (17 persons) (18)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">9,346,080</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2.9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>5%
Stockholders</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">BlackRock, Inc.
(19)</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">55 East 52nd Street</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">New York, New York 10055</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">32,277,378</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10.1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Vanguard Group
(20)</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">100 Vanguard Blvd.</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Malvern, Pennsylvania 19355</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30,059,689</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">9.4</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">FMR LLC (21)</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">245 Summer Street</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Boston, Massachusetts 02210</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">18,804,979</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5.9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Renaissance Technologies
LLC (22)</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">800 Third Avenue</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">New York, New York 10022</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">17,100,778</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5.3</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">T. Rowe Price
Associates, Inc. (23)</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">100 E. Pratt Street</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Baltimore, MD 21202</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">17,099,967</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5.3</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Less than one percent. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">51</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">This table is based upon information supplied by executive officers and directors and upon
information gathered by us about principal stockholders known to us. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, we believe that each of the stockholders named in this table has
sole voting and investment power with respect to the shares indicated as beneficially owned. Applicable percentages are based on 319,930,986 shares outstanding on February&nbsp;28, 2022, adjusted as required by rules promulgated by the SEC. The
percentage of beneficial ownership as to any person as of a particular date is calculated by dividing the number of shares beneficially owned by such person, which includes the number of shares as to which such person has the right to acquire voting
or investment power within 60 days of February&nbsp;28, 2022, by the sum of the number of shares outstanding as of such date plus the number of shares as to which such person has the right to acquire voting or investment power within 60 days of
February&nbsp;28, 2022. Consequently, the denominator for calculating beneficial ownership percentages may be different for each beneficial owner. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 1,246,316 shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the
Morrissey Family Living Trust dated July&nbsp;21, 1994, as amended. Also includes 1,350,224 shares Dr.&nbsp;Morrissey has the right to acquire pursuant to options exercisable within 60 days of February&nbsp;28, 2022. Also includes 17,728 shares held
by Dr.&nbsp;Morrissey under our 401(k) Plan, determined based upon information provided in plan statements. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 585,843 shares Mr.&nbsp;Senner has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2022. Also includes 2,723 shares held by Mr.&nbsp;Senner under our 401(k) Plan, determined based upon information provided in plan statements. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 23,539 shares held by Mr.&nbsp;Haley&#146;s spouse. Also includes 339,259 shares
Mr.&nbsp;Haley has the right to acquire pursuant to options exercisable within 60 days of February&nbsp;28, 2022. Also includes 10,648 shares held by Mr.&nbsp;Haley under our 401(k) Plan, determined based upon information provided in plan
statements. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 313,343 shares Mr.&nbsp;Hessekiel has the right to acquire pursuant to options
exercisable within 60 days of February&nbsp;28, 2022. Also includes 999 shares held by Mr.&nbsp;Hessekiel under our 401(k) Plan, determined based upon information provided in plan statements. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 358,888 shares Dr.&nbsp;Lamb has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2022. Also includes 17,105 shares held by Dr.&nbsp;Lamb under our 401(k) Plan, determined based upon information provided in plan statements. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 161,598 shares Dr.&nbsp;Cohen has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2022, 33,549 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 201,598 shares Mr.&nbsp;Feldbaum has the right to acquire pursuant to options
exercisable within 60 days of February&nbsp;28, 2022, 33,549 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 3,530 shares issuable pursuant to RSUs that will vest within 60 days of
February&nbsp;28, 2022 and 96,802 shares Dr.&nbsp;Freire has the right to acquire pursuant to options exercisable within 60 days of February&nbsp;28, 2022, 16,598 of which would be subject to repurchase by us, if so exercised.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 241,598 shares Dr.&nbsp;Garber has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2021, 33,549 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 80,248 shares Dr.&nbsp;Marchesi has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2022, 16,598 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 48,194 shares Dr.&nbsp;Papadopoulos has the right to acquire pursuant to options
exercisable within 60 days of February&nbsp;28, 2022. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 88,194 shares Dr.&nbsp;Poste has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2022. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 139,919 shares Ms.&nbsp;Smith has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2022. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(15)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 241,598 shares Dr.&nbsp;Willsey has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2022, 33,549 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(16)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 41,717 shares Ms.&nbsp;Wright has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2022, 41,717 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(17)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 160,248 shares Mr.&nbsp;Wyszomierski has the right to acquire pursuant to options
exercisable within 60 days of February&nbsp;28, 2022, 16,598 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">52</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Security Ownership of Certain Beneficial Owners and Management </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(18)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Total number of shares includes 4,844,076 shares of common stock held by our current directors
and executive officers as of February&nbsp;28, 2022, and entities affiliated with such directors and executive officers. Also includes 3,530 shares issuable pursuant to RSUs that will vest within 60 days of February&nbsp;28, 2022. Also includes
4,449,271 shares our directors and executive officers have the right to acquire pursuant to options exercisable within 60 days of February&nbsp;28, 2022, 225,707 of which would be subject to repurchase by us, if so exercised. Also includes 49,203
shares held by our current directors and executive officers under our 401(k) Plan, determined based upon information provided in plan statements. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(19)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">BlackRock, Inc. reported that it has sole voting power over 31,393,879 of such shares and sole
dispositive power over all of the shares. Blackrock, Inc. also reported that Blackrock Fund Advisors beneficially owns 5% or more of our outstanding common stock. The information is based solely on a Schedule 13G/A, filed with the SEC on
January&nbsp;27, 2022, which provides information only as of December&nbsp;31, 2021, and, consequently, the beneficial ownership of BlackRock may have changed between December&nbsp;31, 2021 and February&nbsp;28, 2022. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(20)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The Vanguard Group reported that it has shared voting power over 179,798 of such shares, sole
dispositive power over 29,599,914 of such shares and shared dispositive power over 459,775 of such shares. The information is based solely on a Schedule 13G/A, filed with the SEC on February&nbsp;10, 2022, which provides information only as of
December&nbsp;31, 2021, and, consequently, the beneficial ownership of Vanguard may have changed between December&nbsp;31, 2021 and February&nbsp;28, 2022. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(21)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">FMR LLC reported that it has sole voting power over 668,676 of such shares and sole dispositive
power over all of the shares. The information is based solely on a Schedule 13G filed with the SEC on February&nbsp;9, 2022, which provides information only as of December&nbsp;31, 2021, and, consequently, the beneficial ownership of FMR LLC may
have changed between December&nbsp;31, 2021 and February&nbsp;28, 2022. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(22)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">These shares are beneficially owned by Renaissance Technologies LLC (RTC), and Renaissance
Technologies Holdings Corporation (RTHC), the majority owner of RTC. RTC reported that it and RTHC each have sole voting power over all of the shares and sole dispositive power over all of the shares. The information is based solely on a Schedule
13G/A filed with the SEC on February&nbsp;11, 2022, which provides information only as of December&nbsp;31, 2021, and, consequently, the beneficial ownership of RTC and RTHC may have changed between December&nbsp;31, 2021 and February&nbsp;28, 2022.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(23)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">T. Rowe Price Associates, Inc. reported that it has sole voting power over 4,139,519 of such
shares and sole dispositive power over all of the shares. The information is based solely on a Schedule 13G/A filed with the SEC on February&nbsp;14, 2022, which provides information only as of December&nbsp;31, 2021, and, consequently, the
beneficial ownership of T. Rowe Price Associates may have changed between December&nbsp;31, 2021 and February&nbsp;28, 2022. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">53</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_14"></A>INFORMATION ABOUT OUR EXECUTIVE OFFICERS </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following chart sets forth certain information regarding our executive officers as of March&nbsp;28, 2022: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="70%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02"><B>Age</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02"><B>Position</B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.&nbsp;(1)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">61</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">President and Chief Executive Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">54</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President and Chief Financial Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vicki L. Goodman, M.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">52</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President, Product Development&nbsp;&amp; Medical Affairs, and Chief Medical Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">46</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President, Commercial</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">53</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President, General Counsel and Secretary</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">61</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President, Scientific Strategy and Chief Scientific Officer</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Please see &#147;<A HREF="#tx282574_1007">Director Nominees</A>&#148; in this Proxy Statement for
Dr.&nbsp;Morrissey&#146;s biography. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:18pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Christopher J. Senner</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Executive Vice President and Chief Financial Officer</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner, has served as Executive Vice
President and Chief Financial Officer (and in such capacity, as our principal financial officer and principal accounting officer, as defined under applicable securities laws) since July 2015. Prior to joining Exelixis, Mr.&nbsp;Senner served as Vice
President, Corporate Finance for Gilead Sciences, Inc., a biopharmaceutical company, from March 2010 to July 2015, where he was accountable for controllership, tax, treasury and corporate and operational financial planning. Mr.&nbsp;Senner
previously spent eighteen years at Wyeth, a pharmaceutical company acquired by Pfizer Inc. in 2009, in a variety of financial roles with increasing responsibility, most notably as Chief Financial Officer of Wyeth&#146;s U.S. pharmaceuticals business
and the BioPharma Business Unit. Since 2019, Mr.&nbsp;Senner has served as a member of the board of directors of Cortexyme, Inc., a publicly held clinical-stage biopharmaceutical company. Mr.&nbsp;Senner holds a B.S. in Finance from Bentley
College.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:18pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Vicki L. Goodman, M.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Executive Vice President, Product Development&nbsp;&amp; Medical Affairs, and Chief Medical Officer</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vicki L. Goodman, M.D., has served as Executive Vice
President, Product Development&nbsp;&amp; Medical Affairs, and Chief Medical Officer since January 2022. Dr.&nbsp;Goodman has more than two decades of oncology experience as a drug development leader at global biopharmaceutical organizations,
regulator and clinician. Prior to joining Exelixis, from June 2020 to December 2021 she was Vice President, Clinical Research and (from September 2020 to December 2021) Therapeutic Area Head, Late Stage Oncology at Merck&nbsp;&amp; Co., where she
oversaw key elements of the company&#146;s late-stage development portfolio. Previously, from January 2015 to May 2020, Dr.&nbsp;Goodman served at Bristol-Myers Squibb Company (BMS), most recently as Vice President and Head, New Asset Development
Teams, and throughout her tenure at BMS she was a member of the company&#146;s Oncology Senior Leadership Team. From 2007 to 2015, Dr.&nbsp;Goodman held positions of increasing responsibility at GlaxoSmithKline plc. Prior to entering the
biopharmaceutical industry, from 2004 to 2007, she worked as a Medical Officer in the then-Division of Oncology Drug Products, part of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration. From 2001 to 2004, she
completed a clinical fellowship in hematology and medical oncology at the University of Michigan, Ann Arbor, where she also undertook her internship and residency. Dr.&nbsp;Goodman obtained her M.D. from Albert Einstein College of Medicine and her
B.A. in Biochemistry, with Honors, from Rutgers University.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:18pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Patrick J. Haley</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Executive Vice President, Commercial</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley, has served as the company&#146;s
Executive Vice President, Commercial since February 2020 and has held positions of progressive commercial leadership since September 2010, serving as Senior Vice President, Commercial from December 2016 to February 2020, Vice President, Commercial
from November 2014 to November 2016, Executive Director, Sales&nbsp;&amp; Marketing from September 2013 to October 2014, Senior Director, Marketing from March 2012 to August 2013, and as Director, Marketing from September 2010 to February 2012.
Prior to joining Exelixis, from 2007 to 2010, he held positions of increasing responsibility at Genentech, Inc., on the Avastin marketing team, most recently Group Product Manager. Between 2003 and 2007, Mr.&nbsp;Haley served in various sales and
marketing roles at Amgen, Inc. He served as an analyst at PWC Securities, Lehman Brothers and Accenture from 1998 to 2001. Mr.&nbsp;Haley holds a Masters of Business Administration from University of Michigan, Ross School of Business, and a Bachelor
of Arts in Art History and Medieval and Renaissance Studies from Duke University.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">54</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Information About Our Executive Officers </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:18pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Jeffrey J. Hessekiel, J.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Executive Vice President, General Counsel and Secretary</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; font-family:Calibri; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D., has served as Executive Vice
President and General Counsel since February 2014, and as Secretary from October 2014 to September 2017 and again since January 2022. From 2012 to 2014, he held the position of Senior Counsel at Arnold&nbsp;&amp; Porter Kaye Scholer LLP, where he
advised emerging growth and public companies, primarily in the life sciences sector, on complex legal issues connected with strategic transactions, healthcare compliance programs and investigations, and regulatory matters. Prior to working with
Arnold&nbsp;&amp; Porter, from 2002 to 2012, he held positions of increasing responsibility at Gilead Sciences, Inc., most recently as Chief Compliance&nbsp;&amp; Quality Officer where he was responsible for the creation and management of
Gilead&#146;s Corporate Compliance&nbsp;&amp; Quality department. From 1998 to 2002, Mr.&nbsp;Hessekiel held the position of Associate, working on both litigation and corporate matters for Wilson Sonsini Goodrich and Rosati PC. Mr.&nbsp;Hessekiel
also worked as an Associate focusing on litigation matters for Heller Ehrman LLP from 1996 to 1998. Prior to joining Heller Ehrman LLP, Mr.&nbsp;Hessekiel also worked for several international <FONT STYLE="white-space:nowrap">non-governmental</FONT>
organizations. Mr.&nbsp;Hessekiel received his J.D. from The George Washington University Law School and is admitted to practice in California. Mr.&nbsp;Hessekiel received a B.A. in Political Science from Duke University.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:18pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Peter Lamb, Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Executive Vice President, Scientific Strategy and Chief Scientific Officer</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D., has served as Executive Vice
President, Scientific Strategy and Chief Scientific Officer since February 2016. Previously, he served as Executive Vice President, Discovery Research and Chief Scientific Officer from September 2009 to February 2016, as Senior Vice President,
Discovery Research and Chief Scientific Officer from January 2007 until September 2009, as Vice President, Discovery Pharmacology from December&nbsp;2003 until January 2007 and as Senior Director, Molecular Pharmacology and Structural Biology from
October 2000 until December 2003. Prior to joining Exelixis, from June 1992 until September 2000, Dr.&nbsp;Lamb held positions of increasing responsibility at Ligand Pharmaceuticals, a pharmaceutical company, most recently serving as Director of
Transcription Research. Dr.&nbsp;Lamb has held post-doctoral research fellowships at the Carnegie Institution, Department of Embryology, with Dr.&nbsp;S.L. McKnight and the University of Oxford with Dr.&nbsp;N.J. Proudfoot, working in the field of
gene regulation. He has authored numerous articles in the fields of gene expression, signal transduction and oncology, and is an author on multiple issued and pending U.S. patents. He has a Ph.D. in Molecular Biology from the ICRF/University of
London and a B.A. in Biochemistry from the University of Cambridge.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">55</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_15"></A>COMPENSATION OF EXECUTIVE OFFICERS </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_16"></A><A NAME="tx282574_1003"></A>Compensation Discussion and Analysis </FONT></P>
<P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">This Compensation Discussion and
Analysis (CD&amp;A) explains the strategy, design, and decision-making related to our compensation programs and practices for the following individuals to whom we refer as our Named Executive Officers. This CD&amp;A is intended to provide
perspective on the information contained in the tables that follow this discussion. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Named Executive Officers</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02"><B>Title</B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">President and Chief Executive Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President and Chief Financial Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President, Commercial</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President, General Counsel and Secretary</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President, Scientific Strategy and Chief Scientific Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab,
M.D. (1)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Former President, Product Development and Medical Affairs and Chief Medical Officer</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Dr.&nbsp;Schwab passed away in September 2021. All 2021 compensation decisions for
Dr.&nbsp;Schwab are described below under the heading &#147;<A HREF="#tx282574_1505">Passing of Gisela M. Schwab</A>.<B>&#148;</B> </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">While the principal purpose of this CD&amp;A is to discuss the compensation of our Named Executive Officers, many of the programs discussed apply to other members of senior management who, together with the Named Executive Officers,
are collectively referred to as our executive officers. The market for top talent in the biopharmaceutical industry is intensely competitive. As explained in further detail below, our compensation programs are designed to attract, motivate and
retain job candidates across a variety of disciplines who present the skills, expertise, and experience necessary to grow our business operations and sustain our mission. Our compensation programs necessarily balance shorter- and longer-term
incentives, and they incorporate compensation elements that mix rewards for service over time with performance-based rewards. In this way, we believe our compensation programs are effective for attracting top talent and align favorably with our peer
group. </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_17"></A>Executive Summary </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Our Business </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We are an
oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for patients with <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">difficult-to-treat</FONT></FONT>
cancers. Using our considerable drug discovery, development and commercialization resources and capabilities, we have invented and brought to market innovative therapies that appropriately balance patient benefits and risks; we will continue to
build on this foundation as we strive to provide cancer patients with new treatment options that improve upon current standards of care. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Today, four products that originated in Exelixis laboratories are available to be prescribed to patients. Sales related to our flagship molecule, cabozantinib, account for the large majority of our revenues. Cabozantinib is an
inhibitor of multiple tyrosine kinases including MET, AXL, VEGF receptors and RET and has been approved by the U.S. Food and Drug Administration (FDA) and in 61 other countries as: CABOMETYX<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>
(cabozantinib) tablets approved for advanced renal cell carcinoma (RCC), both alone and in combination with Bristol-Myers Squibb Company&#146;s (BMS) OPDIVO<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (nivolumab), for previously
treated hepatocellular carcinoma (HCC) and, currently by the FDA, for previously treated, radioactive iodine-refractory differentiated thyroid cancer (DTC); and COMETRIQ<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (cabozantinib)
capsules approved for progressive, metastatic medullary thyroid cancer. For physicians treating these types of cancer, cabozantinib has become or is becoming an important medicine in their selection of effective therapies. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The other two products resulting from our discovery efforts are: COTELLIC<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>
(cobimetinib), an inhibitor of MEK approved as part of multiple combination regimens to treat specific forms of advanced melanoma and marketed under a collaboration with Genentech, Inc. (a member of the Roche Group) (Genentech); and MINNEBRO<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (esaxerenone), an oral, <FONT STYLE="white-space:nowrap">non-steroidal,</FONT> selective blocker of the mineralocorticoid receptor approved for the treatment of hypertension in Japan and licensed
to Daiichi Sankyo Company, Limited. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">56</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|&nbsp;Compensation Discussion and Analysis </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2021 Financial Performance Highlights<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </B></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g02a10.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g02z22.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Exelixis team made significant progress across the entire business throughout the year while delivering
strong financial results in fiscal 2021, with total revenues of 1,435.0&nbsp;million, a 45% year-over-year increase, and ending fiscal 2021 with a healthy cash and investments balance of $1.9&nbsp;billion. Other key financial highlights from fiscal
2021 include: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Cabozantinib franchise net product revenues in the U.S. of $1,077.3&nbsp;million, representing a
45% year-over-year increase; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Total operating expenses of $1,148.3&nbsp;million, up 31% from the prior fiscal year and
including research and development expenses of $693.7&nbsp;million, underscoring our commitment to investing in our potential product pipeline; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">A fifth full year of operating profit, resulting in diluted earnings per share of $0.72, driven
by strong revenue growth and disciplined expense management. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Revenues, expenses, cash and investments, and diluted earnings per share included in 2021
Financial Performance Highlights are calculated in accordance with U.S. Generally Accepted Accounting Principles. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2021 Corporate Performance Highlights </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g03a03.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We had a strong fiscal 2021 across all components of our business as we continued to grow the cabozantinib
business and advance a diversified and growing pipeline of clinical and discovery programs, despite the continued challenges imposed by the evolving effects of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. We executed commercially
by utilizing dynamic strategies to maintain engagement with prescribers despite certain periods of restricted <FONT STYLE="white-space:nowrap">in-person</FONT> access and the continued evolution of the digital business environment; we succeeded in
the clinic by adjusting the advancement and operation of our clinical trials in compliance with established protocols, placing the highest priority on patient safety; and we created opportunity with drug
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">57</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">discovery by advancing
our research where it could be done safely and by supplementing it with research collaborations and <FONT STYLE="white-space:nowrap">in-licensing</FONT> arrangements. Key highlights of our corporate performance include: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Achievement of Regulatory Approvals for CABOMETYX for the Treatment of Advanced RCC and DTC </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In January 2021, the FDA approved CABOMETYX in combination with OPDIVO as a first-line treatment
for patients with advanced RCC, the most common form of kidney cancer. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To make the combination regimen available to eligible RCC patients outside of the U.S, we worked
closely with our collaboration partners Ipsen Pharma SAS (Ipsen) and Takeda Pharmaceutical Company Limited (Takeda) on their respective regulatory strategies. In March 2021, Ipsen received regulatory approval from the European Commission for the
combination of CABOMETYX and OPDIVO as a first-line treatment for advanced RCC, and in August 2021, Takeda and Ono Pharmaceutical Co., Ltd. (Ono), BMS&#146;s partner responsible for the clinical development and commercialization of OPDIVO in Japan,
received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to manufacture and market CABOMETYX in combination with OPDIVO as a treatment for unresectable or metastatic RCC. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In September 2021, the FDA approved CABOMETYX for the treatment of patients with locally advanced
or metastatic DTC, the most common type of thyroid cancer in the U.S., and we immediately commenced commercialization of CABOMETYX in this indication following approval. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Continued Successful Commercialization of CABOMETYX in Approved RCC and HCC Indications </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In the U.S., we continued to promote CABOMETYX within its labeled RCC and HCC indications and
educate physicians on the product&#146;s unique clinical profile. These efforts helped drive continued strong product demand in 2021 despite increased competition from therapies that combine an immune checkpoint inhibitor (ICI) with another targeted
agent to treat cancer. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In markets outside of the U.S., we worked closely with our partners Ipsen and Takeda in support
of their respective regulatory strategies and commercialization efforts for CABOMETYX. As a result of additional approvals in territories outside of the U.S., CABOMETYX continued to grow both in sales and the number of RCC and HCC patients
benefiting from its clinical effect in 2021. In the fourth quarter of 2021, Ipsen achieved the significant milestone of $400&nbsp;million in net sales in its licensed territory, triggering a $100.0&nbsp;million milestone payment to us in the first
quarter of 2022. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Achievement of Enrollment Targets for and Positive Results from Multiple Phase
3 Pivotal Trials Evaluating Cabozantinib </B></FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In February 2021, we announced positive phase 2 results for CABOMETYX in patients with metastatic
papillary renal cell carcinoma, a form of kidney cancer, from the S1500 trial (PAPMET), which was designed and managed by SWOG Cancer Research Network. The trial showed CABOMETYX significantly improved progression-free survival (PFS) versus current
guideline-preferred therapy. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Reinforcing our efforts in RCC, in March 2021, we completed the enrollment of <FONT
STYLE="white-space:nowrap">COSMIC-313,</FONT> a phase 3 pivotal trial evaluating the triplet combination of cabozantinib, nivolumab and ipilimumab versus the combination of nivolumab and ipilimumab in patients with previously untreated advanced
intermediate- or poor-risk RCC. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In June 2021, we announced detailed results from
<FONT STYLE="white-space:nowrap">COSMIC-311,</FONT> our pivotal phase 3 trial evaluating cabozantinib in patients with previously treated <FONT STYLE="white-space:nowrap">RAI-refractory</FONT> DTC. The trial met its primary endpoint of demonstrating
a significant improvement in PFS assessed by a blinded independent radiology committee. These positive results led to FDA approval of this indication in September 2021, and Exelixis initiated commercialization for this indication immediately
following this approval. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Expansion of Product Pipeline Beyond the Cabozantinib Franchise
</B></FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">We made substantial progress expanding the clinical development of XL092, a next-generation oral
tyrosine kinase inhibitor, by, among other things, entering into a clinical trial collaboration and supply agreement with BMS for <FONT STYLE="white-space:nowrap">STELLAR-002,</FONT> a new phase 1b trial evaluating XL092 in combination with
immuno-oncology therapies in advanced solid tumors. In December 2021, we initiated the dose-escalation stage of <FONT STYLE="white-space:nowrap">STELLAR-002.</FONT> </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In December 2020, we exercised our exclusive option for XB002, an antibody-drug conjugate (ADC)
that targets tissue factor (TF), under our collaboration with Iconic Therapeutics, Inc. (Iconic), and we subsequently </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">58</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation Discussion and Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">submitted an investigational new drug application (IND) to the FDA for XB002 in March 2021. In June 2021, we initiated a phase 1 trial of XB002 in patients with advanced solid tumors. In December
2021, based on the emerging favorable data from the phase 1 trial, we amended our collaboration with Iconic to acquire broad rights to use the <FONT STYLE="white-space:nowrap">anti-TF</FONT> antibody incorporated into XB002 for any application,
including conjugated to other payloads, as well as rights within oncology to a number of other <FONT STYLE="white-space:nowrap">anti-TF</FONT> antibodies developed by Iconic, including for use in ADCs and multispecific biotherapeutics.
</FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In October 2021, we exercised our exclusive option to
<FONT STYLE="white-space:nowrap">in-license</FONT> XL114 (formerly AUR104), a novel anti-cancer compound that inhibits activation of the CARD11-BCL10-MALT1 (CBM) complex, a key component of signaling downstream of
<FONT STYLE="white-space:nowrap">B-</FONT> and <FONT STYLE="white-space:nowrap">T-cell</FONT> receptors, which promotes <FONT STYLE="white-space:nowrap">B-</FONT> and <FONT STYLE="white-space:nowrap">T-cell</FONT> lymphoma survival and
proliferation. As a result, we assumed responsibility for all subsequent clinical development, manufacturing and commercialization of the compound. In April 2022, we initiated a phase 1 trial of XL114 as a monotherapy in patients with <FONT
STYLE="white-space:nowrap">non-Hodgkin&#146;s</FONT> lymphoma (NHL). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In an effort to expand our pipeline to encompass a variety of promising therapeutic modalities,
in August 2021, we expanded our discovery and licensing collaboration with Invenra, Inc. (Invenra) to include an additional 20 oncology targets. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">As a direct result of our research collaborations and other arrangements, we designated XB010,
our first ADC advanced internally, as a development candidate in late 2021. XB010, which targets the tumor antigen 5T4, incorporates antibodies sourced from Invenra and was constructed using and
SMARTag<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> site-specific bioconjugation platform under our collaboration with subsidiaries of Catalent, Inc. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2021 Executive Compensation Program Highlights </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In 2021, we continued in our efforts to create long-term value for our stockholders by driving the expansion and depth of our commercial and
investigational product offerings, growing our revenues and improving our future business prospects through important partnerships with emerging biotherapeutic companies. The Compensation Committee believes that the 2021 compensation of all our
employees, including our Named Executive Officers, is appropriate not only due to the achievement of critical milestones, but also to continue to encourage their diligent efforts towards the achievement of our key priorities and anticipated
milestones in 2022 and beyond. In consideration of the company&#146;s performance as summarized above, the Board and Compensation Committee took the following key actions with respect to 2021 compensation for our Named Executive Officers:
</FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="63%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.40em; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Key Compensation
Actions</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Description</FONT></B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Approved Salary
Increases for Named Executive Officers</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In February 2021, the Compensation
Committee increased base salaries for our Named Executive Officers by between 3% and 6% over salaries for 2020.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Approved Annual Cash
Bonuses That Are Aligned with Strong Company Performance</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In February 2022, the Compensation
Committee approved the payment of cash bonuses in amounts between 115% and 120% of each Named Executive Officer&#146;s 2021 target cash bonus amounts. These decisions reflected the Compensation Committee&#146;s assessment of the overall achievement
of our <FONT STYLE="white-space:nowrap">pre-determined</FONT> 2021 corporate goals, and the individual contributions of each Named Executive Officer toward the achievement of our corporate goals.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Granted
Performance-Based and Time-Based Awards under Our Long-Term Incentive Program (LTIP)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In early 2021, the Compensation Committee
approved equity awards for each Named Executive Officer to be comprised of approximately 50% performance-based RSU awards (PSUs) and 50% time-based equity awards (in the form of stock options for our CEO and RSU awards for our other Named Executive
Officers). After consulting with its independent compensation consultant, the Compensation Committee changed the weighting of the equity awards from 100% PSUs in fiscal 2020 to 50% PSUs and 50% time-based equity awards in fiscal 2021 to serve as an
effective balance between retention and performance, risk and leverage, as well as alignment with our peer group.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Did Not Adjust
Performance Targets for LTIP or Annual Cash Bonus Plan</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Notwithstanding continuing challenges
imposed by the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on our business, the Compensation Committee believed that the performance targets were critical business objectives for the company and that the established programs remained
appropriate. Consequently, the Compensation Committee did not adjust the performance targets for either our LTIP or our Annual Cash Bonus Plan in 2021.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">59</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Compensation
Practices and Governance Highlights </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="64%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Pay for
Performance</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We link the compensation of our Named Executive Officers to our corporate performance.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Stockholder
Alignment</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We use long-term equity incentives to align the interests of our Named Executive Officers with those of our stockholders.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Alignment of
Compensation Metrics and Corporate Strategy</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Our Compensation Committee establishes long-term incentive compensation programs based on metrics that are aligned with our corporate strategy and designed to build value for our
stockholders.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Compensation
Governance</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Our Compensation Committee is made up entirely of independent directors and engages an independent compensation consultant to advise on executive compensation matters.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Stockholder
Feedback</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We value the feedback of our stockholders and solicit it on a regular basis, including through an annual stockholder vote to approve our <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">say-on-pay</FONT></FONT> proposal.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Recoupment (or
Clawback) Policy</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We maintain a Clawback Policy that permits the company to recoup variable compensation from senior level employees, including our Named Executive Officers, in the event of misconduct that
causes material harm to the company.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Annual Cash Bonus
Amounts Subject to Payment Maximums</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Our Annual Cash Bonus Plan sets a cap of 200% on the payouts of target bonus payments for individual and/or corporate performance.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Equity Plan
Features</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Applies a maximum <FONT STYLE="white-space:nowrap">7-year</FONT> term for stock options.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Prohibits repricing of underwater stock options without prior stockholder approval.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;The 2017 Plan also includes minimum vesting requirements of no less than one year for all types of awards, subject to limited exceptions.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B><A NAME="tx282574_1002">
</A>Stock Ownership Guidelines</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We apply stock ownership guidelines to directors and executive officers to further align their interests with those of our stockholders.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Change in Control
Provisions</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Does not include excessive change in control or severance payments.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Provides &#147;double-trigger&#148; change in control benefits.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Does not include tax <FONT STYLE="white-space:nowrap">gross-ups</FONT> on severance or change in control benefits.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Perquisites,
Retirement and Pension Benefits</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Our Named Executive Officers do not receive excessive perquisites or post-termination retirement or pension benefits that are not available to all employees generally.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Prohibition on
Hedging and Margin Loans</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We prohibit hedging and purchases on margin by executive officers and directors.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Meaningful Limits on
Pledging</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We limit pledging of our common stock by executive officers and directors to circumstances where the individual can clearly demonstrate the financial capacity to repay the loan without
resorting to the pledged securities. No executive officers or directors pledged our common stock during 2021.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Compensation Risk
Assessment</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Our Compensation Committee conducts an annual risk assessment of our compensation policies and practices to ensure that our programs are not reasonably likely to have a material adverse
effect on us.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_18"></A>Objectives of the Compensation Program </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The primary goals of our executive compensation program are to: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Provide market-competitive compensation that attracts, motivates and retains our executive
officers to achieve our short- and long-term business objectives; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">60</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation Discussion and Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Align our executive officers&#146; compensation with the interests of our stockholders; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Reward our executive officers for success in achieving our corporate goals.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The success of any biotechnology company depends in large part upon the quality of its workforce. Therefore, we
believe it is critical to our business that we retain our core team of highly qualified employees, including our Named Executive Officers. As a testament to the high demand for their services in the marketplace, large pharmaceutical and
biotechnology companies and strong local competitors have pursued our executives and other highly skilled employees. In light of this competitive pressure, each year we design our executive compensation program to help attract, motivate and retain
highly qualified individuals with relevant experience in the biotechnology industry to manage the varied aspects of our growing business operations. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT
 COLOR="#fc4c02"><A NAME="toc282574_19"></A>How We Determine Executive Compensation </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Role of the Compensation Committee,
Compensation Consultants and Executive Officers in Compensation Decisions </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Role of the Compensation Committee </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee is responsible for evaluating and approving the compensation packages offered to our Named Executive Officers. When
appropriate, the Compensation Committee will solicit the input of, or present its recommendations on compensation matters for consideration and approval to, the full Board. The Compensation Committee acts on behalf of the Board in discharging the
Board&#146;s responsibilities with respect to overseeing our compensation policies, plans and programs, and establishing and reviewing general policies relating to compensation and benefits of our employees. The Compensation Committee also
administers our equity and other incentive plans. The Compensation Committee does not delegate any of its functions to others in determining executive compensation. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Role of Compensation Consultants </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Under its charter, the Compensation Committee has the authority to obtain the advice and assistance from external advisors to assist it in the performance of its duties. In accordance with this authority, the Compensation Committee
engages external advisors to advise on executive officer compensation, including base salaries, bonus targets and equity compensation, as well as director compensation. These advisors also prepare industry compensation data, assist with the
development of our peer group, and advise the Compensation Committee on best industry practices and relevant changes to regulations that may impact the Compensation Committee&#146;s decision-making process with regard to executive officer and
director compensation determinations. For 2021 compensation matters, the Compensation Committee retained the consulting firm Aon, to advise and assist with the following: </FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Development of a peer group to be used in the evaluation of 2021 executive and director
compensation determinations. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Documentary support, including peer group and industry data with respect to base salaries, target
annual cash bonuses and equity compensation. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">A market analysis of executive officer compensation compared to our peer group, which market
analysis was reviewed with the Compensation Committee and used to guide 2021 base salary and bonus target decisions for our Named Executive Officers. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">A market analysis of long-term incentive compensation of our executive officers compared to our
peer group, which market analysis was reviewed with the Compensation Committee and used to guide 2021 long-term equity compensation determinations. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee assessed the independence of Aon pursuant to SEC rules and concluded that the work performed by Aon for the
Compensation Committee did not raise any conflicts of interest. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Role of Executive Officers </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Dr.&nbsp;Morrissey, our President and Chief Executive Officer, also participates in the Compensation Committee&#146;s deliberations with respect
to Named Executive Officer compensation other than his own; he is not present during deliberations and voting concerning his compensation. Each year, Dr.&nbsp;Morrissey and other senior management develop annual corporate goals and performance
targets for long-term incentive awards for the company, which are reviewed and, subject to their input, approved by the Compensation Committee. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">61</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Compensation
Committee Process </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In setting the level of salary, annual cash bonus and long-term incentive compensation for our Named Executive
Officers, the Compensation Committee typically considers various factors, including: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the performance of the company during the prior year; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the contribution of each Named Executive Officer toward achievement of our corporate goals;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the criticality of each Named Executive Officer&#146;s skill set and relative expected future
contributions to our business; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the growing complexity of our business and expanding workforce resulting in increased workloads
and responsibilities of our Named Executive Officers; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the appropriate mix of compensation for each Named Executive Officer;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the historical salary, cash bonus and percentage of vested versus unvested equity awards held by
each Named Executive Officer; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">market data, which include competitive information relating to compensation levels for comparable
positions in the biotechnology and life sciences sector and for our specific peer group. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Each year, the
Compensation Committee balances each of these factors against our cash resources and the critical need to prioritize clinical development and pipeline expansion investments over other expenditures, as well as our aggregate equity burn rate. Using
this process, the Compensation Committee strives to ensure that our executive compensation program as a whole is competitive. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx282574_1001">
</A>Stockholder Outreach </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">An integral part of the review process for our executive compensation program are our stockholder
outreach initiatives, pursuant to which we elicit and obtain a better understanding of the concerns and perspectives of our stockholders. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:2.5pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Range of Governance and Business Topics Discussed with Stockholders During 2021</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #fc4c02; font-size:2.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;Executive Compensation</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;Human Capital Management</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> <FONT STYLE="white-space:nowrap">&nbsp;&nbsp;&nbsp;&nbsp;COVID-19</FONT> Response</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;Diversity, Equity and Inclusion (DEI)</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;Board Independence, Composition, Tenure and Refreshment</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;ESG Disclosures</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Each year, during the period following the filing of our Proxy Statement with the SEC and the date of our annual
meeting, we reach out to and engage with our major stockholders to seek support for our annual meeting proposals and request feedback regarding governance matters. This outreach effort also provides us with the opportunity to gather our
stockholders&#146; opinions concerning the executive compensation measures that are in the best interest of our stockholders and to reaffirm our commitment to align pay and performance. Participants at these meetings typically include members of the
management team and in some cases the Chair of our Board or the Chair of our Compensation Committee, driven by investor request and availability. Stockholder feedback is then reported to the appropriate committee and/or the entire Board for
consideration. During the Fall each year, we again reach out to stockholders to solicit additional feedback on matters critical to our stockholders&#146; evaluation of our governance profile. Participants in the Fall 2021 stockholder outreach
program included members of the management team, as well as the Chair of our Board. These conversations provided us with the opportunity to discuss how the company was working to ensure its strong performance through continuing challenges imposed by
the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, and our growing DEI programs and initiatives. It also yielded constructive feedback with respect to stockholder views and expectations concerning ESG disclosures, executive compensation
programs and board independence, tenure, diversity and refreshment, all of which was summarized and reported to the Board for consideration in its ongoing evaluation of our governance profile. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">It is our desire and intention to continue to engage with our stockholders throughout the year, and we invite you to reach out with any comments
or questions at any time. Please see our website at <I>www.exelixis.com</I> under the caption &#147;Investors&nbsp;&amp; Media&#151;Contact IR&#148; for the appropriate contact information. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">62</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation Discussion and Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Stockholder Advisory Vote on Executive Compensation </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We provide our stockholders the opportunity to cast an annual advisory vote on our executive compensation program, and the Compensation Committee
takes the results of this vote into account when determining compensation of the company&#146;s Named Executive Officers. At our annual meeting of stockholders held in May 2021, approximately 98% of the votes present and entitled to vote voted in
favor of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> proposal. Our Compensation Committee considered these votes to be an endorsement of the Compensation Committee&#146;s policies and practices.
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Competitive Assessment </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">A key objective of our executive compensation program is to ensure that the overall compensation packages we offer our executive officers remain competitive with the packages offered by companies with which we compete for executive
talent. The Compensation Committee consults with its independent compensation consultant, to develop a peer group of companies to serve as the basis for comparing our executive compensation program to the market. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Peer Group Development Process and How We Used the Data </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee reviews and makes adjustments to the composition of the peer group on an annual basis, or more often as deemed
necessary, to account for changes in both our business and the businesses of the companies in the peer group. The Compensation Committee does not have a specific target compensation level for the Named Executive Officers. Instead, we review data
concerning practices at our peer group companies and within the general biotechnology market as a reference point to assist in developing programs that will attract and retain exceptional talent and drive company performance. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In developing the 2021 peer group, the Compensation Committee considered the continued evolution of our business and meaningful developments in
comparison to the 2020 peer group companies. It also considered what other companies might make suitable additions to the 2021 list. The key qualitative and quantitative considerations that influenced the development of the 2021 peer group were:
</FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">industry&#151;including, biotechnology and pharmaceutical companies;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">therapeutic area, including companies with an oncology product focus;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">stage of business, as reflected by the existence of at least one marketed product;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the size of the organization to reflect organizational complexity; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">whether the company is traded on a major U.S. exchange; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">market capitalization between 0.3x&#151;3.0x of our then-current market capitalization
(approximately $2.5 billion&#151;approximately $20.0 billion); and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">revenues between 0.5x&#151;2.5x of our then-current revenues (approximately $500
million&#151;approximately $2.5&nbsp;billion). </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">63</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Following this
analysis, the Compensation Committee, in consultation with management and Aon, identified the following 20 publicly-traded, U.S.-based biotechnology/pharmaceutical companies as our peer group to be used in reviewing compensation for 2021:
</FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="31%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-left:8pt; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.40em; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Fiscal 2021 Peer Group
(1)</FONT></B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">ACADIA
Pharmaceuticals</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Blueprint Medicines</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Jazz Pharmaceuticals</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Agios
Pharmaceuticals</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Corcept Therapeutics</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Neurocrine Biosciences</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alkermes</FONT></P></TD>

<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Emergent BioSolutions</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">NovoCure</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alnylam
Pharmaceuticals</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Horizon Therapeutics</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Sarepta Therapeutics</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">BeiGene</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Incyte</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Seagen</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">bluebird
bio</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Ionis Pharmaceuticals</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">United Therapeutics</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">BioMarin
Pharmaceutical</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Ironwood Pharmaceuticals</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Emergent BioSolutions Inc. was added to our 2021 peer group because it met the selection
criteria, and Nektar Therapeutics was removed from the peer group because it no longer met the selection criteria. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT
 COLOR="#3f3f3f"><B>Positioning Relative to 2021 Peers </B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>(as of September 2020) </B></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g08x65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">Percentile Rank </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">64</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation Discussion and Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_20"></A>Compensation Elements </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our executive compensation program generally consists of three principal components: base salary; annual cash bonus; and long-term incentive
compensation. A description and objective(s) for each element of compensation, which may vary from year to year, is set forth below: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.40em; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Element</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Description</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Objective(s)</FONT></B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Annual Base
Salary</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Fixed cash compensation to recognize each Named Executive Officer&#146;s role and responsibilities.</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Provide an appropriate and competitive base level of current cash income for Named Executive Officers.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Annual Cash
Bonus</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Variable cash compensation based on corporate performance, including achievement against
<FONT STYLE="white-space:nowrap">pre-determined</FONT> corporate goals and the individual contributions of each Named Executive Officer toward the achievement of such corporate goals.</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Align our Named Executive Officers&#146; compensation with our
annual corporate goals.</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Reward Named Executive Officers for
overall corporate performance and their individual contributions toward achievement of our critical business objectives.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #b2b2b2" BGCOLOR="#f2f2f2">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Long-Term Incentive Compensation</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#f2f2f2" STYLE=" BORDER-LEFT:1px solid #b2b2b2; BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#f2f2f2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>RSUs (or PSUs, if
performance- based)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Variable share-based compensation, subject to either time-based vesting or performance-based vesting based on the
achievement of key corporate goals. PSUs generally have a three-year performance period.</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Align the interests of our Named Executive Officers with those of
our stockholders.</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Motivate our Named Executive Officers to
achieve long-term corporate performance objectives.</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Promote
retention, including during periods of stock price volatility common to biotechnology companies.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" BGCOLOR="#f2f2f2" STYLE=" BORDER-LEFT:1px solid #b2b2b2; BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#f2f2f2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Stock Options</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Variable share-based compensation whereby value is derived from appreciation in stock price.</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Align the interests of our Named Executive Officers with those of our
stockholders.</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Motivate our Named Executive Officers to pursue
our critical business objectives, because stock options only have value if the value of our company as reflected by our stock price increases over time.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">65</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx282574_602"></A>Other Compensation and Benefits </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In addition to the primary elements of compensation described above, all of our employees, including our Named Executive Officers are also
eligible to participate, on the same basis as other employees, in our 401(k) Plan, our employee stock purchase plan (ESPP) and other benefit programs generally available to all employees. These programs are intended to provide <FONT
STYLE="white-space:nowrap">tax-beneficial</FONT> ways to save toward retirement, promote health and wellness and encourage stock ownership. Our Named Executive Officers are also eligible to participate in our Change in Control and Severance Benefit
Plan, a compensation program that incentivizes our executive officers to remain with our company, and objectively evaluate and facilitate an acquisition of our company should consideration of such a transaction be determined appropriate by the Board
and in the best interests of our stockholders. The Compensation Committee believes that considered together, these benefits are critical for motivating and retaining these leaders and are consistent with compensation arrangements provided in the
competitive market for executive talent. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="64%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.40em; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Element</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Description</FONT></B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>401(k)
Plan</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">All employees, including Named Executive Officers, contribute their own funds, as salary deductions, on a <FONT
STYLE="white-space:nowrap">pre-tax</FONT> or <FONT STYLE="white-space:nowrap">after-tax</FONT> basis, subject to plan and government limits. For 2021, we matched <FONT STYLE="white-space:nowrap">pre-tax</FONT> and Roth 401(k) contributions <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">dollar-for-dollar</FONT></FONT> up to $11,000.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Employee Stock Purchase
Plan</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Our ESPP allows for all employees, including Named Executive Officers, to purchase shares of our common stock at a price
equal to the lower of 85% of the closing price on the first day of the <FONT STYLE="white-space:nowrap">six-month</FONT> offering period or 85% of the closing price on the final day of such offering period, subject to specified
limits.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Health Care, Dental and
Vision Benefits</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Subject to applicable laws, these health and welfare benefits are available to all eligible employees, including Named
Executive Officers.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Change in Control
and Severance Benefit Plan (1)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our Change in Control and Severance Benefit Plan is a
double-trigger plan, in which each participant receives plan benefits only if the participant is terminated without cause or is constructively terminated in connection with a change in control. We adopted a double-trigger plan because it protects
the participants from post-change in control events that are not related to the participants&#146; performance, encourages them to stay throughout a transition period in the event of a change in control, and does not provide for benefits for a
participant who remains with the surviving company in a comparable position.</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">To serve our best interests, the plan requires a release of claims against us as a condition to receiving any severance benefits.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">A description of the Change in Control and Severance Benefit Plan is set forth below under the
heading &#147;<A HREF="#tx282574_601">Potential Payments Upon Termination or Change in Control</A>.&#148; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">66</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation Discussion and Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_21"></A>Compensation Mix </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee has not established formal policies or guidelines for allocating compensation between annual and long-term incentive
compensation, or between cash and <FONT STYLE="white-space:nowrap">non-cash</FONT> compensation. Instead each year, through our compensation program, the Compensation Committee seeks to align pay and performance. To that end, a significant portion
of our Named Executive Officers&#146; compensation is always &#147;at risk&#148; because it is variable, performance-based and in large part dependent on the success of our company. <FONT STYLE="white-space:nowrap">At-risk</FONT> compensation for
2021 included PSUs, RSUs, stock options and annual incentive cash bonuses, which annual incentive cash bonuses relate to the Compensation Committee&#146;s assessment of our overall corporate performance, including achievement against our <FONT
STYLE="white-space:nowrap">pre-determined</FONT> 2021 corporate goals, and, other than for Dr.&nbsp;Morrissey, the Compensation Committee&#146;s consideration of the individual contributions of each Named Executive Officer toward the achievement of
our corporate goals. The following charts highlight the 2021 pay mix for our Chief Executive Officer and all of our other Named Executive Officers as a group. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><B>Chief Executive Officer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><B>Pay Mix</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><B>91% of CEO 2021 Compensation is
Considered Variable and <FONT STYLE="white-space:nowrap">At-Risk</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><B>All Other Named Executive Officers</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><B>Pay Mix</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><B>82% of All Other Named Executive
Officers (as a group) 2021<BR>Compensation is Considered Variable and <FONT STYLE="white-space:nowrap">At-Risk</FONT></B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g282574g13a85.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g282574g13b96.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_22"></A>2021 Compensation Decisions </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx282574_501"></A><A NAME="tx282574_504"></A>2021 Base Salaries </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee annually reviews the base salaries of our Named Executive Officers and adjusts them periodically as needed to maintain
competitive market positioning and consistency with evolving role responsibilities. The following table sets forth the 2021 base salaries for the Named Executive Officers included therein, as determined by the Compensation Committee in February 2021
after it considered a market analysis of base salaries of our executive officers compared to our peer group. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020&nbsp;Base<BR>Salary</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2021 Base<BR>Salary</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Percentage&nbsp;&nbsp;&nbsp;&nbsp;<BR>Increase&nbsp;
&nbsp;&nbsp;&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,067,997</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,100,037</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J.
Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">653,189</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">685,849</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J.
Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">510,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">530,400</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">580,384</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">603,599</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">543,297</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">565,029</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">67</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx282574_505"></A>2021 Annual Cash Bonuses </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Rigorous Process for Determining Annual Cash Bonus </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our Annual Cash Bonus Plan is an annual incentive program designed to provide our senior management team, including our Named Executive Officers,
with incentives and rewards for working to achieve the strongest possible corporate performance, while also enhancing our ability to attract and retain highly talented individuals. Under our Annual Cash Bonus Plan, Named Executive Officers are
eligible to receive an annual performance-based cash bonus award, the amount of which is based on a <FONT STYLE="white-space:nowrap">pre-set</FONT> target percentage of the Named Executive Officer&#146;s annual base salary earned during the year.
The Compensation Committee is responsible for establishing the bonus target percentages, as well as the relative percentage contributions of corporate performance and individual performance. For each Named Executive Officer, the amount of the cash
bonus award for each fiscal year depends upon our overall corporate performance, including the achievement of applicable corporate goals established by the Compensation Committee for that year, and, as applicable, the Compensation Committee&#146;s
consideration of the individual contributions of each Named Executive Officer toward the achievement of our corporate goals. Under appropriate circumstances, the Compensation Committee may use discretion to acknowledge progress toward achievement of
a goal when factors outside of our control rendered a performance target impossible or impractical to achieve. The corporate goals under the Annual Cash Bonus Plan may be based on criteria such as the following: sales or commercial goals; research,
development and clinical activities; financial metrics; hiring, retention and other operational goals; commercial, clinical and strategic collaborations and alliance management; acquisitions and licensing or partnering transactions; manufacturing
and supply goals; quality goals; regulatory goals; legal and compliance goals; and government affairs and public policy goals. Individual performance may be assessed by the Compensation Committee based on the Named Executive Officer&#146;s
contributions toward the achievement of our corporate goals, recommended by the Chief Executive Officer and approved by the Compensation Committee, for the Named Executive Officer&#146;s area of responsibility. Taking these factors into account, the
Compensation Committee assigns an individual performance percentage for each Named Executive Officer, other than Dr.&nbsp;Morrissey. For any year, the achieved corporate performance percentage and/or individual performance percentage may exceed
100%, provided that neither percentage may exceed 200%. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>2021 Bonus Targets </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Bonus targets (expressed as a percentage of base salary) are based on the seniority of the applicable position. They are reviewed annually by the
Compensation Committee, taking into consideration competitive market data and the criticality of the role for the organization, and adjusted if deemed appropriate by the Compensation Committee. Following such review in February&nbsp;2021, the
Compensation Committee determined that the existing bonus targets from 2020 remained aligned with competitive market data and therefore would remain unchanged for 2021. The following table sets forth the 2021 bonus targets for the Named Executive
Officers included therein. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Named Executive Officer</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2021&nbsp;Bonus&nbsp;&nbsp;&nbsp;&nbsp;
<BR>Target&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J.
Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J.
Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>2021 Corporate Goal Development and Weighting </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In connection with establishing the bonus program for 2021, the Compensation Committee reviewed management&#146;s proposed discovery, business
development, product development, commercial, and finance, legal and business operations goals and recommended them to the Board for approval. In February 2021, the Board then reviewed and approved the proposed corporate goals for 2021, as
identified in the table below. In selecting these goals, the Compensation Committee and the Board believed they were appropriate drivers for our business, as they provided a balance between the efforts necessary to continue the successful
commercialization of CABOMETYX in its approved indications, further our cabozantinib development program and advance our early-stage product pipeline, all while maintaining a strong financial position, which together would enhance stockholder value.
At the time the 2021 corporate goals were set, the Compensation Committee </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">68</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation Discussion and Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">and management believed that such goals were challenging and achieving
them would require not only continued strong commercial performance, research and product development success, and prudent fiscal and legal management, but also a high level of effort and execution on the part of our Named Executive Officers.
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee also applied a performance weighting to each goal relative to the overall performance of the company to
reflect the prioritization of key business objectives. Target and maximum achievement levels were defined for certain corporate goals and, depending on the level of achievement, Named Executive Officers were eligible to receive a payout ranging from
0% to 150% for such goal. Additionally, a weighting between corporate performance and individual performance was also applied for each Named Executive Officer to reflect the level of impact such individual would be able to make on the overall
corporate performance. The following table sets forth the relative weighting for each corporate goal and corporate versus individual performance for the Named Executive Officers included therein. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP BGCOLOR="#fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Corporate Goals</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" BGCOLOR="#fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Weighting</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>(%)</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Named Executive Officer</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" BGCOLOR="#fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Weighting&nbsp;of</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Corporate</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
 COLOR="#FFFFFF"><B>Goals</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" BGCOLOR="#fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Weighting&nbsp;of</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Individual</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
 COLOR="#FFFFFF"><B>Performance</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Assessment</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Discovery</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">20</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Business/Corporate
Development</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Product Development</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Commercial</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Finance, Legal and Business
Operations</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f"><B>Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>100</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>2021 Performance Evaluation </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">During 2021, management reported regularly to the Compensation Committee and the Board on the status of the company&#146;s performance against
our 2021 goals, including in formal meetings in February, May, September and December. In February 2022, the Compensation Committee evaluated the company&#146;s performance in relation to the 2021 goals, as well as the individual contributions of
each then-serving Named Executive Officer (other than Dr.&nbsp;Morrissey) toward the achievement of </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">69</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">those goals. Following
its evaluation of such performance, the Compensation Committee concluded that 2021 was a year of meaningful accomplishments, during which the company largely achieved each of the goals, as further described in the table below: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>



<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PERFORMANCE&nbsp;OBJECTIVES</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">ACHIEVEMENTS</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">TARGET %</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">ACHIEVEMENT %</FONT></B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="2" COLSPAN="7"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="7" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>&nbsp;&nbsp;&nbsp;&nbsp;Discovery</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>20%</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>20%</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Target</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Maximum</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Submit two INDs to FDA (or equivalent applications to a foreign governmental authority)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Submit three INDs to FDA (or equivalent applications to a foreign governmental authority)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Submitted two INDs to FDA: XB002 (March 2021) and XL114 (September 2021)</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Target Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Advance two compounds from lead optimization decision to Development Candidate (DC)&nbsp;status</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Advance four compounds from lead optimization decision to DC status</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Advanced XB010 from lead optimization decision to DC status</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Advanced seven internal and partnered programs toward DC status</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Below Target Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Advance three programs to lead optimization decision</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Advance five programs to lead optimization decision</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Advanced five programs into lead optimization decision status</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Maximum Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="2" COLSPAN="7"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="7" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>&nbsp;&nbsp;&nbsp;&nbsp;Business/Corporate Development</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>10%</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>15%</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Target</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Maximum</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Complete three transactions for oncology drugs or platform technologies</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Complete five transactions for oncology drugs or platform technologies</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Completed eight transactions for oncology drugs or platform technologies</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Maximum Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="2" COLSPAN="7"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="7" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>&nbsp;&nbsp;&nbsp;&nbsp;Product Development and Medical Affairs</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>30%</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>24%</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Target</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Maximum</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Cabozantinib</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Achieve <FONT STYLE="white-space:nowrap">top-line</FONT> results from and complete trial enrollment in ongoing studies; achieve trial enrollment target for <FONT
STYLE="white-space:nowrap">CONTACT-02;</FONT> submit sNDA based on results from <FONT STYLE="white-space:nowrap">COSMIC-311</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Achieve <FONT STYLE="white-space:nowrap">top-line</FONT> results from additional ongoing studies; complete trial enrollment in <FONT STYLE="white-space:nowrap">CONTACT-02;</FONT>
receive FDA approval of <FONT STYLE="white-space:nowrap">COSMIC-311</FONT> sNDA; submit sNDA for accelerated approval based on results from <FONT STYLE="white-space:nowrap">COSMIC-021</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Achieved <FONT STYLE="white-space:nowrap">top-line</FONT> results from PAPMET, <FONT STYLE="white-space:nowrap">COSMIC-021,</FONT> and
<FONT STYLE="white-space:nowrap">COSMIC-312</FONT></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Completed enrollment for <FONT STYLE="white-space:nowrap">COSMIC-313,</FONT> <FONT STYLE="white-space:nowrap">CONTACT-01,</FONT> and
<FONT STYLE="white-space:nowrap">CONTACT-03</FONT></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Advanced enrollment for <FONT STYLE="white-space:nowrap">CONTACT-02</FONT></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Submitted <FONT STYLE="white-space:nowrap">COSMIC-311</FONT> sNDA, which was approved by FDA in September&nbsp;2021</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Target Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>XL092</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Initiate phase 1b trial with ICI therapy and a phase 3 pivotal trial</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Initiate multiple phase 1b trials with additional ICIs and multiple phase 3 pivotal trials</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Initiated <FONT STYLE="white-space:nowrap">STELLAR-002,</FONT> a phase 1b trial evaluating XL092 in combination with ICI therapy</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Entered into clinical trial collaboration and supply agreement with Merck KGaA and Pfizer for <FONT
STYLE="white-space:nowrap">STELLAR-001</FONT></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Prepared product development plan for XL092, including potential phase 3 pivotal
trials</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Below Target Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Development related to new INDs</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Initiate a phase 1 trial for each of XL102 and XB002, and activate at least three clinical trial sites for each product</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Initiate a phase 1 trial for a third product candidate</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Initiated a phase 1 trial for XL102, expedited site activation and enrollment</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Initiated a phase 1 trial for XB002, expedited site activation and enrollment</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Target Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Partnerships</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Support cabozantinib worldwide regulatory filings by collaboration partners</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Supported Ipsen&#146;s worldwide CABOMETYX regulatory approvals, including approval of the CABOMETYX and OPDIVO combination in RCC in the EU in March 2021</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Assisted Takeda with its application to the Japanese MHLW for the combination of CABOMETYX and OPDIVO in RCC,
approved in August 2021</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Target Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">70</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation Discussion and Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>

<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">PERFORMANCE&nbsp;OBJECTIVES</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">ACHIEVEMENTS</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">TARGET %</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">ACHIEVEMENT %</FONT></B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><B>Organizational Development</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Implement continuous process improvements to enable expeditious compliant trial execution</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Complete reorganization in the Product Development organization by hiring additional senior leaders and implementing individual project/life cycle teams</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Completed
reorganization in the Product Development organization by hiring additional senior leaders and implementing project/life cycle teams for: Cabozantinib Development, XL092 Development, New INDs Evaluation/Development and Collaboration
Management</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Maximum Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="2" COLSPAN="7"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="7" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:14pt" COLOR="#fc4c02"><B>&nbsp;&nbsp;&nbsp;&nbsp;Commercial</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:14pt" COLOR="#fc4c02"><B>30%</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:14pt" COLOR="#fc4c02"><B>45%</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><B>Target</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><B>Maximum</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Meet cabozantinib franchise net product revenue target</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Exceed 105% of target cabozantinib franchise net product revenue target</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;For the full
year 2021, US cabozantinib franchise net product revenue meaningfully exceeded 105% of target</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Maximum Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Progress launch preparations and execute launch readiness reviews for CABOMETYX in DTC, 1L HCC and mCRPC</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Successfully launch CABOMETYX in new indication</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Successfully
executed DTC launch on September&nbsp;17, 2021 (day zero), despite compressed preparation time due to early FDA approval</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Maximum Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="2" COLSPAN="7"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="7" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:14pt" COLOR="#fc4c02"><B>&nbsp;&nbsp;&nbsp;&nbsp;Finance, Legal and Business Operations</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:14pt" COLOR="#fc4c02"><B>10%</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:14pt" COLOR="#fc4c02"><B>11%</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><B>Target</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><B>Maximum</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Achieve <FONT STYLE="white-space:nowrap">year-end</FONT> headcount of 933 (+160) full-time employees (FTEs)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Achieve an overall company FTE turnover rate of 15% or less</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Achieved <FONT
STYLE="white-space:nowrap">year-end</FONT> headcount of 954 FTEs and an overall company FTE turnover rate of 14.4%</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Maximum Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Implement DEI Initiative</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">N/A</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Implemented
DEI programs and initiatives, including hosting DEI trainings and hiring a director of DEI</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Target Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Effectively manage ongoing Abbreviated New Drug Application (ANDA) litigation against MSN Laboratories Private Ltd. (MSN)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Achieve favorable resolution of ANDA litigation</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Effectively
managed the ANDA litigation against MSN, as well as new ANDA litigation against&nbsp;Teva Pharmaceuticals USA, Inc., both of which remain ongoing</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Target Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Initiate high-impact informational technology&nbsp;projects in development, supply chain and human resources to accelerate the adoption of digital technology</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">N/A</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Advanced
enterprise-wide and functional area-specific improvements to data, information management and analytics systems</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Implemented
business process automation to support new hire onboarding processes</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Selected a new
health care professional engagement system</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Implemented enterprise resource planning solutions designed to enhance SOX compliance</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Target Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Complete <FONT STYLE="white-space:nowrap">build-out</FONT> of Building 1701 and achieve substantial progress on construction of Building 1951</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">N/A</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Completed <FONT
STYLE="white-space:nowrap">build-out</FONT> of Building 1701</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Achieved
substantial progress on construction of Building 1951</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><I>Target Achievement</I></FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">Develop long-term site plan for Alameda campus</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">N/A</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Issued
long-term site plan for Alameda campus</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><I>Target Achievement</I></FONT></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">100%</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">115%</FONT></B></FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">71</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Individual
Performance Assessments of our Named Executive Officers other than the CEO </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee also recognized the
individual contributions of each then-serving Named Executive Officer (other than Dr.&nbsp;Morrissey) toward achievement of the 2021 corporate goals. In evaluating the individual contributions of these Named Executive Officers, the Compensation
Committee determined that they all performed above expectations and considered the following contributions from each in such determination: </FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Mr.&nbsp;Senner&#146;s overall leadership of our finance organization and his performance with
respect to the achievement of our financial goals in 2021, particularly regarding: our disciplined expense management; his role in positioning the company to be able to execute on future strategic initiatives; and the continued expansion of
Mr.&nbsp;Senner&#146;s responsibilities leading the Information Technology organization, overseeing the buildout of the Digital Transformation function, and implementing high-impact initiatives that will further enhance our technology
infrastructure. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Mr.&nbsp;Haley&#146;s overall leadership of our Commercial organization and his performance with
respect to the achievement of our commercial goals in 2021, particularly regarding: the continued strong CABOMETYX demand in 2021, including the first time achievement of more than $1&nbsp;billion in U.S. net product revenue for the franchise; and
the commercial launches of (i)&nbsp;CABOMETYX in combination with OPDIVO as a first-line treatment for patients with RCC following FDA approval, and (ii)&nbsp;CABOMETYX for the treatment of patients with locally advanced or metastatic DTC following
FDA approval. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Mr.&nbsp;Hessekiel&#146;s overall leadership of our legal and compliance organizations and his
performance with respect to the achievement of our business and legal goals in 2021, particularly regarding: effective management of the ANDA litigations; the continued growth in the volume and complexity of our business agreements and arrangements;
the effective oversight of our compliance program, which included the continued evaluation of new methods of interactions with healthcare professionals due to the ongoing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic; and our level of
organizational preparedness for potential shifts in healthcare regulations applicable to our business. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Dr.&nbsp;Lamb&#146;s overall leadership of our discovery and scientific strategy organizations
and his performance with respect to the achievement of our discovery goals in 2021, particularly regarding: the company&#146;s small molecule and biotherapeutics pipeline expansion, including advancing five programs into lead optimization decision
status and submitting two IND applications, which were subsequently approved by the FDA; and driving our strategy with respect to research collaborations, <FONT STYLE="white-space:nowrap">in-licensing</FONT> activities and other business activities.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In consideration of the foregoing, in February 2022, the Compensation Committee approved annual cash bonus
payments for each then-serving Named Executive Officer as reflected in the table below. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2021</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Base</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Salary</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2021</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Award</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2021</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Corporate</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Performance</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Weighting</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2021</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Approved</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Corporate</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Performance</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2021</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Individual</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Performance</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Weighting</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2021</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Individual</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Performance</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2021</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Annual&nbsp;Cash</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Bonus&nbsp;Payout</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%&nbsp;of&nbsp;Target</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Award)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2021</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Annual</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Cash&nbsp;Bonus</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Payout</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Michael M. Morrissey,
Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,100,037</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">115</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">115</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,265,043</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Christopher J.
Senner</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">685,849</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">115</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">117</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">399,507</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Patrick J. Haley</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">530,400</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">115</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">117</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">308,958</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Jeffrey J. Hessekiel,
J.D.</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">603,599</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">115</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">115</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">115</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">347,069</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Peter Lamb,
Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">565,029</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">115</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">130</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">337,605</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx282574_600"></A><A NAME="tx282574_502"></A>2021 Long-Term Incentive Awards </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Consistent with our goal to align executive compensation with performance that advances our critical business objectives, a significant portion
of the Named Executive Officers&#146; total compensation typically has consisted of, and is expected to continue to consist of, equity-based awards. In evaluating the mix of equity awards for 2021, the Compensation Committee considered market
trends, as well as feedback from stockholders and proxy advisory firms, and determined that a combination of PSUs and time-based equity awards would be the most appropriate incentive structure for our Named Executive Officers to reward performance
over time and achieve our retention objectives. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">72</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation Discussion and Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Allocation of 2021 Long-Term Incentive Awards </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">For 2021, the Compensation Committee approved equity awards for each Named Executive Officer to be comprised of approximately 50% PSUs and 50%
time-based equity awards (in the form of stock options for our CEO and RSU awards for our other Named Executive Officers). The Compensation Committee changed the weighting of the equity awards from 100% PSUs in fiscal 2020 to 50% PSUs and 50%
time-based equity awards in fiscal 2021 to serve as an effective balance between retention and performance, risk and leverage, as well as alignment with our peer group. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Ascribing a zero-dollar value to the 2020 PSUs in the <A HREF="#tx282574_604">Summary Compensation Table</A> inflates the magnitude of the
increase from 2020 to 2021 in the aggregate dollar value of equity awards granted to our Named Executive Officers. 100% of the equity awards granted to our Named Executive Officers in 2020 were in the form of PSUs, the grant date values of which,
computed in accordance with ASC 718 based upon the then-probable outcome of the performance conditions, were $0. The grant date fair values of the RSU awards granted in 2021 were measured based on the closing price of our common stock on the date of
grant, and the grant date fair value of the stock option granted to our CEO in 2021 was calculated using the Black-Scholes Merton option pricing model. The amounts calculated in accordance with ASC 718 do not necessarily correspond to the actual
value recognized or that may be recognized by our Named Executive Officers or the aggregate value of the equity awards the Compensation Committee determined to grant each of our Named Executive Officers as further described under the heading &#147;<A HREF="#tx282574_1507">Value
 of 2021 Long-Term Incentive Awards</A>&#148; below. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>2021 Time-Based Equity Awards </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The time-based equity awards granted to our Named Executive Officers represent approximately 50% of the total long-term incentive award value. In
determining the form of the time-based equity awards granted to our Named Executive Officers, the Compensation Committee considered that, in recognition of his criticality to the business, our CEO&#146;s equity-based compensation should be more
closely tied to the company&#146;s performance. Accordingly, the Compensation Committee granted our CEO&#146;s time-based equity award in the form of stock options. We consider stock options to be performance-based because they only have value if
the value of our company as reflected by our stock price increases over time. Because this form of compensation only establishes value upon an improvement in corporate performance, this award further aligns our CEO&#146;s interests with those of our
stockholders. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The stock options granted to our CEO have an exercise price of $21.31 per share, the fair market value of our common
stock on the date of grant (March 4, 2021). They expire seven years from the date of grant or earlier upon termination of service with us and vest over a four-year period following the grant date. The RSU awards granted to our other Named Executive
Officers vest in four equal annual installments beginning on May&nbsp;15, 2022. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vesting of these stock options and RSU awards will
cease upon termination of service as an employee for any reason. In addition, the Named Executive Officers are party to our Change in Control and Severance Benefit Plan, which provides for acceleration of vesting of these awards in the event of
certain specified change in control events involving us, as further described under the caption &#147;<A HREF="#toc282574_30">Potential Payments Upon Termination or Change in Control</A>&#148; below. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I><A NAME="tx282574_503"></A><A NAME="tx282574_603"></A>2021 PSU Awards </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee seeks to develop long-term incentive compensation programs based on metrics that are aligned with our corporate
strategy and designed to build value for our stockholders. Accordingly, the PSUs granted to our Named Executive Officers in 2021 vest based on the achievement of <FONT STYLE="white-space:nowrap">pre-established</FONT> performance level targets
related to our cabozantinib global net product revenues over a three-year period (referred to herein as the Cabozantinib Revenue Goal), and any PSUs that vest will then be subject to upward or downward adjustment based on a total stockholder return
(TSR) modifier (referred to herein as the TSR Performance Modifier). The Compensation Committee believes these performance metrics effectively align executive compensation with our long-term growth strategy and reflect our focus on driving long-term
stockholder value creation. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Cabozantinib Revenue Goal is based on the aggregate amount of cabozantinib net product revenue
generated by the company and our collaboration partners during any four consecutive fiscal quarters combined during the three-year performance period ending December&nbsp;29, 2023. Achievement of the threshold, target, and maximum performance level
targets of the Cabozantinib Revenue Goal will result in 50%, 100%, and 160%, respectively, of the target number of shares of our common stock subject to the PSU awards becoming eligible to vest. Additional detail about the performance level targets
will be disclosed at the end of the three-year performance period, as doing so before that time could be competitively harmful to the company. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">73</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To the extent the
Cabozantinib Revenue Goal&#146;s performance level targets are met, the number of vested PSUs are then subject to the TSR Performance Modifier, which measures our three-year relative TSR performance against the Nasdaq Biotechnology Index. The TSR
Performance Modifier will modify the 2021 PSU awards as follows: (i)&nbsp;upwards to a maximum of 125% if our TSR ranking is equal to or exceeds the 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile; and (ii)&nbsp;downwards to a
threshold of 75% if our TSR ranking is equal to or below the 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="46%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5" COLSPAN="3" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt; padding-right:2pt"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">TSR Performance Modifier</FONT></B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Relative TSR Percentile Rank</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">TSR Performance Modifier</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">75th percentile or above</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">125%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">26th percentile &#150; 74th
percentile</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100% (no modification)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">25th percentile or below</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">75%</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Named Executive Officers are therefore eligible to vest up to a maximum of 200% of the target number of
shares of our common stock subject to the PSU award. Failure to achieve the threshold performance level target during the three-year performance period will result in forfeiture of 100% of the 2021 PSU award. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">After the performance period has ended, the Compensation Committee will certify the level of achievement of both the Cabozantinib Revenue Goal
and the TSR Performance Modifier and then determine the number of shares that are entitled to vest based on such achievement, which will be equal to the product of (1)&nbsp;the target number of shares subject to a 2021 PSU award, (2)&nbsp;the
performance achievement percentage of the Cabozantinib Revenue Goal and (3)&nbsp;the TSR Performance Modifier (such number referred to herein as the 2021 PSU Certified Shares). Each 2021 PSU Award will vest as to 50% of the 2021 PSU Certified Shares
upon the Compensation Committee&#146;s certification and 50% of the 2021 PSU Certified Shares on the first quarterly vesting date following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s
certification. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vesting of these PSUs will cease upon termination of service as an employee for any reason. Pursuant to the terms of
the award agreements, following certain change in control events wherein the PSU awards are assumed by the surviving entity, the PSU awards will convert to time-based vesting, as though the target number of shares subject to each PSU award had been
subject to a vesting schedule pursuant to which the shares would have vested annually over a four-year period following the grant date (with any portion that would have vested on or prior to the change in control event under such vesting schedule
becoming vested on the date of the change in control event and any portion that is unvested following the date of the change in control event vesting in accordance with such vesting schedule). The purpose of this conversion feature is to account for
the fact that the goal may not be achievable in the context of the newly formed organization. In addition, the Named Executive Officers are party to our Change in Control and Severance Benefit Plan, which provides for acceleration of vesting of the
award in the event of certain specified change in control events involving us, as further described under the caption &#147;<A HREF="#toc282574_30">Potential Payments Upon Termination or Change in Control</A>&#148; below. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I><A NAME="tx282574_1507"></A>Value of 2021 Long-Term Incentive Awards </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">When determining the appropriate value of equity incentive awards, the Compensation Committee asked Aon to provide guidance with respect to
implementing a program that would incentivize our Named Executive Officers to achieve key company priorities and increase stockholder value over the long-term, while maintaining competitive market practices and being mindful of the company&#146;s
equity burn rate.</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">As part of the decision-making process, the Compensation Committee considered the challenges of managing a rapidly
expanding organization, as well as our need to retain a cohesive management team to facilitate the achievement of product development and pipeline expansion objectives, while supporting the continued commercial success of CABOMETYX, that would
position the company for future success. The Compensation Committee also believed it was important that the value of the equity awards continue to reflect the individual performance of each Named Executive Officer during the fiscal year to date and
the criticality of each Named Executive Officer&#146;s skill set and expected future contributions to our business. Taking these factors into consideration and applying Aon&#146;s market analysis of long-term incentive compensation of our Named
Executive Officers compared to our 2021 peer group, the Compensation Committee determined that the aggregate value of the equity awards granted to each of our Named Executive Officers should generally approximate the 50th percentile of market peers
and approved the aggregate grant amounts to the Named Executive Officers summarized in the table below. The actual number of RSUs and PSUs granted to each executive officer was determined by dividing the value the Compensation
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">74</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation Discussion and Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Committee intended to deliver by the
<FONT STYLE="white-space:nowrap">30-day&nbsp;average</FONT> trailing stock price (as of January&nbsp;25, 2021). <FONT STYLE="white-space:nowrap">A&nbsp;30-day&nbsp;average</FONT> stock price was used, rather than a single day share price, in order
to provide a more stabilized share value less susceptible to possible swings in the market. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;Shares<BR>Subject&nbsp;to Stock<BR>Options</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;Shares<BR>Subject&nbsp;to&nbsp;RSUs</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target<BR>Number&nbsp;of&nbsp;Shares<BR>Subject&nbsp;to&nbsp;2021<BR>PSUs</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">494,700</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">200,300</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">64,150</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">64,150</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">59,570</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">59,570</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">57,135</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">57,135</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">49,395</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">49,395</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2018 Long-Term Incentive Awards Achievements </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In 2018, the Compensation Committee granted PSUs to the Named Executive Officers allocated among five separate awards that only vest upon the
achievement of certain commercial, clinical development and pipeline expansion performance targets. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">On February&nbsp;3, 2021, the
Compensation Committee certified the achievement of 2018 PSU Grant #4, which was one of the two clinical development performance goals established for the 2018 PSU awards. Upon such certification, the PSUs vested as to 50% of the original number of
shares subject to the award, and the remaining 50% of the original number of shares subject to the award vested on February&nbsp;15, 2022. In addition, on December&nbsp;15, 2021, the Compensation Committee certified the achievement of 2018 PSU Grant
#5, which was the only pipeline performance goal established for the 2018 PSU awards. Upon such certification, the PSUs vested as to 50% of the original number of shares subject to the award, and the remaining 50% of the original number of shares
subject to the award will vest on February&nbsp;15, 2023. The following chart reflects the <FONT STYLE="white-space:nowrap">pre-established</FONT> clinical development and pipeline performance targets and the actual results achieved. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="39%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;&nbsp;2018&nbsp;PSU<BR>&nbsp;&nbsp;Grant #</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Business Focus</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff"><FONT STYLE="white-space:nowrap">Pre-Established</FONT> Performance
Target</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Achievement</FONT></B></FONT>
</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Clinical Development</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Achievement of either (i)&nbsp;full target enrollment or (ii)&nbsp;positive <FONT STYLE="white-space:nowrap">top-line</FONT> results for four potential
label-enabling clinical trials evaluating cabozantinib alone or in combination with another therapy</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">CheckMate <FONT STYLE="white-space:nowrap">-9ER:</FONT> Full enrollment achieved in May
2019</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">CANTATA: Full enrollment achieved in September 2019</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><FONT STYLE="white-space:nowrap">COSMIC-312:</FONT> Full enrollment achieved in August 2020</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><FONT STYLE="white-space:nowrap">COSMIC-311:</FONT> Positive <FONT STYLE="white-space:nowrap">top-line</FONT> results achieved in
December&nbsp;2020</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Pipeline</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Approval or acceptance by the FDA of four IND applications (or equivalent filings with foreign government authorities)
with respect to product candidates that have either (x)&nbsp;been discovered by us or <FONT STYLE="white-space:nowrap">(y)&nbsp;in-licensed</FONT> or acquired by us</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">XL092: IND application accepted by FDA in January 2019</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">XL102: IND application accepted by FDA in December 2020</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">XB002: IND application accepted by FDA in April 2021</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">XL114: IND application accepted by FDA in October 2021</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2019 Long-Term Incentive Awards Achievements </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In 2019, the Compensation Committee granted PSUs to the Named Executive Officers that only vest upon the approval by the FDA for the commercial
sale and marketing of one or more products for which we hold, or have licensed to a partner, development and commercialization rights in the U.S. On February&nbsp;3, 2021, following the FDA&#146;s approval of cabozantinib in combination with
nivolumab as a first-line treatment for patients with advanced RCC, the Compensation Committee certified the over achievement of the 2019 PSU award, representing 200% of the target number of shares subject to the award. We
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">75</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">hold the exclusive
rights to develop and commercialize cabozantinib in the U.S. Prior to such certification, in October&nbsp;2020, the Compensation Committee certified the early achievement of the 2019 PSU award, representing 150% off the target number of shares
subject to the award, following the FDA&#146;s approval of cobimetinib in combination with atezolizumab and vemurafenib as a treatment for patients with BRAF V600 melanoma. Accordingly, upon certification of the over achievement by the Compensation
Committee on February&nbsp;3, 2021, the 2019 PSU award vested as to an additional 25% of the target number of shares subject to the award, and an additional 25% of the target number of shares subject to the award vested on February&nbsp;15, 2022
based on such over achievement. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2020 Long-Term Incentive Awards Achievements </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In 2020, the Compensation Committee granted PSUs to the Named Executive Officers allocated among two separate awards that only vest upon or
following achievement of the following performance targets: </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>2020 PSU Grant #1 </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">positive <FONT STYLE="white-space:nowrap">top-line</FONT> results of one or more clinical trials evaluating a product for which
we own, or have licensed to a collaboration partner, development or commercialization rights, that provides data that can reasonably support regulatory evaluation of safety and efficacy to determine the risk/benefit profile of the product
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>2020 PSU Grant #2 </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">the approval by the FDA for the commercial sale and marketing of one or more products for which we own, or have licensed to a
collaboration partner, development or commercialization rights, in one or more new indications or an indication for which the product has previously received FDA approval, if such product is intended to treat a new, additional or expanded set of
patients or is part of a combination therapy </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">On September&nbsp;30, 2021, following the FDA&#146;s approval of cabozantinib as a
treatment for patients with locally advanced or metastatic DTC, the Compensation Committee certified the threshold achievement of 2020 PSU Grant #2, representing 50% of the target number of shares subject to the award. Upon certification of such
threshold achievement by the Compensation Committee, 2020 PSU Grant #2 vested as to 25% of the target number of shares subject to the award. An additional 25% of the target number of shares subject to the award will vest on November&nbsp;15th, 2022
based on such threshold achievement. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx282574_1505"></A>Passing of Gisela M. Schwab </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">As previously announced, Dr.&nbsp;Schwab began a medical leave of absence in June 2021 and later passed away in September&nbsp;2021. It is not a
stretch to say that over the course of a career across leading academic institutions and biopharmaceutical companies in the U.S. and Europe, Dr.&nbsp;Schwab&#146;s work helped millions of patients with cancer. We were incredibly fortunate to hire
Dr.&nbsp;Schwab in September&nbsp;2006, and even more fortunate to have her as our Chief Medical Officer for the past 15 years. As the leader of our Product Development and Medical Affairs organization, Dr.&nbsp;Schwab and her team helped usher in
the company&#146;s transformation from a research and development-stage enterprise into a commercial biotechnology company. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In
February 2021, after it considered the market analysis of base salaries of our executive officers compared to our peer group and the need to maintain competitive market positioning and consistency with evolving role responsibilities, the
Compensation Committee determined that (1)&nbsp;Dr.&nbsp;Schwab&#146;s 2021 annual base salary would be increased by 6.0% (from $750,257 to $795,272), (2)&nbsp;Dr.&nbsp;Schwab&#146;s 2020 bonus target of 60% of base salary remained aligned with
competitive market data and therefore would remain unchanged for 2021, and (3)&nbsp;her 2021 annual cash bonus would be based on a relative weighting of 70% corporate performance and 30% individual performance. However, under our Annual Cash Bonus
Plan, executive officers must be employed by the company on the date annual cash bonus payments are paid in order to be eligible to receive such payment and so Dr.&nbsp;Schwab did not receive a 2021 annual cash bonus payment. Additionally, after
considering the factors described above under the heading &#147;<A HREF="#tx282574_502">2021 Long-Term Incentive Awards</A>,&#148; Dr.&nbsp;Schwab received 72,885 shares subject to her 2021 RSU award and 72,885 shares subject to her 2021 PSU award.
Dr.&nbsp;Schwab&#146;s 2021 PSU award was forfeited upon her passing in September 2021. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In June 2021, in recognition of
Dr.&nbsp;Schwab&#146;s extraordinary contributions to the company, the Compensation Committee determined to (1)&nbsp;amend the terms of each of Dr.&nbsp;Schwab&#146;s then-outstanding and unvested equity awards that were subject solely to time-based
vesting conditions to provide that if her continuous service terminated as a result of her death, then each such award would become fully vested (and exercisable, if applicable) as of the date of such termination, and (2)&nbsp;amend
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">76</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation Discussion and Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">the terms of each then-outstanding stock option award to provide that if
(i)&nbsp;her continuous service terminated as a result of her death and (ii)&nbsp;the expiration date of the original full term of such award (such date referred to herein as the Option Expiration Date) was later than 18 months following the date of
such termination, then the post-termination exercise period of such award would be extended until the Option Expiration Date. Upon Dr.&nbsp;Schwab&#146;s passing in September&nbsp;2021, these equity awards were amended accordingly. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_23"></A>Other Compensation Information </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Timing of Equity Awards </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Annual grants of equity awards to our executive officers, including our Named Executive Officers, are generally determined and approved at <FONT
STYLE="white-space:nowrap">pre-scheduled</FONT> Compensation Committee meetings, with such meeting date typically serving as the grant date. However, the Compensation Committee may sometimes approve the grant of equity awards to executive officers
and other employees in advance of its next scheduled meeting, either at a special meeting or by unanimous written consent, in connection with certain new hires, promotions and other circumstances where the Compensation Committee deems it appropriate
to make such grants. The grant dates for these equity awards are typically the same date that a newly hired officer begins employment or the effective date of an officer&#146;s promotion, as applicable. Grants made to new hires below the level of
Vice President are approved on a monthly basis by our Equity Award Committee, comprised solely of Dr.&nbsp;Morrissey, acting in his capacity as a director pursuant to authority delegated to him by the Compensation Committee. All stock options are
granted with an exercise price that is not less than the closing price of our common stock on The Nasdaq Global Select Market on the grant date. We have no plan or practice to&nbsp;time&nbsp;option grants in coordination with the release of <FONT
STYLE="white-space:nowrap">non-public</FONT> information,&nbsp;and we do not time&nbsp;the release of <FONT STYLE="white-space:nowrap">non-public</FONT> information&nbsp;to affect the value of executive compensation. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx282574_1501"></A>Stock Ownership Guidelines for Named Executive Officers </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board maintains Stock Ownership Guidelines for our Named Executive Officers in order to further align their financial interests with those of
our stockholders, as well as to promote sound corporate governance. For our Named Executive Officers, we amended our Stock Ownership Guidelines in February 2021 to establish the following ownership targets: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="69%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Position</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Ownership Level</FONT></B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Chief Executive
Officer</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Value equivalent to 5 times annual base salary</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Other Named Executive
Officers</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Value equivalent to 3 times annual base salary</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">These new ownership targets represent increases from the prior targets for the Chief Executive Officer (the
lesser of the value equivalent to 5 times the annual base salary or 160,000 shares) and for other Named Executive Officers (the lesser of the value equivalent to 1.5 times annual base salary or 25,000 shares). All Named Executive Officers are
expected to achieve their stock ownership targets within five years of becoming subject to these guidelines. The policy includes procedures for granting exemptions in the case of severe financial hardship. In determining ownership levels for each
Named Executive Officer under our Stock Ownership Guidelines, credit is provided for shares held outright (including shares owned through trusts, our 401(k) Plan, or by a spouse), as well as 50% of the number of vested, but unexercised, stock
options. No credit is provided for RSUs or PSUs until they vest. The values for all shares determined to be held by Named Executive Officers are based on the <FONT STYLE="white-space:nowrap">200-day</FONT> average stock price as of the measurement
date. As of February&nbsp;18, 2022, all of our Named Executive Officers had met the required ownership targets. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">77</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx282574_r36"></A>Clawback Policy </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We are dedicated to maintaining a culture of high integrity and accountability, and to discourage conduct harmful to our business and the
interests of our various stakeholders. In response to this dedication, we adopted a Clawback Policy that applies to all forms of compensation, except base salary, granted after the adoption of the Clawback Policy. A triggering event under the
Clawback Policy shall occur when a covered employee (which includes all Named Executive Officers): </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g31z78.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">For clarity, &#147;material harm&#148; includes, but is not limited to, the requirement to prepare an
accounting restatement for any fiscal quarter or year commencing after adoption of the Clawback Policy due to our material noncompliance with any financial reporting requirement. If triggered, then to the fullest extent permitted by law, we may
recoup all variable compensation granted or paid to the covered employee during each fiscal year in which the covered employee&#146;s &#147;misconduct&#148; occurred. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Accounting and Tax Considerations </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Under ASC 718, we are required to estimate and record an expense for each award of equity compensation (including stock options, RSUs and PSUs) over the vesting period of the award. As long as stock options, RSUs and PSUs remain the
sole components of our long-term compensation program, we expect to record stock-based compensation expense on an ongoing basis according to ASC 718. Compensation expense relating to awards subject to performance conditions is recognized if it is
probable that the performance goals will be achieved. The probability of achievement of such goals is assessed on a quarterly basis. The Compensation Committee has considered, and may in the future consider, the grant of restricted stock to our
executive officers in lieu of stock option grants, RSU and/or PSU awards. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Under Section&nbsp;162(m) of the Internal Revenue Code
(Section 162(m)), compensation paid to each of the company&#146;s &#147;covered employees&#148; that exceeds $1&nbsp;million per taxable year is generally <FONT STYLE="white-space:nowrap">non-deductible</FONT> unless the compensation qualifies for
certain grandfathered exceptions (including the &#147;performance-based compensation&#148; exception) for certain compensation paid pursuant to a written binding contract in effect on November&nbsp;2, 2017 and not materially modified on or after
such date. Although the Compensation Committee will continue to consider tax implications as one factor in determining executive compensation, the Compensation Committee also looks at other factors in making its decisions and retains the flexibility
to provide compensation for the Named Executive Officers in a manner consistent with the goals of the company&#146;s executive compensation program and the best interests of the company and its stockholders, which may include providing for
compensation that is not deductible by the company due to the deduction limit under Section&nbsp;162(m). The Compensation Committee also retains the flexibility to modify compensation that was initially intended to be exempt from the deduction limit
under Section&nbsp;
162(m) if it determines that such modifications are consistent with the company&#146;s business needs. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_24"></A>Compensation
 Policies and Practices as They Relate to Risk Management </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In 2021, the Compensation Committee reviewed our compensation policies and
practices and concluded that the mix and design of these policies and practices are not reasonably likely to encourage our employees to take excessive risks.&nbsp;In connection with its evaluation, the Compensation Committee considered, among other
things, the structure, philosophy and design characteristics of our primary incentive compensation plans and programs in light of our risk management and governance procedures, as well as other factors that may calibrate or balance potential
risk-taking incentives.&nbsp;Based on this assessment, the Compensation Committee concluded that risks arising from our compensation policies and practices for all employees, including executive officers, are not reasonably likely to have a material
adverse effect on us. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">78</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Summary of Compensation </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_25"></A>Summary of Compensation </FONT></P>
<P STYLE="line-height:3.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table shows for the
fiscal years ended December&nbsp;31, 2021, January&nbsp;1, 2021 and January&nbsp;3, 2020 (referred to as fiscal 2021, fiscal 2020 and fiscal 2019, respectively), compensation awarded to, paid to or earned by our Chief Executive Officer, our Chief
Financial Officer and our other three most highly compensated executive officers in 2021, as well as Dr,&nbsp;Schwab, who served as an executive officer for a portion of 2021 until her passing in September 2021 (collectively referred to as our
&#147;Named Executive Officers&#148;). </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B><A NAME="tx282574_500"></A><A NAME="tx282574_604"></A>Summary Compensation
Table </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name&nbsp;and&nbsp;Principal&nbsp;Position</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Year<BR>(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Salary<BR>($)(2)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Bonus<BR>($)(3)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock<BR>Awards<BR>($)(4)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Awards<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff"><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive&nbsp;
Plan<BR>Compensation<BR>($)(5)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">All Other<BR>Compensation<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Total</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,093,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,160,513</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,265,043</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">11,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7,530,431</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;President and Chief</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,058,216</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">128,159</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,153,437</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,349,812</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Executive Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2019</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,005,201</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,118,854</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,132,555</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">679,568</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,367,037</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">399,507</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">11,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,457,112</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">648,358</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">27,434</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">379,176</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,064,968</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;and Chief Financial Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2019</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">622,866</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">310,893</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">942,259</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">526,477</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,269,437</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">308,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">11,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,115,872</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President,</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">500,953</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">21,420</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">763,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(7)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">269,280</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,564,653</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Commercial</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">599,135</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,217,547</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">347,069</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">11,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,147,751</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President,</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">576,091</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">24,376</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">306,443</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">916,910</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;General Counsel and Secretary</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2019</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">553,934</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">276,240</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">838,674</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph. D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">560,850</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,052,607</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">337,605</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">11,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,962,062</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President,</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Scientific Strategy and Chief</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Scientific Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">557,210</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7,020,502</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,280,412</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(9)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">11,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,869,124</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Former President, Product</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">744,044</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">37,813</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">610,409</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,402,266</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Development and Medical</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">710,751</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">409,231</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,128,482</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Affairs and Chief Medical</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The compensation reflected in the Summary Compensation Table reflects a <FONT
STYLE="white-space:nowrap">52-week</FONT> period for fiscal 2021, a <FONT STYLE="white-space:nowrap">52-week</FONT> period for fiscal 2020 and a <FONT STYLE="white-space:nowrap">53-week</FONT> period for fiscal 2019. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amounts shown in this column represent the amount actually earned by each Named Executive Officer
for the indicated fiscal year. For information regarding 2021 base salaries, please see &#147;<A HREF="#tx282574_501">Compensation Discussion and Analysis&#151;2021 Compensation Decisions&#151;2021 Base Salaries</A>.&#148;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amounts shown in this column reflect the discretionary portion of the cash bonuses awarded under
our Annual Cash Bonus Plan for fiscal 2020. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amounts shown in this column reflect the aggregate grant date fair value in the indicated fiscal
year for the RSU and PSU awards as computed in accordance with ASC 718. Other than as reflected in Footnote 7 to the Summary Compensation Table, there were no time-based RSUs granted to the Named Executive Officers in fiscal 2020 or fiscal 2019.
With respect to PSU awards granted to the Named Executive Officers during each of fiscal 2021, 2020 and 2019, the grant date fair values, as computed in accordance with ASC 718, excluding the estimate of estimated forfeitures, and presented in the
table above, are based upon the then-probable outcome of the performance conditions, which was $0 for each Named Executive Officer. Accordingly, the positive amounts set forth in the table for fiscal 2021 and for Mr.&nbsp;Haley in 2020 reflect
solely the aggregate grant date fair value for RSUs granted as computed in accordance with ASC 718. Assuming &#147;Threshold Achievement&#148; (i.e. &#147;Threshold Payout&#148;), &#147;Target Achievement&#148; (i.e. &#147;Target Payout&#148;) and
&#147;Maximum Achievement&#148; (i.e. &#147;Maximum Payout&#148;) of the performance conditions for the PSU awards granted to each </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">79</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Named Executive Officer during fiscal 2021, and in each case using the closing stock price of $21.31 per share of our common stock on the March&nbsp;4, 2021 grant date and excluding estimates of
forfeiture, the values of the PSU awards granted to each Named Executive Officer during fiscal 2021 at the grant date were as follows: </FONT></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name </FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Threshold&nbsp;Payout&nbsp;of</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PSUs&nbsp;Granted</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2021</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target&nbsp;Payout&nbsp;of</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PSUs&nbsp;Granted</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2021</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Maximum&nbsp;Payout</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">of&nbsp;PSUs&nbsp;Granted</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2021</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,600,637</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,268,393</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,536,786</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J.
Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">512,633</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,367,037</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,734,073</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J.
Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">476,023</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,269,437</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,538,873</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">456,567</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,217,547</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,435,094</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">394,725</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,052,067</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,105,215</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">582,424</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,553,179</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3,106,359</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">For a description of the PSU awards granted during fiscal 2021, see &#147;<A HREF="#tx282574_502">Compensation
 Discussion and Analysis&#151;2021 Compensation Decisions&#151;2021 Long-Term Incentive Awards</A>&#148; above. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Assuming &#147;Threshold Achievement&#148; (i.e. &#147;Threshold Payout&#148;), &#147;Target Achievement&#148; (i.e. &#147;Target
Payout&#148;) and &#147;Over Achievement&#148; or &#147;Early Achievement&#148; (i.e. &#148;Maximum Payout&#148;) of the performance conditions for the PSU awards granted to each Named Executive Officer during fiscal 2020, and in each case other
than Dr.&nbsp;Morrissey, using the closing stock price of $21.73 per share of our common stock on the September&nbsp;11, 2020 grant date (and for Dr.&nbsp;Morrissey, using the closing stock price of $21.83 per share of our common stock on the
October&nbsp;22, 2020 grant date) and excluding estimates of forfeiture, the values of the PSU awards granted to each Named Executive Officer during fiscal 2020 at the grant date were as follows: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name </FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Threshold&nbsp;Payout&nbsp;of</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PSUs&nbsp;Granted</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target&nbsp;Payout&nbsp;of</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PSUs&nbsp;Granted</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Maximum&nbsp;Payout</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">of&nbsp;PSUs&nbsp;Granted</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,104,149</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,208,298</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">16,416,597</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J.
Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,415,384</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,830,767</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,661,534</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J.
Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,258,167</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,516,334</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,032,668</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,258,167</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,516,334</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,032,668</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,415,384</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,830,767</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,661,534</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Assuming &#147;Target Achievement&#148; (i.e. &#147;Target Payout&#148;) and &#147;Over
Achievement&#148; (i.e. &#147;Maximum Payout&#148;) of the performance conditions for the PSU awards granted to each Named Executive Officer during fiscal 2019, and in each case using the closing stock price of $19.56 per share of our common stock
on the September&nbsp;20, 2019 grant date and excluding estimates of forfeiture, the values of the PSU awards granted to each Named Executive Officer other than Mr.&nbsp;Haley during fiscal 2019 at the grant date were as follows: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5" STYLE="BORDER-TOP:2.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Name </FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target&nbsp;Payout&nbsp;of</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PSUs&nbsp;Granted</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2019</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Maximum&nbsp;Payout</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">of&nbsp;PSUs&nbsp;Granted</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2019</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,774,107</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">17,548,215</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J.
Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,324,139</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,648,278</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,324,139</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,648,278</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,788,982</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,577,964</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amounts shown in this column represent the portion of the cash bonuses awarded under our Annual
Cash Bonus Plan that was based on the Compensation Committee&#146;s assessment of the achievement of <FONT STYLE="white-space:nowrap">pre-determined</FONT> corporate goals. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">80</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Summary of Compensation </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amount shown does not reflect compensation actually received or the amount that may be realized
in the future by Dr.&nbsp;Morrissey. The amount shown reflects the aggregate grant date fair value in the indicated fiscal year for the option award as computed in accordance with ASC 718. The stock option vests over a four-year period following the
grant date and expires seven years from the date of grant or earlier upon termination of service with us. The stock option has an exercise price of $21.31 per share. The assumptions used to calculate the value of option awards are set forth in Note
8 of the Notes to Consolidated Financial Statements included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021, filed with the SEC on February&nbsp;18, 2022.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amount shown reflects the grant date fair value of the time-based RSU award granted to
Mr.&nbsp;Haley in connection with his promotion to Executive Vice President, Commercial as computed in accordance with ASC 718. The grant date fair value of the RSU award was measured based on the closing price of $21.80 per share of our common
stock on the February&nbsp;19, 2020 grant date. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">As indicated in Footnote 4 above, the amount shown includes the aggregate grant date fair value
of the RSU and PSU awards granted to Dr. Schwab in fiscal 2021 as computed in accordance with ASC 718, which was $1,553,179. As described under &#147;<A HREF="#tx282574_1505">Compensation Discussion and Analysis&#151;Passing of Gisela M.
Schwab</A>&#148; above, the Compensation Committee determined to (1) amend the terms of each of Dr. Schwab&#146;s then-outstanding and unvested equity awards that were subject solely to time-based vesting conditions to provide that if her continuous
service terminated as a result of her death, then each such award would become fully vested (and exercisable, if applicable) as of the date of such termination, and (2) amend the terms of each then-outstanding stock option award to provide that if
(i) her continuous service terminated as a result of her death and (ii) the expiration date of the original full term of such award (such date referred to herein as the Option Expiration Date) was later than 18 months following the date of such
termination, then the post-termination exercise period of such award would be extended until the Option Expiration Date. Under applicable SEC rules, the incremental fair value, as computed in accordance with ASC 718, associated with the
modifications of her equity awards must also be reported in the Stock Awards column or the Option Awards column, as applicable. Accordingly, in addition to the aggregate grant date fair value for the RSU and PSU awards actually granted to Dr. Schwab
in fiscal 2021, the amount shown includes an aggregate of $5,467,323 in incremental fair value associated with the modification of Dr. Schwab&#146;s RSUs and PSUs (for which the performance-vesting criteria had already been met and were subject only
to remaining time-vesting conditions). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amount shown consists solely of the incremental fair value, as computed in accordance with ASC
718, associated with the modifications of Dr. Schwab&#146;s stock option awards to provide for full vesting acceleration and an extended post-termination exercise period, as described under &#147;<A HREF="#tx282574_1505">Compensation Discussion and Analysis&#151;Passing
 of Gisela M. Schwab</A>&#148; above. See also Footnote (8) above. No option awards were granted to Dr. Schwab in fiscal 2021, 2020 or 2019. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">81</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_26"></A>Grants of Plan-Based Awards </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table shows for the
fiscal year ended December&nbsp;31, 2021 certain information regarding grants of plan-based awards to the Named Executive Officers: </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT
 COLOR="#3f3f3f"><B>Grants of Plan-Based Awards in Fiscal&nbsp;2021 </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Estimated
Future<BR>Payouts Under<BR><FONT STYLE="white-space:nowrap">Non-Equity</FONT> Incentive<BR>Plan Awards (1)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Estimated
Future<BR>Payouts Under<BR>Equity Incentive<BR>Plan Awards</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">All
Other<BR>Stock<BR>Awards:<BR>Number&nbsp;of<BR>Shares of<BR>Stock or<BR>Units<BR>($)(2)</FONT></B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">All&nbsp;
Other<BR>Option<BR>Awards:<BR>Number&nbsp;of<BR>Securities<BR>Underlying<BR>Options<BR>(#)(3)</FONT></B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Exercise&nbsp;or<BR>Base&nbsp;
Price<BR>of&nbsp;Option<BR>Awards<BR>($/Sh)</FONT></B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Grant&nbsp;Date<BR>Fair&nbsp;Value<BR>of
Stock<BR>and<BR>Option<BR>Awards<BR>($)(4)</FONT></B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Grant&nbsp;Date</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Threshold<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Maximum<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Threshold<BR>(#)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target<BR>(#)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Maximum<BR>(#)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-1.00em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael&nbsp;M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">494,700</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">21.31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,159,721</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">75,112</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">200,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">400,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,100,037</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,650,056</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-1.00em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">64,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,367,037</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">24,056</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">64,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">128,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">342,925</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">565,825</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-1.00em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">59,570</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,269,437</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">22,338</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">59,570</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">119,140</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">265,200</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">437,580</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-1.00em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">57,135</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,217,547</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">21,425</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">57,135</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">114,270</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">301,800</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">497,969</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-1.00em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">49,395</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,052,607</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">18,523</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">49,395</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">98,790</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">282,515</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">466,149</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-1.00em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.(6)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2/11/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(7)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">9/22/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">14.74</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100,920</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(7)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10/3/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">24.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">464,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(7)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10/3/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">420,188</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(8)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">9/10/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">129,314</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">18.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">714,867</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(7)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">9/10/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,873</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">109,204</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(8)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">9/10/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,873</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">109,204</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(8)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">9/20/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">142,587</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3,195,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(8)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">72,885</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,553,179</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">72,885</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,633,353</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(8)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3/4/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">27,332</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">72,885</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">145,770</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The dollar amount represents the target and maximum amounts of each Named Executive Officer&#146;s
potential annual cash bonus award pursuant to our Annual Cash Bonus Plan for the fiscal year ended December&nbsp;31, 2021. The amounts shown under &#147;Target&#148; reflects the applicable target payment under the Annual Cash Bonus Plan if
(i)&nbsp;we achieved 100% of the <FONT STYLE="white-space:nowrap">pre-determined</FONT> 2021 corporate goals established by the Compensation and (ii)&nbsp;as </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">82</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Grants of Plan-Based Awards </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">applicable, each Named Executive Officer&#146;s individual performance percentage was assessed at 100% by the Compensation Committee with respect to his or her contributions toward the achievement
of our corporate goals. The amounts shown under &#147;Maximum&#148; reflects the applicable maximum payment under the Annual Cash Bonus Plan if (i)&nbsp;we achieved 150% of the <FONT STYLE="white-space:nowrap">pre-determined</FONT> 2021 corporate
goals established by the Compensation Committee, and (ii)&nbsp;as applicable, each Named Executive Officer&#146;s individual performance percentage was assessed at 200% by the Compensation Committee with respect to his or her contributions toward
the achievement of our corporate goals and the departmental achievements in each Named Executive Officer&#146;s area of responsibility that drove the achievement of such corporate goals; provided, however, that neither the corporate performance
percentage nor the individual performance percentage may exceed 200% in any given year. There is no threshold or minimum possible payment under the Annual Cash Bonus Plan. For more information regarding our Annual Cash Bonus Plan, please see &#147;<A HREF="#tx282574_505">Compensation
 Discussion and Analysis&#151;2021 Compensation Decisions&#151;2021 Annual Cash Bonuses</A>&#148; above. </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The RSU award was granted pursuant to our 2017 Plan. The RSU award will vest as to 1/4th of the
shares subject to the RSU award on May&nbsp;15, 2022 and thereafter as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the number of shares subject to the RSU award on each
May&nbsp;15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> until fully vested. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The option award was granted pursuant to our 2017 Plan and expires seven years from the date of
grant or earlier upon termination of service. The option will vest as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the option on the <FONT STYLE="white-space:nowrap">one-year</FONT>
anniversary of the grant date and will continue to vest thereafter as to 1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the option on each monthly anniversary of the grant date. Vesting is
subject to acceleration as described under the caption &#147;<A HREF="#tx282574_601">Potential Payments Upon Termination or Change in Control</A>&#148; below. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amounts shown in this column do not reflect compensation actually received or amounts that may be
realized in the future by the Named Executive Officers. The amounts shown in this column reflect the aggregate grant date fair value in fiscal year 2021 for the RSU and PSU awards as computed in accordance with ASC 718. The assumptions used to
calculate the grant date fair value of the PSU awards are set forth in Note 8 of the Notes to Consolidated Financial Statements included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended
December&nbsp;31, 2021, filed with the SEC on February&nbsp;18, 2022. The grant date fair values of the PSU awards, as computed in accordance with ASC 718, granted to each Named Executive Officer presented in the table above are based upon the
then-probable outcome of the performance conditions, which was $0 for each Named Executive Officer. For additional information regarding the values of the PSU awards granted to each Named Executive Officer during fiscal 2021, see Footnote 4 to the <A HREF="#tx282574_604">Summary
 Compensation Table</A> above. The grant date fair value of the RSU award was measured based on the closing price of our common stock on the date of grant. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The PSU award was granted pursuant to our 2017 Plan. PSUs vest in accordance with the following:
if the Compensation Committee&#146;s defined Cabozantinib Revenue Goal is achieved during the performance period from January&nbsp;2, 2021 through December&nbsp;29, 2023, at or above the threshold level of performance, and subject to the application
of the TSR Performance Modifier, (i) 50% of the 2021 PSU Certified Shares will vest upon the Compensation Committee&#146;s certification of such achievement, and (ii) 50% of the 2021 PSU Certified Shares will vest on the first quarterly vesting date
(i.e. February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated). For clarification,
(i)&nbsp;the shares of common stock subject to the award will be eligible to vest if and only if the Cabozantinib Revenue Goal is satisfied at or above the threshold level of performance, and failure to achieve the threshold level of performance set
forth in the Cabozantinib Revenue Goal will result in forfeiture of 100% of the PSU award, and (ii)&nbsp;the level of achievement of the Cabozantinib Revenue Goal and application of the TSR Performance Modifier will not be determined by the
Compensation Committee until after the end of the three-year performance period on December&nbsp;29, 2023, and no shares will vest prior to that time. The &#147;certification date&#148; shall mean the date the Compensation Committee determines the
2021 PSU Certified Shares, which shall occur as soon as administratively practicable following the end of the three-year performance period on December&nbsp;29, 2023, but no later than March&nbsp;15, 2024. For purposes of these calculations in the
table above, we assumed no adjustment for the TSR Performance Modifier. For more information regarding the PSUs granted in 2021, please see &#147;<A HREF="#tx282574_503">Compensation Discussion and Analysis&#151;2021 Compensation Decisions&#151;2021 Long-Term
Incentive Awards&#151;2021 PSU Awards</A>&#148; above. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">As described under &#147;<A HREF="#tx282574_1505">Compensation Discussion and Analysis&#151;Passing of
 Gisela M. Schwab</A>&#148; above, the Compensation Committee determined to (1)&nbsp;amend the terms of each of Dr.&nbsp;Schwab&#146;s then-outstanding and unvested equity awards that were subject solely to time-based vesting conditions to provide
that if her continuous service terminated as a result of her death, then each such award would become fully vested (and exercisable, if applicable) as of the date of such termination, and (2)&nbsp;amend the terms of each then-outstanding stock
option award to provide that if (i)&nbsp;her continuous service terminated as a result of her death and (ii)&nbsp;the expiration date of the original full term of such award (such date referred to herein as the Option Expiration Date) was later than
18 months following the date of such termination, then the post-termination exercise period of such award would be extended until the Option Expiration Date. Upon Dr.&nbsp;Schwab&#146;s passing in September 2021, these equity awards were amended
accordingly. Dr.&nbsp;Schwab was not eligible to receive an annual cash bonus payment for 2021 following her passing in September 2021. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Represents the incremental fair value, as computed in accordance with ASC 718, associated with the
modifications of Dr. Schwab&#146;s stock option awards to provide for full vesting acceleration and an extended post-termination exercise period, as described under &#147;<A HREF="#tx282574_1505">Compensation Discussion and Analysis&#151;Passing of Gisela
 M. Schwab</A>&#148; above. See also Footnote 6 above. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Represents the incremental fair value, as computed in accordance with ASC 718, associated with the
modifications of Dr. Schwab&#146;s RSU and PSU awards to provide for full vesting acceleration, as described under &#147;<A HREF="#tx282574_1505">Compensation Discussion and Analysis&#151;Passing of Gisela M. Schwab</A>&#148; above. See also
Footnote 6 above. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_27"></A>Compensation Arrangements </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Base Salaries.</I></B> For a
description of actions taken by the Compensation Committee with respect to base salaries for our Named Executive Officers for fiscal 2021, please see &#147;<A HREF="#tx282574_504">Compensation Discussion and Analysis&#151;2021 Compensation Decisions&#151;2021
 Base Salaries</A> &#148; above. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">83</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Annual Cash
Bonuses.</I></B> In 2018, we adopted our Annual Cash Bonus Plan that provides for annual bonus awards based on our corporate performance, including achievement against <FONT STYLE="white-space:nowrap">pre-determined</FONT> corporate goals and the
individual contributions of each Named Executive Officer toward the achievement of such corporate goals. For more information regarding our Annual Cash Bonus Plan, please see &#147;<A HREF="#tx282574_505">Compensation Discussion and Analysis&#151;2021
 Compensation Decisions&#151;2021 Annual Cash Bonuses</A>&#148; above. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Stock Awards and Option Awards.</I></B> Our 2017 Plan
provides for the grant of RSUs, PSUs and time-based and performance-based stock options to our Named Executive Officers and other employees. In March 2021, we granted PSU awards, which will only vest following our achievement of a certain
performance target in line with our longer-term business strategy, to all of our Named Executive Officers. In addition, in March 2021, we granted time-based equity awards, in the form of RSUs to all of our Named Executive Officers except
Dr.&nbsp;Morrissey, who received his time-based equity award in the form of stock options. For information regarding PSU and RSU awards granted to the Named Executive Officers, and the stock option granted to Dr.&nbsp;Morrissey, in fiscal 2021,
including the number of underlying shares and vesting conditions related thereto, please see &#147;<A HREF="#tx282574_600">Compensation Discussion and Analysis&#151;2021 Compensation Decisions&#151;2021 Long-Term Incentive Awards</A>&#148; above.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Employment Agreements. </I></B>We have no employment agreements with our Named Executive Officers. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Change in Control and Severance Benefit Plan.</I></B> Each of our Named Executive Officers participates in our Change in Control and
Severance Benefit Plan, a description of which is included below under the heading &#147;<A HREF="#tx282574_601">Potential Payments Upon Termination or Change in Control.</A>&#148; </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Other Compensatory Arrangements.</I></B> Please see &#147;<A HREF="#tx282574_602">Compensation Discussion and Analysis&#151;Compensation Elements&#151;Other
 Compensation and Benefits</A>&#148; above for a description of other executive compensatory arrangements, including our 401(k) Plan and other benefits. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">84</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Outstanding Equity Awards at Fiscal <FONT STYLE="white-space:nowrap">Year-End</FONT> </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_28"></A>Outstanding Equity Awards at Fiscal <FONT
STYLE="white-space:nowrap">Year-End</FONT> </FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The following table shows certain information regarding outstanding equity awards at December&nbsp;31, 2021 for the Named Executive Officers. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Outstanding Equity Awards at December&nbsp;31, 2021 </B></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt"> &nbsp;&nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="padding-bottom:2pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option Awards(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="padding-bottom:2pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock Awards(2)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.57em; font-size:7pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Grant</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Date</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Exercisable</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Unexercisable</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Exercise<BR>Price</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Expiration</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Date</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Shares&nbsp;or<BR>Units
of<BR>Stock&nbsp;That<BR>Have&nbsp;Not<BR>Vested</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(#)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Market<BR>Value&nbsp;of<BR>Shares<BR>or&nbsp;Units<BR>of&nbsp;Stock<BR>That<BR>Have&nbsp;
Not<BR>Vested<BR>($)(3)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity&nbsp;Incentive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Plan
Awards:<BR>Number&nbsp;of<BR>Unearned&nbsp;Shares,<BR>Units&nbsp;or<BR>Other&nbsp;Rights That<BR>Have Not<BR>Vested</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(#)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity&nbsp;Incentive<BR>Plan&nbsp;Awards:<BR>Market&nbsp;or<BR>Payout&nbsp;
Value&nbsp;of<BR>Unearned<BR>Shares,&nbsp;Units&nbsp;or<BR>Other&nbsp;Rights<BR>That Have&nbsp;Not<BR>Vested</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)(3)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; line-height:12.0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/26/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">360,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">15.31</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/25/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">480,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24.41</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/2/2024</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">250,546</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">57,819</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18.80</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/9/2025</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">11,619(5)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">212,395</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">23,239(6)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">424,809</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/20/2019</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">112,144(7)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2,049,992</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/22/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">94,002(8)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,718,357</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/22/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">47,001</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">859,178</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">94,002</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,718,357</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/4/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">494,700</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">494,700</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(10)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">21.31</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/3/2028</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/4/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">200,300</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(11)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3,661,484</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; line-height:12.0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/16/2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">225,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">6.21</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/15/2022</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/22/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">120,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">14.74</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/21/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">125,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24.41</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/2/2024</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">105,067</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24,247</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(10)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18.80</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/9/2025</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4,873(5)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">89,078</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9,746(6)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">178,157</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/20/2019</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">29,706(7)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">543,026</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">32,567</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(8)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">595,325</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">16,284</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">297,672</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">32,568</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">595,343</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/4/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">64,150</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(13)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,172,662</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/4/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">64,150</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(11)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,172,662</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; line-height:12.0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/5/2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">60,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1.90</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/4/2022</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/16/2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">60,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">6.21</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/15/2022</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/11/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">25,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4.20</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/10/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">12/19/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">50,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">16.29</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">12/18/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">100,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24.41</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/2/2024</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">94,561</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">21,822</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(10)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18.80</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/9/2025</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2,249(5)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">41,112</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4,498</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(6)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">82,223</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/20/2019</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">29,706</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(7)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">543,026</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/19/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">26,250(14)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">479,850</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(8)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">529,206</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">14,475</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">264,603</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">529,206</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/4/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">59,570</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(13)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,088,940</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/4/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">59,570</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(11)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,088,940</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">85</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>

<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt"> &nbsp;&nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="padding-bottom:2pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option Awards(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="padding-bottom:2pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock Awards(2)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.57em; font-size:7pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Grant</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Date</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Exercisable</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Unexercisable</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Exercise<BR>Price</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Expiration</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Date</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Shares&nbsp;or<BR>Units
of<BR>Stock&nbsp;That<BR>Have&nbsp;Not<BR>Vested</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(#)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Market<BR>Value&nbsp;of<BR>Shares<BR>or&nbsp;Units<BR>of&nbsp;Stock<BR>That<BR>Have&nbsp;
Not<BR>Vested<BR>($)(3)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity&nbsp;Incentive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Plan
Awards:<BR>Number&nbsp;of<BR>Unearned&nbsp;Shares,<BR>Units&nbsp;or<BR>Other&nbsp;Rights That<BR>Have Not<BR>Vested</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(#)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity&nbsp;Incentive<BR>Plan&nbsp;Awards:<BR>Market&nbsp;or<BR>Payout&nbsp;
Value&nbsp;of<BR>Unearned<BR>Shares,&nbsp;Units&nbsp;or<BR>Other&nbsp;Rights<BR>That Have&nbsp;Not<BR>Vested</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)(3)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; line-height:12.0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/22/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">97,500</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">14.74</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/21/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">100,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24.41</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/2/2024</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">105,067</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24,247</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(10)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18.80</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/9/2025</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2,499(5)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">45,682</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4,997(6)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">91,345</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/20/2019</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">29,706(7)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">543,026</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950(8)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">529,206</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">14,475</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">264,603</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">529,206</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/4/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">57,135</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(13)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,044,428</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/4/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">57,135</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(11)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,044,428</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; line-height:12.0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/11/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">40,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4.20</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/10/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/22/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">97,500</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">14.74</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/21/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">110,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24.41</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/2/2024</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">101,027</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">23,314</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(10)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18.80</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/9/2025</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4,685(5)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">85,642</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9,371(6)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">171,302</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/20/2019</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">35,647(7)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">651,627</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950(8)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">529,206</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">14,475</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">264,603</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">529,206</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/4/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">49,395</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(13)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">902,941</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/4/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">49,395(11)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">902,941</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; line-height:12.0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.(12)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">150,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24.41</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/3/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">129,314</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18.80</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3/3/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Option awards granted on or after May&nbsp;28, 2014, and prior to May&nbsp;24, 2017, were issued
under our 2014 Equity Incentive Plan (2014 Plan) and are either subject to time-based vesting or were subject to performance-based vesting and expire seven years from the date of grant or earlier upon termination of continuous service. Vesting of
option awards granted under the 2014 Plan is set forth in the applicable footnote accompanying the entry. Option awards granted pursuant to our 2014 Plan subject to time-based vesting vest as to
1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the option on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the vesting commencement date and thereafter as to 1/48<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the option on each monthly anniversary of the vesting commencement date. Option awards granted pursuant to our 2014 Plan subject to performance-based
vesting are vested in full. Option awards granted on or after May&nbsp;24, 2017 were issued under our 2017 Plan and are subject to time-based vesting and expire seven years from the date of grant or earlier upon termination of continuous service.
Vesting of option awards granted under the 2017 Plan is set forth in the applicable footnote accompanying the entry. Option awards granted pursuant to our 2017 Plan subject to time-based vesting vest as to 1/4<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the option on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the vesting commencement date and thereafter as to 1/48<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the option on each monthly anniversary of the vesting commencement date. Vesting of all options issued to our Named Executive Officers are subject to
acceleration as described under the caption &#147;<A HREF="#tx282574_601">Potential Payments Upon Termination or Change in Control</A>&#148; below. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">RSU awards granted on or after May&nbsp;28, 2014 and prior to May&nbsp;24, 2017 were issued under
our 2014 Plan, and RSU awards granted on or after May&nbsp;24, 2017 were issued under our 2017 Plan. RSU awards generally vest as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the RSU award
on the first established RSU vesting date following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date and thereafter as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares
subject to the RSU award on each anniversary of the first established RSU vesting date following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date, until fully vested. We have established February 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August&nbsp;15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November&nbsp;15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> as quarterly vesting dates. Vested shares will be delivered to the Named Executive Officer on the applicable quarterly vesting date, provided that delivery may be delayed pursuant to the terms of
the award agreement. In addition, PSU awards granted pursuant to our 2017 Plan vest based on the achievement of certain performance targets set by the Compensation Committee as described below in Footnotes 5, 6, 7, 8, 9, 11 and 14. Vesting of all
RSU awards and PSU awards issued to our Named Executive Officers is subject to acceleration as described under the caption &#147;<A HREF="#tx282574_601">Potential Payments Upon Termination or Change in Control</A>&#148; below.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">For purposes of determining market value, we assumed a stock price of $18.28, the closing sale
price per share of our common stock on December&nbsp;31, 2021, the last business day of our last fiscal year. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">86</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Outstanding Equity Awards at Fiscal <FONT STYLE="white-space:nowrap">Year-End</FONT> </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Option vests as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original
number of shares subject to the option on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date and thereafter as to 1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to
the option on each monthly anniversary of the grant date with a final vesting date of September&nbsp;10, 2022 (assuming that such options are not accelerated). The option became exercisable upon the achievement of the performance condition that
required the closing market price of our common stock to be equal to or greater than 125% of the exercise price of the option over a period of at least 30 consecutive calendar days. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the original number of shares subject to the award upon the
Compensation Committee&#146;s certification that Exelixis has achieved either (x)&nbsp;full target enrollment, as specified in the applicable clinical trial protocol, or (y)&nbsp;positive <FONT STYLE="white-space:nowrap">top-line</FONT> results, in
each case with respect to a target number of potentially label-enabling clinical trials for cabozantinib (both alone or in combination with another therapy), and (ii) 50% of the original number of shares subject to the award on the first quarterly
vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated).
On February&nbsp;3, 2021, the Compensation Committee convened to determine that full target enrollment and/or positive <FONT STYLE="white-space:nowrap">top-line</FONT> results from the target number of potentially label-enabling clinical trials had
been achieved, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% vested on February&nbsp;15, 2022 (reported in the table as &#147;earned&#148; but unvested, since such PSUs were still unvested as of December&nbsp;31,
2021). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the original number of shares subject to the award upon the
Compensation Committee&#146;s certification that a target number of IND applications have become effective with respect to product candidates that have either (x)&nbsp;been discovered by Exelixis or
<FONT STYLE="white-space:nowrap">(y)&nbsp;in-licensed</FONT> or acquired by Exelixis, and (ii) 50% of the original number of shares subject to the award on the first quarterly vesting date (i.e. February 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>&nbsp;and November
15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) following <FONT STYLE="white-space:nowrap">the&nbsp;one-year&nbsp;anniversary</FONT> of the Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated). On
December&nbsp;15, 2021, the Compensation Committee convened to determine that the target number of effective IND applications had been achieved, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% (reported in the
table) will vest on February&nbsp;15, 2023 (assuming such PSUs are not accelerated). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the number of shares subject to the award that are entitled to vest
based upon the Compensation Committee&#146;s certification that the company has obtained approval by the FDA for the commercial sale and marketing of one or more products for which we hold, or have licensed to a partner, development and
commercialization rights in the U.S. in one or more new indications, on the date of such certification, and (ii) 50% of the number of shares subject to the award that are entitled to vest based on such certification on the first quarterly vesting
date (i.e. February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) following <FONT STYLE="white-space:nowrap">the&nbsp;one-year&nbsp;anniversary</FONT> of the Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated). On
October&nbsp;22, 2020, the Compensation Committee convened to determine that certain performance criteria had been achieved early, resulting in the immediate vesting of 75% of the target number of shares subject to the PSU award, and an additional
75% of the target number of shares subject to the PSU award vested on November&nbsp;15, 2021. On February&nbsp;3, 2021, the Compensation Committee convened to determine that the maximum performance criteria had been achieved, resulting in the
immediate vesting of an additional 25% of the target number of shares subject to the PSU award, and the remaining 25% of the target number of shares subject to the PSU award (to complete maximum vesting of 200% of the target number of shares) vested
on February&nbsp;15, 2022 (reported in the table as &#147;earned&#148; but unvested, since such PSUs were still unvested as of December&nbsp;31, 2021). </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the number of shares subject to the award that are entitled to vest
based upon the Compensation Committee&#146;s certification that the company has achieved positive <FONT STYLE="white-space:nowrap">top-line</FONT> results of one or more clinical trials evaluating a product for which we own, or have licensed to a
partner, development or commercialization rights, that provides data that can reasonably support regulatory evaluation of safety and efficacy to determine the risk/benefit profile of the product, and (ii) 50% of the number of shares subject to the
award that are entitled to vest based on such certification on the first quarterly vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the
Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated). The number of shares reported in the table above represents threshold achievement, or 50% of the target number of shares of Exelixis common stock subject to
the PSU award. Depending on the level of achievement of such performance target, Named Executive Officers are eligible to vest up to a maximum of 200% of the target number of shares of Exelixis common stock subject to the PSU award. Failure to
achieve the aforementioned performance target by December&nbsp;31, 2024 will result in forfeiture of 100% of the PSU award. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the number of shares subject to the award that are entitled to vest
based upon the Compensation Committee&#146;s certification that the company has obtained approval by the FDA for the commercial sale and marketing of one or more products for which we own, or have licensed to a partner, development or
commercialization rights, in one or more new indications or an indication for which the product has previously received FDA approval, if such product is intended to treat a new, additional or expanded set of patients or is part of a combination
therapy, and (ii) 50% of the number of shares subject to the award that are entitled to vest based on such certification on the first quarterly vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the <FONT
STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated). On September&nbsp;30, 2021, the Compensation Committee convened to determine that certain
performance criteria had been achieved, resulting in the immediate vesting of 25% of the target number of shares subject to the PSU award, and an additional 25% of the target number of shares subject to the PSU award (reported in the table as
&#147;earned&#148; but unvested) will vest on November&nbsp;15, 2022 (assuming such PSUs are not accelerated). Because the Compensation Committee has already certified as to the threshold achievement of this PSU award, the number of shares reported
in the table above as &#147;unearned&#148; represents additional shares that will begin vesting upon target achievement, or 50% of the target number of shares of Exelixis common stock subject to the PSU award (and collectively with those shares
vested and entitled to vest based on the Compensation Committee&#146;s prior certification on September&nbsp;30, 2021, 100% of the target number of shares of Exelixis common stock subject to the PSU award). Depending on the continued level of
achievement of such performance target, Named Executive Officers are eligible to vest up to a maximum of 200% of the target number of shares of Exelixis common stock subject to the PSU award. Failure to achieve the next level of the aforementioned
performance target by December&nbsp;31, 2024 will result in forfeiture of 50% of the PSU award reported in the table above as &#147;unearned.&#148; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Option vests as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original
number of shares subject to the option on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date and thereafter as to 1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to
the option on each monthly anniversary of the grant date until fully vested (assuming that such options are not accelerated). </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">87</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Holders of 2021 PSU awards may earn up to 200% of the target number of shares depending on
(i)&nbsp;the level of achievement with respect to the Compensation Committee&#146;s defined Cabozantinib Revenue Goal (related to certain net product revenues over four consecutive quarters), to be evaluated at the end of the three-year performance
period ending December, 29, 2023, and (ii)&nbsp;the application of the TSR Performance Modifier (which measures our relative TSR performance, expressed as a percentile rank, against the Nasdaq Biotechnology Index during the three-year performance
period from January&nbsp;2, 2021 through December&nbsp;29, 2023). PSUs vest as to (i) 50% percent of the 2021 PSU Certified Shares will vest upon the Compensation Committee&#146;s certification at the end of the performance period, and (ii) 50% of
the 2021 Certified Shares will vest on the first quarterly vesting date (i.e. February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> and November 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) following <FONT STYLE="white-space:nowrap">the&nbsp;one-year&nbsp;anniversary</FONT> of the Compensation Committee&#146;s
certification (assuming that such PSUs are not accelerated). The 2021 PSUs will be forfeited if the performance condition at or above a threshold level is not achieved by the end of the three-year performance period, or December&nbsp;29, 2023. The
performance condition for a threshold of net product revenues relative to the 2021 PSUs was deemed probable of achievement in the fourth quarter of 2021; however, there will be no certification by the Compensation Committee until after the
evaluation at the end of the three-year performance period. For purposes of these calculations in the table above, we assumed no adjustment for the TSR Performance Modifier. For more information regarding the PSUs granted in 2021, please see &#147;<A HREF="#tx282574_603">Compensation
 Discussion and Analysis&#151;2021 Compensation Decisions&#151;2021 Long-Term Incentive Awards&#151;2021 PSU Awards</A>&#148; above. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In recognition of Dr.&nbsp;Schwab&#146;s extraordinary contributions to the company, the
Compensation Committee determined in June 2021 to (1)&nbsp;amend the terms of each of Dr.&nbsp;Schwab&#146;s then-outstanding and unvested equity awards that were subject solely to time-based vesting conditions to provide that if her continuous
service terminated as a result of her death, then each such award would become fully vested (and exercisable, if applicable) as of the date of such termination, and (2)&nbsp;amend the terms of each then-outstanding stock option award to provide that
if (i)&nbsp;her continuous service terminated as a result of her death and (ii)&nbsp;the expiration date of the original full term of such award (such date referred to herein as the Option Expiration Date) was later than 18 months following the date
of such termination, then the post-termination exercise period of such award would be extended until the Option Expiration Date. Upon Dr.&nbsp;Schwab&#146;s passing in September 2021, these equity awards were amended accordingly, and her estate
holds these options. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The RSU award was granted pursuant to our 2017 Plan. The RSU award will vest as to 1/4th of the
shares subject to the RSU award on May&nbsp;15, 2022 and thereafter as to 1/4th of the number of shares subject to the RSU award on each May&nbsp;15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> until fully vested.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">RSUs vest as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number
of shares subject to the RSU award on each May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>&nbsp;with a final vesting date of May&nbsp;15, 2024 (assuming that such RSUs are not accelerated). </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_29"></A>Option Exercises and Stock Vested </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table includes certain
information with respect to stock options exercised and stock awards that vested during the fiscal year ended December&nbsp;31, 2021. </FONT></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT
 COLOR="#3f3f3f"><B>Options Exercised and Stock Vested in Fiscal 2021 </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9.5pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option Awards</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock Awards</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Exercise(#)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Value</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Realized&nbsp;on<BR>Exercise($)(1)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Shares</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Acquired&nbsp;on</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Vesting(#)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Value</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Realized&nbsp;on</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Vesting($)(2)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.47em; text-indent:-1.00em; font-size:9.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>

<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,048,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">580,643</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">11,310,537</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.47em; text-indent:-1.00em; font-size:9.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,140,500</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">178,015</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3,460,925</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.47em; text-indent:-1.00em; font-size:9.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">466,383</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">167,589</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3,306,608</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.47em; text-indent:-1.00em; font-size:9.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">770,400</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">160,289</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3,111,985</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.47em; text-indent:-1.00em; font-size:9.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">620,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,719,354</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">197,048</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3,825,909</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.47em; text-indent:-1.00em; font-size:9.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">890,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">13,853,474</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">292,282</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,921,110</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Value Realized on Exercise&#148; reflects the closing market price of our common stock on
the applicable exercise date, net of the applicable exercise price, multiplied by the number of shares acquired upon exercise of stock options. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Value Realized on Vesting&#148; reflects the closing market price of our common stock on
the applicable vesting date, multiplied by the number of units vested. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">88</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Potential Payments Upon Termination or Change in Control </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="tx282574_601"></A><A NAME="toc282574_30"></A>Potential Payments
Upon Termination or Change in Control </FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>Change in Control and Severance Benefit Plan </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board, upon recommendation of the Compensation Committee,
has adopted a Change in Control and Severance Benefit Plan that provides for certain severance benefits to our officers in connection with specified termination events. Eligible plan participants may include any employee having a rank of vice
president or above, which includes the Named Executive Officers. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If a Named Executive Officer&#146;s employment terminates due to an
involuntary termination without cause or a constructive termination (Covered Termination) during a period starting one month prior to and ending 13 months following a change in control (Change in Control Termination), then the Named Executive
Officer would be entitled to the following benefits under the plan: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">a cash payment paid in installments pursuant to our regularly scheduled payroll periods equal to
the sum of the Named Executive Officer&#146;s base salary and target bonus for (i) 18 months for Named Executive Officers (other than the Chief Executive Officer) and (ii) 24 months for the Chief Executive Officer; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the vesting of up to all of the Named Executive Officer&#146;s options, RSUs and PSUs will
accelerate in full, and the exercise period of such options will be extended to the later of: (i) 12 months after the later of (x)&nbsp;the participant&#146;s termination date, or (y)&nbsp;the change in control; and (ii)&nbsp;the post-termination
exercise period provided for in the applicable option agreement; the plan also provides that any reacquisition or repurchase rights held by us in respect of common stock issued or issuable pursuant to any stock awards granted under any of our equity
incentive plans shall lapse; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">payment of COBRA premiums, or the cash equivalent thereof, for any health, dental or vision plan
sponsored by Exelixis for a period of up to (i) 18 months for Named Executive Officers (other than the Chief Executive Officer) and (ii) 24 months for the Chief Executive Officer; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">payment of outplacement services for (i) 18 months for Named Executive Officers (other than the
Chief Executive Officer), subject to a $30,000 limit and (ii) 24 months for the Chief Executive Officer, subject to a $50,000 limit. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">In the event of a Covered Termination of a Named Executive Officer that is not also a Change in Control Termination, such Named Executive Officer would be entitled to receive a cash severance benefit under the plan equal to 12
months of base salary paid in installments pursuant to our regularly scheduled payroll periods. In such circumstances, we would also pay for a period of up to 12 months of such Named Executive Officer&#146;s COBRA premiums, or the cash equivalent
thereof, for any health, dental or vision plan that we sponsored and that the Named Executive Officer is enrolled in. However, such Named Executive Officer would not be entitled to any vesting acceleration benefits by virtue of such termination.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The payments and benefits described above are subject to certain reductions and offsets if, for example, the Named Executive Officer
received other severance benefits from us pursuant to a written employment agreement. In addition, if any of the severance benefits payable under the plan would constitute a &#147;parachute payment&#148; subject to the excise tax imposed by
Section&nbsp;4999 of the Code, a Named Executive Officer may receive a reduced amount of the affected severance benefits. The plan does not provide for the gross up of any excise taxes imposed by Section&nbsp;4999 of the Code. No Named Executive
Officer would receive benefits under the plan if (i)&nbsp;the Named Executive Officer has entered into an individually negotiated employment agreement that provides for severance or change in control benefits, (ii)&nbsp;the Named Executive Officer
voluntarily terminates employment with us to accept employment with another entity that is controlled by us or is otherwise affiliated with us or (iii)&nbsp;the Named Executive Officer does not confirm in writing that he or she is subject to
agreements with us relating to proprietary and confidential information. In addition, as a general matter, to be eligible to receive benefits under the plan and if requested by Exelixis, a Named Executive Officer must execute a general waiver and
release of claims, and such release must become effective in accordance with its terms. A Named Executive Officer&#146;s right to receive payment of benefits under the plan will immediately terminate if, at any time prior to or during the period the
Named Executive Officer is receiving such benefits, the Named Executive Officer, without the prior written approval of Exelixis, (i)&nbsp;willfully breaches a material provision of a proprietary and confidential information agreement with Exelixis
or (ii)&nbsp;willfully encourages or solicits any of Exelixis&#146; then current employees to leave Exelixis&#146; employ. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Treatment of Equity Awards </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Pursuant to our 2014 Plan and 2017 Plan, in the event of an asset sale, merger or consolidation in which we are not the surviving corporation, or a reverse merger in which we are the surviving corporation but our common stock is
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">89</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">converted by virtue of
the merger into other property, then any surviving or acquiring corporation may assume outstanding stock awards or substitute similar stock awards for those under the plan. If any surviving or acquiring corporation refuses to assume such outstanding
stock awards or substitute similar stock awards, stock awards held by participants whose service has not terminated will be accelerated in full. In addition, if any person, entity or group acquires beneficial ownership of more than 50% of our
combined voting power, then stock awards held by participants whose service has not terminated will be accelerated in full. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The
following table sets forth the potential severance payments and benefits under our Change in Control and Severance Benefit Plan to which a Named Executive Officer would be entitled in connection with specified termination events, as if such Named
Executive Officers&#146; employment terminated as of December&nbsp;31, 2021, the last day of our last fiscal year. In addition, the table sets forth the amounts to which such Named Executive Officers would be entitled under our equity plans either
(i)&nbsp;in connection with a change in control transaction in which the successor corporation did not assume or substitute outstanding stock awards (and with respect to PSU awards granted to each Named Executive Officer, a change in control
transaction in which a successor corporation does assume outstanding stock awards), or (ii)&nbsp;an entity or group acquired more than 50% of our combined voting power, in each case, as of December&nbsp;31, 2021. There are no other agreements,
arrangements or plans that entitle any of the above-mentioned Named Executive Officers to severance, perquisites or other enhanced benefits upon termination of employment, other than certain extensions of the termination date to avoid violation of
registration requirements under the Securities Act of 1933, as amended, or for such Named Executive Officer&#146;s death or disability. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>Potential Payments Table </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table shows the potential payments upon termination of employment or a
change in control for the Named Executive Officers. The table assumes that the triggering event took place on December&nbsp;31, 2021, the last day of our 2021 fiscal year. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Potential Payments Upon Termination or Change in Control Table </B></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" STYLE="padding-bottom:3pt ;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Benefit</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="padding-bottom:3pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Change&nbsp;in&nbsp;Control&nbsp;and&nbsp;Severance<BR>Benefit
Plan</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity Plans</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Involuntary<BR>Termination</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Without</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Cause&nbsp;or</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Constructive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination&nbsp;in</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Connection</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">with&nbsp;a Change</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;Control&nbsp;($)(1)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Involuntary</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Without</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Cause or</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Constructive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination&nbsp;Not</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;Connection</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">with a Change</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in Control ($)(2)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Certain</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Change in</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Control</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Transactions</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">without</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)(3)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Base Salary</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,200,074</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,100,037</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Bonus</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,200,074</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,100,037</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Vesting&nbsp;Acceleration (4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">19,236,428</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">19,236,428</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">COBRA Payments</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">71,067</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">35,533</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Outplacement Services</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;<B>Benefit
Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>23,757,643</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>2,235,607</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>19,236,428</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Base Salary</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,028,774</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">685,849</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Bonus</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">514,387</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">342,925</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Vesting&nbsp;Acceleration (4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7,620,603</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7,620,603</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">COBRA Payments</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">53,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">35,533</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Outplacement Services</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;<B>Benefit
Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>9,247,064</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>1,064,307</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>7,620,603</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Base Salary</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">795,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">530,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Bonus</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">397,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">265,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Vesting&nbsp;Acceleration (4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7,293,135</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7,293,135</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">COBRA Payments</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">93,068</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">62,045</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Outplacement Services</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;<B>Benefit
Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>8,609,603</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>857,645</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>7,293,135</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">90</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Potential Payments Upon Termination or Change in Control </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>

<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE="padding-bottom:3pt ;"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Benefit</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="padding-bottom:3pt ;border-bottom:1.00px solid #ffffff"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Change&nbsp;in&nbsp;Control&nbsp;and&nbsp;Severance<BR>Benefit Plan</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;border-bottom:1.00px solid #ffffff"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity Plans</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">Involuntary<BR>Termination</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Without</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Cause&nbsp;or</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Constructive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination&nbsp;in</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Connection</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">with&nbsp;a Change</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;Control&nbsp;($)(1)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Involuntary</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Without</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Cause or</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Constructive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination&nbsp;Not</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;Connection</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">with a Change</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">in Control ($)(2)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Certain</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Change in</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Control</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Transactions</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">without</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)(3)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Base Salary</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">905,399</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">603,599</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Bonus</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">452,699</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">301,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Vesting&nbsp;Acceleration (4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">6,737,953</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">6,737,953</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">COBRA Payments</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">53,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">35,533</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">Outplacement Services</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;<B>Benefit
Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>8,179,351</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>940,932</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>6,737,953</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Base Salary</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">847,544</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">565,029</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Bonus</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">423,772</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">282,515</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Vesting&nbsp;Acceleration (4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">6,683,497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">6,683,497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">COBRA Payments</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">20,272</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">13,514</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">Outplacement Services</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;<B>Benefit
Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>8,005,085</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>861,058</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>6,683,497</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.(5)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Base Salary</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Bonus</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Vesting&nbsp;Acceleration (4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">COBRA Payments</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">Outplacement Services</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;<B>Benefit
Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">These benefits would be payable under the Change in Control and Severance Benefit Plan if the
involuntary termination without cause or constructive termination occurred during a period starting one month prior to and ending 13 months following the change in control. The amounts shown in this column do not include any value associated with
the extension, if any, of the post-termination exercise period provided for in the Change in Control and Severance Benefit Plan. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">These benefits would be payable under the Change in Control and Severance Benefit Plan if the
involuntary termination without cause occurred more than one month before the change in control or if the involuntary termination without cause or a constructive termination occurred more than 13 months following the change in control.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">These benefits would be payable under the 2014 Plan and/or the 2017 Plan if either (i)&nbsp;a
successor corporation does not assume outstanding stock awards in a change in control transaction or (ii)&nbsp;a person, entity or group acquires beneficial ownership of more than 50% of our combined voting power, and, in each case, the Named
Executive Officers do not terminate employment in connection with such a transaction or event.</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In addition, if a successor corporation does assume outstanding stock awards in a change in
control transaction and the Named Executive Officers do not terminate employment in connection with such a transaction, then each Named Executive Officer&#146;s then-outstanding PSUs will be revised in a manner as though the target number of shares
subject to such PSUs had been subject solely to a time-based vesting schedule pursuant to which one third of the target number of shares subject to such PSUs (and for the PSUs granted during fiscal 2020, one fourth) would have vested on each of the
first three anniversaries (and for the PSUs granted during fiscal 2020, each of the first four anniversaries) of the date the PSUs were granted, subject to the Named Executive Officer&#146;s continuous service through the applicable vesting date
(with any portion that would have vested on or prior to the change in control transaction under such vesting schedule becoming vested on the date of the change in control transaction and any portion that is unvested following the date of the change
in control transaction vesting in accordance with such vesting schedule). With respect to PSU awards granted during fiscal 2021, the vesting acceleration benefit for each Named Executive Officer would be $0 because the first anniversary of the grant
date will not yet have occurred as of December&nbsp;31, 2021. With respect to PSU awards granted during fiscal 2018 and fiscal 2019, the vesting acceleration benefit for each Named Executive Officer would be
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">91</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">$0, because the performance criteria for such PSUs at or above the target level had already been certified as of December&nbsp;31, 2021. With respect to PSU awards granted during fiscal 2020, the
vesting acceleration benefit for each Named Executive Officer would be as follows: </FONT></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="98%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Vesting&nbsp;Acceleration&nbsp;Benefit&nbsp;for&nbsp;
Outstanding</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PSUs&nbsp;Granted&nbsp;in&nbsp;2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,288,758</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">446,489</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">396,895</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">396,895</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">396,895</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab,
M.D.&nbsp;(5)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Assumes that the triggering event occurred on December&nbsp;31, 2021, the last business day of
our last fiscal year, when the closing sale price per share of our common stock was $18.28. The amount of the vesting acceleration is determined by: (i)&nbsp;aggregating for all accelerated options, the amount equal to (A)&nbsp;the excess, if any,
of $18.28 over the relevant exercise price of the option, multiplied by (B)&nbsp;the number of shares underlying unvested options at such exercise price as of December&nbsp;31, 2021; and (ii)&nbsp;aggregating for all accelerated RSUs and PSUs, the
amount equal to (X) $18.28 multiplied by (Y)&nbsp;the number of shares underlying the unvested RSUs and PSUs. There can be no assurance that a similar triggering event would produce the same or similar results as those estimated if such event occurs
on any other date or at a time when our closing sale price is different. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">At December&nbsp;31, 2021, Dr.&nbsp;Schwab was no longer employed by the Company and a change in
control would not impact any benefits her estate may hold, as described in &#147;<A HREF="#tx282574_1505">Compensation Discussion and Analysis&#151;Passing of Gisela M. Schwab</A>&#148; above. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_31"></A>CEO Pay Ratio </FONT></P>
<P STYLE="line-height:3.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We believe that we provide fair and
equitable compensation to our employees through a combination of competitive base pay, incentives, retirement plans and other benefits. In accordance with Item 402(u) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> promulgated by the Dodd
Frank Act, we determined the ratio of: (a)&nbsp;the annual total compensation of our Chief Executive Officer; to (b)&nbsp;the median of the annual total compensation of all of our employees, except for our Chief Executive Officer, both calculated in
accordance with the requirements of Item 402(c)(2)(x) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> (CEO Pay Ratio). </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In
order to determine the median of the annual total compensation of all of our employees, we were required to identify the &#147;median employee&#148; of our workforce, without regard to his or her location or employment status (full-time or
part-time). The applicable SEC rules require us to identify a median employee only once every three years, as long as there have been no material changes in our employee population or employee compensation arrangements that we believe would
significantly impact the calculation of our CEO Pay Ratio. However, because there was a significant increase in our employee population between October 2020 and October 2021, when we identified our median employee to calculate our CEO Pay Ratio for
fiscal 2020, and October 2021, we decided to identify a new median employee for purposes of calculating our CEO Pay Ratio for fiscal 2021. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Consistent with the process we adopted for prior fiscal years, to determine the median of the annual total compensation of all of our employees, except for our Chief Executive Officer, we used the following methodology: </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To identify our employee population, we used tax and payroll records to determine all full-time
and part-time employees, excluding our Chief Executive Officer, who were employed as of October&nbsp;31, 2021. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To identify the median employee with respect to annual total compensation of all of our
employees, we calculated each employee&#146;s &#147;target total direct compensation,&#148; which consists of: (i)&nbsp;fiscal 2021 base salary (using a reasonable estimate of the hours worked and overtime actually paid during fiscal 2021 for hourly
employees); (ii) target cash bonus; and (iii)&nbsp;the grant date fair value of any equity awards granted during fiscal 2021 (using the same methodology that we use for estimating the value of the equity awards granted to our Named Executive
Officers and reported in our <A HREF="#tx282574_604">Summary Compensation Table</A>). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In making this determination, we annualized the base salary and target cash bonus for all
full-time and part-time employees who were employed by us for less than the entirety of fiscal 2021. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">92</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Executive Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;CEO Pay Ratio </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Once our representative median employee was identified in the manner described above, we calculated the annual total compensation of the
representative median employee using the same methodology that we used to determine the annual total compensation of our Chief Executive Officer, as reported in the <A HREF="#tx282574_604">Summary Compensation Table</A> included in this Proxy
Statement. For fiscal 2021, the median of the annual total compensation of our employees (other than our Chief Executive Officer) was $283,758 and the annual total compensation of our Chief Executive Officer, as reported in the <A HREF="#tx282574_604">Summary
 Compensation Table</A> included in this Proxy Statement, was $7,530,431. Based on this information, our CEO Pay Ratio for fiscal 2021 was 27 to 1. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">This CEO Pay Ratio represents our reasonable estimate calculated in a manner consistent with Item 402(u) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> and applicable guidance, which provide significant flexibility in how
companies identify the median employee. Each company may use a different methodology and make different assumptions particular to that company. As a result, and as explained by the SEC when it adopted these rules, in considering this CEO Pay Ratio
disclosure, stockholders should keep in mind that the rule was not designed to facilitate comparisons of CEO Pay Ratios among different companies, even companies within the same industry, but rather to allow stockholders to better understand and
assess each particular company&#146;s compensation practices and CEO Pay Ratio disclosures. Neither the Compensation Committee nor our management used our fiscal CEO Pay Ratio for fiscal 2021 in making compensation decisions. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">93</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_32"></A>COMPENSATION COMMITTEE REPORT </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the Securities and Exchange
Commission and is not deemed to be incorporated by reference in any filing of Exelixis under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of
any general incorporation language in any such filing. </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee of the Board of Directors of Exelixis, Inc.,
consisting solely of independent directors, has reviewed and discussed with management the Compensation Discussion and Analysis contained in this Proxy Statement and, based on this review and discussion, the Compensation Committee recommended to the
Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement and incorporated into our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the year ended December&nbsp;31, 2021.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Compensation Committee: </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Charles Cohen, Chair </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent T. Marchesi </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie A. Smith </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Lance Willsey
</FONT></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_33"></A>COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">During 2021, the Compensation Committee comprised Drs. Cohen, Marchesi and Willsey and Ms.&nbsp;Smith. None of the members of the Compensation
Committee during 2021 has at any time been an officer or employee of Exelixis, except that Dr.&nbsp;Cohen served as our acting Chief Scientific Officer from December 1995 to April 1997, and was named an officer of one of our former subsidiaries from
2001 through March 2005, for which he did not receive any compensation. No interlocking relationship exists between the Board or Compensation Committee and the board of directors or compensation committee of any other company, nor has any
interlocking relationship existed in the past. </FONT></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_34"></A>DELINQUENT SECTION 16(a) REPORTS </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Section&nbsp;16(a) of the Securities Exchange Act of 1934, as amended, requires our directors and executive officers and persons who own more
than ten percent of a registered class of our equity securities to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities of Exelixis. Officers, directors and greater than
ten percent stockholders are required by SEC regulation to furnish us with copies of all Section&nbsp;16(a) forms they&nbsp;file. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To
our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were required, during the fiscal year ended December&nbsp;31, 2021, all Section&nbsp;16(a) filing requirements
applicable to our officers, directors and greater than ten percent beneficial owners were complied with, except as follows: (a)&nbsp;a Form 4 relating to a transaction by Lance Willsey, director, in which 90,000 shares of our common stock were sold
in three transactions beginning on February&nbsp;16, 2021, was not timely filed (a Form 4 reporting the transaction was subsequently filed on February&nbsp;24, 2021); (b)&nbsp;a Form 4 relating to a transaction by Maria Freire, director, in which
8,275 shares of our common stock were sold on May&nbsp;11, 2021, was not timely filed (a Form 4 reporting the transaction was subsequently filed on May&nbsp;17, 2021); and (c) three Forms 5 relating to transactions by Charles Cohen, director, in
which 13,845 shares of our common stock were given collectively to his three children in nine transactions (1,699 shares given to each child on December 12, 2019, 1,513 shares given to each child on January 17, 2020, and 1,403 shares given to each
child on January 5, 2021), were not timely filed (such transactions were reported on Forms 5 subsequently filed on April 13, 2022). </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">94</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Certain Relationships and Related Party Transactions </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_35"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY
TRANSACTIONS </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board recognizes that related party transactions can present a heightened risk of potential or actual conflicts of
interests. The Board adopted a written Statement of Policy with respect to Related Person Transactions entered into with related parties. Under this policy, the Audit Committee has been tasked with responsibility to review and approve related party
transactions. The policy provides that management shall present related party transactions to the Audit Committee for approval. The policy does not prevent management from entering into any related party transaction without prior approval of the
Audit Committee, so long as such related party transaction is thereafter presented to the Audit Committee for ratification. If ratification is not forthcoming, then management shall make all reasonable efforts to cancel or annul such
transaction.</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Under the policy, a &#147;related party&#148; includes: any senior officer (including each executive officer or officer
subject to Section&nbsp;16 of the Exchange Act) or director of Exelixis; a person who is an immediate family member of a senior officer, director or director nominee; a security holder who is known to own of record or beneficially more than 5%
percent of any class of our securities; a person who is an immediate family member of such security holder; or an entity which is owned or controlled by one of the aforementioned persons, or an entity in which one of the aforementioned persons has a
substantial ownership interest in or control over such entity. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All related party transactions shall be disclosed in our applicable
filings with the SEC as required under SEC rules. There were no related party transactions reportable under the SEC rules during fiscal 2021, other than as follows: </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">During 2021, BlackRock, Inc. (BlackRock), a global provider of investment, advisory and risk management solutions and a greater than 5% holder of
our common stock, managed a portion of our cash and investments portfolio. As of December&nbsp;31, 2021 and January&nbsp;1, 2021, respectively, the fair value of cash and investments managed by BlackRock was $683.3&nbsp;million and
$574.6&nbsp;million, which included $14.5&nbsp;million and $10.3&nbsp;million and invested in the BlackRock Liquidity Money Market Fund. We incurred $0.3&nbsp;million in fees for BlackRock advisory services performed during the year ended
December&nbsp;31, 2021. </FONT></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_36"></A>HOUSEHOLDING OF PROXY MATERIALS </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers, banks and other fiduciaries) to satisfy the delivery
requirements for Notices of Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice or other Annual Meeting materials addressed to
those stockholders. This process, which is commonly referred to as &#147;householding,&#148; potentially means extra convenience for stockholders and cost savings for companies. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">This year, a number of brokers with account holders who are our stockholders will be householding proxy materials. A single Notice will be
delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be householding communications to your address,
householding will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive a separate Notice, please notify your broker or direct your
written request to Investor Relations, Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, California 94502 or contact Exelixis, Inc., Investor Relations at <FONT STYLE="white-space:nowrap">(650)&nbsp;837-7000.</FONT> Stockholders who currently
receive multiple copies of the Notice at their address and would like to request householding of their communications should contact their broker. </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT
 COLOR="#fc4c02"><A NAME="toc282574_37"></A>ANNUAL REPORT ON FORM <FONT STYLE="white-space:nowrap">10-K</FONT> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">A copy of our Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021, including the consolidated financial statements, schedules and list of exhibits, and any particular exhibit specifically requested, is
available without charge upon written request to: Investor Relations, Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, California 94502. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2022 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">95</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc282574_38"></A>OTHER MATTERS </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to
vote on such matters in accordance with their best judgment. </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:63%; text-indent:-2%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">By Order of the Board of Directors
</FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:63%; text-indent:-2%">


<IMG SRC="g282574g99m98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:63%; text-indent:-2%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">JEFFREY J. HESSEKIEL </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:63%; text-indent:-2%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Executive&nbsp;Vice&nbsp;President,&nbsp;General&nbsp;Counsel&nbsp;and&nbsp;Secretary </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alameda, California </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">April&nbsp;14, 2022 </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">96</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc282574_39"></A>A<SMALL>PPENDIX</SMALL> A </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>E<SMALL>XELIXIS</SMALL>, I<SMALL>NC</SMALL>. </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>2017 E<SMALL>QUITY</SMALL> I<SMALL>NCENTIVE</SMALL> P<SMALL>LAN</SMALL> </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>A<SMALL>DOPTED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>:
F<SMALL>EBRUARY</SMALL>&nbsp;23, 2017 </B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>A<SMALL>MENDED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL>
C<SMALL>OMPENSATION</SMALL> C<SMALL>OMMITTEE</SMALL>: M<SMALL>ARCH</SMALL>&nbsp;22, 2017 </B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> S<SMALL>TOCKHOLDERS</SMALL>: M<SMALL>AY</SMALL>&nbsp;24, 2017
</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>A<SMALL>MENDED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>:
D<SMALL>ECEMBER</SMALL>&nbsp;18, 2017 </B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>A<SMALL>MENDED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL>
C<SMALL>OMPENSATION</SMALL> C<SMALL>OMMITTEE</SMALL>: M<SMALL>ARCH</SMALL>&nbsp;18, 2020 </B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> S<SMALL>TOCKHOLDERS</SMALL>: M<SMALL>AY</SMALL>&nbsp;20, 2020
</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>A<SMALL>MENDED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL>
D<SMALL>IRECTORS</SMALL>: A<SMALL>PRIL</SMALL>&nbsp;5, 2022 </B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>[A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL>
<SMALL>THE</SMALL> S<SMALL>TOCKHOLDERS</SMALL>: M<SMALL>AY</SMALL>&nbsp;25, 2022] </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;G<SMALL>ENERAL</SMALL>.</B> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Successor to and Continuation of 2014 Plan.</B> The Plan is intended as the successor to and
continuation of the Exelixis, Inc. 2014 Equity Incentive Plan (the &#147;<B><I>2014 Plan</I></B>&#148;). Following the Effective Date, no additional stock awards may be granted under the 2014 Plan. Any unallocated shares remaining available for
grant under the 2014 Plan as of 12:01 a.m. Pacific time on the Effective Date (the &#147;<B><I>2014 Plan</I></B><B><I>&#146;</I></B><B><I>s Available Reserve</I></B>&#148;) will cease to be available under the 2014 Plan at such time and will be
added to the Share Reserve (as further described in Section&nbsp;3(a) below) and be then immediately available for grant and issuance pursuant to Stock Awards granted under the Plan. In addition, from and after 12:01 a.m. Pacific time<B> </B>on the
Effective Date, all outstanding stock awards granted under the 2014 Plan, the Exelixis, Inc. 2000 Equity Incentive Plan, as amended and restated (the &#147;<B><I>2000 Plan</I></B>&#148;), the Exelixis, Inc. 2000
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors&#146; Stock Option Plan (the &#147;<B><I>2000 <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</I></B><B><I>&#146;</I></B><B><I> Plan</I></B>&#148;), the Exelixis, Inc.
2011 Equity Incentive Plan (the &#147;<B><I>2011 Plan</I></B>&#148;), and the Exelixis, Inc. 2016 Inducement Award Plan (the &#147;<B><I>2016 Inducement Plan</I></B>&#148;) will remain subject to the terms of the 2014 Plan, the 2000 Plan, the 2000 <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Directors&#146; Plan, the 2011 Plan or the 2016 Inducement Plan, as applicable; <I>provided, however</I>, that any shares subject to outstanding stock awards granted under the 2014 Plan, the 2000 Plan,
the 2000 <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors&#146; Plan, the 2011 Plan or the 2016 Inducement Plan that (i)&nbsp;expire or terminate for any reason prior to exercise or settlement, (ii)&nbsp;are forfeited, cancelled or
otherwise returned to the Company because of the failure to meet a contingency or condition required for the vesting of such shares, or (iii)&nbsp;other than with respect to outstanding options and stock appreciation rights granted under the 2014
Plan, the 2000 Plan, the 2000 Nonemployee Directors&#146; Plan, the 2011 Plan or the 2016 Inducement Plan with respect to which the exercise or strike price is at least one hundred percent (100%) of the Fair Market Value of the Common Stock subject
to the option or stock appreciation right on the date of grant (the &#147;<B><I>Prior Plans</I></B><B><I>&#146;</I></B><B><I> Appreciation Awards</I></B>&#148;), are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding
obligation in connection with a stock award (collectively, the &#147;<B><I>Prior Plans</I></B><B><I>&#146;</I></B><B><I> Returning Shares</I></B>&#148;) will immediately be added to the Share Reserve (as further described in Section&nbsp;3(a) below)
as and when such shares become Prior Plans&#146; Returning Shares and become available for issuance pursuant to Awards granted hereunder. All Awards granted on or after 12:01 a.m. Pacific time<B> </B>on the Effective Date will be subject to the
terms of this Plan, as amended from time to time. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Eligible Award Recipients.</B>
Subject to Section&nbsp;4, Employees, Directors and Consultants are eligible to receive Awards. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Available Awards.</B> The Plan provides for the grant of the following types of Awards:
(i)&nbsp;Incentive Stock Options, (ii)&nbsp;Nonstatutory Stock Options, (iii)&nbsp;Stock Appreciation Rights, (iv)&nbsp;Restricted Stock Awards, (v)&nbsp;Restricted Stock Unit Awards, (vi)&nbsp;Performance Stock Awards, (vii)&nbsp;Performance Cash
Awards, and (viii)&nbsp;Other Stock Awards. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Purpose.</B> The Plan, through the
granting of Awards, is intended to help the Company and any Affiliate secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and
provide a means by which the eligible recipients may benefit from increases in value of the Common Stock. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-1
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2.&nbsp;&nbsp;&nbsp;&nbsp;A<SMALL>DMINISTRATION</SMALL>.</B> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Administration by Board.</B> The Board will administer the Plan. The Board may delegate
administration of the Plan to a Committee or Committees, as provided in Section&nbsp;2(c). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Powers of Board.</B> The Board will have the power, subject to, and within the limitations
of, the express provisions of the Plan: </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;To determine (A)&nbsp;who will be granted
Awards; (B)&nbsp;when and how each Award will be granted; (C)&nbsp;what type of Award will be granted; (D)&nbsp;the provisions of each Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive
cash or Common Stock under the Award; (E)&nbsp;the number of shares of Common Stock subject to, or the cash value of, an Award; and (F)&nbsp;the Fair Market Value applicable to a Stock Award. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;To construe and interpret the Plan and Awards granted under it, and to establish, amend and
revoke rules and regulations for administration of the Plan and Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement, in a manner and to the extent it will deem
necessary or expedient to make the Plan or Award fully effective. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;To settle all
controversies regarding the Plan and Awards granted under it. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;To accelerate, in
whole or in part, the time at which an Award may be exercised or vest (or the time at which cash or shares of Common Stock may be issued in settlement thereof). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or an
Award Agreement, suspension or termination of the Plan will not materially impair a Participant&#146;s rights under his or her then-outstanding Award without his or her written consent except as provided in subsection (viii)&nbsp;below. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(vi)</B>&nbsp;&nbsp;&nbsp;&nbsp;To amend the Plan in any respect the Board deems necessary or advisable, including, without
limitation, by adopting amendments relating to Incentive Stock Options and certain nonqualified deferred compensation under Section&nbsp;409A of the Code and/or to make the Plan or Awards granted under the Plan compliant with the requirements for
Incentive Stock Options or exempt from or compliant with the requirements for nonqualified deferred compensation under Section&nbsp;409A of the Code, subject to the limitations, if any, of applicable law. However, if required by applicable law or
listing requirements, and except as provided in Section&nbsp;9(a) relating to Capitalization Adjustments, the Company will seek stockholder approval of any amendment of the Plan that (A)&nbsp;materially increases the number of shares of Common Stock
available for issuance under the Plan, (B)&nbsp;materially expands the class of individuals eligible to receive Awards under the Plan, (C)&nbsp;materially increases the benefits accruing to Participants under the Plan, (D)&nbsp;materially reduces
the price at which shares of Common Stock may be issued or purchased under the Plan, or (E)&nbsp;materially expands the types of Awards available for issuance under the Plan. Except as otherwise provided in the Plan (including
Section&nbsp;2(b)(viii)) or an Award Agreement, no amendment of the Plan will materially impair a Participant&#146;s rights under an outstanding Award without the Participant&#146;s written consent. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(vii)</B>&nbsp;&nbsp;&nbsp;&nbsp;To submit any amendment to the Plan for stockholder approval, including, but not limited to,
amendments to the Plan intended to satisfy the requirements of (A)&nbsp;Section&nbsp;162(m) of the Code regarding the exclusion of performance-based compensation from the limit on corporate deductibility of compensation paid to Covered Employees,
(B)&nbsp;Section&nbsp;422 of the Code regarding incentive stock options or (C)&nbsp;Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>(viii)</B>&nbsp;&nbsp;&nbsp;&nbsp;To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited to, amendments to provide terms more favorable to the
Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; <I>provided, however,</I> that a Participant&#146;s rights under any Award will not be impaired by any
such amendment unless (A)&nbsp;the Company requests the consent of the affected Participant, and (B)&nbsp;such Participant consents in writing. Notwithstanding the foregoing, (1)&nbsp;a Participant&#146;s rights will not be deemed to have been
impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant&#146;s rights, and (2)&nbsp;subject to the limitations of applicable law, if any, the
Board may amend the terms of any one or more Awards without the affected Participant&#146;s consent (A)&nbsp;to maintain the qualified status of the Award as an Incentive Stock Option under Section&nbsp;422 of the Code; (B)&nbsp;to change the terms
of an Incentive Stock Option, if such change results in impairment of the Award solely because it impairs the qualified status of the Award as an Incentive Stock Option under Section&nbsp;422 of the Code; (C)&nbsp;to clarify the manner of exemption
from, or to bring the Award into compliance with, Section&nbsp;409A of the Code; or (D)&nbsp;to comply with other applicable laws or listing requirements. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-2
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ix)</B>&nbsp;&nbsp;&nbsp;&nbsp;Generally, to exercise such powers and to
perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(x)</B>&nbsp;&nbsp;&nbsp;&nbsp;To adopt such procedures and <FONT STYLE="white-space:nowrap">sub-plans</FONT> as are necessary
or appropriate to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or
any Award Agreement that are required for compliance with the laws of the relevant foreign jurisdiction). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;Delegation to Committee.</B> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>General.</B> The Board may delegate some or all of the administration of the Plan to a
Committee or Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee,
including the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as
applicable). Any delegation of administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Committee may, at any time, abolish the
subcommittee and/or revest in the Committee any powers delegated to the subcommittee. The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers
previously delegated. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Section 162(m) and Rule
<FONT STYLE="white-space:nowrap">16b-3</FONT> Compliance.</B> The Committee may consist solely of two or more Outside Directors, in accordance with Section&nbsp;162(m) of the Code, or solely of two or more
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors, in accordance with Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Delegation to an Officer.</B> The Board may delegate to one or more Officers the authority to do one or both of the following: (i)&nbsp;designate Employees who are not Officers to be recipients
of Options and SARs (and, to the extent permitted by applicable law, other Stock Awards) and, to the extent permitted by applicable law, the terms of such Awards, and (ii)&nbsp;determine the number of shares of Common Stock to be subject to such
Stock Awards granted to such Employees; <I>provided, however</I>, that the Board resolutions regarding such delegation will specify the total number of shares of Common Stock that may be subject to the Stock Awards granted by such Officer and that
such Officer may not grant a Stock Award to himself or herself. Any such Stock Awards will be granted on the form of Award Agreement most recently approved for use by the Committee or the Board, unless otherwise provided in the resolutions approving
the delegation of authority. The Board may not delegate authority to an Officer who is acting solely in the capacity of an Officer (and not also as a Director) to determine the Fair Market Value pursuant to Section&nbsp;13(w)(iii) below. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Effect of Board&#146;s Decision.</B> All determinations, interpretations and constructions
made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>(f)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Repricing; Cancellation and <FONT STYLE="white-space:nowrap">Re-Grant</FONT> of Awards.</B> Neither the Board nor any Committee will have the authority to (i)&nbsp;reduce the exercise, purchase
or strike price of any outstanding Option or SAR under the Plan, or (ii)&nbsp;cancel any outstanding Option or SAR that has an exercise price or strike price greater than the then-current Fair Market Value of the Common Stock in exchange for cash or
other Awards under the Plan, unless the stockholders of the Company have approved such an action within 12 months prior to such an event. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>(g)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Minimum Vesting Requirements.</B> No Award may vest until at least twelve (12)&nbsp;months following the date of grant of the Award; <I>provided, however</I>, that shares of Common Stock up to
five percent (5%) of the Share Reserve (as defined in Section&nbsp;3(a)) may be issued pursuant to Awards which do not meet such vesting requirement. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(h)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Dividends and Dividend Equivalents. </B>Dividends or dividend equivalents may be paid or
credited, as applicable, with respect to any shares of Common Stock subject to an Award, as determined by the Board and contained in the applicable Award Agreement; <I>provided, however</I>, that (i)&nbsp;no dividends or dividend equivalents may be
paid with respect to any such shares before the date such shares have vested under the terms of such Award Agreement, (ii)&nbsp;any dividends or dividend equivalents that are credited with respect to any such shares will be subject to all of the
terms and conditions applicable to such shares under the terms of such Award Agreement (including, but not limited to, any vesting conditions), and (iii)&nbsp;any dividends or dividend equivalents that are credited with respect to any such shares
will be forfeited to the Company on the date, if any, such shares are forfeited to or repurchased by the Company due to a failure to meet any vesting conditions under the terms of such Award Agreement. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-3
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>3.&nbsp;&nbsp;&nbsp;&nbsp;S<SMALL>HARES</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL>
<SMALL>THE</SMALL> P<SMALL>LAN</SMALL>.</B> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;Share Reserve.</B> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;Subject to Sections 3(b)(i) and 9(a) relating to Capitalization Adjustments, the aggregate
number of shares of Common Stock that may be issued pursuant to Stock Awards from and after the Effective Date will not exceed (A) 73,953,064 shares (which number is the sum of (i)&nbsp;the number of shares (453,064) subject to the 2014 Plan&#146;s
Available Reserve, (ii)&nbsp;an additional 24,000,000 shares that were approved at the annual meeting of stockholders of the Company held in 2017, (iii) an additional 21,000,000 shares that were approved at the annual meeting of stockholders of the
Company held in 2020, and (iv)&nbsp;an additional 28,500,000 shares that were approved at the annual meeting of stockholders of the Company held in 2022), <I>plus</I> (B)&nbsp;the Prior Plans&#146; Returning Shares, if any, which become available
for issuance under this Plan from time to time (such aggregate number of shares described in (A)&nbsp;and (B) above, the &#147;<B><I>Share Reserve</I></B>&#148;). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;For clarity, the Share Reserve in this Section&nbsp;3(a) is a limitation on the number of
shares of Common Stock that may be issued pursuant to the Plan. Accordingly, this Section&nbsp;3(a) does not limit the granting of Stock Awards except as provided in Section&nbsp;7(a). Shares may be issued in connection with a merger or acquisition
as permitted by Nasdaq Listing Rule 5635(c) or, if applicable, NYSE Listed Company Manual Section&nbsp;303A.08, AMEX Company Guide Section&nbsp;711 or other applicable rule, and such issuance will not reduce the number of shares available for
issuance under the Plan. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;Subject to Section&nbsp;3(b), the number of shares of
Common Stock available for issuance under the Plan will be reduced by: (A)&nbsp;one share for each share of Common Stock issued pursuant to an Option or SAR with respect to which the exercise or strike price is at least 100% of the Fair Market Value
of the Common Stock subject to the Option or SAR on the date of grant; (B) 1.5 shares for each share of Common Stock issued pursuant to a Full Value Award granted under the Plan prior to May&nbsp;25, 2022; and (C)&nbsp;two shares for each share of
Common Stock issued pursuant to a Full Value Award granted under the Plan on or after May&nbsp;25, 2022. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;Reversion of Shares to the Share Reserve.</B> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Shares Available For Subsequent Issuance.</B><B> </B>If (A)&nbsp;any shares of Common Stock
subject to a Stock Award are not issued because such Stock Award or any portion thereof expires or otherwise terminates without all of the shares covered by such Stock Award having been issued or is settled in cash (<I>i.e.</I>, the Participant
receives cash rather than stock), (B) any shares of Common Stock issued pursuant to a Stock Award are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition required for the vesting of such shares,
or (C)&nbsp;with respect to a Full Value Award, any shares of Common Stock are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with such Full Value Award, such shares will again become
available for issuance under the Plan (collectively, the &#147;<B><I>2017 Plan Returning Shares</I></B>&#148;). For each (1) 2017 Plan Returning Share subject to a Full Value Award or (2)&nbsp;Prior Plans&#146; Returning Share subject to a stock
award other than a Prior Plans&#146; Appreciation Award, the number of shares of Common Stock available for issuance under the Plan will increase by (x) 1.5 shares for each such 2017 Plan Returning Share or Prior Plans&#146; Returning Share that
returns to the Plan prior to May&nbsp;25, 2022 and (y)&nbsp;two shares for each such 2017 Plan Returning Share or Prior Plans&#146; Returning Share that returns to the Plan on or after May&nbsp;25, 2022. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Shares Not Available For Subsequent Issuance. </B>Any shares of Common Stock reacquired or
withheld (or not issued) by the Company to satisfy the exercise or purchase price of a Stock Award or a Prior Plans&#146; Award will no longer be available for issuance under the Plan, including any shares subject to a Stock Award or a Prior
Plans&#146; Award that are not delivered to a Participant because such Stock Award or Prior Plans&#146; Award is exercised through a reduction of shares subject to such Stock Award or Prior Plans&#146; Award (<I>i.e</I>., &#147;net exercised&#148;).
In addition, any shares reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with an Option or Stock Appreciation Right or a Prior Plans&#146; Appreciation Award, or any shares repurchased by
the Company on the open market with the proceeds of the exercise or strike price of an Option or Stock Appreciation Right or a Prior Plans&#146; Appreciation Award will no longer be available for issuance under the Plan. In the event that a Stock
Appreciation Right or a Prior Plans&#146; Award that is a stock appreciation right is settled in shares of Common Stock, the gross number of shares of Common Stock subject to such award will no longer be available for issuance under the Plan.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Incentive Stock Option Limit. </B>Subject to the Share Reserve and
Section&nbsp;9(a) relating to Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options will be 50,000,000 shares of Common Stock. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-4
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Individual Award Limitations.</B> Subject
to the Share Reserve and Section&nbsp;9(a) relating to Capitalization Adjustments: </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;A maximum of 5,000,000 shares of Common Stock subject to Options, SARs and Other Stock Awards
whose value is determined by reference to an increase over an exercise or strike price of at least 100% of the Fair Market Value on the date any such Stock Award is granted may be granted to any one Participant during any one calendar year.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;A maximum of 5,000,000 shares of Common Stock subject to Performance Stock Awards
may be granted to any one Participant during any one calendar year (whether the grant, vesting or exercise is contingent upon the attainment during the Performance Period of the Performance Goals). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;A maximum of $10,000,000 subject to Performance Cash Awards may be granted to any one
Participant during any one calendar year. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Limitation on Grants to <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Directors. </B>The (i)&nbsp;maximum number of shares of Common Stock subject to Stock Awards granted under the Plan or otherwise during any one calendar year (beginning with the 2017 calendar year) to
any <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director, taken together with the (ii)&nbsp;cash fees paid by the Company to such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director during such calendar year, and in both cases for
service on the Board, will not exceed $750,000 in total value (calculating the value of any such Stock Awards based on the grant date fair value of such Stock Awards for financial reporting purposes), or, with respect to the calendar year in which a
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director is first appointed or elected to the Board, $1,500,000. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(f)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Source of Shares.</B> The stock issuable under the Plan will be shares of authorized but
unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>4.&nbsp;&nbsp;&nbsp;&nbsp;E<SMALL>LIGIBILITY</SMALL>.</B> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Eligibility for Specific Stock Awards.</B> Incentive Stock Options may be granted only to
employees of the Company or a &#147;parent corporation&#148; or &#147;subsidiary corporation&#148; thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code). Stock Awards other than Incentive Stock Options may be granted to
Employees, Directors and Consultants; <I>provided, however</I>, that Stock Awards may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#147;parent&#148; of the Company, as such term is defined
in Rule 405, unless (i)&nbsp;the stock underlying such Stock Awards is treated as &#147;service recipient stock&#148; under Section&nbsp;409A of the Code (for example, because the Stock Awards are granted pursuant to a corporate transaction such as
a spin off transaction) or (ii)&nbsp;the Company, in consultation with its legal counsel, has determined that such Stock Awards are otherwise exempt from or alternatively comply with the requirements of Section&nbsp;409A of the Code. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Ten Percent Stockholders.</B> A Ten Percent Stockholder will not be granted an Incentive
Stock Option unless the exercise price of such Option is at least 110% of the Fair Market Value on the date of grant and the Option is not exercisable after the expiration of five years from the date of grant. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>5.&nbsp;&nbsp;&nbsp;&nbsp;P<SMALL>ROVISIONS</SMALL> R<SMALL>ELATING</SMALL> <SMALL>TO</SMALL> O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL>
S<SMALL>TOCK</SMALL> A<SMALL>PPRECIATION</SMALL> R<SMALL>IGHTS</SMALL>.</B> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Each Option or Stock Appreciation Right
Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be separately designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are
issued, a separate certificate or certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. If an Option is not specifically designated as an Incentive Stock Option, or if an Option is designated as an
Incentive Stock Option but some portion or all of the Option fails to qualify as an Incentive Stock Option under the applicable rules, then the Option (or portion thereof) will be a Nonstatutory Stock Option. The provisions of separate Option or
Stock Appreciation Right Agreements need not be identical; <I>provided, however</I>, that each Award Agreement will conform to (through incorporation of provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of
each of the following provisions: </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Term.</B> Subject to the provisions of
Section&nbsp;4(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the expiration of seven years from the date of its grant or such shorter period specified in the Award Agreement. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Exercise Price.</B> Subject to the provisions of Section&nbsp;4(b) regarding Ten Percent
Stockholders, the exercise or strike price of each Option or SAR will be not less than 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Award is granted. Notwithstanding the foregoing, an Option or SAR
may be granted with an exercise or strike price lower than 100% of the Fair Market Value of the Common Stock subject to the Award on the date the Award is </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-5
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">
granted if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Transaction and in a manner consistent with the
provisions of Section&nbsp;409A of the Code and, if applicable, Section&nbsp;424(a) of the Code. Each SAR will be denominated in shares of Common Stock equivalents. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Purchase Price for Options.</B> The purchase price of Common Stock acquired pursuant to the
exercise of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below. The Board will have the authority to grant Options that
do not permit all of the following methods of payment (or that otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method of payment. The permitted methods of
payment are as follows: </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;by cash, check, bank draft or money order payable to the
Company; </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;pursuant to a program developed under Regulation T as promulgated by the
Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the
Company from the sales proceeds; </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;by delivery to the Company (either by actual
delivery or attestation) of shares of Common Stock; </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;if an Option is a Nonstatutory
Stock Option, by a &#147;net exercise&#148; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the
aggregate exercise price; <I>provided, however</I>, that the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of
whole shares to be issued. Shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that (A)&nbsp;shares issuable upon exercise are used to pay the exercise price pursuant to the &#147;net
exercise,&#148; (B) shares are delivered to the Participant as a result of such exercise, and (C)&nbsp;shares are withheld to satisfy tax withholding obligations; or </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;in any other form of legal consideration that may be acceptable to the Board and specified in
the applicable Award Agreement. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Exercise and Payment of a SAR.</B> To exercise
any outstanding SAR, the Participant must provide written notice of exercise to the Company in compliance with the provisions of the Award Agreement evidencing such SAR. The appreciation distribution payable on the exercise of a SAR will be not
greater than an amount equal to the excess of (A)&nbsp;the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant is vested
under such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B)&nbsp;the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such
date. The appreciation distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Award Agreement evidencing such SAR. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Transferability of Options and SARs.</B> The Board may, in its sole discretion, impose such
limitations on the transferability of Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the restrictions set forth in this Section&nbsp;5(e) on the transferability of Options and SARs
will apply. Notwithstanding the foregoing or anything in the Plan or an Award Agreement to the contrary, no Option or SAR may be transferred to any financial institution without prior stockholder approval. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Restrictions on Transfer.</B> An Option or SAR will not be transferable except by will or by
the laws of descent and distribution (and pursuant to Sections 5(e)(ii) and 5(e)(iii) below) and will be exercisable during the lifetime of the Participant only by the Participant. Subject to the foregoing paragraph, the Board may permit transfer of
the Option or SAR in a manner that is not prohibited by applicable tax and securities laws. Except as explicitly provided in the Plan, neither an Option nor a SAR may be transferred for consideration. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Domestic Relations Orders.</B> Subject to the approval of the Board or a duly authorized
Officer, an Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by Treasury Regulations
<FONT STYLE="white-space:nowrap">Section&nbsp;1.421-1(b)(2).</FONT> If an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Beneficiary Designation.</B> Subject to the approval of the Board or a duly authorized
Officer, a Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-6
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">
third party who, upon the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. In
the absence of such a designation, upon the death of the Participant, the executor or administrator of the Participant&#146;s estate will be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from
such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with the provisions of applicable laws. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(f)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Vesting Generally.</B> The total number of shares of Common Stock subject to an Option or
SAR may vest and become exercisable in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when it may or may not be exercised (which may be based on the
satisfaction of Performance Goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section&nbsp;5(f) are subject to Section&nbsp;2(g) and any Option or SAR
provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(g)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination of Continuous Service.</B> Except as otherwise provided in the applicable Award
Agreement or other written agreement between the Participant and the Company or an Affiliate, if a Participant&#146;s Continuous Service terminates (other than for Cause and other than upon the Participant&#146;s death or Disability), the
Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of
(i)&nbsp;the date three months following such termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the Award Agreement.
If, after such termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR (as applicable) will terminate. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(h)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Extension of Termination Date.</B> Except as otherwise provided in the applicable Award
Agreement or other written agreement between the Participant and the Company or an Affiliate,<B> </B>if the exercise of an Option or SAR following the termination of the Participant&#146;s Continuous Service (other than for Cause and other than upon
the Participant&#146;s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the
earlier of (i)&nbsp;the expiration of a total period of time (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#146;s Continuous Service during which the exercise of the
Option or SAR would not be in violation of such registration requirements, or (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement. In addition, unless otherwise provided in a Participant&#146;s
Award Agreement or other written agreement between the Participant and the Company or an Affiliate, if the sale of any Common Stock received upon exercise of an Option or SAR following the termination of the Participant&#146;s Continuous Service
(other than for Cause) would violate the Company&#146;s insider trading policy, then the Option or SAR will terminate on the earlier of (i)&nbsp;the expiration of a period of time (that need not be consecutive) equal to the applicable
post-termination exercise period after the termination of the Participant&#146;s Continuous Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the Company&#146;s insider trading
policy, or (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Disability of Participant.</B> Except as otherwise provided in the applicable Award
Agreement or other written agreement between the Participant and the Company or an Affiliate, if a Participant&#146;s Continuous Service terminates as a result of the Participant&#146;s Disability, the Participant may exercise his or her Option or
SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i)&nbsp;the date 12 months following such
termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after such termination of Continuous
Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR (as applicable) will terminate. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(j)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Death of Participant.</B> Except as otherwise provided in the applicable Award Agreement or
other written agreement between the Participant and the Company or an Affiliate, if (i)&nbsp;a Participant&#146;s Continuous Service terminates as a result of the Participant&#146;s death, or (ii)&nbsp;the Participant dies within the period (if any)
specified in the Award Agreement for exercisability after the termination of the Participant&#146;s Continuous Service (for a reason other than death), then the Participant&#146;s Option or SAR may be exercised (to the extent that the Participant
was entitled to exercise such Option or SAR as of the date of death) by the Participant&#146;s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR
upon the Participant&#146;s death, but only within such period of time ending </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-7
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">
on the earlier of (i)&nbsp;the date 18 months following the date of death (or such longer or shorter period specified in the Award Agreement), and (ii)&nbsp;the expiration of the term of such
Option or SAR as set forth in the Award Agreement. If, after the Participant&#146;s death, the Option or SAR (as applicable) is not exercised within the applicable time frame, the Option or SAR (as applicable) will terminate. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(k)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination for Cause.</B> Except as explicitly provided otherwise in a Participant&#146;s
Award Agreement or other individual written agreement between the Participant and the Company or an Affiliate, if a Participant&#146;s Continuous Service is terminated for Cause, the Participant&#146;s Option or SAR will terminate immediately upon
such termination of Continuous Service, and the Participant will be prohibited from exercising his or her Option or SAR from and after the time of such termination of Continuous Service. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(l)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Employees.</B> If an Option or SAR is
granted to an Employee who is a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock until at
least six months following the date of grant of the Option or SAR (although the Award may vest prior to such date). Consistent with the provisions of the Worker Economic Opportunity Act, (i)&nbsp;if such
<FONT STYLE="white-space:nowrap">non-exempt</FONT> employee dies or suffers a Disability, (ii)&nbsp;upon a Transaction in which such Option or SAR is not assumed, continued, or substituted, (iii)&nbsp;upon a Change in Control, or (iv)&nbsp;upon the
Participant&#146;s retirement (as such term may be defined in the Participant&#146;s Award Agreement, in another written agreement between the Participant and the Company or an Affiliate, or, if no such definition, in accordance with the
Company&#146;s or Affiliate&#146;s then current employment policies and guidelines), the vested portion of any Options and SARs may be exercised earlier than six&nbsp;months following the date of grant. The foregoing provision is intended to operate
so that any income derived by a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. To the extent permitted and/or required
for compliance with the Worker Economic Opportunity Act to ensure that any income derived by a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee in connection with the exercise, vesting or issuance of any shares under any other Stock Award
will be exempt from the employee&#146;s regular rate of pay, the provisions of this Section&nbsp;5(l) will apply to all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>6.&nbsp;&nbsp;&nbsp;&nbsp;P<SMALL>ROVISIONS</SMALL> <SMALL>OF</SMALL> A<SMALL>WARDS</SMALL> O<SMALL>THER</SMALL> <SMALL>THAN</SMALL>
O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL> SAR<SMALL>S</SMALL>.</B> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Restricted
Stock Awards.</B> Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate. To the extent consistent with the Company&#146;s bylaws, at the Board&#146;s election, shares of
Common Stock underlying a Restricted Stock Award may be (i)&nbsp;held in book entry form subject to the Company&#146;s instructions until any restrictions relating to the Restricted Stock Award lapse, or (ii)&nbsp;evidenced by a certificate, which
certificate will be held in such form and manner as determined by the Board. The terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need
not be identical. <I></I>Each Restricted Stock Award Agreement will conform to (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions: </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Consideration.</B> A Restricted Stock Award may be awarded in consideration for
(A)&nbsp;cash, check, bank draft or money order payable to the Company, (B)&nbsp;past services to the Company or an Affiliate, or (C)&nbsp;any other form of legal consideration (including future services) that may be acceptable to the Board, in its
sole discretion, and permissible under applicable law. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Vesting. </B>Subject to
Section&nbsp;2(g), shares of Common Stock awarded under the Restricted Stock Award Agreement may be subject to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination of Participant&#146;s Continuous Service.</B> If a Participant&#146;s
Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant that have not vested as of the date of such termination of Continuous
Service under the terms of the Restricted Stock Award Agreement. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Transferability.</B> Rights to acquire shares of Common Stock under the Restricted Stock
Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, so long as Common Stock awarded under the
Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement. Notwithstanding the foregoing or anything in the Plan or a Restricted Stock Award Agreement to the contrary, no Restricted Stock Award may be
transferred to any financial institution without prior stockholder approval. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-8
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Restricted Stock Unit Awards. </B>Each
Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time, and the terms and
conditions of separate Restricted Stock Unit Award Agreements need not be identical. Each Restricted Stock Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance
of each of the following provisions: </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Consideration.</B> At the time of grant of
a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid (if any) by the
Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Vesting. </B>Subject to Section&nbsp;2(g), at the time of the grant of a Restricted Stock
Unit Award, the Board may impose such restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Payment</B><B>.</B> A Restricted Stock Unit Award may be settled by the delivery of shares
of Common Stock, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Additional Restrictions. </B>At the time of the grant of a Restricted Stock Unit Award, the
Board, as it deems appropriate, may impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted Stock Unit Award to a time after the vesting of such Restricted Stock
Unit Award. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination of Participant</B><B>&#146;</B><B>s Continuous Service.
</B>Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement or other written agreement between the Participant and the Company or an Affiliate, such portion of the Restricted Stock Unit Award that has not vested will be
forfeited upon the Participant&#146;s termination of Continuous Service. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;Performance
Awards.</B> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Performance Stock Awards.</B> A Performance Stock Award is a Stock
Award (covering a number of shares not in excess of that set forth in Section&nbsp;3(d)(ii)) that is payable (including that may be granted, vest or be exercised) contingent upon the attainment during a Performance Period of certain Performance
Goals. A Performance Stock Award may, but need not, require the Participant&#146;s completion of a specified period of Continuous Service. Subject to Section&nbsp;2(g), the length of any Performance Period, the Performance Goals to be achieved
during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined by the Committee (or, if not required for compliance with Section&nbsp;162(m) of the Code, the
Board or the Committee), in its sole discretion. In addition, to the extent permitted by applicable law and the applicable Award Agreement, the Board may determine that cash may be used in payment of Performance Stock Awards. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Performance Cash Awards.</B> A Performance Cash Award is a cash award (for a dollar value
not in excess of that set forth in Section&nbsp;3(d)(iii)) that is payable contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Cash Award may, but need not, require the Participant&#146;s completion
of a specified period of Continuous Service. Subject to Section&nbsp;2(g), the length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals
have been attained will be conclusively determined by the Committee (or, if not required for compliance with Section&nbsp;162(m) of the Code, the Board or the Committee), in its sole discretion. The Board may specify the form of payment of
Performance Cash Awards, which may be cash or other property, or may provide for a Participant to have the option for his or her Performance Cash Award, or such portion thereof as the Board may specify, to be paid in whole or in part in cash or
other property. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Committee and Board Discretion.</B> The Committee (or, if not
required for compliance with Section&nbsp;162(m) of the Code, the Board or the Committee) retains the discretion to reduce or eliminate the compensation or economic benefit due upon the attainment of any Performance Goals and to define the manner of
calculating the Performance Criteria it selects to use for a Performance Period. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Section 162(m) Compliance.</B> Unless otherwise permitted in compliance with
Section&nbsp;162(m) of the Code with respect to an Award intended to qualify as &#147;performance-based compensation&#148; thereunder, the Committee will establish the Performance Goals applicable to, and the formula for calculating the amount
payable under, the Award no later than the earlier of (A)&nbsp;the date 90 days after the commencement of the applicable Performance Period, and (B)&nbsp;the date on which </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-9
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">
25% of the Performance Period has elapsed, and in any event at a time when the achievement of the applicable Performance Goals remains substantially uncertain. Prior to the payment of any
compensation under an Award intended to qualify as &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code, the Committee will certify the extent to which any Performance Goals and any other material terms under such Award
have been satisfied (other than in cases where the Performance Goals relate solely to the increase in the value of the Common Stock). Notwithstanding satisfaction or any completion of any Performance Goals, shares subject to Options, cash or other
benefits granted, issued, retainable and/or vested under an Award on account of satisfaction of such Performance Goals may be reduced by the Committee on the basis of any further considerations as the Committee, in its sole discretion, will
determine. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Section 162(m) Transition Relief.</B> Notwithstanding anything in the
Plan to the contrary, any provision in the Plan that refers to &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code will only apply to any Award that is intended to qualify, and is eligible to qualify, as
&#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code pursuant to the transition relief provided by the Tax Cuts and Jobs Act (the &#147;<B><I>TCJA</I></B>&#148;) for remuneration provided pursuant to a written binding
contract which was in effect on November 2, 2017 and which was not modified in any material respect on or after such date, as determined by the Board, in its sole discretion, in accordance with the TCJA and any applicable guidance, rulings or
regulations issued by the U.S. Department of the Treasury, the Internal Revenue Service or any other governmental authority. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Other Stock Awards</B><B>.</B> Other forms of Stock Awards valued in whole or in part by reference to, or otherwise based on, Common Stock may be granted either alone or in addition to Stock
Awards granted under Section&nbsp;5 and this Section&nbsp;6. Subject to the provisions of the Plan (including, but not limited to, Sections 2(g) and 2(h)), the Board will have sole and complete authority to determine the persons to whom and the time
or times at which such Other Stock Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other terms and conditions of such Other Stock Awards.
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>7.&nbsp;&nbsp;&nbsp;&nbsp;C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>.</B> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Availability of Shares.</B> The Company will keep available at all times the number of
shares of Common Stock reasonably required to satisfy then-outstanding Stock Awards. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Securities Law Compliance.</B> The Company will seek to obtain from each regulatory
commission or agency having jurisdiction over the Plan the authority required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards; <I>provided, however</I>, that this undertaking will not require the
Company to register under the Securities Act the Plan, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such
regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock
upon exercise of such Stock Awards unless and until such authority is obtained. A Participant will not be eligible for the grant of an Award or the subsequent issuance of cash or Common Stock pursuant to the Award if such grant or issuance would be
in violation of any applicable securities law. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>No Obligation to Notify or
Minimize Taxes. </B>The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising a Stock Award. Furthermore, the Company will have no duty or obligation to warn or otherwise advise such
holder of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>8.&nbsp;&nbsp;&nbsp;&nbsp;M<SMALL>ISCELLANEOUS</SMALL>.</B> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Use of Proceeds from Sales of Common Stock. </B>Proceeds from the sale of shares of Common
Stock issued pursuant to Stock Awards will constitute general funds of the Company. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Corporate Action Constituting Grant of Awards.</B> Corporate action constituting a grant by
the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to,
or actually received or accepted by, the Participant. In the event that the corporate records (<I>e.g</I>., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (<I>e.g</I>., exercise price,
vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-10
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">
clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect terms
in the Award Agreement or related grant documents. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Stockholder Rights.</B> No
Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to an Award unless and until (i)&nbsp;such Participant has satisfied all requirements for exercise of, or
the issuance of shares of Common Stock under, the Award pursuant to its terms, and (ii)&nbsp;the issuance of the Common Stock subject to such Award has been entered into the books and records of the Company. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>No Employment or Other Service Rights.</B> Nothing in the Plan, any Award Agreement or any
other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or
will affect the right of the Company or an Affiliate to terminate (i)&nbsp;the employment of an Employee with or without notice and with or without cause, (ii)&nbsp;the service of a Consultant pursuant to the terms of such Consultant&#146;s
agreement with the Company or an Affiliate, or (iii)&nbsp;the service of a Director pursuant to the bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is
incorporated, as the case may be. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Change in Time Commitment.</B> In the event a
Participant&#146;s regular level of time commitment in the performance of his or her services for the Company or any Affiliate is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a
change in status from a full-time Employee to a part-time Employee) after the date of grant of any Award to the Participant, the Board has the right in its sole discretion to (x)&nbsp;make a corresponding reduction in the number of shares or cash
amount subject to any portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (y)&nbsp;in lieu of or in combination with such a reduction, extend the vesting or payment schedule
applicable to such Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced or extended. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(f)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Incentive Stock Option Limitations.</B> To the extent that the aggregate Fair Market Value
(determined at the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or
such other limit established in the Code) or otherwise does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not
comply with such rules will be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(g)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Investment Assurances.</B> The Company may require a Participant, as a condition of
exercising or acquiring Common Stock under any Award, (i)&nbsp;to give written assurances satisfactory to the Company as to the Participant&#146;s knowledge and experience in financial and business matters and/or to employ a purchaser representative
reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the
Award; and (ii)&nbsp;to give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Award for the Participant&#146;s own account and not with any present intention of selling or otherwise
distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A)&nbsp;the issuance of the shares upon the exercise or acquisition of Common Stock under the Stock Award has
been registered under a then currently effective registration statement under the Securities Act, or (B)&nbsp;as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the
circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with
applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(h)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Withholding Obligations.</B> Unless prohibited by the terms of an Award Agreement, the
Company may, in its sole discretion, satisfy any federal, state, local or foreign tax withholding obligation relating to an Award by any of the following means or by a combination of such means: (i)&nbsp;causing the Participant to tender a cash
payment; (ii)&nbsp;withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Stock Award, provided that notwithstanding anything to the contrary in the terms of an Award
Agreement, the Company will have the discretion to determine the basis upon which the number of shares to be withheld will be calculated; <I>provided, however, </I>that no shares of Common Stock are withheld with a value exceeding the maximum amount
of tax that may be required to be withheld by law (or such other amount as may be permitted while still avoiding classification of the Stock Award as a liability for financial accounting purposes); (iii) withholding cash from an Award settled in
cash; (iv)&nbsp;withholding payment from any amounts otherwise payable to the Participant; or (v)&nbsp;by such other method as may be set forth in the Award Agreement. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-11
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Electronic Delivery.</B> Any reference
herein to a &#147;written&#148; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#146;s intranet (or other shared
electronic medium controlled by the Company to which the Participant has access). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(j)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Deferrals.</B> To the extent permitted by applicable law, the Board, in its sole discretion,
may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish programs and procedures for deferral elections to be made by
Participants. Deferrals by Participants will be made in accordance with Section&nbsp;409A of the Code. Consistent with Section&nbsp;409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise
providing services to the Company or an Affiliate. The Board is authorized to make deferrals of Awards and determine when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the
Participant&#146;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(k)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Compliance with Section</B><B></B><B>&nbsp;409A of the Code. </B>Unless otherwise expressly
provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section&nbsp;409A of the Code, and, to the extent not
so exempt, in compliance with Section&nbsp;409A of the Code. To the extent that the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section&nbsp;409A of the Code, the Award Agreement evidencing such
Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section&nbsp;409A(a)(1) of the Code, and, to the extent applicable, the Plan and Award Agreements will be interpreted in accordance with the
requirements of Section&nbsp;409A of the Code. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded and a Participant holding an
Award that constitutes &#147;deferred compensation&#148; under Section&nbsp;409A of the Code is a &#147;specified employee&#148; for purposes of Section&nbsp;409A of the Code, no distribution or payment of any amount will be made upon a
&#147;separation from service&#148; before a date that is six&nbsp;months following the date of such Participant&#146;s &#147;separation from service&#148; (as defined in Section&nbsp;409A of the Code without regard to alternative definitions
thereunder) or, if earlier, the date of the Participant&#146;s death, unless such distribution or payment may be made in a manner that complies with Section&nbsp;409A of the Code. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(l)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Clawback/Recovery.</B> All Awards granted under the Plan will be subject to recoupment in
accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#146;s securities are listed or as is otherwise required by the
Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law, and any other clawback policy that the Company adopts. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement
as the Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause. No recovery of compensation under
such a clawback policy will be an event giving rise to a right to resign for &#147;good reason&#148; or &#147;constructive termination&#148; (or similar term) under any agreement with the Company or an Affiliate. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>9.&nbsp;&nbsp;&nbsp;&nbsp;A<SMALL>DJUSTMENTS</SMALL> <SMALL>UPON</SMALL> C<SMALL>HANGES</SMALL> <SMALL>IN</SMALL> C<SMALL>OMMON</SMALL>
S<SMALL>TOCK</SMALL>; O<SMALL>THER</SMALL> C<SMALL>ORPORATE</SMALL> E<SMALL>VENTS</SMALL>.</B> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Capitalization Adjustments.</B> In the event of a Capitalization Adjustment, the Board will
appropriately and proportionately adjust: (i)&nbsp;the class(es) and maximum number of securities subject to the Plan pursuant to Section&nbsp;3(a), (ii) the class(es) and maximum number of securities that may be issued pursuant to the exercise of
Incentive Stock Options pursuant to Section&nbsp;3(c), (iii) the class(es) and maximum number of securities that may be awarded to any person pursuant to Section&nbsp;3(d), and (iv)&nbsp;the class(es) and number of securities and price per share of
stock subject to outstanding Stock Awards. The Board will make such adjustments, and its determination will be final, binding and conclusive. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Dissolution or Liquidation.</B> Except as otherwise provided in the Stock Award Agreement or
any other written agreement between the Company or any Affiliate and the Participant, in the event of a dissolution or liquidation of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of
Common Stock not subject to a forfeiture condition or the Company&#146;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the shares of Common Stock subject to the Company&#146;s
repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous Service. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-12
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Transaction.</B> The provisions of this
Section&nbsp;9(c) will apply to Stock Awards in the event of a Transaction unless otherwise provided in the instrument evidencing the Stock Award or any other written arrangement between the Company or any Affiliate and the Participant or in any
director compensation policy of the Company. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Stock Awards May Be Assumed.</B> In
the event of a Transaction, any surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#146;s parent company) may assume or continue any or all Stock Awards outstanding under the Plan or may substitute similar
stock awards for Stock Awards outstanding under the Plan (including but not limited to, awards to acquire the same consideration paid to the stockholders of the Company pursuant to the Transaction), and any reacquisition or repurchase rights held by
the Company in respect of Common Stock issued pursuant to Stock Awards may be assigned by the Company to the successor of the Company (or the successor&#146;s parent company, if any), in connection with such Transaction. A surviving corporation or
acquiring corporation (or its parent) may choose to assume or continue only a portion of a Stock Award or substitute a similar stock award for only a portion of a Stock Award, or may choose to assume or continue, or substitute similar stock awards
for, the Stock Awards held by some, but not all Participants. The terms of any assumption, continuation or substitution will be set by the Board. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Stock Awards Held by Current Participants.</B> In the event of a Transaction in which the
surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding Stock Awards or substitute similar stock awards for such outstanding Stock Awards, then with respect to Stock Awards that have not
been assumed, continued or substituted and that are held by Participants whose Continuous Service has not terminated prior to the effective time of the Transaction (referred to as the &#147;<B><I>Current Participants</I></B>&#148;), the vesting of
such Stock Awards (and, with respect to Options and Stock Appreciation Rights, the time when such Stock Awards may be exercised) will be accelerated in full (and with respect to any such Stock Awards that are subject to performance-based vesting
conditions or requirements, vesting will be deemed to be satisfied at the target level of performance) to a date prior to the effective time of such Transaction (contingent upon the effectiveness of the Transaction) as the Board will determine (or,
if the Board does not determine such a date, to the date that is five days prior to the effective time of the Transaction), and such Stock Awards will terminate if not exercised (if applicable) at or prior to the effective time of the Transaction,
and any reacquisition or repurchase rights held by the Company with respect to such Stock Awards will lapse (contingent upon the effectiveness of the Transaction). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Stock Awards Held by Current Participants in Certain Control Acquisitions.</B> In the
event of a Control Acquisition that was not approved by the Board prior to the consummation of such transaction, then with respect to Stock Awards that are held by Current Participants, the vesting of such Stock Awards (and, with respect to Options
and Stock Appreciation Rights, the time when such Stock Awards may be exercised) will be accelerated in full (and with respect to any such Stock Awards that are subject to performance-based vesting conditions or requirements, vesting will be deemed
to be satisfied at the target level of performance) to a date prior to the effective time of such Control Acquisition (contingent upon the effectiveness of the Control Acquisition) as the Board will determine (or, if the Board does not determine
such a date, to the date that is five days prior to the effective time of the Control Acquisition) and any reacquisition or repurchase rights held by the Company with respect to such Stock Awards will lapse (contingent upon the effectiveness of the
Control Acquisition). </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Stock Awards Held by Persons other than Current
Participants.</B> In the event of a Transaction in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding Stock Awards or substitute similar stock awards for such outstanding
Stock Awards, then with respect to Stock Awards that have not been assumed, continued or substituted and that are held by persons other than Current Participants, such Stock Awards will terminate if not exercised (if applicable) prior to the
effective time of the Transaction; <I>provided</I>, <I>however</I>, that any reacquisition or repurchase rights held by the Company with respect to such Stock Awards will not terminate and may continue to be exercised notwithstanding the
Transaction. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Payment for Stock Awards in Lieu of Exercise.</B> Notwithstanding
the foregoing, in the event a Stock Award will terminate if not exercised prior to the effective time of a Transaction, the Board may provide that the holder of such Stock Award may not exercise such Stock Award but instead will receive a payment,
in such form as may be determined by the Board, equal in value to the excess, if any, of (A)&nbsp;the value of the property the Participant would have received upon the exercise of the Stock Award immediately prior to the effective time of the
Transaction, over (B)&nbsp;any exercise price payable by such holder in connection with such exercise. For clarity, this payment may be zero if the value of the property is equal to or less than the exercise price. Payments under this provision may
be delayed to the same extent that payment of consideration to the holders of the Company&#146;s Common Stock in connection with the Transaction is delayed as a result of escrows, earn outs, holdbacks or any other contingencies. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-13
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Change in Control.</B> The provisions of
this Section&nbsp;9(d) will apply to Stock Awards in the event of a Change in Control unless otherwise provided in the instrument evidencing the Stock Award or any other written arrangement between the Company or any Affiliate and the Participant or
in any director compensation policy of the Company. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;If a Change in Control occurs
and within one month before, as of, or within thirteen months after, the effective time of such Change in Control a Participant&#146;s Continuous Service terminates due to an involuntary termination (not including death or Disability) without Cause
or due to a voluntary termination with Good Reason, then the vesting of such Stock Awards (and, with respect to Options and Stock Appreciation Rights, the time when such Stock Awards may be exercised) will be accelerated in accordance with the
vesting schedule applicable to such Stock Awards as if (A)&nbsp;with respect to any such Stock Awards that are subject to vesting conditions or requirements based solely on such Participant&#146;s Continuous Service, such Participant&#146;s
Continuous Service had continued for twelve months following the date of termination of Continuous Service, and (B)&nbsp;with respect to any such Stock Awards that are subject to performance-based vesting conditions or requirements, vesting has been
satisfied at the target level of performance. Such vesting acceleration will occur on the date of termination of such Participant&#146;s Continuous Service, or if later, the effective date of the Change in Control (if the Participant&#146;s
termination of Continuous Service occurs prior to the Change in Control). </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;If any
payment or benefit a Participant will or may receive from the Company or otherwise (a &#147;<B><I>280G</I></B> <B><I>Payment</I></B>&#148;) would (i)&nbsp;constitute a &#147;parachute payment&#148; within the meaning of Section&nbsp;280G of the
Code, and (ii)&nbsp;but for this sentence, be subject to the excise tax imposed by Section&nbsp;4999 of the Code (the &#147;<B><I>Excise Tax</I></B>&#148;), then any such 280G Payment (a &#147;<B><I>Payment</I></B>&#148;) will be equal to the
Reduced Amount. The &#147;Reduced Amount&#148; will be either (x)&nbsp;the largest portion of the Payment that would result in no portion of the Payment (after reduction) being subject to the Excise Tax or (y)&nbsp;the largest portion, up to and
including the total, of the Payment, whichever amount (<I>i.e</I>., the amount determined by clause (x)&nbsp;or by clause (y)), after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all
computed at the highest applicable marginal rate), results in the Participant&#146;s receipt, on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may
be subject to the Excise Tax. If a reduction in a Payment is required pursuant to the preceding sentence and the Reduced Amount is determined pursuant to clause (x)&nbsp;of the preceding sentence, the reduction will occur in the manner (the
&#147;<B><I>Reduction Method</I></B>&#148;) that results in the greatest economic benefit for the Participant. If more than one method of reduction will result in the same economic benefit, the items so reduced will be reduced pro rata (the
&#147;<B><I>Pro Rata Reduction Method</I></B>&#148;). </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Notwithstanding any provision of the foregoing paragraph to the
contrary, if the Reduction Method or the Pro Rata Reduction Method would result in any portion of the Payment being subject to taxes pursuant to Section&nbsp;409A of the Code that would not otherwise be subject to taxes pursuant to Section&nbsp;409A
of the Code, then the Reduction Method and/or the Pro Rata Reduction Method, as the case may be, will be modified so as to avoid the imposition of taxes pursuant to Section&nbsp;409A of the Code as follows: (A)&nbsp;as a first priority, the
modification will preserve to the greatest extent possible, the greatest economic benefit for the Participant as determined on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis; (B)&nbsp;as a second priority, Payments that are contingent on
future events (<I>e.g</I>., being terminated without Cause), will be reduced (or eliminated) before Payments that are not contingent on future events; and (C)&nbsp;as a third priority, Payments that are &#147;deferred compensation&#148; within the
meaning of Section&nbsp;409A of the Code will be reduced (or eliminated) before Payments that are not deferred compensation within the meaning of Section&nbsp;409A of the Code. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If a Participant receives a Payment for which the Reduced Amount was determined pursuant to clause (x)&nbsp;of the first
paragraph of this Section&nbsp;9(d)(ii) and the Internal Revenue Service determines thereafter that some portion of the Payment is subject to the Excise Tax, the Participant agrees to promptly return to the Company a sufficient amount of the Payment
(after reduction pursuant to clause (x)&nbsp;of the first paragraph of this Section&nbsp;9(d)(ii)) so that no portion of the remaining Payment is subject to the Excise Tax. For the avoidance of doubt, if the Reduced Amount was determined pursuant to
clause (y)&nbsp;of the first paragraph of this Section&nbsp;9(d)(ii), the Participant will have no obligation to return any portion of the Payment pursuant to the preceding sentence. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Unless the Participant and the Company agree on an alternative accounting firm or law firm, the accounting firm engaged by the
Company for general tax compliance purposes as of the day prior to the effective date of the Change in Control will perform the foregoing calculations. If the accounting firm so engaged by the Company is serving as accountant or auditor for the
individual, entity or group effecting the Change in Control, the Company will appoint a nationally recognized accounting or law firm to make the determinations required hereunder. The Company will bear all expenses with respect to the determinations
by such accounting or law firm required to be made hereunder. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Company will use commercially reasonable efforts to
cause the accounting or law firm engaged to make the determinations hereunder to provide its calculations, together with detailed supporting documentation, to the Participant </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-14
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">
and the Company within 15 calendar days after the date on which the Participant&#146;s right to a 280G Payment becomes reasonably likely to occur (if requested at that time by the Participant or
the Company) or such other time as requested by the Participant or the Company. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>10.&nbsp;&nbsp;T<SMALL>ERMINATION</SMALL>
<SMALL>OR</SMALL> S<SMALL>USPENSION</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>.</B> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination or Suspension.</B> The Board may suspend or terminate the Plan at any time. No
Incentive Stock Option will be granted after<B> </B>the tenth anniversary of the earlier of (i)&nbsp;the date the Plan is adopted by the Board, or (ii)&nbsp;the date the Plan is approved by the stockholders of the Company. No Awards may be granted
under the Plan while the Plan is suspended or after it is terminated. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>No
Impairment of Rights. </B>Suspension or termination of the Plan will not materially impair rights and obligations under any Award granted while the Plan is in effect except with the written consent of the affected Participant or as otherwise
permitted in the Plan. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>11.&nbsp;&nbsp;E<SMALL>FFECTIVE</SMALL> D<SMALL>ATE</SMALL> <SMALL>OF</SMALL> P<SMALL>LAN</SMALL>.</B>
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">This Plan will become effective on the Effective Date. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>12.&nbsp;&nbsp;C<SMALL>HOICE</SMALL> <SMALL>OF</SMALL> L<SMALL>AW</SMALL>.</B> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The laws of the State of California will govern all questions concerning the construction, validity and interpretation of this
Plan, without regard to that state&#146;s conflict of laws rules. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>13.&nbsp;&nbsp;D<SMALL>EFINITIONS</SMALL>. </B></FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">As used in the Plan, the following definitions will apply to the capitalized terms indicated below:</FONT><FONT STYLE="font-family:Calibri; font-size:12pt" COLOR="#3f3f3f"> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp; &#147;<B><I>Affiliate</I></B>&#148; means, at the time of determination, any
&#147;parent&#148; or &#147;subsidiary&#148; of the Company as such terms are defined in Rule 405. The Board will have the authority to determine the time or times at which &#147;parent&#148; or &#147;subsidiary&#148; status is determined within the
foregoing definition. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Award</I></B>&#148; means a Stock Award or a
Performance Cash Award. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Award Agreement</I></B>&#148; means a written
agreement between the Company and a Participant evidencing the terms and conditions of an Award. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Company. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Capitalization Adjustment</I></B>&#148; means any change that is made in, or other
events that occur with respect to, the Common Stock subject to the Plan or subject to any Stock Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization,
reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar
equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible
securities of the Company will not be treated as a Capitalization Adjustment. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(f)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Cause</I></B>&#148;<B><I> </I></B>will have the meaning ascribed to such term in
any written agreement between the Participant and the Company or an Affiliate defining such term and, in the absence of such agreement, such term will mean, with respect to a Participant, the occurrence of any of the following events: (i)&nbsp;such
Participant&#146;s conviction of, or plea of no contest with respect to, any crime involving fraud, dishonesty or moral turpitude; (ii)&nbsp;such Participant&#146;s attempted commission of or participation in a fraud or act of dishonesty against the
Company or an Affiliate that results in (or might have reasonably resulted in) material harm to the business of the Company or an Affiliate; (iii)&nbsp;such Participant&#146;s intentional, material violation of any contract or agreement between the
Participant and the Company or an Affiliate, or any statutory duty the Participant owes to the Company or an Affiliate; or (iv)&nbsp;such Participant&#146;s conduct that constitutes gross misconduct, insubordination, incompetence or habitual neglect
of duties and that results in (or might have reasonably resulted in) material harm to the business of the Company or an Affiliate. The determination that a termination of a Participant&#146;s Continuous Service is for Cause will not be made unless
and until there will have been delivered to such Participant a copy of a resolution duly adopted by the affirmative vote of at least a majority of the Board at a meeting of the Board called and held for such purpose (after reasonable notice to such
Participant and an opportunity for such Participant, together with such Participant&#146;s counsel, </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-15
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">
to be heard before the Board), finding that in the good faith opinion of the Board, such Participant was guilty of the conduct constituting &#147;Cause&#148; and specifying the particulars. Any
determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant will have no effect upon any determination of the rights or obligations of
the Company or an Affiliate or such Participant for any other purpose. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(g)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Change in Control</I></B>&#148; means the consummation, in a single transaction or
in a series of related transactions, of any one or more of the following events: </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;a
sale, lease or other disposition of all or substantially all of the assets of the Company; </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;an acquisition by any Exchange Act Person of the beneficial ownership (within the meaning of
Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act, or comparable successor rule) of securities of the Company representing at least 50% of the combined voting power entitled to vote in the election of Directors
other than by virtue of a merger, consolidation or similar transaction; </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;a merger,
consolidation or similar transaction in which the Company is not the surviving corporation; or </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;a reverse merger, consolidation or similar transaction in which the Company is the surviving
corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted by virtue of the merger, consolidation or similar transaction into other property, whether in the form of
securities, cash or otherwise. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Notwithstanding the foregoing definition or any other provision of this Plan, the term
Change in Control will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(h)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Code</I></B>&#148; means the Internal Revenue Code of 1986, as amended, including
any applicable regulations and guidance thereunder. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Committee</I></B>&#148; means a committee of one or more Directors to whom
authority has been delegated by the Board in accordance with Section&nbsp;2(c). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(j)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Common Stock</I></B>&#148; means the common stock of the Company. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(k)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Company</I></B>&#148; means Exelixis, Inc., a Delaware corporation. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(l)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Consultant</I></B>&#148; means any person, including an advisor, who is
(i)&nbsp;engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii)&nbsp;serving as a member of the board of directors of an Affiliate and is compensated for such services. However,
service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#147;Consultant&#148; for purposes of the Plan.<B><I> </I></B>Notwithstanding the foregoing, a person is treated as a Consultant under
this Plan only if a Form <FONT STYLE="white-space:nowrap">S-8</FONT> Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#146;s securities to such person. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(m)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Continuous Service</I></B>&#148; means that the Participant&#146;s service with the
Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Director or Consultant or a
change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#146;s service with the Company or an Affiliate, will not terminate a Participant&#146;s Continuous
Service; <I>provided, however,</I> that<I> </I>if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#146;s Continuous Service will be
considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of
Continuous Service. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#146;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i)&nbsp;any
leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii)&nbsp;transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a
leave of absence will be treated as Continuous Service for purposes of vesting in a Stock Award only to such extent as may be provided in the Company&#146;s or Affiliate&#146;s leave of absence policy, in the written terms of any leave of absence
agreement or policy applicable to the Participant, or as otherwise required by law. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-16
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(n)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Corporate
Transaction</I></B>&#148; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events: </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;a sale, lease or other disposition of all or substantially all of the assets of the Company;
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;an acquisition by any Exchange Act Person of the beneficial ownership (within the
meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act, or comparable successor rule) of securities of the Company representing at least 50% of the combined voting power entitled to vote in the election of
Directors (a &#147;<B><I>Control Acquisition</I></B>&#148;); </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;a merger,
consolidation or similar transaction in which the Company is not the surviving corporation; or </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;a reverse merger, consolidation or similar transaction in which the Company is the surviving
corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted by virtue of the merger, consolidation or similar transaction into other property, whether in the form of
securities, cash or otherwise. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Notwithstanding the foregoing definition or any other provision of this Plan, the
terms Corporate Transaction and Control Acquisition will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(o)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Covered Employee</I></B>&#148; will have the meaning provided in
Section&nbsp;162(m)(3) of the Code. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(p)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Director</I></B>&#148; means a
member of the Board. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(q)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Disability</I></B>&#148; means, with respect to a
Participant, the inability of such Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last
for a continuous period of not less than 12 months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(r)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Effective Date</I></B>&#148; means the effective date of this Plan
document, which is the date of the annual meeting of stockholders of the Company held in 2017, provided this Plan is approved by the Company&#146;s stockholders at such meeting. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(s)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Employee</I></B>&#148; means any person employed by the Company or an Affiliate.
However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#147;Employee&#148; for purposes of the Plan. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(t)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Entity</I></B>&#148; means a corporation, partnership, limited liability company or
other entity. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(u)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange
Act of 1934, as amended, and the rules and regulations promulgated thereunder. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Exchange Act Person</I></B>&#148;<B><I> </I></B>means any natural person, Entity or
&#147;group&#148; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act), except that &#147;Exchange Act Person&#148; will not include (i)&nbsp;the Company or any Subsidiary of the Company, (ii)&nbsp;any employee benefit plan of the
Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii)&nbsp;an underwriter temporarily holding securities pursuant to an
offering of such securities, (iv)&nbsp;an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v)&nbsp;any natural person, Entity or
&#147;group&#148; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of
the Company&#146;s then outstanding securities. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(w)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Fair Market
Value</I></B>&#148; means, as of any date, the value of the Common Stock determined as follows: </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;If the Common Stock is listed on any established stock exchange or traded on any established
market, the Fair Market Value of a share of Common Stock will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in
the Common Stock) on the date of determination, as reported in a source the Board deems reliable. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided by the Board, if there is no closing sales price for the Common
Stock on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;In the absence of such markets for the Common Stock, the Fair Market Value will be determined
by the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-17
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(x)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Full Value Award</I></B>&#148;
means a Stock Award that is not an Option or SAR with respect to which the exercise or strike price is at least 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date of grant. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(y)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Good Reason</I></B>&#148; means that one or more of the following are undertaken by
the Company or an Affiliate without the Participant&#146;s express written consent: </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;reduction of such Participant&#146;s rate of compensation as in effect immediately prior to a
Change in Control by greater than 10%, except to the extent the compensation of other similarly situated persons are accordingly reduced; </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;failure to provide a package of welfare benefit plans that, taken as a whole, provide substantially similar benefits to those in which such Participant is entitled to participate immediately prior
to a Change in Control (except that such Participant&#146;s contributions may be raised to the extent of any cost increases imposed by third parties) or any action by the Company or an Affiliate that would adversely affect such Participant&#146;s
participation or reduce such Participant&#146;s benefits under any of such plans; </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;a change in such Participant&#146;s responsibilities, authority, titles or offices resulting
in diminution of position, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith that is remedied by the Company or an Affiliate promptly after notice thereof is given by such person; </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;a request that such Participant relocate to a worksite that is more than 50 miles from such
Participant&#146;s prior worksite, unless such person accepts such relocation opportunity; </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;a material reduction in duties; </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(vi)</B>&nbsp;&nbsp;&nbsp;&nbsp;a failure or refusal of any successor company to assume the obligations of the Company or an
Affiliate under an agreement with such Participant; or </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(vii)</B>&nbsp;&nbsp;&nbsp;&nbsp;a material breach by the
Company or an Affiliate of any of the material provisions of an agreement with such Participant. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Notwithstanding the
foregoing, a Participant will have &#147;Good Reason&#148; for his or her resignation only if: (a)&nbsp;such Participant notifies the Company in writing, within 30&nbsp;days after the occurrence of one of the foregoing event(s), specifying the
event(s) constituting Good Reason and that he or she intends to terminate his or her employment no earlier than 30 days after providing such notice; (b)&nbsp;the Company does not cure such condition within 30&nbsp;days following its receipt of such
notice or states unequivocally in writing that it does not intend to attempt to cure such condition; and (c)&nbsp;the Participant resigns from employment within 30&nbsp;days following the end of the period within which the Company was entitled to
remedy the condition constituting Good Reason but failed to do so. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(z)</B>&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<B><I>Incentive Stock Option</I></B>&#148; means an option granted pursuant to Section&nbsp;5 that is intended to be, and that qualifies as, an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Code. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(aa)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director</I></B>&#148;<B>
</B>means a Director who either (i)&nbsp;is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in
any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated pursuant to the Securities Act (&#147;<B><I>Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT></I></B>&#148;)), does not possess an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> and is not engaged in a
business relationship for which disclosure would be required pursuant to Item&nbsp;404(b) of Regulation <FONT STYLE="white-space:nowrap">S-K;</FONT> or (ii)&nbsp;is otherwise considered a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT>
director&#148; for purposes of Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(bb)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Nonstatutory Stock Option</I></B>&#148; means any option granted pursuant to
Section&nbsp;5 that does not qualify as an Incentive Stock Option. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(cc)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Officer</I></B>&#148; means a person who is an officer of the Company within the
meaning of Section&nbsp;16 of the Exchange Act. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(dd)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Option</I></B>&#148;
means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>(ee)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Option Agreement</I></B>&#148; means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an Option grant. Each Option Agreement will be
subject to the terms and conditions of the Plan. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ff)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Optionholder</I></B>&#148; means a person to whom an Option is granted pursuant to
the Plan or, if applicable, such other person who holds an outstanding Option. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-18
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(gg)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Other Stock Award</I></B>&#148;
means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;6(d). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(hh)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Other Stock Award Agreement</I></B>&#148;<B><I> </I></B>means a written agreement
between the Company and a holder of an Other Stock Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms and conditions of the Plan. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Outside Director</I></B>&#148; means a Director who either (i)&nbsp;is not a
current employee of the Company or an &#147;affiliated corporation&#148; (within the meaning of Treasury Regulations promulgated under Section&nbsp;162(m) of the Code), is not a former employee of the Company or an &#147;affiliated corporation&#148;
who receives compensation for prior services (other than benefits under a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan) during the taxable year, has not been an officer of the Company or an &#147;affiliated
corporation,&#148; and does not receive remuneration from the Company or an &#147;affiliated corporation,&#148; either directly or indirectly, in any capacity other than as a Director, or (ii)&nbsp;is otherwise considered an &#147;outside
director&#148; for purposes of Section&nbsp;162(m) of the Code. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(jj)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Own,</I></B>&#148;<B><I> </I></B>&#147;<B><I>Owned,</I></B>&#148;<B><I>
</I></B>&#147;<B><I>Owner,</I></B>&#148;<B><I> </I></B>&#147;<B><I>Ownership</I></B>&#148;<B> </B>A person or Entity will be deemed to &#147;Own,&#148; to have &#147;Owned,&#148; to be the &#147;Owner&#148; of, or to have acquired
&#147;Ownership&#148; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting,
with respect to such securities. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(kk)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Participant</I></B>&#148; means a
person to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Stock Award. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>(ll)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Cash Award</I></B>&#148; means an award of cash granted pursuant to the terms and conditions of Section&nbsp;6(c)(ii). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(mm)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Criteria</I></B>&#148; means the one or more criteria that the
Committee (or, if not required for compliance with Section&nbsp;162(m) of the Code, the Board or the Committee) will select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to
establish such Performance Goals may be based on any one of, or combination of, the following as determined by the Committee (or Board, if applicable): (1) earnings (including earnings per share and net earnings); (2) earnings before interest, taxes
and depreciation; (3)&nbsp;earnings before interest, taxes, depreciation and amortization; (4)&nbsp;total stockholder return; (5)&nbsp;return on equity or average stockholder&#146;s equity; (6)&nbsp;return on assets, investment, or capital employed;
(7)&nbsp;stock price; (8)&nbsp;margin (including gross margin); (9) income (before or after taxes); (10) operating income; (11)&nbsp;operating income after taxes; <FONT STYLE="white-space:nowrap">(12)&nbsp;pre-tax</FONT> profit; (13)&nbsp;operating
cash flow; (14)&nbsp;sales or revenue targets; (15)&nbsp;increases in revenue or product revenue; (16)&nbsp;expenses and cost reduction goals; (17)&nbsp;improvement in or attainment of working capital levels; (18)&nbsp;economic value added (or an
equivalent metric); (19) market share; (20)&nbsp;cash flow; (21)&nbsp;cash flow per share; (22)&nbsp;share price performance; (23)&nbsp;debt reduction; (24)&nbsp;implementation or completion of projects or processes; (25)&nbsp;customer satisfaction;
(26)&nbsp;stockholders&#146; equity; (27)&nbsp;capital expenditures; (28)&nbsp;debt levels; (29)&nbsp;operating profit or net operating profit; (30)&nbsp;workforce diversity; (31)&nbsp;growth of net income or operating income; (32)&nbsp;billings;
and (33)&nbsp;to the extent that an Award is not intended to comply with Section&nbsp;162(m) of the Code, other measures of performance selected by the Committee or Board. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(nn)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Goals</I></B>&#148; means, for a Performance Period, the one or more
goals established by the Committee (or, if not required for compliance with Section&nbsp;162(m) of the Code, the Board or the Committee) for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide
basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices.
Unless specified otherwise by the Committee (or, if not required for compliance with Section&nbsp;162(m) of the Code, the Board or the Committee)&nbsp;(i) in the Award Agreement at the time the Award is granted or (ii)&nbsp;in such other document
setting forth the Performance Goals at the time the Performance Goals are established, the Committee (or Board, if applicable) will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance
Period as follows: (1)&nbsp;to exclude restructuring and/or other nonrecurring charges; (2)&nbsp;to exclude exchange rate effects, as applicable, for <FONT STYLE="white-space:nowrap">non-U.S.</FONT> dollar denominated Performance Goals; (3)&nbsp;to
exclude the effects of changes to generally accepted accounting principles; (4)&nbsp;to exclude the effects of any statutory adjustments to corporate tax rates; and (5)&nbsp;to exclude the effects of any items that are &#147;unusual&#148; in nature
or occur &#147;infrequently&#148; as determined under generally accepted accounting principles. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(oo)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Period</I></B>&#148; means the period of time selected by the
Committee (or, if not required for compliance with Section&nbsp;162(m) of the Code, the Board or the Committee) over which the attainment of one or more Performance Goals </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-19
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">
will be measured for the purpose of determining a Participant&#146;s right to and the payment of a Performance Stock Award or a Performance Cash Award. Performance Periods may be of varying and
overlapping duration, at the sole discretion of the Committee (or Board, if applicable). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(pp)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Stock Award</I></B>&#148; means a Stock Award granted under the terms
and conditions of Section&nbsp;6(c)(i). </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(qq)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Plan</I></B>&#148; means this
Exelixis, Inc. 2017 Equity Incentive Plan. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(rr)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Prior Plans&#146;
Award</I></B>&#148; means any stock award granted under the 2014 Plan, the 2000 Plan, the 2000 <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors&#146; Plan, the 2011 Plan or the 2016 Inducement Plan, in each case that was outstanding as
of the Effective Date. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ss)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Stock Award</I></B>&#148; means an
award of shares of Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;6(a). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(tt)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Stock Award Agreement</I></B>&#148; means a written agreement between
the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(uu)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Stock Unit Award</I></B>&#148;<B><I> </I></B>means a right to receive
shares of Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;6(b). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(vv)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Stock Unit Award Agreement</I></B>&#148;<B><I> </I></B>means a written
agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award Agreement will be subject to the terms and conditions of the
Plan. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ww)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></I></B>&#148;
means Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act or any successor to Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> as in effect from time to time. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(xx)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Rule 405</I></B>&#148; means Rule 405 promulgated under the Securities Act.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(yy)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as
amended, and the rules and regulations promulgated thereunder. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(zz)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Stock
Appreciation Right</I></B>&#148; or &#147;<B><I>SAR</I></B>&#148;<B><I> </I></B>means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section&nbsp;5. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(aaa)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Stock Appreciation Right Agreement</I></B>&#148; means a written agreement
between the Company and a holder of a Stock Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will be subject to the terms and conditions of the Plan. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(bbb)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Stock Award</I></B>&#148; means any right to receive Common Stock granted under
the Plan, including an Incentive Stock Option, a Nonstatutory Stock Option, a Stock Appreciation Right, a Restricted Stock Award, a Restricted Stock Unit Award, a Performance Stock Award or any Other Stock Award. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ccc)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Stock Award Agreement</I></B>&#148; means a written agreement between the Company
and a Participant evidencing the terms and conditions of a Stock Award grant. Each Stock Award Agreement will be subject to the terms and conditions of the Plan. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(ddd)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Subsidiary</I></B>&#148; means, with respect to the Company, (i)&nbsp;any
corporation of which more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such
corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii)&nbsp;any partnership, limited liability company or other entity in which the
Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(eee)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Ten Percent Stockholder</I></B>&#148; means a person who Owns (or is deemed to
Own pursuant to Section&nbsp;424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>(fff)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Transaction</I></B>&#148; means a Corporate Transaction or a Change in Control.
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">A-20
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g06l27.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA, CA 94502&nbsp;&nbsp;&nbsp;&nbsp;SCAN TO VIEW MATERIALS&nbsp;&amp; VOTE w VOTE BY
INTERNET Before The Meeting&#151;Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on May&nbsp;24, 2022. Have your
proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting&#151;Go to www.virtualshareholdermeeting.com/EXEL2022 You may attend the
meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">PHONE&#151;1-800-690-6903</FONT></FONT></FONT> Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time on May&nbsp;24, 2022. Have your proxy card in hand when you call and then
follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.&nbsp;&nbsp;&nbsp;&nbsp;TO
VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: D80678-P69244-Z82049 KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY&nbsp;&nbsp;&nbsp;&nbsp;EXELIXIS, INC. The Board
of Directors recommend a vote FOR all the nominees listed in Proposal 1 and FOR Proposals 2, 3 and 4. 1. To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of
Stockholders. Nominees: 1a. Carl B. Feldbaum, Esq. 1b. Maria C. Freire, Ph.D. 1c. Alan M. Garber, M.D., Ph.D. 1d. Vincent T. Marchesi, M.D., Ph.D. 1e. Michael M. Morrissey, Ph.D. 1f. Stelios Papadopoulos, Ph.D. 1g. George Poste, DVM, Ph.D., FRS 1h.
Julie Anne Smith 1i. Lance Willsey, M.D. 1j. Jacqueline Wright 1k. Jack L. Wyszomierski&nbsp;&nbsp;&nbsp;&nbsp;For Against Abstain&nbsp;&nbsp;&nbsp;&nbsp;2. To ratify the selection by the Audit Committee of the Board of Directors of Ernst&nbsp;&amp;
Young LLP as Exelixis&#146; independent registered public accounting firm for the fiscal year ending December&nbsp;30, 2022. 3. To amend and restate the Exelixis 2017 Equity Incentive Plan to, among other things, increase the number of shares
authorized for issuance by 28,500,000 shares. 4. To approve, on an advisory basis, the compensation of Exelixis&#146; named executive officers, as disclosed in the accompanying Proxy Statement. NOTE: Such other business as may properly come before
the meeting or any adjournment thereof.&nbsp;&nbsp;&nbsp;&nbsp;For Against Abstain&nbsp;&nbsp;&nbsp;&nbsp;Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full
title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint
Owners) Date </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g282574g82m13.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Annual Report
are available at www.proxyvote.com.&nbsp;&nbsp;&nbsp;&nbsp;D80679-P69244-Z82049 EXELIXIS, INC. Annual Meeting of Stockholders May&nbsp;25, 2022 9:00 AM This proxy is solicited by the Board of Directors The undersigned hereby appoints Michael M.
Morrissey, Christopher J. Senner and Jeffrey J. Hessekiel, and each of them, as attorneys and proxies of the undersigned, with full power of substitution, to vote all of the shares of stock of Exelixis, Inc. that the undersigned may be entitled to
vote at the Annual Meeting of Stockholders of Exelixis, Inc. to be held at www.virtualshareholdermeeting.com/EXEL2022 on Wednesday, May&nbsp;25, 2022, at 9:00 a.m. Pacific Time, and at any and all postponements, continuations and adjournments
thereof, with all powers that the undersigned would possess if personally present, upon and in respect of the following matters and in accordance with the following instructions, with discretionary authority as to any and all other matters that may
properly come before the meeting. UNLESS A CONTRARY DIRECTION IS INDICATED, THIS PROXY WILL BE VOTED &#147;FOR&#148; ALL NOMINEES LISTED IN PROPOSAL 1 AND &#147;FOR&#148; PROPOSALS 2, 3 AND 4, AS MORE SPECIFICALLY DESCRIBED IN THE PROXY STATEMENT.
IF SPECIFIC INSTRUCTIONS ARE INDICATED, THIS PROXY WILL BE VOTED IN ACCORDANCE THEREWITH. Continued and to be signed on reverse side. </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g282574g01w73.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g01w73.jpg
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M"  )&EB7$A,4&);2UPIWMM81%18A(B,R-SA4F/_$ !<! 0$! 0
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; _+^@.$R3PA=U_&GAXL9RE@/R_J*$R3PA__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g282574g02a10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g02a10.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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M+Q'B)CS/7/'TG=H>'=WN7<HR.:(T74\CCH:%55"\>><6STJU62:Q8$9P"F'
MK\P/M/DH+Q$132T]P.\NQ:A(;=U%KW\(Z?JX*G)&?37X*9*E41;.$STTZBQ.
M%$EQ@Y31;I/X7C'1((=IX:0E2G02C.55H]T.[^YF/Y-QG$_3.+YR9)]V*-.T
MRS%<(BY;*+TF;*X&#"9^G5R53"#6^RPDFWKH["^G?Z7>'<AJ=ONX7+_Z0=Q-
MRU 4\F=?5SJ] KS)G*S5GC@A*+K4L0"?UR\NQJ.8MU2@@+*:_5Y>CW:23[+Z
M]GB[8!'1UWHTF'&6%<2VZ/%R8,F*\1#S3(S[KZ@7ROA20QHB7G6$D **'RRP
M6@,6X.T/<2QS_#NLTTH1KX]A5>\5:""O8386;*ML5F1RDV?$];5P9![HEJY
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MK)JTS,P!1R1"1WSPWZ=/I:J[(=JN0<J/EW=6*S2T5U]?5S/@NHKE8N5<M6?
M9*W4U QI9M^WHZBUI:VPH0$UKV>.[R]L>PM?CH/KCJ0<>UP,(V9LJSLC1TE'
M#RBGB4,,5M%F-;A8\60&'^8P!+NR\V4\LH&/8<:BER,CL$=W^Y7-Z2*?!.-
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MXDO6238TDFJ?+2%@3URQ]2?8-G8WDN:K/OV=;BG)$6K&%=N@N+]=U$TA?R]
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M5D)^S0-EHGV:HTN4=_..9"^7:P93,B/MW6<PZ="64T6# 53;36%-Y0&3%K.
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M<<B;VWY:OF:>0TJ]&-+D,6MZR-$]"FB[6;9*C(T#:=6S7LE]C@VJRH;"S&&
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M)@Q$K2K+"!S/D*DI!UM3,:&RX^XAU_(XI%I#R/.[8]L^.OW/,6JF%F5$9H%
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M:;ST,CVLMH]M?4<9*V_3CT*PYIQ'KPI/EY9POU*RKSQ^UE6<Y\_//+0J"/\
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MS:=Q?]/_ !C_ *WX1_M"IU&^Q7_(G[B?ZN=VO]B7^N[_ #LGK^5G7&3Q??\
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MZA6*8&2_HYCS-V(\0'RU;K @H9^Z6N\W^GYI'_Z.FO\ U%EN2;N__IIXE_\
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M+=5(AC\S'IY_C'7I] K:C.VO/ZBUK?H+Y;+;-?W%;&U+6!05169S^5K:^MH
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M,%X\%'YQ?J7N8_8:UV.'B%9Z;-#:SXY(6RU;5JVMFWKL.<J,TP-B"N,0'C0
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M?%5BL2]5L@FM;>5!2.8*MBW**/(*@V#X)E0D^JL#2[S9KS!^6$M/ENG4L/\
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MO\(GN52Y\$+%?IEMLMCD+X-KL6L5B6UU8G'YV1I4A>HMYFS15X)I3T81%QQ
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M<\W3K2X+J[JROQT+"B_C$R K%HBK558"8N]CEX6K$PL?:(R-BJ^ ><^S&0;
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MJGC1@;+,TEBLG0<@],'M&@(=>^X8$SSY133J<ZYU>NS3H7HT-5^;H3Q6_>Y
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MT_:VYOG\X%^978FZ[1&;5@K/]W8:W'3%**U%][K"O&#;#JF.ST9#3-MG!"8
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MTZ<=.G'3IQTZ<=.G'3IQTZ<=.G'3K5[=2JK?(E,);X,&>C&C19,<<U"_4))
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?CITXZ=..G3CITXZ=..G3CITXZ=?4_KC^./Y\=.O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g282574g02z22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g02z22.jpg
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M P$      1'P B&!,4%187&QP3*1H=$#$N'Q(D(34H)#_]H # ,!  (1 Q$
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M*E_?HO\ 7F<?IG3O#6#U1KVE;G9GZ<T_Q(7^$3SG@]4:]I;Q[(Z^)4#SLY'
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M[16@7$JW#F<P:.2%@R.P?ZQPPZ8DC@PR$AYO%$88IOGXZ;/FHZ,<P' <!P'
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ME/KK)8,[8T]/Z<2,LD^O_&7._P#XN/\ \[_]AVGYS#@. X#@. X#@. X#@.
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M@2))( E@D<6)HFSWTQ,Q/,C'P/,5++KK)$$$!G<8HB*16L[Z1>0Z-JU:](M
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M#_(5SG^3=KX=/Q[]/**]C?J>;]T#_AYY<&R>OB&<?JG3M""<VR<!P' <!P'
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M_P!9//%*+,6*N412(&\?,AP' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
M<!P' <!P' <!P' <!P' D52_4J7]^B_UYG'Z9T[PU@]4:]I6YV9^G-/\2%_A
M$\YX/5&O:6\>R.OB5 \[.1P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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M8\W5'6K^[!J='S84FN(:\EF+RO&:VJZVA+2:F"<?K 3N"N)LMA51,C8QB91
M-B"(AYY(]8MTY$7X]T$L-R[@ZIZUO]O[%/ZUN;D!4JBZ^ H]9M%/C:WJPE[U
M]!2V@3ZY7*0V)M;F=63+'H+19,9]R,S.A7;CP;$,^M[/Z9=+V_Q53_R5NBSI
MR@6,\SKJDWXWNB?H_M!A84E@?4FH6*OD6]=8FH",2W5IU.L9D5D)Q6(R[/C?
M-?L"TD@@S;?63=\=>OG=<'UXZ;KG>_5/\C^P>R:]U0EING7FM\[,LW<Z_2Z$
M /FW7PU+Z6LA-?87P&G06-39B2+3N75-E-,96]26KP_*G/?$PJM-6<O_ #7C
MMX;UF(C?79\\8^O?<P'87DOW7U\@N=?TJM$N/;- [3I54FC3@6%76K_4;A2C
M[V 974A-B8MJQ;6 REI5QUC&Q65:"\%A8[F,EQNH\%1/[MY-%1]@] 5WK(5!
M9:GV;O3W=RL1^I\LBFG]E:'Q];;(L!F"PQMK7LDM3.&=CH8,.NJIL.P6\S <
M@==W_%W?]Q_4'<79W<1%U&4]E=+*7:BP=H)%U+WZFO35Q71J/V@XHRIO8W6.
MYU(-AB.6*1S31%:NN[_6N1OA(A@"DA+#"UON_O<+JZ?NN[&=5.J76NT;C5KZ
MGJO7]PKCE+U_U_VM<^JK;? W#3M2V"3;*-$ 78;!=,DUT"K(5@4QDGGX!8ZS
M/E[3_=_M"Y3_ &8_F[Y?1YY47&DT2J]Z6^I+I^F;PZMX"(%$O:ZWX16T],]
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M2+?T"TYNZ%*;IP+N*WUZQU8 @%)--6SHE4K^,^PN@:ZD TR,VE3::N6[-=J
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M9XB:RF-)"R=,*%.S5JEP,?G0J4I8T&8A"%8DBAD&^FSKNZHZ?Y5G(K2K-?\
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MIK;.[0SU29/&TMC93%+UG5![X#);V+%F6N+[-&UT=,TZV5J8&KBW &:Y5ZB
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MYV<C@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.!<O5/]@[_O0/\
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M"(92X-T)8JEH+U>H9,:T4Y!&V(R*7?SPWL!UOWX;V7W%)5 :U::S4\]/+>P
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M$%%DYTYWE_%RWUV1>=*?.K>+7/KC&?\ CC&?_P!<<(_O <!P' <!P' <!P'
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M!_P\\N#9/7Q#./U3IVA!.;9. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@2*I?J5+
M^_1?Z\SC],Z=X:P>J->TK<[,_3FG^)"_PB><\'JC7M+>/9'7Q*@>=G(X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@7+U3_8._[T#_(5SG^3=KX=
M/Q[]/**]C?J>;]T#_AYY<&R>OB&<?JG3M""<VR<!P' <!P' <!P' <!P' <!
4P' <!P' <!P' <!P' <!P' __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g282574g03a03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g03a03.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ S0*I P$1  (1 0,1 ?_$ !X
M 0 # 0 # 0$!           %!@<( P0) @$*_\0 1Q   @(" @$!!04%!@4!
M! L ! 4#!@$"  <(%1$2$Q06-E5UE=,7(3(SM")R<[&RLPD8(R4Q-28W=[49
M)#0X15%78I:VTO_$ !L! 0 # 0$! 0             ! @,%! 8'_\0 .A$
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MU/>?N8?4#[[[;_F1OZW&A;B]B#4]Y^YA]0/OOMO^9&_K<:%N+V(-3WG[F'U
M^^^V_P"9&_K<:%N+V(-3WG[F'U ^^^V_YD;^MQH6XO8@U/>?N8?4#[[[;_F1
MOZW&A;B]B#4]Y^YA]0/OOMO^9&_K<:%N+V(-3WG[F'U ^^^V_P"9&_K<:%N+
MV(-3WG[F'U ^^^V_YD;^MQH6XO8@U/>?N8?4#[[[;_F1OZW&A;B]B#4]Y^YA
M]0/OOMO^9&_K<:%N+V(-3WG[F'U ^^^V_P"9&_K<:%N+V(-3WG[F'U ^^^V_
MYD;^MQH6XO8@U/>?N8O/7K5H8_VA,9'EP_($[_"),(GC]_7>#&NWN2R;Z^]C
M&<XQM[/;CVY]F?WYY19$1=A$7;N\Q=!F9GJ9GV;_ !(379C \'9+\B<8'\75
MA\7Y4F8?XGN9"]SXGP=]/?\ <][;W?>]ON^]M[/9[<^T@B/74B/9M]069EIH
M9EM^!EGU ^^^V_YD;^MR^A;B]B%-3WG[F'U ^^^V_P"9&_K<:%N+V(-3WG[F
M'U ^^^V_YD;^MQH6XO8@U/>?N8?4#[[[;_F1OZW&A;B]B#4]Y^YA]0/OOMO^
M9&_K<:%N+V(-3WG[F'U ^^^V_P"9&_K<:%N+V(-3WG[F'U ^^^V_YD;^MQH6
MXO8@U/>?N8?4#[[[;_F1OZW&A;B]B#4]Y^YA]0/OOMO^9&_K<:%N+V(-3WG[
MF'U ^^^V_P"9&_K<:%N+V(-3WG[F'U ^^^V_YD;^MQH6XO8@U/>?N8?4#[[[
M;_F1OZW&A;B]B#4]Y^YA]0/OOMO^9&_K<:%N+V(-3WG[F'U ^^^V_P"9&_K<
M:%N+V(-3WG[F'U ^^^V_YD;^MQH6XO8@U/>?N8?4#[[[;_F1OZW&A;B]B#4]
MY^YA]0/OOMO^9&_K<:%N+V(-3WG[F'U ^^^V_P"9&_K<:%N+V(-3WG[F'U ^
M^^V_YD;^MQH6XO8@U/>?N8?4#[[[;_F1OZW&A;B]B#4]Y^YCHQ#-+-7%<\LL
MDLTBL>3>:3?;>7>3(^,YWWDVSG?;?.?WYVSG.V<_OSGV\Q/:?F?Y&Q;"\B'.
M?U ^^^V_YD;^MS;0MQ>Q#'4]Y^YA]0/OOMO^9&_K<:%N+V(-3WG[F'U ^^^V
M_P"9&_K<:%N+V(-3WG[F'U ^^^V_YD;^MQH6XO8@U/>?N8?4#[[[;_F1OZW&
MA;B]B#4]Y^YA]0/OOMO^9&_K<:%N+V(-3WG[F'U ^^^V_P"9&_K<:%N+V(-3
MWG[F'U ^^^V_YD;^MQH6XO8@U/>?N8?4#[[[;_F1OZW&A;B]B#4]Y^YA]0/O
MOMO^9&_K<:%N+V(-3WG[F'U ^^^V_P"9&_K<:%N+V(-3WG[F'U ^^^V_YD;^
MMQH6XO8@U/>?N8?4#[[[;_F1OZW&A;B]B#4]Y^YA]0/OOMO^9&_K<:%N+V(-
M3WG[F'U ^^^V_P"9&_K<:%N+V(-3WG[F'U ^^^V_YD;^MQH6XO8@U/>?N8?4
M#[[[;_F1OZW&A;B]B#4]Y^YA]0/OOMO^9&_K<:%N+V(-3WG[F'U ^^^V_P"9
M&_K<:%N+V(-3WG[F'U ^^^V_YD;^MQH6XO8@U/>?N8OO735F:]GA,8GEQ86$
M28B),(GCQOJ0)KC?&DLF^N-\8VVQC;&/;C&VV,9]F<\HLB(NPB+MW>8N@S,S
MU,S[-_B0D^RV+ &91@(XP/$D9N9,"E3CXDSKL-C7.^(=],;YUQMM[N=O;[/;
MGV>SVYX01'KJ1'LV^H+,R/L,R[-_B8R_Z@???;?\R-_6Y?0MQ>Q"FI[S]S#Z
M@???;?\ ,C?UN-"W%[$&I[S]S#Z@???;?\R-_6XT+<7L0:GO/W,/J!]]]M_S
M(W];C0MQ>Q!J>\_<P^H'WWVW_,C?UN-"W%[$&I[S]S#Z@???;?\ ,C?UN-"W
M%[$&I[S]S#Z@???;?\R-_6XT+<7L0:GO/W,/J!]]]M_S(W];C0MQ>Q!J>\_<
MP^H'WWVW_,C?UN-"W%[$&I[S]S#Z@???;?\ ,C?UN-"W%[$&I[S]S#Z@???;
M?\R-_6XT+<7L0:GO/W,/J!]]]M_S(W];C0MQ>Q!J>\_<P^H'WWVW_,C?UN-"
MW%[$&I[S]S#Z@???;?\ ,C?UN-"W%[$&I[S]S#Z@???;?\R-_6XT+<7L0:GO
M/W,/J!]]]M_S(W];C0MQ>Q!J>\_<P^H'WWVW_,C?UN-"W%[$&I[S]S#Z@???
M;?\ ,C?UN-"W%[$&I[S]S#Z@???;?\R-_6XT+<7L0:GO/W,/J!]]]M_S(W];
MC0MQ>Q!J>\_<P^H'WWVW_,C?UN-"W%[$&I[S]S$1R1 < ' !P < ' !P < '
M #YU]F_\0BIUYB:GZZJI%QD#FE&W?M#LIDDDL6^=-I5PT0Y;%D+G;&<:RS^D
M>_\ QQ8EBSIOO<D&?;L^X#)%/_$=N<1NFSWKBL&KL[X^)"I9M5AN(\Y_?G0D
MS+>#;?7'[\8V$UUWSCV9VTQGWL3T?C]O[ ?1OJ#N"H=U5..UU&>?72.?(392
M=I'$T2LM(])=PS8HY)8ML;Q[Z3"E022C%0[8VTWQ+I/##0R,CT,!JG( . #@
M X . #@ X . &@]:?:/;\.*_W!^47L+S^#%T;3\ODA.]K_QHO[K+_,#D-]_I
M\B7.[U^!D/-!F' !P < ' !P < ' !P X!\S_)=]U;LCHG7+>-9<#],.7S30
M4 ^50ESB2$ &.%@,8+&8VFQ*3O)O#\P*&'%O'C7#"*;6Z$ZF>NPON?\ 7Z <
MC=->4O?;?MCKI Y[ .9J']XK"-NO.5(-XR5[5T& ;#C?53H0-)F">3&DPTL$
MT6^-=M=\>S.,V-*=#,B[M2[3 ?;?F0!P < ' !P < ' !P < .GZ[]F%/X0-
M_3:\P5M/S/\ (W3L+R+\#F#FXP#@ X . #@ X . #@ X >*>>$:&8DF6,<<>
M*2>>>;?6*&&&+3,DLLLF^==(XX]-=MY-]\XUTUUSMMG&,9SP ^8=H_XC6 WK
M0*K=<"M489Q(R]NQL9 I#42";>.%A\C$EV^1U+TUUGC&WG(DBTWUUDW]_P![
M76Y(,R[3T]/\ =E>._=.W>]"GN<E>Q6IA+ ?7YU^C++6*24$-:;\W"3D(#?6
M.6-EII\#>#;:/>+?_JR8VQG%3+0S+< W?D ' !P < ' !P < ' #1>L?M"1^
M%$_U(7*+V%Y_!BZ-I^7R0ENUOYZ3_"/_ -8O(;[_ $^07M+R^3&2<T% X .
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M.AWVQ^[:19!.1,7[/;B-DP.@TDEAAADVHH]3\"V?L!U7RH!P < ' !P < '
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M6#!..+#J:$K!C%BT)VS+M[FBS6:3?.NF,RS[ZZZYQK[^^)GJ>H#H+D ' !P
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M@@P$-C']G486'77]VN,YHK_Z/CS^X#J'E0#@ X . #@ X . #@ X . #@ X
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M < ' #I^N_9A3^$#?TVO,%;3\S_(W3L+R+\#F#FXP#@ X . #@ X . #@ X
M. #@ X . #@ X . #@ X . #@!HO6/VA(_"B?ZD+E%["\_@Q=&T_+Y(2W:W\
M])_A'_ZQ>0WW^GR"]I>7R8R3F@H' !P < ' !P < ' !P < ' !P < ' !P
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M3J4E4GM;"Y7ME49'MP:5=3=L4ZI0JZ;:H,3!UFPUT@U^\* !A9.QEN@4T8K
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M,G%UK]>M$%<DKMIL]:7I74S.L5IHU?QR)'@D:Z4U(W'" /<+[_Z?"DLD,]W
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M"\B_ Y@YN,!1^R:,'V32']+-.*5:.1Q\B-@=8I#%#98<*W2-QHI\9@GE5.0
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MRT;2\Q+<HDM8,W9FR)X&CP?:JR/01ZV!.P;E+9A3AQFO&AB=-F_M[RTXV[?
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M)U?Y$=:6?6*OZI=WT'?W9R?L$]K!'AHPB5;IX%I"O433!6)R"HCX" ]1L"R
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M8KC8J#9]B%-E&[>OO6=:F%J5RTJS*>K:G,EB@N[3+BJ?'<V%=6'N=D67HIY
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MD&ZN>1&OGV;.W8+]Y*^--B[]]8!%[!7(T#WK1Y09DE@KM@L@")DWE,WS>*X
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MH!P^-"IL0;P!DR1-2X]/V0C3CCR$!-Y14DVU256N#/&8QW2XO<U=OF*G>"Z
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M(F ^+2*3=4UP$$#0> #@ X . #@ X . #@ X . #@ X . #@ X . #@ X .
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MXV$BD#A"'PL%7Q;C;E1DF% &J\ ' !P < ' !P < ' !P < ' !P < ' !P
M< ' !P < ' !P < ' #0>M/M'M^'%?[@_*+V%Y_!BZ-I^7R0G>U_XT7]UE_F
M!R&^_P!/D2YW>OP,AYH,PX . #@ X . #@ X . #@ X . #@ X . #@ X .
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MM'M^'%?[@_*+V%Y_!BZ-I^7R0G>U_P"-%_=9?Y@<AOO]/D2YW>OP,AYH,PX
M. #@ X . #@ X . #@ X . #@ X . #@ X . #@ X =/UW[,*?P@;^FUY@K:
M?F?Y&Z=A>1?@<P<W& < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P
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M["\_@Q=&T_+Y(3O:_P#&B_NLO\P.0WW^GR)<[O7X&0\T&8< ' !P < ' !P
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M #@ X . #@ X . #@ X . '3]=^S"G\(&_IM>8*VGYG^1NG87D7X','-Q@'
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M;$O26=I9K4==1C5T4.9U.^</&ZQ*&GC!R=LS,B%DBCWQO[@!F(7DQUHQ5Q,
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M ' !P Z?KOV84_A W]-KS!6T_,_R-T["\B_ Y@YN, X . #@ X . #@ X .
M#@ X . #@ X . #@ X . #@ X :+UC]H2/PHG^I"Y1>PO/X,71M/R^2$MVM_
M/2?X1_\ K%Y#??Z?(+VEY?)CE?M3KG/::)74CW.5U3ELJAE>DVB_!>]WJZB2
M4_>DS%Y-&PL4/6\"G6R29&98;UH=O6=Q8H7LIPF@H,1A\;;G6HNO(NO.T:^F
MCZEM/8)G7@=PZW9W)8DH5Y5X7A=?3CJNRZ2<:/2\3%A5=OJS%^!78DJ0E41(
MJD9'@XXT'GSXW6<ILP$9]DII^N[-VE2^[+E40J 4$W9=A5">H/)!D5G(O3&!
M'0W=WI*:V&5P^O6)[!G=DETM\H)NL@T:?WY_&O?Y[Q.O]>7SIW>6X207CXXS
MV*=V@R?]:AVQ>NN<=(-I73D=5V$L5M"W6QW'L,HJ\V%IV(Y3+-I%X@\3&IK)
MX6;Z6<7)#$&5,[?#P[-GW_0CW\>W;]OV(BD]4]Z=2T)O7T=XZ^O-IL-B1GDV
MW'6SBJ.RG#FQ+<=@=B7]B\[:N\5N8YK$16%:5,LK\ LH2>OIX5E=&!$43QQ\
M">SC@O7:?SJG9?6EBM-GH5^H]M4U*[4"&V+ 9[)52[I66E?NXRB)^L:(UUJI
M3/!&#*Z@8K&0-C$W$G7R03C&B&SPX'X<?<A''!Z&,8W\5'ZA6B%I/:@R1KM0
M^TJ'>W3ZA1V3-DB[>N>>P[58J\N%M=>%JCZ"VEN2DNAN;6D$7M=0#5#+8" B
M0 V#JGIS7K!FT8XL67?J=!ZDH^8<JL+O@XZL1N$V&?Q,,COB>N8;?,Y#]S3T
MW(_PL%'_ !?B1N_7R^VO[#NT\_OI^A!VCH/6R;=K;9M6P?[3^Q.GK]G&$F"/
M1,]3S]=3:JL9]6A]1]>S0,:Y.S\CZ9ZM[<"'_(^PN#+4C+7;^B+X$D>AD>FS
M]F?R*;3O%N"AWEQ:T$O4I$!%O[&OE?9V#ICU7LZO63L0BRMB==>Q1[\MC-4*
M7MI98$BQ5PW,U4W^E-GD6/\ N^6G;KV>W;Y:ZAKV:=OOV>>F@A4WB(74Z;9Z
ME5.SI8OJ*]=6=S?.V2J>O:8[PHESK]UMMV8"AV5%N4@[/9U1%*ZI:TM+$A+]
M6+0.AXF4804_GO/>(UUV\>^O>)+R+Z0P_P"N&Y--I2PKLJR6CJ@Z\6FCIU:&
MU-5M3[!J%J>-5^#;"G8&2"?3D9ZY1]>+W,.1Q]EK^=J$+J9&GEJ>FNG&OEN$
MZ^>A:Z:\:>>\9G6/&:R7FL5@NTH:76W'6]X[&VI(_9?7\M]%N],[% K+"Q6'
MLJK;]M.&T=_8W->8:'8?VF$M9 %H9CE?!.\8I@FF_0_3N^X:]O>6_3L]M"[!
MLC#QC$.K?95?%>UZMP]C>-0'CWD.I42-#6:U(+MVA*3:D=<TLA.(0"".RYI8
M*ILRQN+JJ]V6QF2L-YQ9[O'>([_#</2B\6%87:[?L0;'5K@"QW&IWML+>.HM
M+7=%5AJR:KIM)*3>M;HHCKPTWT@H=+=6-8L1%>L6Q[->1OH0**OC3MUX].-.
MSL+M$Z]FF[9QQMV]F@DF_CHT(ZLK77*F]AP9KW9MG["-V=U=BTJEP!LUEO=B
MEIMQJJFYULYLB"GN@Y<44=H%A*>5A*S-#G"^9323^_']_P!> C]>'Z_OQ'J4
M#QL<=;;=*S5V^)=I^JXNX4K:,NA2ZK;)4^Y+^COSI8E7K[D#](MDQ5;4+4C2
M0FR+81<&;DUXCXT$(KR#S%=7>*EKJB;150^V5B25WT\GZ7OISKKJ2P[MD%>;
MWAJC?U0>&\I8ZM9UVO8UL$Q(VVN"0O!"V<M++LMVB, +?)XQK(*]>:NHM$R]
M1:V_1IRR.=1@Z= NZ2'H0@"V6;U4;U>5V-1HM)3O<7?(;L-M\"G?+>Z1&GP?
M9V;-/MV!KZ[=OC\CJ/D@' !P < ' !P < ' !P < ' !P < ' !P < ' !P
M< ' !P < -!ZT^T>WX<5_N#\HO87G\&+HVGY?)"=[7_C1?W67^8'(;[_ $^1
M+G=Z_ R'F@S#@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@!T_7?
MLPI_"!OZ;7F"MI^9_D;IV%Y%^!S!S<8!P < ' !P < ' !P < ' !P < ' !
MP < ' !P < ' !P T7K'[0D?A1/]2%RB]A>?P8NC:?E\D);M;^>D_P (_P#U
MB\AOO]/D%[2\ODQDG-!0. #@ X . #@ X 8I_P P/6OUEI2OG7WS,EMWZ^TL
M?TG9?H7>_P 8\A$E*UNWIGTWFP:_"D#R/AA\MZU'O7/FOJ+7*K !Z*/R+H5I
MKQEHJR?LRRI1F\:(4M)U7?C8W3'VM]#=4DFJ#6%@"G)1,P'+C271,M:Q#J2&
M&K-@O$*C77\D>_CQT$F6G'G^OP/'3^Z1K[V36D]4F"84&T=,3]EK6DRYHO>[
M'Z6\*O:ADC,-Q)5T8\$Y$1ZH]1 T#9P[PDR0;0RC<D.[7Q/[:?L5Q=V%WC/W
MN?U66JZHU0JZL@[ +;C&V_+>6J/K=9*Y$ .-*+@+%A''K<Q,F\DF%N\Q,4>N
MV---]N [-._7S[/QQXC-:1Y</^P^GK;V_6J<GF0==])/[Q<3Y69F5Q':@%2Q
M;H.M:WMI!B4T5$MUUWNCZ;;$:XUJJ1+XC6PUBT2../QY@9:'IQM[^.\AVPF/
MV:)U3/>/6'=BM!/WBUVSMK%L6+$1M'KMG&,[:Z9DSKC;.,9SC'MSC&<\"!)<
M ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !
MP < -!ZT^T>WX<5_N#\HO87G\&+HVGY?)"=[7_C1?W67^8'(;[_3Y$N=WK\#
M(>:#,. #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . '3]=^S"G\(&
M_IM>8*VGYG^1NG87D7X','-Q@' !P < ' !P < ' !P < ' !P < ' !P <
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MS8#&C'Q+F/WM_<S)\/W_ '/?W]WV^[[VWL]N0@2' !P < ' !P < ' !P <
M' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' #0>M/M'M^'%?[@_*
M+V%Y_!BZ-I^7R0G>U_XT7]UE_F!R&^_T^1+G=Z_ R'F@S#@ X . #@ X . #
M@ X . #@ X . #@ X . #@ X . #@!T_7?LPI_"!OZ;7F"MI^9_D;IV%Y%^!
MS!S<8!P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P T7K'[0D?A1
M/]2%RB]A>?P8NC:?E\D);M;^>D_PC_\ 6+R&^_T^07M+R^3&2<T% X . #@
@X . #@ X . #@ X . #@ X . #@ X . #@ X . '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g282574g03a55.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g03a55.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"NP,T P$1  (1 0,1 ?_$ /T  0 !! ,! 0$
M       &! 4'" ,)"@(!"P$!  $$ P$!              8#! 4' 0@) @H0
M  $%  ( ! ,$!@@# P@!%00! @,%!@ '$1(3""$4%9875QDQ(M/5%@DC-W>G
MUVBX*4$R)%%")6%Q4C,TQ4=X0S4F-AA84U1VMM:7F)%B8T2UMR@XV!$  @$#
M P(!!0<+#P<'"0$1 0(#  0%$1(&(1,',4$BDQ1183(C518(<='2TU24%59F
M&!F!0E(SI-2EM=4V=K8G-RB18G(D=84)H;&"0U-C-,&2PG/#)45&%Z*R@[-$
M-97A=+3PHR;QXN-DUO_:  P# 0 "$0,1 #\ B'/':OU0TXI3BE.*4XI3BE.*
M4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3
MBE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5NMGO8SV#J*+K,RJ
M[)Z;=L.X<.7V!USU43>;87?Z6C!6Y^8A$];K]N+CM?\ P OR#R7+5D]+P:JJ
MJ(NS[/PJS%_:6,MO?8W\)9*U-Q;6I><7$J+OU UM^SO^+?13,-=.E==\K])'
MBV&R68M[W$9\8' 9);*_R2PVC65O,_:VEM+WVLQ_'Q:NMH0N[5@ ":U(_A34
M_P /?Q;_  U?_P *?-?(_P 3?1['^'OGO-Y/D_K7RWTWYKS_  ]/U?/X_#PY
MKO\ !]_['^$>Q-^#]VWN[&[>[]COTVZ^]KK6]/PWA?PK^ O;+7\-[-_L_=C[
M^SR[^UN[FW3KNVZ>_5<1@=T(-0F%XK6BB:IDDF8*(SEQ"-HXXFJ^62AGD#;%
M<,C8GBY1UD1$^*\JOB,M&D,DEK<+'<#XHF-P)-/+VR5T?3_-UJVBY/QJ>:YM
MX,C8O/9$"X59XBT!/0"8!]8B3Y X76K[E.I.P-9K*K(B9+40'6"T!1;WYJZE
M^CT&A*!'!U%E!$'ZP^??'81RM*<C89(W(K7JCD7EWC^.YC(9"/'1V\XE?MD_
M%.=D<A4+*P U$>C ACZ)!&AZUC<WSGB^#PD^=GOK)K:+O*H%Q".[/ KL]O&Q
M?1IP493&-75@05Z&LGC>V+3G=B^YKKL/14*F>V#-]KZG3V1++" ;1UO4VQK\
M;:Q4,,0Q,L9MH78LF'80L<;8T<CWHY$\<ZG!;^7,YW#1S0]S!07<LK'<!(MI
M,L+B, $AF+ J&T&FNIUJ&S>,F&MN*<.Y7<6EU[/S*\QMM;QJ4+029.U>ZC,Q
M+*"D:QE7*;F+$;5(UTP78XO8T]3'?6V3TM71S&-KH;FQHK0*IEL'C-,:!'8D
MBQ!O,<&Y)4B1ZO6-4=X>7X\BLV,R5M;B[N+>>.T+;0[1NJ%M-VT,0!NTZZ:Z
MZ=?)6R;3D. O[XXRQOK.;)+'W#%'-&\H0-LWF-6+!-PV[M--W377I63;#H/9
MTO2)'=E\*=0U[>R<IUY7YZYH[6MM+AFOQVHV-;IZV8R"" JD<)EY(FN8CDE?
M*US'*B+S.3<1R=MQ8\HNU>&'VV*W6-T=6?O0RS+*I8 %-(B 1KJ2"#I4.M?$
M_CV0\1E\.\8\5U=?@BYOGGBFBDCB-K=6]K);R!"2LVZX5B#IM"D,-2*Q>W'Z
MUUE+2MR^B=<01"3S5+:2S6RA@/)#"!FE 0;YJ.(PRQ'BB<K$226>-K?%SVHN
M!&-R)G-L()O:0 2FQMP#$*I*Z:Z$LH!TZE@!U(J9G/8,68R!O;06#,RB7O1]
MLE%=W ?=M)1$=F .JJCL= I(28_6Q7IV7ER^BBTM8I*66=DI+-E[7J%&LQB'
M5#ADL!%$B172^I&WTV_%W@G#8W(K=O8-!,+Y-=T91NXNWJ=R:;AH.IU'3ST3
M/8.3&QYE+VT;#S;>W.)HS"^\Z)LEW;&W'HNUCN/0:U]UN+V-S7%W%1D]+:U(
M 9=B=:5M%:'5P=?7O8P\\LT4648<,)\C4FE>Y&1JY$<J>*<^H,9DKF%KFVMY
MY+=%+,RQNRJJ_"8L 0%77J2=!YZ^;OD. Q]VEA?WUG!?2R+&D<DT:2.[@E$5
M&8,SN 2J@$L = :R9U+T)LNV0=K= #&TV;Q?6_9?8,VG.I+6;/V4G6>5*UEC
MEQ+:&% &WAX0WEC8LBK'YD<YOEYG./<2R?(8KJZA5X[*ULKFX,K(YC;V:(RM
M$' V[V4: :]-=2-*A_.?$[C_  >YQV/NGCN,OD,OC[$6Z31B>,9"Y6VCN&B)
MW]E';5B%]+0@'6L3QYS0S1U$T5%<RQ: KY&AECJSGQW9WK,&^3J'M@5MD5\Q
M(V/TX5>_SN1OAXJB<CPLKQEC98I2LS;8SM;1VUTT3IZ1UZ:+J=>E3ALMBT>>
M-[FW#VJ;Y@9$!A30MOE&OQ:[06W/H- 3KI5788W7U,U(/:9325L^FB@GS<%A
M16@<V@@*F:.--21D"QOMHB)WM8QT"2(]ZHB>*KX<J38S)6[1)<6\Z/. 8PT;
M*9 3H"@(&\$] 5UU/2J%KR# WT=S+97UI-%9L5N"DT;B J-S"8JQ$15020^T
M@#4]*YC,+MJZY.SEACM4!H:P64ZRH3,];"W->#!&DLYAU7.(PX06&)?,^21C
M6-;\57PY]2XK*07+V4UM<)>1J6:-HW#JHZEF4C< !U)(T%4[?DG';O'QY:TO
M[*7%3.$CF2>)HG=CH$20,49B>@5223T J*\L*S=.*4XI3BE.*4XI3BE.*4XI
M3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI
M3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5W.8'W>]*YW >W$:Z[.&=1]:]*6
MF [3ZGK^DX['L36F6+M<A=/DNYRZBJM\<%9!W4 [W@WPL+/Z1RL?YY$=V8Q'
MB-QBRQ&%2ZOE]EL<6]O=6BV0:XF+=[5(;THCPJRNJDQSHH](Z'4Z^?7*/ CQ
M#RW*.6S8[#.,EE^11WN-R;Y<QV-JL8M=LMSB5EDBNGC>%W FLI'/H ,NU2,-
MR>XSJEW5,DT78%Q&.[V@N]NT?ML6EUT@$?8JRJ,SL9;+]7K]]2VY_P#KJ^:^
M92T6U_H_E/\ O<C;<TX^>/EEO) GS<_!WX-V3;?:==/:=W_A]F__ %K=N[O=
M]'M^>I^GA/S8<W"/B[<RCG@SIS_=M0YL--QL.W_XX2F+_P!V]OM^S^S>GW_-
M6Q&%]W_MAQA. K?X\V.AI,OWGTUV,+>;$3M?7Z^#,YSK?:971NTA6GO[ZA%U
M%:7:PBO$S-97URAOC;%,:QOE%F.*\1^"8R2S@]KN9K6#*V5R'F%W-,(H[::*
M3NF622,2J752EM%''L*A6E TCU5R3P&\9.00Y2\_!EA:Y&]XUEK!H;5L;:VK
M7$]_:7,'LZV\,,S6TBQO()<A<3S]T.7CMV;6;5'I#W-4W\$WPG:?='9^,[$3
MOGKCN2SWE6'?[+0=FY;&5%C3KUT=8#:2F,A(J"#U,K8S28ZM/4E:Y\3FQ<U_
MQ;G-M^"YH\_D[^VS/X6MKQIT62:2ZBA1D]F9A(C H6WQ!V$75@2I"UNWQ&\'
M<A\X[6?A?'L-D.*?-F_Q4=E(\-K!C[F[ECE]O1&MY4*RJ@BN&AC:X]%"%<%Z
MI*3O[K$+O#^81MB+DMF>[_ZW]RF=ZP+2GM'2W-KV/VG0ZC)P&"M%4FG8=3 R
M2/>4V)D#D\DBM<J)RG:\OP47*>8Y1Y6]CR]EDH[4[&U=[FZCEB!&FJ;D4DE@
M OD.AJOD?"_F5QX<>%?'8K>,Y7B^7P$^17NQ@116&.FM[DJV[;*4E=5 C+%P
M=R@@:UE;9>\+K2\N_< EEH;_ &^&O\A[-1NN<-<"W\M"?:=/VW3A_9E4'56<
M?T[-^N-G[^)9WL'86A,OD<_YE?/(,EXD8.ZNLQWYIKK%36V&%M XD,;-9O9M
M<H$8;8]1'<#<0H?<VA._K"<!X"<OQN.XN;.UM<=R2UO^5M?WD30"9(\I%E4Q
M\C2QGN7&C3V3; 7,7;3<%[0VSTWWE](Y^\@T)'96][P'*][><]QS,[JLA<!,
MQV#/Q'9]*16TWUK0EUY>HP-CI:]R#P_(@RS"C*+++$DBCY:7Q+XM9W0O'OKO
M*HW*8\CVY877LP-!=(53?(5,MNTL?HC8A*)VV90=D8M_H_\ B-E,:V*BQ&,X
MY*GAU/@3/;743FZO4O,=,LDO9@5UMKV.WG&]N],JR3"9$<J):CKKN^K[ M^Z
MQX.Z<[1Q9OV9=LT@/96;RW;5$[.0ZGN;J.R:.78Z[6['LS03M=,3*3 %$K 4
M)G01#?,Y5J87E,&8N<HB9.&)8.,W:+<QQ7<?;$M[:-H6FEFN9#U8LJ#1-S]O
MNZFJ7+/#B\XM8<=EEX]=W+WGB#C)GQ]Q<XR83FVQ.3CW+':VUKCX%Z1K&\K
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MN5&L8QJ*JJJHB(G.&8*"S$!0-23YJ^D1Y'$<8+.Q   U))\@ \Y/F%8$ZO\
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M]362]]46L=EAO;YD02+*VK#:H:TK0&M>5INW=@@4!8K6M5J%35#BAZ41'?\
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MM[A%::-DD/:)&ADFD':7N@1[#.ZJ&[HVA 0=IW7L_-;"]NX[B^LII([6X26
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M;7FT#$'SB)(]02&W#I7<OPK^A=X.^$&WE'+IAG,W; /W[X1Q64#+U[D=J69
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MVM+2$[?6U%.N?"/GM&O+K@QX(XT26/T$FB3"XZ>Z3CR9#;>0W4L%N&FFF[J
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M ](U'2>I2295J,+:]GS?J>IZ WAZ?,D;V_'MEI=",30VBRAHRWED[XVZ-U]
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MG !@@F0"&1\HU9%*QGJ#U(<DCE@$C5HT'F7TV-\5Y4M,9C[!B]G#'&Q&FJJ
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MCT5EUD #DD\(.%SE<77&""D-DK+$VXA6<\PZ2>Y,J/X?;:G&V$Q5D<4!GWR
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MC#JC\=>POLYF_P!IQ^:IQ_Y6O/5QT_22\W_%K%>ON/K4_(PZH_'7L+[.9O\
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MY'DM@PV$\5DM<#&U_%DLI>Q8^2^N)TAM(0MLMS=0F1H_:54&(6[ I'O9UVL
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ME.*4XI3BE.*4XI3BE.*4XI3BE:]>WS_XW_\ S"]E?^Y>0[A__P 4_P!L7/\
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MR7.9X[B,7AKPN(C)Q/"6X"2 E5AG?$))N5#Z,B2=P:!PV[TJE&DK8^P._K+
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M6@<=16Q^*NADV&B!B/N#O%/!CIJG/$##L1?-Y%,F_0[]$8C7\)\DDG;K:XY
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MQ_'QC* V5\/,U?%$5$=Y$<GBB+Y7)XHB_#D>XL=,.L1^''/<(P]QEGD!^O\
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M0_I=PCT:R=OPK#YI+9,)+<17-W;PW">T&,HBRY)<687**I8K,W?[X"@Q?%F
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M?8HB*JXV$J^_>P7MLRLFCEB3&5;'?@*SLWO;K*K<+8VDD2+$CQ=US<!WB/=
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M/6LZ5UT>9LJ^:9KHQY3]C&7%+!.UD<=2K'-=$>CD5MO<<@R<0EF6.#L(EY(
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M"R6E3I DC(_3E?&1#D,PE_;<;F,$QAN8;>1BR[I&.R-V 5Y2S E@NKMN;;N
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MG?B\BRK[I_6R@:[7'N,*DO)\9:31IRC!KIA+MCN0=3:W'E>!O<7RO Q WQD
M=5:LG<D=0VG%*<4IQ2G%*B.SUHN0J?FW0/L;8Z9M=G:$9S4.OKHA%:'7"M7_
M )6N?^M-*J*R"%'2.^#?CB\OE(L5:]TJ9+ISLBC'PI9#\%5_YV;R*NK'H*SO
M'L%/GK[L!A%8Q+W)YF'H0PK\*1O?TZ(OE=R%'4UP83,E9NGE=;D1'::].GO=
M381(J1$W)K8VOA%\4:YM=6#11BC-\$\(86KX(JKRGA,=+C[0FZ8/D9W,DS#R
M&1M.@_S4 "(/V*CSDU5Y-F(,O?J+!#%A[:(0VR'RK$FNA;_O)&+22'KZ;GKH
M!4UYF*CM.*5;+JH!T%/:T5I$Z:MN:XRK/B9))#)(&>/(*0V.:)S)89%BE7RO
M8J.8[P5%141>4+JVBO+:2TG&L$J,K#73HP(/4=0=#Y1U%7F/OKG%W\.2LR%N
M[>5)$) (#(P9=0=01J!J""".AZ5;/X,RS[>'0D4%.5H87P3_ %TBKKUM)31P
MFUT-E*1&-&BV40#5@9.C6OB@<Z)BMC<K5H?@RP-P+QX8VO 0>X57<6"[0Q(
M](+Z(;RA=5&BG2KSYP9I;%L5%=7"8I@5[*R/VPC/W#&%+'XLOZ90DAG =@7
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M;/G&#AAD=9W*^-N>KHVM_P"JLW>+IW_\TKE5SO%555IQ6%E"_=AB19"[/J
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M3(8:> I60+XLA%C<QC6QM\J6PL<5:QFT6*%(KC5"NT 2>BQ*:><! ^B^14!
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M+H+^#F\AGY@4 J*2I)E,)^GNB'%&*)L)ZU6$^C)X-G+,=3UGE=\7O04;P_\
M5Q_JW<5ECK-D[4<4;ECMT !+%>NGG+;%]\[5]Q>F+N<OG<I'+[3/<3PK&N_5
MF9502:KJ/(J=V34>0=R37X3]3<5D62 S,S=,V:LKJ6IKY6@#I()69RPAMJ "
M%Z,\S!:6S@;.*S_E@E17,\%5?$,7C@R,((MT:(BG:.BQL'C4>\C ,H_6GJ*'
MD6=9)(VN[@QS2RRN-[:-).ABG<C7JTL9*2'RNO1M0!I:K?/9.](!R4[((4I[
MZG[)GHV!1-'L#A=,;HZNR=(0*^-\HVZ!CLY'C/0B,N&)95:R=$EM[FSQ]VZ8
MYM (YDN2FT:,PE:16U(\HG42DJ=P=5W:!O2OK'*YS&Q29V,LQGM9; 3%SN1&
MMT@DCT5@0&LW:W42 HT3N$!:,E+KH<7E]6^%^AIQ[5(13 %B(?.@Y5>>L#RZ
MZQ%BFC&M*Z:86*7T"62PI-$R1&I(QKDN+S&6&0(-Y&LFBE=#KH5;356 (#*2
M =K C< VFH!JQQ7(,SA%9<5</ 6='U4+N5TU"R1L06CD 9EWQE6*,R$E6(-4
M%F*.OMBKP0%([0MA,;R'D%SM@C.(@+L8Z\:>>42K9:&#13EH,R%"YXV23>=[
M6N2I%8VD-PUW&FD[ C74G3<06V@DA-Q 9]H&]@"VI -4;C,9*ZL4QL\FMG&5
M(4*HU**5C+LH#2&-&9(C(6[:,R1[5)!^7Y/,2AA5\V?IYP*ZGDSX()%>*0&-
M1RK6.EJ8AIHWPI7R.IA%6+R^15'C^'ZJ<X./L6C6%H8S"D9C52H("';J@!&F
MWT$Z>3T1[E<KG,PD\EU'=7"W4MP)W=796:8=S24L"#O'=ET;77XQO=-?55EL
MY2**ZHI:VN>% >,/**+%%,V*UEKY[17SM;ZTTMD15#2$2/<Z2>2%CGN<Y/'G
M-O865KM-O$B%0P!  .CE2W7RDL44L3J6*@DDUQ>YG+9$.+ZXFE61D9@S$@F,
M.L>@\@$:R2*B@!45V"@ Z5]D9K/F9R;(%TM85EB*9^=(SQ <$]//12!+7/J)
M@)6.&EKG@+Z*Q.:K%C_5\/#G+V-G)9''21(U@T7;,9 *&/;MV%3T*[>FGDTZ
M5\Q9?*099<[!<3)FDN!.LZN1*)@_<$H<'<'#^D&!UW===:2YK/SF&V$M+6//
MLI**:Q,4.#YDZ;,&NL<[*7,C$D(DI#G+*,YZJL+_ (M\/#AK&S:1IFB0RN8R
MQT&K&)MT9)\Y1NJZ^0^2B9?*1V\=JEQ,+:$3!$WG:@N$[<X4:Z*)D]&0#3</
M+K7S-E\X218%DT=421;#V =I(0"/.MB);!T]=9BG-EC>PH>P SP,,S'HYLD0
ML37(J,1.<-863N\CQ1L\BL&)4'<'5%8-KY0RQHI!Z$(H/DKF/,Y:&**"&YG2
M*!T:,*[+VVB>62-DT(*LCSS.A&A5I'(ZL:HW8C(22UT\N:I9IZF(6"NGGKQI
MIAHP"G'@M265CWR*%8.<1"KU<L1#EE:J2*KEIG%XTLCM!$7C "DJ"0%.Y>I\
MNUO2&OD;5AU.M5QR+/*DL27EPL4[,7 =@&+KL?H" -Z 1L!H&C 0ZJ *E/+^
ML-3BE.*4XI3BE.*4XI3BE.*4XI3BE1'6XZOU@XCI)B:N[J)GF9[1UKFQVM&<
M]GINF&>Y%C(%(9^H0-*CX"(_U7M7P:K<7E,3!E(U+%H[R([HI4Z/&WDU'F(/
MD9&U5AT(\A&=P6?NL'+(J*DV.G4+/!)UCF0'71AY593U212'C;JI\H,2&WUG
MDW1UG:0<=6B.; +NZV&:3&VWBJ-B?8R(DLV3/D14\\1G@,KT=Z4SD\$3%1YR
MYQ9%MR5!%UT6Y0$V[^YN/4P,?.']#77:Y'2L[-Q>SS@-YPJ0S'35K*0@7<7N
MB,=!=(/,T6LFFF^,'K65!2A3AXBPB8"Q9V)) 2+-&0/-&OZ'Q31.?'(Q?#]*
M*J<DT<L<T8EA97B8:@@@@CWB.AJ%3036TK07"-'.IT*L"K ^X0="#]6N?GW5
M*BJB(JJO@B?%57X(B)_Q7BGEZ#RUC.V[-K$,FHL<)-NM/'Y625U)(QU76/>Y
M&I)H="J/JZ>%GQ5S%=(2OAX-B<J\CMUR*W$ILL2AO<B/*D9]!/?EEZI&/>U+
M^XIJ8V/#KPVZY//R+C,,>HDF![D@'F@@Z22D^8@+'YRXKFR^+-'M';#9'#WN
MTG&>+#(-$^*DS $R^:6IS DROEBCD7P2<N55)*\J>96L_HT^\;B)DN?PKEW6
M;+LN@(&D<*GRI"IZ@']<Y]-_/H/1JGFN0V\MD,!Q^)[;CRN&(8@S7#CH);AA
MH"1Y4B7XN/7IJWI5D;F?J)4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4X
MI6O7M\_^-_\ \PO97_N7D.X?_P#%/]L7/_H5M3Q2_P#ES^BMA_[6MA>3&M5T
MXI3BE8UT61MQK>38X,H6OT,L<;+NF/61F?V(\#4;"RT]!KW@7(L2>4:PC8Z1
MC?Z.5LD7@UL>O\5=1W1RV$94OR/C(VU$4X'DWZ=5D Z)* 2/@L&7H)?B<[83
M6 P')D>7%*2894T,]JQZDQZZ!XF/62!B%)])"K]3RT795'8&1T=[$1C-8O@U
MV;TJQ!SDR?JM<^CL//\ 3-&(Z151D@DLCE1/%S&+\$^K+D-G/*+*]#6F4_[*
M7123_P!VWP)5U\A0D^Z!Y*^,EP_)6D!R6,*9#!_=%OJZJ/+I-'^V0-IY5E51
MK\%F'6LB\S]1.G%*HK"RKZD28^U.#K01V^><P\F$06%J?]Z6<A\<3$^'_%>4
M9[B"UB,]RZ1PKY68A0/JDZ"KBUM+N^G6ULHI)KECH$12S'ZBJ"3_ )*Q=+L[
MW<.=7]:#K!5O7TR^QK<*1M*/&O@DBY:M(2&?4&M\51DJI& US?%9)/\ E6-M
ME[W,GL<=7;;'HUTZGM@>?LH=#,WN-TB!'PF\E31./8SC8%US!]UZ.JV$3CNL
M?-[3(NJVZ>35?2G(/P$\HG&4R=3CZOZ;5MGE=-/*=9V9\OS5M=69*^8NUMC5
M:UY9Q+_BYW@C6HB-8UK&M:F9QF+M<3;>SVVXDL6=V.KR.?A.[?KF/^0>0
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MRM+>QD*]B(B6=;:!IUG8KOE#3"1)(V;MMHQV[BS-CBI'[CM#*0FU9;T\FR.
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MBE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI6O7M\_P#C?_\
M,+V5_P"Y>0[A_P#\4_VQ<_\ H5M3Q2_^7/Z*V'_M:V%Y,:U73BE.*4XI3BE.
M*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI
M3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI
M3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI3BE.*4XI3BE.*5KU[?/_ (W_ /S"]E?^Y>0[A_\ \4_VQ<_^A6U/%+_Y
M<_HK8?\ M:V%Y,:U73BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5X&OO<[7_$[L+[::3]Y<\COG%R#[OO
M/72?95^G;YB<(^1L5]Z6_P!KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PC
MY&Q7WI;_ &NGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO\ :Z?>
MYVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_P!KI][G:_XG=A?;32?O
M+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_ &NGWN=K_B=V%]M-)^\N/G%R#[OO/72?
M94^8G"/D;%?>EO\ :Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6
M_P!KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_ &NGWN=K_B=V
M%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO\ :Z?>YVO^)W87VTTG[RX^<7(/
MN^\]=)]E3YB<(^1L5]Z6_P!KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PC
MY&Q7WI;_ &NGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO\ :Z?>
MYVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_P!KI][G:_XG=A?;32?O
M+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_ &NGWN=K_B=V%]M-)^\N/G%R#[OO/72?
M94^8G"/D;%?>EO\ :Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6
M_P!KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_ &NGWN=K_B=V
M%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO\ :Z?>YVO^)W87VTTG[RX^<7(/
MN^\]=)]E3YB<(^1L5]Z6_P!KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PC
MY&Q7WI;_ &NGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO\ :Z?>
MYVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_P!KI][G:_XG=A?;32?O
M+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_ &NGWN=K_B=V%]M-)^\N/G%R#[OO/72?
M94^8G"/D;%?>EO\ :Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6
M_P!KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_ &NGWN=K_B=V
M%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO\ :Z?>YVO^)W87VTTG[RX^<7(/
MN^\]=)]E3YB<(^1L5]Z6_P!KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PC
MY&Q7WI;_ &NGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO\ :Z?>
MYVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_P!KI][G:_XG=A?;32?O
M+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_ &NGWN=K_B=V%]M-)^\N/G%R#[OO/72?
M94^8G"/D;%?>EO\ :Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6
M_P!KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_ &NGWN=K_B=V
M%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO\ :Z?>YVO^)W87VTTG[RX^<7(/
MN^\]=)]E3YB<(^1L5]Z6_P!KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PC
MY&Q7WI;_ &NGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO\ :Z?>
MYVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_P!KI][G:_XG=A?;32?O
M+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_ &NGWN=K_B=V%]M-)^\N/G%R#[OO/72?
M94^8G"/D;%?>EO\ :Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6
M_P!KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_ &NGWN=K_B=V
M%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO\ :Z?>YVO^)W87VTTG[RX^<7(/
MN^\]=)]E3YB<(^1L5]Z6_P!KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PC
MY&Q7WI;_ &NII@K;W)]IZ&/)]<:#N';::84HZ*BS6BUMM:2!A-:\LE@@A\DR
MPC,<BO=X>#47X\RF(N.;9^\&/PLV2NKXJ6$<4DSMHOE.@;70>>H_R>P\(N%X
MHYSEMK@,=AU=4,UQ!:Q1AW.BJ69 -6/D'GKCW-W[D>LM!/E.Q;WNC#:4>&$F
M6CU=UM**T00CS_+&,#LBQYI0R?3=Z4S4=%(B*K7+X<^<K=<VP5X<?FI<G:7P
M )CE>:-M#Y#HQ!*GS$=#YC7UQO'>$?,<6N;XG;<>R6(=BHFMH;2:/<NFY"\:
ML ZZC<I(9=>H%0_[W.U_Q.["^VFD_>7,;\XN0?=]YZZ3[*L]\Q.$?(V*^]+?
M[73[W.U_Q.["^VFD_>7'SBY!]WWGKI/LJ?,3A'R-BOO2W^UU+J^?W&?Q@+U]
M3V/;\VYT,E=8AY&FM=:5H;J71TX>AKCQZJN*E,L)+:A+A,9*UCUD&>V15\OQ
MYD87YI^$EP]L^2.5F*L(4>8R.9$$BL$4DMOC*N#H=5(;R5@KJ+PF_ #\IOXL
M"O&[4/&]U+%:K!"()6@D1I)%"((IE>(J2-L@*:;NE7K81>ZKKT:Q+WAO=^,B
MJ;X/,63-3<[*A*#O;&K(NZ^OF"LS1C4>=4"R$PO]-8Y86^9KE14\;K)#G^'1
MY,L^5MECF$3=UYHR)&4NJE68-Z2 L#IH1U!K'X%O!/E4T4'&8^.9!Y[9[B,V
MT5I,KPQR+"[AXT9-$E98W&[<KG0@'6N<8+W6&5H5Q!9=QNK++.4VO -?J-)"
M.9F=%MX.N*2Z&?-:Q^L#9[@F.NB>WQ\T\C?^XY'+])'X@20+<I)DNP\"3*W=
ME :*2<6R.-7ZJTY$8/[(CS'6J<T_@E!=R6$L/'Q>0W<MJZ"WMRR7$%H;^:%@
M(SH\=FK3L#Y$4_K@14#NNP^ZL[<6V?N^P>R*VZHK,^FMZXG9Z)I %I6%2A'A
M3HVT<U)A2X'L<B*J>9J\Q-UF>465S)9W5Y>I=1.R.IFDU5E)5E/I>4$$&I+C
M^*>'>6L(,ICL5B)L?<PI+%(MI!M>.10Z.OQ?D92"/>-6S[W.U_Q.["^VFD_>
M7*'SBY!]WWGKI/LJO/F)PCY&Q7WI;_:Z?>YVO^)W87VTTG[RX^<7(/N^\]=)
M]E3YB<(^1L5]Z6_VNGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO
M]KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_:Z?>YVO^)W87VT
MTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_VNGWN=K_B=V%]M-)^\N/G%R#[OO/7
M2?94^8G"/D;%?>EO]KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI
M;_:Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_VNGWN=K_B=V%]
MM-)^\N/G%R#[OO/72?94^8G"/D;%?>EO]KI][G:_XG=A?;32?O+CYQ<@^[[S
MUTGV5/F)PCY&Q7WI;_:Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]
MZ6_VNGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO]KI][G:_XG=A
M?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_:Z?>YVO^)W87VTTG[RX^<7(/N^
M\]=)]E3YB<(^1L5]Z6_VNGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%
M?>EO]KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_:Z?>YVO^)W
M87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_VNGWN=K_B=V%]M-)^\N/G%R#[
MOO/72?94^8G"/D;%?>EO]KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&
MQ7WI;_:Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_VNGWN=K_B
M=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO]KI][G:_XG=A?;32?O+CYQ<@
M^[[SUTGV5/F)PCY&Q7WI;_:Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^
M1L5]Z6_VNGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO]KI][G:_
MXG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_:Z?>YVO^)W87VTTG[RX^<7
M(/N^\]=)]E3YB<(^1L5]Z6_VNGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"
M/D;%?>EO]KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_:Z?>YV
MO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_VNGWN=K_B=V%]M-)^\N/G
M%R#[OO/72?94^8G"/D;%?>EO]KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)
MPCY&Q7WI;_:Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_VNGWN
M=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO]KI][G:_XG=A?;32?O+C
MYQ<@^[[SUTGV5/F)PCY&Q7WI;_:Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3Y
MB<(^1L5]Z6_VNGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO]KI]
M[G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_:Z?>YVO^)W87VTTG[R
MX^<7(/N^\]=)]E3YB<(^1L5]Z6_VNGWN=K_B=V%]M-)^\N/G%R#[OO/72?94
M^8G"/D;%?>EO]KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_:Z
M?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_VNGWN=K_B=V%]M-)^
M\N/G%R#[OO/72?94^8G"/D;%?>EO]KI][G:_XG=A?;32?O+CYQ<@^[[SUTGV
M5/F)PCY&Q7WI;_:Z?>YVO^)W87VTTG[RX^<7(/N^\]=)]E3YB<(^1L5]Z6_V
MNGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO]KI][G:_XG=A?;32
M?O+CYQ<@^[[SUTGV5/F)PCY&Q7WI;_:Z?>YVO^)W87VTTG[RX^<7(/N^\]=)
M]E3YB<(^1L5]Z6_VNGWN=K_B=V%]M-)^\N/G%R#[OO/72?94^8G"/D;%?>EO
M]KK'O,/4KIQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2
MG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<
M4IQ2G%*<4IQ2MSO8WH,C0]G]@P[.VQ]56:?V^=WXL-N\T3\GEKBZU>*,IZG/
M6V@A+!*JQ;LHA())H)HIXHWN?&YKFHJ;,\*[S'6F=O%R<EM'!/A[Z$=^3M1.
M\L!1(WD!4J')VEE(8 D@@C6NOOTD,7G<GPW%R<?@OY[RSY3B+MC90"YN8HK:
M[266>* JZR-"J[U1T9&8!6!!(K;'8:SHT\&GH*;1=%/[CQ/MUS.-Z[I]%85W
M9GMVP5P'W1=6VEIL_K.RJJWI=#IKO 6*V'J7ZV00))1 HA7F:+%!L')9#BLL
M4=G;38GYRVN%BAMTD9;G'0.+UWE2.6Y1TDE>W;N:W'=1&=XXY-1&J:.P.#\2
M+:YGRF0M.2C@&1Y9<75]+ DF/SM[$V)ABMY9[;'R1306\-['V-MD+>::..*:
M>'0S/)350_M!EUG;!X>JZ53K#3WNTSK\H9E<V':5%A'TY1O"TV&U&PKS^QZG
M'W';LYZ4,6?CK6@Q#(ZP-^7E8,[XMT\.&R.0FBN,7^ IY9H^T8HU9&]C3;+!
M+,K7*0O>&3L"W$0C"@S2[&"&M>R^/"8/!VMQ9<A^>5G;6DXN5N;AXY4.5F#V
M]Y;VKI82W46+$/MK7S7!F:0BUM^ZC3"#MVW1QG8>GSE#2^W*J3)>VC$D=+WM
MYCL0_&W/>N@P72A._*[$L[BLLJ+37M6YFCAKQ;MLE(%:Q/\ ,/\ ,RR/DQ0R
MG%9<S/96D6%C]GP<!LI)(8.R]]);V1N#<,ZM'+(O^LK&D^L"2@ZIW&):2'CO
MB/;\5L\MD[CELYON87:Y:&&ZO!=18:"]RRV2V,<4D<UO#)K8//)9D7DMLR[9
M>RBJE%==IB.]ZUGL,-O.B7U=MTGUWC+ [;SW=5TWK12?;1U_A=OA6V&9 #/R
MT9A,9H(\CG5<=?/!Z<LL'D5BT[K/QGQ/DR6*N\28),7;PLTY=+.8'&6\$\&Z
M)5:($AT4_%"-ET9DTTJXQW"YQ]'B' <DQG)A>0<BOKM$LQ#)E;9EY!>WEG>;
M+AW2Y**89G4"Y:='W(DNX-6;P]+[.JVBM<15WV*^<-V^2L\I5:?3%]B]-8OM
MYO0.HI(BK>38A-O]ITAEM82/70$F+,&.8Z*0A3JZ%\4\ICO?#:"TDQ<$UKW&
MNH6B264W%G#>?@^5 7[R]R:QBE*QJSZHK[2_=A4J^N)\1X^7F2@Y'>VV1[$>
M.NH[F2WMUL<K=XLYNVF*Q"U?L6F7N;99)WCBVRO$'6+V:[D5X\2X7==29O$5
M <>CP-+=F^W#I.LU45630@O/W])_,'&V5_!8K5^F.=>U_6]<.?*Y5>]M1!$]
M%]!C/".XK*\=LL7'&)K.*Z;"62RA3&NZX3D FD#;>C2+;*LA/4B%5/P *G7)
M>-<YR_(Y[AK3*7&.CY;EY+8R+,X2RFX.UI"8^YJR0O?R/"HZ W3NI'<9M;'W
MS8=5:GJ'MV^J[GJ.FT2=S]B7%"33S=6;7?=S1:#NNW*$*(F95??#UC%0X\M)
MX)HSWYFTK!&,]%AI+G.M>6S8"_XYD;N"7'17OX3N'C*&UGN+T27KD$G9[9:B
M.$[E82&VEB0#:)7).1\,K7FV%YW@L9>V^=N,5\WK&*991DK2RQ1@Q$2LJ@R?
M@O(F:Z78Z-",A;7$K-W&MX0%ZU>:1KM[3BE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI
M3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5WH_D8=K_CKUY]G-)^TYVL_
M-4Y!\K6?JY/KUYL?I)>$?BUE?7V_UJ?D8=K_ (Z]>?9S2?M./S5.0?*UGZN3
MZ]/TDO"/Q:ROK[?ZU/R,.U_QUZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$?BUE?7V
M_P!:GY&':_XZ]>?9S2?M./S5.0?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_QUZ\
M^SFD_:<?FJ<@^5K/U<GUZ?I)>$?BUE?7V_UJ?D8=K_CKUY]G-)^TX_-4Y!\K
M6?JY/KT_22\(_%K*^OM_K4_(P[7_ !UZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$?
MBUE?7V_UJ?D8=K_CKUY]G-)^TX_-4Y!\K6?JY/KT_22\(_%K*^OM_K4_(P[7
M_'7KS[.:3]IQ^:IR#Y6L_5R?7I^DEX1^+65]?;_6I^1AVO\ CKUY]G-)^TX_
M-4Y!\K6?JY/KT_22\(_%K*^OM_K4_(P[7_'7KS[.:3]IQ^:IR#Y6L_5R?7I^
MDEX1^+65]?;_ %J?D8=K_CKUY]G-)^TX_-4Y!\K6?JY/KT_22\(_%K*^OM_K
M4_(P[7_'7KS[.:3]IQ^:IR#Y6L_5R?7I^DEX1^+65]?;_6I^1AVO^.O7GV<T
MG[3C\U3D'RM9^KD^O3])+PC\6LKZ^W^M3\C#M?\ '7KS[.:3]IQ^:IR#Y6L_
M5R?7I^DEX1^+65]?;_6I^1AVO^.O7GV<TG[3C\U3D'RM9^KD^O3])+PC\6LK
MZ^W^M3\C#M?\=>O/LYI/VG'YJG(/E:S]7)]>GZ27A'XM97U]O]:GY&':_P".
MO7GV<TG[3C\U3D'RM9^KD^O3])+PC\6LKZ^W^M3\C#M?\=>O/LYI/VG'YJG(
M/E:S]7)]>GZ27A'XM97U]O\ 6I^1AVO^.O7GV<TG[3C\U3D'RM9^KD^O3])+
MPC\6LKZ^W^M3\C#M?\=>O/LYI/VG'YJG(/E:S]7)]>GZ27A'XM97U]O]:GY&
M':_XZ]>?9S2?M./S5.0?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_P =>O/LYI/V
MG'YJG(/E:S]7)]>GZ27A'XM97U]O]:GY&':_XZ]>?9S2?M./S5.0?*UGZN3Z
M]/TDO"/Q:ROK[?ZU/R,.U_QUZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$?BUE?7V_
MUJ?D8=K_ (Z]>?9S2?M./S5.0?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_QUZ\^
MSFD_:<?FJ<@^5K/U<GUZ?I)>$?BUE?7V_P!:GY&':_XZ]>?9S2?M./S5.0?*
MUGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_QUZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$?B
MUE?7V_UJ?D8=K_CKUY]G-)^TX_-4Y!\K6?JY/KT_22\(_%K*^OM_K4_(P[7_
M !UZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$?BUE?7V_UJ?D8=K_CKUY]G-)^TX_-
M4Y!\K6?JY/KT_22\(_%K*^OM_K4_(P[7_'7KS[.:3]IQ^:IR#Y6L_5R?7I^D
MEX1^+65]?;_6I^1AVO\ CKUY]G-)^TX_-4Y!\K6?JY/KT_22\(_%K*^OM_K5
MC;J?^3QV3VQC4V5=W'AZD5=9V+E/DC:*^GG^8ZZ[$U779I?J0/2/T;$W*R$Q
M-_YF12M:[]9%YA./?1NS?(<9^$X<E:QI[1<Q;6CD)UMKB6W8]/,S1%A[@(!Z
MU+N<?3WXCP?D'S?NL!DIYO8;"YWI-"!MO[&VOD70C76-+E8V/D+*2.A%9)_(
MP[7_ !UZ\^SFD_:<S?YJG(/E:S]7)]>HC^DEX1^+65]?;_6I^1AVO^.O7GV<
MTG[3C\U3D'RM9^KD^O3])+PC\6LKZ^W^M3\C#M?\=>O/LYI/VG'YJG(/E:S]
M7)]>GZ27A'XM97U]O]:GY&':_P".O7GV<TG[3C\U3D'RM9^KD^O3])+PC\6L
MKZ^W^M3\C#M?\=>O/LYI/VG'YJG(/E:S]7)]>GZ27A'XM97U]O\ 6I^1AVO^
M.O7GV<TG[3C\U3D'RM9^KD^O3])+PC\6LKZ^W^M3\C#M?\=>O/LYI/VG'YJG
M(/E:S]7)]>GZ27A'XM97U]O]:GY&':_XZ]>?9S2?M./S5.0?*UGZN3Z]/TDO
M"/Q:ROK[?ZU/R,.U_P =>O/LYI/VG'YJG(/E:S]7)]>GZ27A'XM97U]O]:GY
M&':_XZ]>?9S2?M./S5.0?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_QUZ\^SFD_:
M<?FJ<@^5K/U<GUZ?I)>$?BUE?7V_UJ?D8=K_ (Z]>?9S2?M./S5.0?*UGZN3
MZ]/TDO"/Q:ROK[?ZU/R,.U_QUZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$?BUE?7V
M_P!:GY&':_XZ]>?9S2?M./S5.0?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_QUZ\
M^SFD_:<?FJ<@^5K/U<GUZ?I)>$?BUE?7V_UJ?D8=K_CKUY]G-)^TX_-4Y!\K
M6?JY/KT_22\(_%K*^OM_K4_(P[7_ !UZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$?
MBUE?7V_UJ?D8=K_CKUY]G-)^TX_-4Y!\K6?JY/KT_22\(_%K*^OM_K4_(P[7
M_'7KS[.:3]IQ^:IR#Y6L_5R?7I^DEX1^+65]?;_6I^1AVO\ CKUY]G-)^TX_
M-4Y!\K6?JY/KT_22\(_%K*^OM_K4_(P[7_'7KS[.:3]IQ^:IR#Y6L_5R?7I^
MDEX1^+65]?;_ %J?D8=K_CKUY]G-)^TX_-4Y!\K6?JY/KT_22\(_%K*^OM_K
M4_(P[7_'7KS[.:3]IQ^:IR#Y6L_5R?7I^DEX1^+65]?;_6I^1AVO^.O7GV<T
MG[3C\U3D'RM9^KD^O3])+PC\6LKZ^W^M3\C#M?\ '7KS[.:3]IQ^:IR#Y6L_
M5R?7I^DEX1^+65]?;_6I^1AVO^.O7GV<TG[3C\U3D'RM9^KD^O3])+PC\6LK
MZ^W^M3\C#M?\=>O/LYI/VG'YJG(/E:S]7)]>GZ27A'XM97U]O]:GY&':_P".
MO7GV<TG[3C\U3D'RM9^KD^O3])+PC\6LKZ^W^M3\C#M?\=>O/LYI/VG'YJG(
M/E:S]7)]>GZ27A'XM97U]O\ 6I^1AVO^.O7GV<TG[3C\U3D'RM9^KD^O3])+
MPC\6LKZ^W^M3\C#M?\=>O/LYI/VG'YJG(/E:S]7)]>GZ27A'XM97U]O]:GY&
M':_XZ]>?9S2?M./S5.0?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_P =>O/LYI/V
MG'YJG(/E:S]7)]>GZ27A'XM97U]O]:L;8W^3QV3L=EVYC1NX\.&5U'K,]E+$
MV>BOI(+<C0]=X_L2$L*.-_J00CA;",9S9/UEEA<Y/U53F$QOT;LWDLGD<8F2
MM5?'7$<3,8Y-',EO#< K[@"S!3KYU)\E2[/_ $]^(X#C^"Y!-@,E)#G;&>YC
M030@Q+!?75B5<D:$L]JT@(Z!7 /4&LD_D8=K_CKUY]G-)^TYF_S5.0?*UGZN
M3Z]1'])+PC\6LKZ^W^M3\C#M?\=>O/LYI/VG'YJG(/E:S]7)]>GZ27A'XM97
MU]O]:GY&':_XZ]>?9S2?M./S5.0?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_P =
M>O/LYI/VG'YJG(/E:S]7)]>GZ27A'XM97U]O]:GY&':_XZ]>?9S2?M./S5.0
M?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_QUZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$
M?BUE?7V_UJ?D8=K_ (Z]>?9S2?M./S5.0?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,
M.U_QUZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$?BUE?7V_P!:GY&':_XZ]>?9S2?M
M./S5.0?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_QUZ\^SFD_:<?FJ<@^5K/U<GU
MZ?I)>$?BUE?7V_UJ?D8=K_CKUY]G-)^TX_-4Y!\K6?JY/KT_22\(_%K*^OM_
MK4_(P[7_ !UZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$?BUE?7V_UJ?D8=K_CKUY]
MG-)^TX_-4Y!\K6?JY/KT_22\(_%K*^OM_K4_(P[7_'7KS[.:3]IQ^:IR#Y6L
M_5R?7I^DEX1^+65]?;_6I^1AVO\ CKUY]G-)^TX_-4Y!\K6?JY/KT_22\(_%
MK*^OM_K4_(P[7_'7KS[.:3]IQ^:IR#Y6L_5R?7I^DEX1^+65]?;_ %J?D8=K
M_CKUY]G-)^TX_-4Y!\K6?JY/KT_22\(_%K*^OM_K4_(P[7_'7KS[.:3]IQ^:
MIR#Y6L_5R?7I^DEX1^+65]?;_6I^1AVO^.O7GV<TG[3C\U3D'RM9^KD^O3])
M+PC\6LKZ^W^M3\C#M?\ '7KS[.:3]IQ^:IR#Y6L_5R?7I^DEX1^+65]?;_6I
M^1AVO^.O7GV<TG[3C\U3D'RM9^KD^O3])+PC\6LKZ^W^M3\C#M?\=>O/LYI/
MVG'YJG(/E:S]7)]>GZ27A'XM97U]O]:GY&':_P".O7GV<TG[3C\U3D'RM9^K
MD^O3])+PC\6LKZ^W^M3\C#M?\=>O/LYI/VG'YJG(/E:S]7)]>GZ27A'XM97U
M]O\ 6I^1AVO^.O7GV<TG[3C\U3D'RM9^KD^O3])+PC\6LKZ^W^M3\C#M?\=>
MO/LYI/VG'YJG(/E:S]7)]>GZ27A'XM97U]O]:GY&':_XZ]>?9S2?M./S5.0?
M*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_P =>O/LYI/VG'YJG(/E:S]7)]>GZ27A
M'XM97U]O]:GY&':_XZ]>?9S2?M./S5.0?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.
MU_QUZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$?BUE?7V_UJ?D8=K_ (Z]>?9S2?M.
M/S5.0?*UGZN3Z]/TDO"/Q:ROK[?ZU/R,.U_QUZ\^SFD_:<?FJ<@^5K/U<GUZ
M?I)>$?BUE?7V_P!:GY&':_XZ]>?9S2?M./S5.0?*UGZN3Z]/TDO"/Q:ROK[?
MZU/R,.U_QUZ\^SFD_:<?FJ<@^5K/U<GUZ?I)>$?BUE?7V_UJ]*W.[M>0M.*4
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI3BE.*4XI3BE:L^S7^HQO\ ;)[GO]3G;_(%X:?S4_WEE/XS
MO*W3](#^\D_T?X]_5[%UM-R>UI:G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G
M%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4K5GHW^O/
MWI?VR=9_Z8^D>0+BO\Z^3_[2MOXLL:W3XD?W;>'G]'\A_6'+UM-R>UI:G%*<
M4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2
MG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<
M4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*U9]FO
M]1C?[9/<]_J<[?Y O#3^:G^\LI_&=Y6Z?I ?WDG^C_'OZO8NMIN3VM+4XI3B
ME.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI3BE.*4XI3BE:L]&_UY^]+^V3K/_3'TCR!<5_G7R?\ VE;?Q98U
MNGQ(_NV\//Z/Y#^L.7K:;D]K2U.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*
M4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3
MBE.*4XI4%[1W0G5_6?8G9AX!%H#UWA==NC:P22.$NQ$R-!87Y( LTWC#$07#
M7K&QS_U6N<BK\.8K/96/ X.]SDR-)%96DT[*" 6$,;2%03T!(70$]-:DO#.-
M3\SYAB>'VLJ0W.6R5K9I(P)6-KJ=(%=@.I52X8@=2!TZUU#Y_P#GB]!F%LAT
MO4O;-$*^1C/G*IV2T/I-?XHZ:<>>]H9$CB=X*Y(UD>K?%4:JHC7=<[/Z4_$9
M)-M]CLC%&3Y4[,FGOD&2/H/>U.GD&O0][<I_PX?$^" R8?.8.YG )V2>U0:Z
M>8,(9AJ>NF[:-=-2 21O!T__ #"?:+W9./6Y7N"BIK\F2."'-[QL^&MYR9E1
ML(H"Z)@59<E2N7P;&"22_P ?AX>/-I\<\8O#KE#B"PR445XQ $<^L#DGR!>Y
MM5R?<1F-=<N>_17\=O#N)KO-X&YN,6@)-Q9;;R)5'E9^P7DB4>=IHXQ6Z7-G
M5UZIQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4I
MQ2G%*<4IQ2M6?9K_ %&-_MD]SW^ISM_D"\-/YJ?[RRG\9WE;I^D!_>2?Z/\
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MV2:9=\@GFA9+6;=&\$4.C(=Y>;5KK=3BE.*4XI3BE.*4XI3BE:L^S7^HQO\
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M&J.QZ<*4FH,C\ZJV)-)5CRUTJ,3SSD_)(J^6+F[OHV\VDP?*VXK=N?P7E!Z
M)Z)<HI*$>YW$!C.G5F[6O1:ZH?3Y\(H>7^&R>)&-C'SBXZ092!Z4MA*X653I
MY?9Y&6=23HD?M&G5Z]4'._%>*U<! HI;6,*&@)9'+'/&PB&.9K)X7(^&9C9&
MN1LL3T\6N3XM7XISX>..0 2*& (/4:]1Y#U\X\QJK%-- Q:!V1BI4E202#T(
M.GF(Z$>0TE%%GDAEG&@FE&611Y)88Y)(%FB=!,L+WM5T2RPO5CO+X>9JJB_!
M>&CC<AG4%EUT)&NFHT.GN:CH?>HDTT2LD;LJ/IN ) ;0ZC4#RZ$ C7R$:CK7
M VLK6)"UE>"QHXT@0[6B0-2 .5&)*)"B1HD0TB1M\T;?!B^5/%/@G/D00  !
M$ 5=HZ#HI\H'N ^YY*J->7;%BTLA+N';5FZN-=&/7JPU.C'J-3UK\;5UC?0\
MM< WY7Y;Y7RB#I\M\G%+"'Z'A'_0_*0SO9'Y?#TVO<C?!%7@00#31$]'33H.
MFT$#3W- 2![@)TH;V\;=K+*=^[=Z3>EO(+;NO7<5!;7RD G4@5]K75[H91W
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MZU]000"PQ#C0Q#CPL;'#!!&R&&*-B>#8XHHT:R-C4^"(B(B<Y1$C4(@"H!H
M!H!]05\R2R32&69F>5CJ22223YR3U)]\UR\^J^*<4IQ2H1V1=F9_%7UA6?\
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M-;R@#]D8(BQ^J7!;]6O?#Z&MX_(/HQX.UO2S;([ZV8GKJBWERJ >\L15 /\
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M] GF\?U8 K'-7K&1^#U:L7K:B1R?!'>=SO'Q3PYTZOCOP-@Y\JO<)^H&C?\
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M8JZEH\IVSTQA@(J*;K*WZ>UFFQ=1%B+.1)>O=UU%=ZGJ.^GR-M:AEPW%(?"
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M",,_ZE7?BES>U\-_#K,\YNRNW&V$LJ!N@>;3;;Q?_?9VCC'ON*]WH8@P @H
M4$8P80\ @@T+49$.,-$V&"")B?!L<43$:U/^")SUBCC2&-8H@%B50 !Y  -
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M0K/KO%[ .ON*B+-I754\QFFD>0=&X\IGJ+"B2101>;%X/(7^3EN[THG8UC$
M,K?!:WAF5701[4):4EI!W&&NWJJKK(>7X/"\>ML9B!-(;TB<W;+;1GTX[Z[M
M7>*4W'<D4);J$A801G;W"5>1]()5]F]E09K.Z^TK<^;)%T/#V+IJUFA-8&5,
M+&/8RS5LD65%\EI;A>HBM="P<-_ZB>LWP=S%09S-I90Y&=(688D7$J]QMI(
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M;>".W7?+[3O)=D""VG2!MH,9=B^\NBL$ "[68$@U3RO$,=B[>^O)[V3M6_L
MA58DD:4Y"RFO(P[K.(D6(1"*5T:4DN'2-@K*(!H]_L+.G'U$*0YZK,Z1WG:6
M<%K+HPLJ8W/$=;Z#/QZ*%U56PIZ4):QDPQ2S0SP'$#.\6-26;#WN7R4]LM^N
MD-NV+GNHPKDDM&;:2/N#8HZ Z, 2K*[H>@W-*,3QC V=^^&DW75['R.RQT[2
M0JJA)UOX)S 1)(>I7=&S*KH\,4PT9MD>T7)Y6F:U9]FO]1C?[9/<]_J<[?Y
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MMRU^UX8I]401H"FX+$NXM(R@;C(SQAB_;$:B/NR?.4M-3)HKVAT!]-<I65%
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MG2H,3,V)&Q,FF>QK6(WR-R6+N9;BW87!!GBFDC8Z::['(5CITU9-K-IT#$@
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M/DED<\RP)7P3S+Y&,\]N3<FY'XH\A?+99U6-%Z#J(+:$$G0:Z]/*222\C?J
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MQANGK?EJR9@\15,QU;*(]U$=")"PD!RJ&2R)C98WM8U$3XVQN42.6-=D:[5
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MN[OHIT[MXL:S=-WP (EV#75>NI.O3[^[JO4 NE=>:)^=F8^,/.N)K$K:ACK
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M_P :9C=O666OHP3+0HFZR(?S!ATI1Q;$>Z>>2:1TRT(N-6<;(3),RQG5 2@
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M?_TJXQ=I:V"SRM'> ,;R"&70M;6\A8I$G<,D@D5.\C2'M21[5TWA##$KQ!0
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MS@TJ1<4IQ2M6?9K_ %&-_MD]SW^ISM_D"\-/YJ?[RRG\9WE;I^D!_>2?Z/\
M'OZO8NLQ4%V>1O\ L>E.-\0J47%GU@4J0QJ(#;UMFA!C/!C)GBF6-7.U)'JY
MBR#R-:OBQR)/O-6EJPEB.Z-J1E<(6;1U-N(RA]NXFJT!M^0)>6]SW*F;J)[
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M)MC1K)5GBFN*.,N'3U.OL(%RQY:TL55J[JFB=>0",#?;,=(LLJ3.29O.M*H
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MDQD2OE4J_P!-!J[:>MD9L^RTK(APA\:=#G^U+?Y+84O8.SAV>=UZ :D!AO\
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M= _//MM'V=G=>^.+K#M)U]-)=6EP!V'58AVD;FV"L(F%<ZWBG5C7#RPND?\
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MG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2M6>C?Z\_>E_;)UG_ *8^D>0+BO\
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MNMOB6P2Z?-658&4J(':^G&;1G*OF^%?>U\A=,>O@U5_H9W_#X_HY97N*R..
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M&"&-D>(4.4R&:0:9PT\4[8B(51)8)'1.<C)HE7]9J^#F_P#%.?"21R F-E8
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M*<4IQ2H)<]E8RD.=4S6_U&[;\%H<\&=I+MKOAX,EJZ,8\L9SO,GAZK6(J?\
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M6=Q;]J#M1M>!"P]H:<3S2JLBRHT$)A"Z+)UU81[A?@GQG,>&>5R.9L6AR<>
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MC*C;,$HI*P1)-X+\WF:SUW?8.;-I%)=VN?F6,1/"TDB#%SR*)5@FFCCF+,5
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M0"S><D$GSU&,SR?DO([N*_Y#D;Z_OH(UCCDN)Y9Y(XT^ B/*[,J)^M52%7S
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MB&Y*A2LR]0ZHS!MH%2T;K'K8/(1=?"=>X<7!#M5D&(&R=#!D(6.F>0YL6:B
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MV\N[VXCC$:-/-),RHOP45I&8J@U.B@@#S"I#R\K%4XI6K/LU_J,;_;)[GO\
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MH!V2=3%T'[63UV?!U\U5I>3<DG?N39"^>0W8NM6GE)]J  %SJ7U[X  $W[8
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M;J-675'5U.E2?J[H_K;J#-9_,X_.A,CS<6DCK[BP#KR;]%V-Y+I-8Y+&((9
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M !MJ0/(-="FNNF'OOH[(_P#N1_<+]I?:C_\ ].<C?SGS?XNYGUN*_E.I[_\
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M_G;3-VVHN+2YCE'O]MPQ4^\0"I!Z$$@]*E7-.,V/..'9/B5]M:QRF/GMF/E
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M'R>:YF(TT\P4J/=U!^J?$'Z:]@+#Z2G(2@ CG%C* "3\+'VH?77R$R*[: D
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MB\&LC;,]/KD(S$7)\=D++'W%[96]K=Z]J2W3;-(;=8RW?FB]$1"<>B')9UZ
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MHO$!=UM'+B74D[;@QSJR@^0FV#LKL!Y=+F-6/7:HZ5M>.X\$I"F0GMN31R*
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M TXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE:L^S7^HQO]LGN>_U.=O\
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MN+ >?Z)6,B:J2R"#OB<6:YOQC!'E<GBY&HL(\1>;67 N*W&=N2IN@I2WC/\
MUL[ [%T\N@T+OIY$5CY=!6WO GPCRWC3XCV/#;!9%QQ<2WLRCI;V:,.](3Y
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MAXKY61M55_\ (G#NL:&1SHB@DGW .I-<Q123RK!""TKL%4#RDDZ #ZIKAAL
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M.,O6QN1BO--1&XW#W5/1U_Z2DK^K7Z&N485.2\=N\,6VM<0D(_["0:-%(/\
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M'22RR.:R..-C5<^21[E1K&,:BJJJJ(B)SEF"@LQ 4#4D^:N$1Y'$<8+.Q
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MMUF2K,=HPRLU]9L'5M:5J9D(I#IKL6LKS9H=:0Q?G*^Q@\T<;EB<U',=7O\
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M!+V(R1?&,%SF64?@Y%BD8Q)W][O#KQMXKSF&.SNI$L.2$ -!(VBNWNP2'02
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M%?\ *N1K_/&D;7-SG(K*W'&[FU,<D^D#]M2)+A^X5;81KW)&8,00QUV=#J
M1$."Y:^//K#(BXM[/==P]]PT%E"( Z&93H8(41HU(9%T[@)7:Q<@V_=Z2FN!
MVT46>V4(NZSA0.BU(W5N\-,!RC"#0):-T(V3*L(;^P<>4@0YD4<(<4DICVN\
M8(#*.6O;:Y3V18;D)=P%9)1:SLRQ:LI301%A(VY]BN $!:0@ZJDEUQK$Y"PE
M.2>ZQ[38V[5X+9LC9(KW)5'$P+7*H8$V1]UXF+2LJ6ZE=))(.;MRLU-KYI,X
M1K1G5_6/:%I5KFK.YJO-NQ7XJ7$(7#6D#1VI:.0WY<(QDXQ#5E;)#(WQ;SZY
M%!?W'I637"E+&Z9>TSI\>.R8-0I <_#VHX96](%2-17QP6\PMEHN62Q<2YG'
M1R>T1Q2?ZFPNQ>;3(K&-=.SOFB*2(=C)(AT-1FSIM2#<V=7*?N8< -J;9HLP
MY/8VENG.+Q?7,],]EGGM(+NR,_'<SZ%KU:1.+$6K&O:UL<:QV,]M?Q7+P,]V
M,0MP^A!N97ZPVQ3THY!.8]YN =&9 ^@( 5=,O9Y#"W./AO$BQK<H>RBW!EL+
M>+T;N_64&.>W:S6<Q+8D:HDC1!BI8N^[]'S&PL%&EM;CL$F<;;8NM4P:XT^6
MCL,I+UIC6:0Z>CJK>,02,K2J:^5_C)*&7ZC8YFN1SE)8Y*;:UQ)>,ZW4*ZAY
M8@T1MH>XQ1'  ,N\D]2C[@&!U-)<Q@;7>EE!BTB?'7<FUHK>Y*7(R%T;=%FD
MB+,5M^R%&BK+%L+1E2 (X^HUK3]@^4?L6/2LS4-!UM:A3ZOY8FSSW8W=H^4=
MI;$0EM7;"!T)=,03)H7RBECD-D>LKI9?-9&WR FN2PO1?=@1VSJ9="T=S>B+
MNL#M<",PLQN"5=6#'<6;7++?X-K6P5&Q)Q!O#-?QN+;<L<]AB&N?9XV7N1,T
MRW:1K8A9(W0HH1432YV('8+JSL&46^W NZ3/=K0C#@TNKDJE<6RX=B"LN797
M%IU]'8A^G6RUWR0DIJ1JZ$R-9G%>6O-#F#!>-'-=+E>S=@!4E*==_8,19VM]
MPTC,>Q"^FJR+N,FEG:77%A>8I)K;&OQOVK&EF>:V$GHF+VM;A8XH[XHVLZS]
MV18M=)+=^VL.LS,KCL_V%GV5<^ST%;) (']&+.[1E"ID*L+$BQOY]9-8%XB^
MBAB,5SJZW\QL<<2-%(\K1@^9.6&6SS,(@-U- 0%V%KHJFK,6D,I8P2 !M3'-
MZ8  C?0)%4?M[NVRG%;IKU<?:W89G[JIC@\NU(UCA%L$6\A)*:">UTA8L3-%
MJ9KBN*V$OB=+9P*FW;?$[&A2IEKS]6)BF]>/3/Q:"3U ;&'*"G)3I:1K\RK+
M=MG_ $HS$C^3?SYN([M[YT_UKVMKF/85:40>S_%B3JK"(-L[H]+2;N^D@V]L
MU]V,^,AQ$,H_!QQB6$W=#I;-=^W#OF :/&;ED[OL[?%@VIM_0E;?WUJ,NP/R
MGM]ZXSI0NX^8HY.E;:W #T.])TPCJ;18TG1Q(^NMI=-)'5 CDR(%$YS('0HZ
M&)LD<:ML3B.WP^RLI%NM\1LG=5DN#*-DD)D'HN92$4,=@)"D:JH*C3,#D_?\
M4LMEH7QO:N1EHHG>"R6W;NP72P'22(6X,CM&O=8 N&(=RKMK^EY;;5I%I<8^
M33C:"SWN_0.,RTN),\RM(ZSU*YLP[/FFLH)!)-D'7/\ FB(5G=.Y&+,C7>7G
M,EAE('DN<:9UO)+NXVAG<Q[3;2]LM&S=O0S",[V7<6.A;0Z5Q!FN.W<4-AGA
M9OBX<99;RD<0G,BY"V]H5)T0S!A:-..VC[ @W"/<-:E.:K;!V>W44%AL+*$_
M+PC"U6GJ-L*6-=(#?0G*(5M[V\..F/;(+')&&YH$;H&OB5[IGKR_L8)C9W:H
M]RZO  $E2<$/MD#:&=W9BVJ@A"(P5!74L36&R]W:C*8UY(K"&2*\+-);RVC*
MT6^$IN6SAA1 A$C*TH,S!RK[1&HK']&)J)0:V>M)[&OUKL52U5N=I\F9B-#G
MPET^*EU%#DTAS."?;3WN7#/=ZT$1)@A%=!Z,[9)VL?A[6._:)&@:]F*6J([2
MQ&"2->[ 98XM(H-YDB60ZJ&=&C3:X+@&49*?#)<S1W:8FU$N1EDB2WN5O()W
M]GNQ;S7.MQ>B)8;AX1M=HXI8YY.Y$5C9EX-J5JH*/1AY>K[3D$) UEGUW<2$
M]K378.AJ<OG_ )$ ^K@F9>&UUYHB"& QZ2<,2.88J14F%>*R3XR<E^EK/'81
MWYC9)6MW)NRZR)%'M5E![C*\A8(+ED0%9#Z49C!J<>@PDF2M)\U-A1.DMM'?
M1!<:(7@EN)][I(P,*/# J&9K!)9662%08YEF99_>5>G:;V!<2$;<@1V_R0 H
MM39WD4HO7#Z#K272?PE3U) L,[VWD-C*27%%-<)"\Z$.7U5@A3,74%\);RY9
MKIH_;(5 1G!%MV[8R=E$(!],2%G ,VAE6-MVQ:C&-O,,;?%V")CDG&+N79I8
MX2&OQ/D!![5+*K$ PF!8XV9+7>+:2=-G<D-GS-<\6UQ0D(M[$DW<6]UX@^A6
MW?>.RKL!K*M;PQ+Y\EVP!EII0!_,5X21/+AB>C7JC4MK&$QW%K&JRC7)7$P$
MF_?VO9Y5WMW/3V[I(U]+J"ZJ=#TJ^S%VLUED9Y'MF*X"RM6:#M"'VGVVVD[*
M]D"$N8[>:32/T6$4CJ64%JV2Y-JU)3BE.*4XI6+;+#VU+9&:+K>P$J#CYWF7
M66M6S29'1%2(OJEN8,BE9^YF7P5Q8J.;*K4]:&3]/(U<8:ZL[AK_ (_(L4SM
MNDA?4P2D^5M!Z44A\[IJ#^N1JFMIR2QR-I'B>71//;1*$AN8]!=0*/(NK>C/
M$/-%(05!/;D3R5\Q]JUM8J#[RFN< 8B^5T]N.X[-3O1?!S@=75L(J7PIYD_]
MI427X_&-.%Y-;VWQ>;AEL9O=<;HC_HSIJFG^GL;K\$5R_";N\'=XQ<6^4M_+
MMB;9< ?Y]M(5E!\O[6)5Z=&-6[M7L4.MZ=[3U6'U5)-?4'6NWOL\?6&T]S\O
M<U>8LSZ@J(5ZG!F+$=!&YL<D<D<BIY7-<BJB_&>SL$7&[_(8FYA:[AL9Y(V1
MD?1UB9D('I*VC '0@@^0@BKKA/$[B[Y]A<)R2QN%QEUE[.&=)$EBW127$:2J
M6&QTU0L"RLK+Y001K7DQO/>'_,)[@BDK']H]S64)CGLFAPM*N0;(R5OI3132
M]?45!Y!%8JH]CG)$C?'S)X>///6\\3/%[D*F!\CDG5O*($[.NO0@FW2/I[H\
MGNU[C8WP#^BQP-Q>+A>/PO& 0;R7VK0CJ"!?33ZMKY"!NUTTZZ5K]+U?%3E$
M6W<FYK\U/*^4LJBKSAMMV+:D/_IW,DK:TZ<.H(,5519[4P96O7Q5C_BG(6V'
M$,C3\@N5B<DDH&$T['R]54D*3[LC+U\QK:2<R>_A6RX!C9;R, *LSHUI81J.
MFHDD0/*J?L+:*34#0,O0U8]5V3 12R8K!4RXS"ODAD/%0GYS1ZXD;Q] _97;
M8X7'K&]SGQ!0MB '<[]6-SFM?RVO<LKVYQ^,C]GQNHW#7624CR-*_3=[H0:(
MOF&H!K)87B,D60'(>37'X0Y( 0C;=D%JK?"2UAU.S4:!I6+32 =7 )6MB?9-
M[(NP/=]NX(1H#\[U-0'P_P >]A2"O00>*/T9YLWG))F?+6>N/&E;Y(D\S HI
M$GG3RK''-.?"_P +<QXC98+&'AX]"X]HN-.@ T)CC)Z-,P/0=0@(=^FT-JCZ
M17TC.+^ _&FDF:*[YQ=1'V*Q##<Q.H%Q< '=':HP.K=#*RF*+KO:/V+X#!9+
MJ[%YKKW"THN?R.2JAZ>CJ0VJD0P@Z*JODD<JRE&%SO?,1/(KIB")'RR.<][G
M+Z28C$8[ XR##XF)8<=;QA$0>0 >[YRQ.K,QU+,2Q)))KP*Y1R?.<SY#><JY
M+</=9V^G:6:5_*S-Y@/(J* $C10%1%5$ 50!,.9*L#3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE:L^S7^HQO\ ;)[GO]3G
M;_(%X:?S4_WEE/XSO*W3](#^\D_T?X]_5[%UM%-#$1%*.1%'/!/&^&:&9C98
MIHI6JR2*6-Z.9)'(QRHYJHJ*B^"\G;*KJ4< H1H0>H(/E!'N5IF.1XG66)BL
MBD$$'0@CJ"".H(/4$>2O*3_,E_EZ6_M[TUKV]U+1E6'1&@*>=8A@0NF7JFW.
M+;&M,:QCGRID3"2&I6EJGE@5_P I,J.;#(1Y_P#C9X.7/#KZ3D?'HF?B<S;F
M51K[(['X#>?LDGXM_(NO;;J%+^VWT1OI4V'BGAX.!\YN4B\2[5 D;N=/PE$B
MZ]U"=![4BJ>_%KJ^G?CU4R)%UJ8CL6TQL=A4RA@Z3'WOD;HL9>-DFI;5&(B1
M&0K$]A-3=B(B*.<*Z,B%S4^+F^+%T9CLK-8!H&59K"3X<3]4;WQYU<?K771A
M[XZ5V^Y%Q2RS[Q7R226F>MM>Q=PZ"6/7RJ=05EA;R/#(&1@3T#:,)9)@\+ME
M4KK36B4UE,Y7.P'8M@%26$,K_%4&H=C.H^9OH?.OEC^:?7$JB)XL<Y?%;XXW
M&Y'T\1.L<Q_ZB=@C ^XDITC<>8;BC>\36$7DO)>._$<OL7N+11_XVQ1YD('Z
MZ:U&ZXA.G5NV)XQUT8 5FO*][>_+H8&&JSF[[LSE")$L8 1?U'59(<=(_#PI
MX[H6_P W&,V-OBBB^#$_YD_[>2K'<Q\5>*1"WL;W)PVBC15):6(#3]8'$D8'
M^CT\]:[S?AI]&;Q-N6O<MC..W>3=M7==EM<LVO\ UIA:&X+:^7N=?,?<J:'_
M ,Q'^89KFMK?O>VLSW-<UL6:Z\Q-(<Y)9(6^*3Y?#UQRN]1K&M7S>+5<J-5/
M,J+E9O&?QAR [)R5R3_W=O!&W73SQ0*WN:=?J>4U'K7Z*7T5<$WM?X!QRJ#K
MK<7UW,G0'];<7DB>34D::'34_!&F!-;E>^^R+"/6=XZ^\#<^-7)I^\-C8ML&
M#RO3QCK:R]*/U9D;O3_4A""D:B,1$1$1.0[(V_*LW,+_ )/<S;M/VR\F8MH?
M,JN6D(Z= B$=*V=@\UX9<2M3@_#BPMI #_X?#VL>PL!Y9)(52V4]>KS2J>NN
MI)-6*/9XGK)KX^L(Y]-L?(Z-W9^BK6A0U"O14>_!9>=Y#J\I$\$99'JXMOZW
MI00*J.Y9C(8[#C3#@S7_ -T.N@7_ -3&==I]R1_2\NBKY:R3<?Y%S AN9%;/
M :ZC'P2;S+IY!>W "[U]VWA B/3?)*!I4'P/7^_[GW=1A\'1VNTW6NL7Q UP
MSDF-.+F5Y)AQYQDL8XHL#$?.483+'#!$U\LLC6HYR6.'P^7Y+E8\5B(I+G*W
M#Z*HZEB>I9F)   U9G8A5 +,0 34CY1RCB_A]QJ?DG)KF#'\:L(@7D;HB*-%
M1$1069F.B1Q1JSNQ5$4L0*]@7L1]EN:]GW67R$SA+OM;81 G]D:R%JOA<5#$
MKALMGY)(H9H\S0R2R>FY[6RF3O?/(C4=%#!Z.^$_AC8^'&"[+;9>07(5KF4>
M34#I%&2 >U'J="0"[$NVFJJO@O\ 27^D+E_'KF/M48DMN$6#.EA;'H=I/I7,
MX!(-Q, NX E8D"Q(20\DF]'-K5UMIQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4
MIQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2M6>C?Z\_>E_;)UG_ICZ1Y N*_SKY/_M*V
M_BRQK=/B1_=MX>?T?R']8<O6TW)[6EJPUWYT5@?<=U?HNJ>Q:]2Z.\B;*(>.
MD3;;.7@K9%JM'1$RLD02VK)9%5J^"LEB?)#*U\,LC'1KEW%,1S7 S<?S2;K6
M4:AAIOC<? DC)\CJ?)YB"58%68'8'AAXE<G\)>9VG-N)R[,E;-HR-KVIX6T[
MD$R@C=%( -1Y58+(A61$8>-/W0>U;M/VG]A$8KL*M?+7%2DD8W;5\,G\.[.G
M@E1K+"LG5S_E3X&O8A8,KOF0Y')YD=&^*63S2YWP#/\ A]F#C,RFL#$F&=0>
MW,@/PE/F8=-\9.Y">NJE6;] 7@SXU\*\;^+)R'BLP6[0*MW:.1W[24CJDB]-
MR'0]J91VY5!TT=71(N+V'G-L '1]OAV!)8 T0-+V700CS;"M%AC2$4+2!%3#
M#;2G%:UOD]66 ^%C51D[D7R<Q*96TR,2VV=5BZ@*EP@!E4#H!("0)5'FU(<#
MR,?)6:FXKEN.W4F2X))$D$KEY<?.6%K(Q.K/;NH9K25NNNU7A<D%HP1NJ\4'
M7G9V<M8=9T7MGZ0H1KY0;_JG3G4NW A7RRM0G.Q$U.WJR%1B*]K()(T<WP21
MW@BK=6>-S=C<"_XQ<M)*O59+65DF4>7J@*3*?=T!&H\IJPRG*N'9:R;!^)..
M%I Y >')6Z2VCGR>C.5ELY%Z]"75B#U4=16?ZSW\_P PWK]K*YW;?9 SXXW#
MI%L\5GM*=X-2!7>I-M\A;FR3-1K%5[G+(GF7X_KN\TSM_%_QAQ([(R5X"!I\
M=#'*WF\\\+L3Y.I.O^4ZZNO?HP_15Y03=C!8AU)W:VEW/;I^N\@L[J) /+T
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MVR>">17M8..B(V&*-$^-K?Y<W$ L+*,6^,!U[:G4L?V4K]"[>YKHJ^15%93
M\17'WISV;G;(<H=-IG=0JQ(?+%;1 E8(O=T)=SJ9'8FNP[^77_+KT'N0T%5V
MIVI5%TW05,6A4412$!F]IFAD21/I*1\4D!4&;@*@<RPL&.;YO*HXZK*LLHVZ
M?!GP9O.:WD>?S\;1<1B;4 ZJUTRG38FFA$0(TDD'^@GI;F3JG]*[Z5V+\),7
M/PKA4\=QXGW$>TE=KIC4=01-,"&4W!5@8("#IJ)90$")-ZP @@ZT,2NKA!@*
M\ : ($$*"(4,(,6)D H@@L#(X!AAH(VLCC8UK&,:B(B(G/06**."-8855(44
M*JJ  H T  '0 #H .@%>(5Q<7%W</=W;O+=2NSN[L6=W8DLS,22S,22S$DDD
MDG6JGGW5&OQ415151%5J^+55$56KX*WQ3_L7RN5/_,O&@KD$CR>>OWBN*<4I
MQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*_/!/%'>">9$5$=X
M)XHCE17(B_I1%5J>/_FXT&NOGKG4Z:>:OWBN*<4IQ2G%*<4K\5$<BM<B.:Y%
M145$5%14\%147X*BIP1KT/DKD$@ZCRUKW[ALADX>DNZ+V++YV*[K>JNQK2NN
M8Z6M9:U]F'C[<@2Q"L&C(6*<*1"Q\<T;VR,>QKFJBHB\A7,\3BAQ?)W8MK?V
MI,?<NK]M-ZL(7(96TU# @$$'4$ @UM3PJSV<D\1>/8U[V[;'39NPCDB,TAC>
M-[J)6C=-VUD920RL"I!((()KQ&V_8>_T$3H+[<["[@>WR/AM]-=643V?']1T
M9ALS'-_67X*GA\>>74^5R=TNVYN9Y%]QI'8?\I-?HML>*\7Q;B7&8VPMY =0
M8K>*,@^[JB ZU4X'K'L7M2ZCSO6V&U>ZNY53_P .RM%8W9$3%1568I !YVAC
M1M:KGRRJR)C45SG(B*O*V(P6:S]T+/"6MQ=W1_6Q1LY'OG:#H/=)T '4FJ/)
M^8\3X5CSE>79*RQN.'_67,T<*D^XN]AO8^0*NK$D  DUW5>UG^3#K+DNOUGN
MGMV92CB?$2WJ_)V@MAIK/R/:_P"6TFH >53T84J-\LD=?(85+&]42<61J+SL
M[P'Z,V0N9$R'/I!;VH(/LL3!I6]Z25=4C4^<1EV(/PXR*\\O&G_B#8/'P2X/
MP5@-[DF!7\(W,;);QZC3=;V[A99G'E#3K%&K :QS*2*]"^&PF-ZSRU1B<#FZ
MG)Y2A&:)54=**P0(6)/B]_E;XR3DSR*KYII7/FGD<KY'.>Y7+W&Q6)QN#L(\
M7B(([?'PKHB(-% _\I/E+'4L=222=:\K.2<FS_,,U/R/E%W/?9NZ?=+-*Q9V
M/F'N*JCHJ* B* JJ% %2WF1K!TXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI
M3BE.*4XI3BE.*4XI3BE.*4XI3BE:L^S7^HQO]LGN>_U.=O\ (%X:?S4_WEE/
MXSO*W3](#^\D_P!'^/?U>Q=;3<GM:6JDL*\"V!,J[0(2RK; :<*PKK :$P$X
M,F-T)(A@A#)!R1B(7JU\;VN8]JJBHJ+RG-##<1-!<*KP.I5E8!E8$:$$'4$$
M="#T(JO:W5S8W,=Y9220WD3ATD1BCHZG561E(964@$,"""-0:Z(?=I_)IJ=(
M;9;CVL6U;E#R5G-.ZGTQ)#,V04]SII$QNB\I,] DOQ2, QDHB2/\&$"PM;&G
M4[Q#^C3;WLKY7@,B6\K:LUI*3VR?*>S)U,>OFC<%-3T>-0 /2[P-_P"(#?8B
MWAXWXU037ULFU$R=NJFX51T'M<'HB?3RM-$5EVC5HII"7/0YVMT+W-T=:/I^
MV>M==A2DF=! 1=U,[*>P>WS(KJ?0CH10W</BQR)(&3/&JM7P=\%YU-Y!Q+DW
M%;@VW(;&XM)-= 70[&_T)!K&X]]&8>_7IEPGQ-\/_$>R%_P;+V.2AV[BL,JF
M5 ?^U@;;-">H]&6-&ZCIUJ#TNPUN;1$SNIT="B.\Z)2W=G5HC_,CO.B E0>#
MO,B+X_I\4YA[>_OK3_PDTL7^@[+_ ,Q%23(8'!Y?KE;*TNNFGQL,<G3W/34U
M?R>W.US(E@,[.["*A5?%82=II)XE7P5OBL<MDYBKY7*GZ/T+RZ?.9N1=LEY=
M,ON&60C_ .ZK%P\%X3;OW(,/BDD]U;2 '_*(P:AL<=K>V,<,,=A<VUC.R***
M-I-A8G$R>#(XXV-28DF=_P $1$1SE_0G+!5GNI@B!Y+ASH -69C[@'4DU('>
MRQMH9',5O8Q*22=J1HHZDD]%4#RD]!79#[<_Y5?N<[P)!LM70S=)869S7D:'
ML"OG&T4X_C^M]&P3Y0[\F9S51S'&_3Q9&KXMF=^A=V<+\ >=<J=)\A"<7B3Y
M9+A2)"/\R#59"?<W]M2/(QKJ/XL?37\'/#B&2SP=TO(^2J-%@LG5H W_ 'MZ
M \"CS$1=^13T:,>6O2;[7?9UTM[3,W)4];4CRM'9C10:CL"^] S7Z16/;*L$
MYL<,,-;3LG8CHP1&1#-5K7O225'2N[L\#\-N,>'MD;?"1%KV10);B31II//H
M6T 5->HC0!>@)U;5CY%^,WC[XA^..7%]RZY"8F%R;>QAW):V^H(U5"29)2"0
MTTI:0ZE5*IH@VIY/ZTI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3
MBE.*4XI3BE.*4XI3BE.*5JST;_7G[TO[9.L_],?2/(%Q7^=?)_\ :5M_%EC6
MZ?$C^[;P\_H_D/ZPY>MIN3VM+4XI6->V>H.M^\L79=?=J9.KU^6LT\SP;&-R
M3@F-CDB@M*>Q@=%84MP*R9Z1%BRQ3QHYR([RN<BX3D/',)RK&/A\_;QW-A)^
MM8=5/4!D8:,CC4Z.I##4]=":E_!^><N\-^0P\IX5?36&:AZ!XST==03'+&=4
MEB8@;HY%9&T!(U (\[WN8_DQ=FY$NSTGMNNH>RLJKI28</HC0:7?5</_ #_*
MA61"A9O4QPL:Y4>KZXER>5C8)G_K.Z:\X^C-G<=(][PF47UAU(@D94N$'N*Q
MVQRZ>[K&WD 5CU/JQX/_ /$%X=G8(<1XN6[8C-:!3>0(\ME(?)N>-=]Q;$G3
MH!/&.K-)&OHCI^V_6G975=O])[#PVQP-S#,[TA=3G[?/$O? ]?"<)UB*-\S%
MYF>9DL*O8Y/!S7*BHO.N.5P>;P%Q[/F;2YM+D'H)8WC/3SKN U'N$:@^4&N^
MG'.7\0YK8>W<5R6/RF/9>K6T\4Z@$>1^VS;3UT*L 0>A /2OL+M;M&LA0>N[
M)WU>.U$1( MAH1(41J>#42*"QC8B(GZ/ASXCS69A79%=W*K[@E<#_D:N+CA/
M#;R3NW>(QDLONO:P,?\ *T9-6VYWNYT4;X=!M-9>Q2)Y7Q7.BN+.-Z>#4\'L
M-,G:Y/!J)\4_X)RC<9/)78VW5Q/*ON/(S?\ .35WC^,\;Q+B3%X^QMG'D,4$
M49'U"B"LJ]/^U;W#=\EC#]5]3;#3"$N8G\0K6OJ,D.U_F5'EZZZ6OS8WBUCE
M:UQ7J/1J^1KE^')%QO@',N6R*F QUS/&W_6;=D(^K,^V,?4W:GS U">>^-?A
M5X90/+S7.6%G.@/Q'<$MTVGF6UAWW#=2 2(]HU&X@=:[V?:A_)JR6*+K-M[F
M[FN["O170&"=9Y]2FX4$EG]*Q--;$1B66M=$]6^82.(0'SL<R13(7^'.U_A]
M]&G'8R2/*<YE2\NUT(MH]>PI\OQKG1IM.GH (FH(;NJ=*\U/&[_B 9WD,$W'
M?!VWEQ6-<%&R$^WVQU/0^SQ*6CM=1KI(S2S:$,@MY%UKO$""#K0Q*ZN$& KP
M!H @00H(A0P@Q8F0"B""P,C@&&&@C:R.-C6L8QJ(B(B<[4111P1K#"JI"BA5
M50 % &@  Z  = !T KSAN+BXN[A[N[=Y;J5V=W=BSN[$EF9B269B268DDDDD
MZU4\^ZHTXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI3BE.*4XI5IOJ.JT]'=9J^#98T>AJ;&CN:^1\L<9U5;!S 6
M(<D@\D4\;"0R'L5S'M>B.\45%^/+>[M;>^M9;&[4/:S1LCJ=0&1P58=-#U!(
MZ$'W*OL9DK[#9*WR^,D,62M)XYHG !*2Q,'C<!@5)5E! ((.G4$5J[G_ &%^
MS?,R0RUGMRZOG>.C$C6]S[-4GZCE<UTC-/+<,F?XK\7/1SE_XK\$Y [/PE\-
M;%@T&%L"1Y.Y'W?_ ,*7U_5K<V4^DUX_YA62\Y;F55M=>S.;;R^X;<1$#WAH
M*V?H<YGLK604N7HJ;-TXWC\M4T-6%3U@_BC6KZ %? .+%XM:B?JL3X(G)W:6
M5GCX!:V$44%LOD2-511]15  _P E:;R>6RN;O&R&9N;B[OW^%+-(\LC?5=RS
M'R^<U>>7-8^G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G
M%*<4IQ2G%*<4IQ2G%*U9]FO]1C?[9/<]_J<[?Y O#3^:G^\LI_&=Y6Z?I ?W
MDG^C_'OZO8NMIN3VM+4XI3BE4IP(-F(17V08M@ 7&L)01P\)8A,3O^:(@:=D
MD,T;O#XM<U47E.6**>,PSJKQ,-"K $$>X0>A'U:KVUS<V<ZW5I(\5RAU5T8J
MRGW592"#[X-:SZ;V3>T?7DO,O/;KU,\N5WGF)K,?5Y^>>3P>BR$2Y^&K?/(Y
M'KXN>KE54157Q:GA![[PO\.\BYDNL-CC(?*5A2,GZIC"Z_J_^05M_#_2)\=,
M#$(,;RS."!1H%DNI)U Z=%$YD"CIY!H/+[IUA=9_+G]DU3*LPOMYQ<KU=$[P
MLR-%=1>,+E>Q$@N;L^!&JJ_K(C?!Z?!R*GPYC(/!CPOMVW1X:U)Z?",CCI[S
MNP^KTZ^>I#>?2Q^D5?)VY^59!5T/[6L$)Z]#Z44*-]0ZZCRC0UL9A>FNHNKV
MHWK?J[K[!KZ20OER&.S^>)FC1OD7YDJJKQ22GO3_ )W2/<YZJJN5555Y-,3Q
MKCN!&F$L+.T.FFL,,<9/U2B@GWR22?/6I^2^('.^9G7EV:RN3&[4"ZNIYU!U
MU]%9'95 \P4 #R  5DKF;J(4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI3BE.*4XI3BE.*4XI6K/1O]>?O2_MDZS_TQ](\@7%?YU\G_
M -I6W\66-;I\2/[MO#S^C^0_K#EZVFY/:TM3BE.*4XI5OLZFKNPI:ZYK:^WK
MR$\)P+,,<\*9/BGA**5'+!(G@O\ Q:O*,]O;W41AN422$^564,I^J""#5U9W
MU[CKA;O'S2P72^1XW9''U&4@C]0U@>X]HOM6OG/DM?;AT<3/*^.24MO5N+%.
ME=%&D4:2'"4T!DC&Q(C?*KU;X(GP^">$3N?#K@%V2;C"8IF)&I]EA#'3H-6"
M ^3S:ULRP\=O&O& +9<MY(D8! 4Y&[9!J=3HC2L@)/74#7J>O4U?<Y[:_;MC
MYXR\IT-TUG#(DA1AU+UEBZT_Q':YL+WG"4L1<LL:/=X/<]7^+E7Q\57QNK+A
M'#,:XDQ^)QD,HT])+6%6Z>3T@@)/ODZUC<MXN^*^>B,&;Y-R"[MVUU2;(7<B
M>EY0$:8J =!T  Z#IT%9J1$:B-:B-:U$1K41$1$1/!$1$^"(B<E   T'DK7A
M))U/4FOWBN*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<
M4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2
MG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2M6?9K_48W^V3
MW/?ZG.W^0+PT_FI_O+*?QG>5NGZ0']Y)_H_Q[^KV+K:;D]K2U.*4XI3BE.*4
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI6K/1O]>?O2_MDZS_TQ](\@7%?YU\G_ -I6W\66-;I\2/[M
MO#S^C^0_K#EZVFY/:TM3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3
MBE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE:R]:ZG;7A>
MZMR+#L[1$4FJ[G J,O8TG7=!@[,?(]E:C+YREHM'!E +UYJ5M;!'%*99.8][
M9))WJB*O.:5>L[WJSL%M'-UGFVZ$#55NPN<Q;Z"YGR=9:UF&/Q5-?DR,2BO+
MNN?%H-;+7QQS!-D>172N5&P/BF<TI7QF^^':\NE)SV$TA>9/?B1;6Q>'<ON:
M<W>Y;*ZZJE;7UF?M,P;15%7M ?JICKR!X;FDJV&6.!'R-*5:Q>\9B*C"[>SH
M-)2A['KBWV^:Q5>5379=]#:&]15N6K;^*&AFL*[93WG8<0(T%?8OKHDEED)D
MG\85%:4J_0]M:XDNOST/6DD&LM+NVJ0V6]U=T./G#JLT!IGWT&BN,,'H2JN1
M#75RI%1R3QV<+F.C^6\"^-*4I>[DO\R;O0LRL&&SN4K=1KS3KAW\2UJ677=-
MV7]/I,U5U%J/?S@T&B"297GA*Z9[VPMF\C?.TI4FRW85Q;#Z>328NPRLF<J
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M+7T!J45S/U;HKF5!Z^N?(=*!&3$-*6V:29TI5:\?;7*!AUNN[#BS(V'[BO\
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MM*YM5WAUAE*'47QFSS)$>3@=):"PZ&FBE9,EH/1-@68LV 2-$ORXP9)7/2*
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MJR&:-J_%J\:]=:5=]/U5J33M)=Y;25U'?G]AVW8-!83 H4E58$>W.;IBH<1
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MZ80>]-=UNP43#86NWV^^M:6RI#P:B2\["J+6+)516*>;HR(!>N2C05/;1QV
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M)' TI4\/[<L:YA%W-E1'8MNCU^2$MF:$M=#)=Y!^FKRG&YE<P@@E2??Y0@2
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M5PBE5MWW1"7%1TX===5]W/K*FFU:5=C5H1CIA>XLCUJ@YTQU1:PD"ZRQNG3
MLE%&DLZ.$F>%X\B,5K2E6&#M_45- -K.P@(Z^JK>V.[J@=,-=)<DWF9ZVKN]
MRFBZ"GML76/8HU7@8%@A ,2<JPCAE>0R))A9VE*OY_<^SJ@99K3J]X4T=EG1
MYK&4_>QX^LJKP'3DE6M[H)^I(+2O90%9IL!SH:LH$7ZD%+.7%#)*^%I2L^UI
MC+&N L(I0IXSPA3(YZTQ+&NF85!'.R4"P;% T\*1K_&*9&,26-4=Y4\?#G%*
MK>*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE:L^S7^HQO\ ;)[GO]3G;_(%
MX:?S4_WEE/XSO*W3](#^\D_T?X]_5[%UL#)C\W+G;O)R5<3L]H_XH^M5BRDI
M$?\ QH=9V6G]25)T(C^K'7)4C_(]OD6549Y41J)/:TM46;T]@G#68IP-[?,M
MJ6WSI,NKV^YV!L%)?CQBWM;4V.IT=P?0CW(\,;"OD91U(2*/SJ[TV>5K2IR=
M25=D?2VA@C)K#/%%&4Y:/FBE#G.K2ZDQ/&&2-)QR037M?#*CX5>C)/+ZD43V
M*58C,!DS:N*HDK)1Q1[^XU04U;:7%1:UNBOSKFPNKBIO:H\*[J3;.;1'LF<,
M1%YQC9AU_H)'QJI6/K'I0<C4"7M=<Q5X\,N8D>5(!:E;T8;*DH0+04_8,.F!
M.ARMG)*7(<%8"V;BB;,V5TJ+,U(^=:5(:[I?K>KG#)%HC))*R,$>I98:756X
MU*%6:.@UM95T8=M=FB4E-6W^6KYQPA&0B0-%9$R-L/C&O&M*_8^F>N8WVC_H
MALOU:MT5/)&3I]66/75>KM0KR\!S8Q5Y,/D1R+>L&(B2J:'\K(-$L'I>FSR\
MZFE7@CK?'E"S#2UYJ23VX6@=:0W^B&T4=\!F0L9!="Z@:VBT85K)E &5\Y$)
M3)217RLF=(D\_J<4KZ9UQB(ZVZJ(\^*RNT68CQMX,R4MJ6>=CET4_P B5(A"
M3/EG)UME+,3YD*GF,DDDD<]4<BE?@O7.1&71.E .MUU=6^DO4TV@T>L:922*
M>LM-$W3VUNT"IG^IS^H,,D,,GG3S-7RM\JE4U1U;BJ2S%NQ:^R+N@Y:Z>"YO
MM/JM1;)+45.GHZYTMEI;JV-(^5JMG:1(DCWHOSCW+XO1KFJ52%]/=='%3&3Y
M]S9BI2)K!HMS?@"V[R-->;-J7H0-J.%>Q!:K36!XD9D<[ 23)7CI$KUYSK2I
M!=8?-W]F/<6 IK+* >(.4JKO+VA=9U\$A4H]5H&45E6Q:6H%E/(?"'8-)&B<
M3,K&-6:17<4KX$P>5"/99#5TK"(=*=L!(WVEO,!7Z2TK;NJM;2KJICY*NJEM
M1=(>XI@T,41))<I$K7$/67BE6Y_5N#="^%E"@RN&JA(BP;*WK[(*.D/T5G52
M5=L#8#V=08&9K;)6D"S0SJPR2-SUC7RHI5/#U+A(+B"^96V;[*"SKKQ'$:O7
M%A37]55QT@>A-JBKV:JL-"VJA9!(?/!(7/&QJ2R/\J>#6E<-]U3G+JNZVI('
MV%)1]9V\-C2 TEI=5)C1!,%JL"#6"WM5:U]Y7,&K].KEECG=)(V'TG^+9'+S
MG6E79.ML0RDN,[!GQA*:]J0:2R# G-K_ #5U8$M?6L#(")'*JR:X=46 @5\)
M$,K6RL>DK6O3C6E6N'J'!#QS^A77$)A5@79E7D>PV;-044>!0U9Z$ZU- FG(
M$/K\M6Q3CO+4>9@,'G8[TF>#6E7P? Y06X?>P5DC+!;YNHC3ZG;/KQ+],[99
M26TKJ9YSJ>L),HK<F$GY>")I3Y5EF1\R-D12K3'U/A8*Z&J'K;(4(&4":F8)
MJ=8)-F%JPK"L BQI8UY$7BQ1JFV*"2&ID#A4$B096K ]T:J5\F=3XL]\;S(M
M-.L )H C7;[?)'7)8T%AF#;&KA;IFQ56AGI;4J);09L5DCR994G2:1TBJ5DC
MBE.*4XI3BE.*4XI3BE.*4XI3BE.*5JST;_7G[TO[9.L_],?2/(%Q7^=?)_\
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MRX2O',BDF9/*-&YK)XW.5_.=:4J.JJN+*D9G1G&7#"=##IF/I[#39<>AL1)
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M;&SJ2P[.ND68$X2PJ# #Q2195\S'1RM5%XI4*M>DNM;D!M6=1&I7OJK6DLA
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94XI3BE.*4XI3BE.*4XI3BE.*4XI3BE?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g282574g06f64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g06f64.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 00!% P$1  (1 0,1 ?_$ *H   (" P #
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M]?[1R7T5=E=<G:Y(YSH\#!UEKBEB<OGS+/<[JMRT)6R.I7,D)2_SBR 2<I#
MS.1ZD*'SG.B1:WGVT<:FP_!Y<S94K-D[)==_0F&(=$9/Z7[K#YJ5(]#KE_\
MS N?5>4>7Z_%,?()*G'Z BDV.X%JPW>F (]/RQ"NC#W6174[%2-,LC^U.RY"
M]V[G4O)F2(]05-;.K6I$&Z,?'QF0QS0JIJ,JC<4+VGE1K.WMD/<,Q4@%8%6$
M*=91\F^2<&9)+*$L7JB.AC^66OL[?:\!J>&16SS7=$VM(-:0PYZOKC,KFMS%
M_-=07Z'9Z'>%;!7*A6L_EXML@TB74^O\*=G6;"R#Y <B#30#M]ORG1*]SYP+
M1.,MPQ_J#!;[G4U3,<F$H*2B<MQMK885>Z;=/[A#35ES^VY7-1YG"+ERA)N)
M67M:14!1%R05?6@^0."4N<X^O'(5CR=*TD\$A'ZK*RET;;UZ)%'2VV^Q"/L2
MH!FOPCYFRWA[-WIX%>?CV6Q\U.[ "/SI)&ZQ2IN0O=KN_6A)&Z-)'NHD+!/?
M4<'-5WI#=HR?BI&%D0UF_/OH91FNQ="QEK/)RD6\!!RFFH9K)1CQ%P@H >"R
M"I#E$2F 1YP<]J6J7-<M!;C>*;^(V&Z6!4]+RLZML?@RD,I]BI!'H==Z?"^2
MQ^6\2<:N8R>*Q4_@=).N-E=>N*O''(FZDCJCD1D=?=75E8 @C6W=._W;S'_E
M9S[_ !7H/K(\Z_N,%_V"O_BV-8/PY_G.9?\ FE[_ $U'56?6A:FG5IMA_P#7
M+D'_ (>VK_N],^M]Y)_]+XY_R;O^L?4+<"__ %GGG_5XG_VN+5M/QL<QR73=
M=Z H\@>2@:)-DR9I/VM)DN9 Z==OS.VRU>B'HI&9FL3V&CQ*0#"8&P+D64*)
M?$BDA^$N"S<YIYC%3%X<3**@DE"G;:.PLSQHVW3W&1?3]WJ#$$; P;]W?F.I
MX=RO%^1U1#:Y-6.3:"L77<&>D]6*>5-^OL)*^YV [A1HU(/4RLK_ "@]6\?9
M%R/MO(:-UQ:6U:<RJ,R'/\ DIZ'>+U^1MBD)3J-)3[)PJY:5-'/BR36Q)K2B
MK51NWC2.BF#V(H/0"E3JXZG%0I(L=."-8XT'LJ( JJ/P   UQ)RV5R.=REG-
M9>5Y\K<GDFFE;]:265B\CMML-V9B3L -SZ#1:0_%-R4VYME,I;Q4XC9IJ)@K
M5+[ZGJ6H$TB2U2L918\UKNI/;Z%X"=<1D)"V^44;0)G0U=%O(+I%CP15,0?3
MK'ZW3H^A= 9OTW1^QL#S-GT DCC$KS[K.)I6BM42[GJ"MU1T.OW_ #*S6U9A
M6GTU"S)'+>0AW[QH1^U52^ _SD 2M->.;Z%T%I'3EZ[&W[-&6 (KXU$\^Y'B
M2EGK=YO"=.2N:NAV"_:?9ZDXD*TSG)J;,W0CXB/=N2,&B2GSF^<PF.TT9NGN
M+\+ZQADVNE5T[2TQ[8S: T.M'0B[G")^1E"-0D#-W#>8B04.<?HGZ3EL05#G
M2*FJ;Y C[G7C+BGD&L(\W"5OHNT=B+99D_#JV(=/?\D@91N2H5CU:F_PW]P?
MDKP?D#-Q"V'PLK]4]&P#)4F.VQ;HZE:*78#^UA:.0]*JY=!T%1_4OXD-LM"F
M9!C]OI%LA,[RN S;X+0]?U.S/U(6=LTHG)$;)QTO B@9M.$(<3/TC_(F(E3\
M3>Q:[\]^W?E%\T?_ (W9JV*M+'QUMI6:*5NB25NK;I>/;9P#_: [CT&Q]+T^
M%_OH\=89<R>>T,C1R.6S<U_>LB6:Z"6&O&8RQDBFZNJ$D;0L.E@"VXW--(W\
M07;3YX5JZIU,AD!$ &1DM"KBK,H"JFF(F)#N)60]BD.*@^R CX%'_6\2C&D'
MVY>499>W)6K1+^\UB,K[_P! NWX_J^P^>P-@+GWX_;K6K]Z'(9"Q)_PXZ,X?
MV)]Y5B3W&WZ_N1\-R&CY]^(N#FJ!@U;Z$O1I,V1L;JA+5;.#N6\/9%+5=Y"V
M)(*VZ69L9E*.1;NB-W!$(]JX./F*3A,?$P3SA_MUJVL1B:7,;?<..28/%6W"
M2&6=I0#,X5PH!"L%C5CZ]+KZ'5,.4_?7DL=R?DV7\5XT0C.RU&BLWPK2UQ6I
MI6)%6)GB,A92Z%YY$'Y0\3^HTW*@Y]2<MJD11L[K$/3ZE!(?3QD%!M"-&;<H
MCYK+J>/NJ[>NU1%1=PL91PX5,914YSF,8;$XC#XO X^/%8:".MCHALL:#91\
MS\RQ/JS$EF.Y8DDG5%>3\IY%S3-S\DY7<L7\Y9;JDFF8L[?  ?!44;*D:!41
M0%154 !#G*G1/$W,W+6F\Z=IGK-/Z+1M.F)]5YCHM1>S&A])72V7BS/F5WK<
M4XB74GM\/I<9(-CP2K$S\C9!1)L!R%1!0<EK :+/[,=$_P#PY_9W^5KQ^[7[
M&?#^V7W&0_<G]H?W _F+]F?G^H^Y_P \?^.?^['TGM\OU_\ 9O@]_P"S^FFG
I=^FFIZ::GIIJ>FFIZ::GIIJ>FF@3??\ K!C_ /S+_L)/331V]--?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g282574g06l27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g06l27.jpg
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M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
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M-OX?'9GNS>43T>CS#D8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'G"^^/_OF_85_[C@;
M_P#72<>;KA\<O1Z/<.1@,#SR?PT7^XCV[_G^]=__ )7A\.G<XQZ0]#>',P&!
MYQ?XD+[BGJ#P)YZX1'\OE(O/CW?.F6"E6CMDFO1+*_SD-7J]&,MC@4(H.+AH
MUCM?XMYQJ0]$EO-0Q<K\,SM_:'&CKVL(RF;\D:?:HK/W*+-U/E/7P?WE//GW
M&O(1%\A^_JEQ1$370*X@E4K!L"D I^N2[76B@ZY:@*=B$Y()Y41+NE1-[_T>
M%SVU6V8EC1.]W_=0^\YZ[[UPG[876*IY \A^;SKE6M_H8H#AE[9<)R29<*/+
M(GR@IXFB5<)8"?*"AQ+8WZ J.F00GZ<=::U%VX]N+SUREM.\">5_O)^9?14.
M#ZN]V4/V;Y--4FV-E-E:FS6NK57H+.Q3U0FPEOU[9"2"E)W-9D)T<EIUO:-[
MCH^&EZK&4X3&D5DUQ_?2^Y#[K!>S^9^$OMHW\S4^GT/A71^^]W=JH.E'BL^#
M!J)&]C:T_J[5NS1(3M<Y[3I)1IJ.VT_.E'(+&E*4MM.1OMX8[=V7-M\^T+[Z
ME?<!^V_SOO9@S&F=DJ]<.<W[8[%8B1EHZU0!B&IU@V/CM-Q(C=U$O0+ TTVT
MVPVDG]-"-)1\NJYYX[<J\GF5^SQ_$7>A0?9XO._N5]&)7_@O:[5NF4/T78:K
M6JO#X_TX:S WNOGRM1KE<KY&C&(9F$HBX\A<P$[(CS'%Z@O/*;CKGVHJ\.+;
M98_<WJ=C^):Y[XI&]G*?^D\[PM-NE\D8"4MX%/-.<%O%O;+)L/Z=<MWQ6?&1
MI:=-DM-;VWK6D_3WM.WFSMC^K=Y_]MTWN?D/JKMO#'*1XY]+PO)_8U7&LET=
M8GT05T5A%5&N2U6&M?IPPV[#VLZAUK6G_A\[/T_V?Y<KGC,1/Y1</(H0Z#]\
M@?\ =>!_:E5]V)QVZ&^>+Z$WV;7GSE2*O'C(YJ:Z2H6NF[JRBSC_ .%"JB:=
MT0TG;CFG/EUK6T9':NWLWTS#]@^Z/N9_;DI_!_MT!^^5CVW]S7V'TXB6H7;"
MG-*W2@'*N1V4@!I%)!Q:0TAFM%K5/N0LNZS/)I<@0(#$J1)9?TVRC#....=Y
M56$+;[IYY_B.?"''K1[,C?<EIWJ23RP%)Z)V#SZ6H$2965TX(SLI;_TRT2K(
MEH\/!"FGWY*(&JQ/W#9<7$5]9*&E58GM93MJGH2^V)[QK'W(/'',_4( $FHF
M#ZB]5Z-2FY:R#%/Z549?Y9:PT @XVTY/#/N_2G#GEITZL=,8VYK3GSZT<L\=
MN5-@&&3 8'E%\L]@^[G7>@^_>[>>R]<]K>?^5?<:]7<@.^).G'G*KUFNU6H6
M@99&3'F7LQ5V:-8?1$M*V&ZF;3^5HU'TF#\CCWRICM,8343I-1JW9^,/N9^7
MO;<DW2J*=/\ -/05(TMCJ/E?N -_F?H?FI&-I6I[!OGQQ:)A<7%6C?P)BESQ
MRD;3O;R5*^35<\L)Q]&P?#)@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,#SA??'_WS?L*_P#<<#?_ *Z3CS=</CEZ/1[AR,!@>>3^
M&B_W$>W?\_WKO_\ *\/AT[G&/2'H;PYF P--_P!Y_P!#4GA'"Z!#[CX)MGO+
MR]T>X%*[WNO4ZL*MQ3DPL>%V3JW1$B5C),5I:"Z7(S4M4X,[%>6E;,UMSX)6
M;PB9G2:R>3+[<]%HW0OO5>=>G_9RXMZ^X]Y@"2(TSTXOMS+[=6 TYW5@_>'4
MY!U)JSQI-,-!=P8H<6:+DBJS_P K\9*$-(4U/1WS_P#YS&=;F4?G;HOH7^&F
M]=>IJ#W#S+U?MWACT;=VK?0^V\D [+OCXX8@>>J9!,R0IFMI/0ZQ8%##X I/
M%RDR8;4R&Z]'5KZYF8CNXQ,3^4-W7E+[\ ;V=VH@'Y%XQ].U?RU0.5=,ZCU_
MU!U>G/ @]?U1JTZ<%56N@:RFU"3)JQ.LN):0HRB4Y]+:6HJ_C\Z:YY=O;&LQ
M;S]_;?X1]Y#USZ5]=_=9\MZ\^<5N?:.E7GG#Z?95.OJS3-0*2*Q9VJ_SZNJH
MY9V$#K59A @;TYQ;.WTPUQVTJ2EW>HZY3AC$83<^B=_L_P!6]3_:L^YIZ'^W
MYZ5JL:34O7/.9%_ V_D=>N,_@D/K;(&QVVJO5$\2JXI@*,,@5FZV[#?1&6T0
M'0(_Q6A+*UDSG'/&,H\E-^P]]N3G_NK[6GMKS+Z=H=LJ#1_U FQ<\M)NIDP%
MQYS=X?(:A#!=%IK%D@CUR5P'G7(\IG_YE)0G'X;V_D=5\+Y'=RVY1./)CQ]K
MGS'[3\V_Q _G_E/K@7>[8<XCS/IG+JQUJ0&L!BBV3CU9X3T 9R6?7KX] 5#E
MUU81]$6"S.D[(0/DT/>UIV-]-,\USRQGMS./F_H397F>1"Q5&W*_B[*+;DU&
MV*J*/.4B,Y;DUDXJIMR?_3%>8WX9=FU V#1(_%.):^GM_2_JJTCX?-O6LGF[
M7']/CFD7[]7C[U)6/5OCC[N/D7FD_NMJ\CJ"">I<<"09Y2Q$*C5+8:MH>Q"@
MPEN6;,B)4*VFA1A(]AZ= :D1IC;+K;4C;8[>4;9PR\T!^H?XB]7L7S?T'RGX
MN\+>O#_JWT!1#_()U;L_/8,@)S=-^#R:S:"+;M<)FB]CFCQ9&2B%N9!"Q&WM
MID2W6&VEM*+':VSNRF-L-VWV1?!5Q^W3]O[G/">FRH3G6+!8;/UOJ(X7,;)"
MJS;[TH>G50@$V5*CD_TK70X^#)DL[VQ(FLO.-*4TI"E5S[F6[*XX-N&&# 8&
MD_[*_P#\S?=(_P"\%[2__:<]R0WGY>D,N_9_VVO*_N:.$,=8J)*K]BI*D2N6
M^DN1FI/-O0O*BL=>GH,^F]. :9,)CQ']?/H?._&C%[WO:H^U;^;53'/+'AP:
M]_W_ 'W+?M=:T/\ 7U2/_<A\8!]?)']=\(J3,7UAR.O1T;TB9Z&X*-7^"Z8(
M%1&/FEV&L+_$I:2N1+:6XK3>&JQSX:9?1N \W^I?/?KWFHSKOFSK5.Z]0"?R
MMZ-5,FB2^*G;1\[@:RA9"8YRJ'XVO_EAY*-%F-?_ 'S>M;U\3$Q.,U/%/N$,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@><+[X_^^;]
MA7_N.!O_ -=)QYNN'QR]'H]PY& P//)_#1?[B/;O^?[UW_\ E>'PZ=SC'I#<
MMZL](53R)Y]Z7Z1OM6OMOHG) C=INPSF@4?8K=!J;)"'%/62(%(F 34\;4QT
MEPD1TA_ZS8^*^XVVXI&D*,1&Z:CBP][I]W;RKPR5V/3\/IG30G!O,7,?5W2;
M?RFO5^P543S[M-Q'U'DX%@F7ME>5*OE\CS]FH,#3:6=@V7)2Y"-_3;6:C#*?
MY7**^Y-6+=Z5ZEYEYGYA]5=2.<3O_.^<]6Z13JWQ]KE=(-=,J%?O0&:6+VKM
M-:M+H:'6K$U(FO10\A;.F7=)0YM*=+)LFKT0V7^^-X;K'+_-W4;D3Z-3(OI3
MT9;_ "\+J-DJXB'=N5]+YU;WJ/T=WLHEFSR852K%"/+@I)S8THAMIDM"=0VM
M#V]H+_7E,S'*&;7#_7?+^^]!]34#G(:YO,>1^E1^0]%NT\,-A4:P=*:JT.V6
MNK4$FR8DSST^@1R4:(:4_$A-QR#^F6U/?*M23,XS$1,^;7@S_$%?;@F^8Z5Z
M9BWJV3(=][-#X$+XDT"!J[[#Z1)+1H,J 9H*[0F#"!C TUDP^5_,5C=C'VMM
MO.2741E&_P"K.ZZ,J.D_<Z\S\I]P\Z^W\?3>I':>CUH>8&&@]?&/<P '[$(O
M!VC<UM=NE'H"P?1NB">>D7@@_<1;<Q*6_B\CY_V&8PF<=WDCGE?W5PO5_11C
MR] \3>XZMU&F,\Z*]18M],X1##<EJ74WB#=/N]Z(!_0IMU-;FLB);R_RQDE-
M::C.?&/\VM)V6<*B[BCAWW9N=]ZY#<_1%<\O>NJWYZIW)NQ]?_?5<JCQZ!2K
M*#XC^=-VH)6XP?MQRVOV8C+KD]@<S*%Q(S[L5?U'V4[0I0G"8FIJT6B/OL>4
MY/+NQ]-M/*?3O.-\;\]\E]5RZ-=J!1VKE>_/_;+,-J7/^C4#=<Z=8ZG.@$C!
M5E+D0B5&$6FU;7N/O6M_ O\ 7E=:<:9+=S^Z#YC\]>J_.WD#H"[YKI?I"%7Y
MU?.A:Y (<_Y^F[FI]7YPQUBR.'(KU0D=)M8N0+")3%EZE36MI5MM/P7LS&$S
MC.4<(9 <Q]3\ZZOZ(]-^9JV-ML:_^44<;7T<@7&#HM6):[A3B-WJ/Z1(QC$P
M@3W#$C'$3_Q,2']%_:4M_53O:]$F)B(GRE _F_[DG)O5W6+9SOB_*?0MBI50
MZ'TSDY#T2N@ VN#KZ'R-V5&N=;?-,W*5>Z\MN=#7'@2S->&P2C_P1$>=^='S
M%G&<8U??<_N7^>O/_JKF?D.Y">HD^D=)WRY"CE5J,$I2J4OMEW-<YY2BUSI9
M\;89GZON%?EQ?F!C#21B&_KD=PXZM.[$83,;O))M^]I\8Y1Z< >7NDHLE&M5
MRX/?_0=1Z">&C8O*[35>336&^G5T=:&R[I']<40%+:-3X+\%IM(9?XA#R_E6
MA(VS,7#$*H?>8X/T\#S*7QC@/KWMUWZ;R?7?FN0\OY/63/1Z-PHG8C%>HW4>
MD,%.BA*C5!75$A'I]7%J+O6$R.VA]H?K2]:PNR8XU&JE7O[U_GNK\^Y)V&G\
M*]6=FXYVNR4[G-*Z;S*B<YT$;[9<[8;HD;@=F W_ *U0[[5>N@KB ?'%!\X0
MS%A2=HTJ3M*OFT-D\-+7]9/NG" '4*IPN'XH]O6KN5AX2UZ),\CK=/X,Y;N?
M\\D]%L/,8J[J\8]"AZRP8E6 !IQ# \B11^%FQU[<TI3K;0C"9B[BK;1H$I<V
M#"F.0Y0]R7$C2EP)R64S8*Y#*'50YB8[TF.F5&4OY'-(<<1I:=_*I6OAO9AI
M:^RO_P#,WW2/^\%[2_\ VG/<D-Y^7I#:WVGN?'?.7.C_ %OO'2Z9R7FM7C*D
MG+G>CT&OA(>M(6XW&1)G.M[FDI?T]ICQ&$NRI+GP0TVM>])W68B9FHXM+COM
M;WO]RQURN_;,YL_Y=\O$'5Q"?W%O4E(F,&;8(4Y]&00\H^<#281FW;?:;<W#
ML%EU$$J^/_R*'$IWLWMQP^>L\F:_@7[7/FS[?2;M:^=(M?0N]]><<G]R]&].
M,;,],ZL8F$-FR+Y%N"W K->$/G7')+< ;"CMI4K6W5ON)^ILF6<Y<>#9#A@P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!YO_OF.M,>R
M/L,O/NMLLM?<:$..O.K2VTTVC]$J6MQQ>TH0A*=?'>][UK6/-UP^.7H]$GZF
MK?\ M #_ *6@?SC+4N1^IZW_ +0@_P"EH'\XQ4C]39:XK>DI/A%*5O6DI25@
M[WO>_P!FM:UI_P".][WBI'G^_AH=Z5X0[8I.]*2KW[ZZ4E2=ZVE2=VX/O2D[
MU\=;UO6_V;_\<CIW.,>D/0'8ZZ#M]>/5.SBX9RM6@,4KMA"$64R!Y@&;@OC2
MPN?'5_)?AD($EQEU&_V*0O>O_'#F\_U.^Q5'Y9]M;V?X?H'9(I/HGJJY)E0>
MSWT4:,;K7,*+:JO%X+S0I%05<*D!7+.35&.)92R\TSJ;(D.-(;96EM)U_LO.
M,IX0NZ']J#J=?^X;U?V1&$^&NG@NG]MXAU(22[;Q[I%C[SQL?RVA4BD%8G([
MJ$N0FO SA!RLODH3[\-]EF<ME3J%I1M.R;XV[=5P6/[&7 +UZA]_]XO!71JI
M^T^-$N>USG2H+[D7B]\Z3!'_ +].MU=R5+=AQ[??;'2:R6:D16H[[4R#(^JM
MQ#J$H']D[8CDS;^WKXF@>%/&?/\ S&U:4WNXC1UD.]4ZB]%EQY?3>N7TA..W
MN^D6YTR>2<63,$-ML_B'WGTPH[*%K4I.][,Y9;LK\FJB#_#X\V@^&J1QUA?'
M6?:0"J<KYW8/5C-+.(CF*!SKU5"]"R!,4!^9_BHY<H!B_DFR:M[(+8;98=>5
M":0QHW_9.Z__ %_Z5+KGV-^K]E?]4]K-^T;S5_5?9/4U>]/<FD5*((1P"@&^
M'38<'RK!ME7+5:=T\_-Y92H[PV4^-L8N-)W->4F-\-KTZ/[*B(B-*;+>*>0+
M_0/<7J;V%;[M4"C/I'A'F7F/Z-KHDS%?K5HXF-N[-I+[)$I3K<T$?GV[2H#6
MD)D,M,[TZI2MX8G+\8CDU@^1/LM=A\W<9[%Q8FWX-D3^E^:O3'#=>DJ-Q?IX
M3TT8(]Q2>> R;Y;B=VFU\Q5 ,HRRW,B1X++[\4;%2TM"D*4HWEW(F;UXK2D?
M8#M]*X5W/@G!.N<FYS2O47B+SGQ/N@=VB'G1LWU9Y_L=6FK]$5;\).3-@5_H
ME>@$F2X9;J5N$9#4WY]N?52H?V7,3/&)2GZ ^QO=?4%D]O\ 5.D^OK]3NI^A
MS7/4\4%\JB AO*^>53SH#$2/,$'H@FRU8Y=;,7HO284H_/>!& *9#\USY/Y>
M]KV([D141&B?N<^.?N)\;]6]V]+T7K_CH\[ZGK7DJ!V\1?\ G'97Y\6Q>?.6
M1>>W(KSR55+S71XZ+=)\XG.AM3X\K\'IR.A>EZ;<^<DY8S$1KI:E\M^UAT2H
M?<H@^[)MU\]\W'"7NP;LXSS/R>_\GNGJ"%TB))@5>#ZBAD>J6CF%A(<[2\B?
M^:C S$\P89U*=4Q\4H;$YWAMU8Z>]OLL>G?5'K+H7J/E7L*M<MMY&#7M<7OQ
MBL=+D]AX$"@<Q,\UN_".>'JKT@#3A/&>M;L4XR5FH#?J2"6E*?BR/JZ^KLN/
M<C&*F&:7W!/M8UOWGY2X/P29<'N073B!KGC@*_U@C9SY 92/T_'YQW7G<"QE
MR3%O+ANG\E($Q2Y)&0X_*D?A9$[3WR.H69QSVS,OVW> .W<;]*6?TS]OKJ/%
M>4$>H<-Y/P'J/(>\<OME_P"8_D/"8,\)Q^Z\]DT*^4.RUBPTVKD7!;HQYV4*
M)14-[5]!U'U-C=$Q67-&4K[04X%Y"\[^;J;VB,8N7.??/-O>/:.K72L.Q==7
MOHWKY'KO54!:K7R&X=,39R))441%2](CCHS+275/KTMQ9=^LS/*E+]W_ &L.
MC>G_ &J*]75L1XHZ> A>: G!D\K]D<DZ%TP&'.">EV6_;Z!6_P!$6^K:A%7(
MIIL?K;FU[TQM[_\ K3\!CG$8UKQ\F[X-&E0PXF).2/1-BC8,:8@2R]'%(E,1
M6FI"1C$AQZ0P/2ZG>F4.+6M+?PTK>]ZWO#F\D/B?VAZ7H72/N8^4_#ODJR^A
M_1]G^Z=Z^NY#I-^D.T+R/PNK'S5;""[!U;IVE*(6$]N76ICC=6"-[+266]*T
MXCYDI5';+&*B<ITJ/5M)XM]H:'<NA@/2_P!SOL$[[@'I8+(25J5=M0E(+R5P
M><O;3OX'B7GO2G*VY(@.(^31L\W.(R_E2]MMA[XJRL3GY8:0W2---,--LLMM
MLLLMH::::0EMIIIM.D-MMMHUI*&T)UK6M:UK6M:PP^\!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>17^+@X[U[IO!/'1WF/,N@]#
M'4GLG046R10*F>MTBM?J:D0(X"25AUR$0(08A*4+>:;D*;TSIY*4*7I:T:5)
M=NS,1,Q+PP?^GCTW_<!Z-_\ )[K/]FL/1>/1O8O]"^W7*^SW3*+1_%WK>)]S
M^/'K#)JUJX%Z-:/HOL>SQ)%YM!^\R /[O2?)2E4U*8'"HRE2&MN1DZBM2&W9
M&K>CE&[^S68V-$__ *>/3?\ <!Z-_P#)[K/]FLCK>/1_1F_A@.6]+Y3]KP<-
MZA0;ASLM9^_]@N(0/>*^4JYPA6"*ZV-'G=!C4:&48@$9@>3IA;K2/K(;^HGX
MH4E2K#S=V8G/3D]$>'(P& P& P& P& P& P& P& P& P&!1@=<KU8C2H5;!!
MJ_#G%2IV;$"#(0J-,-G9SQ0V8E,0&&&I!4P2DN2)4A>MO2'W%..*4I6]["LX
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&NDC[3M,&//-
M1*O6"XLOWFV<9I(KZAD1+2"KEE.<^WU^Q6-UTB,<YD*NS(Q9XBQ$9:##2'P^
M,F9N/'D&ML?1TJS[?L1&M'+(3 5->E<\ZC?ZD.9V8!/DF %_!\ZY/$T^4FSM
M&H/429-V5J?&;9:AMM_1^FXO6U[+M40I[OO#B+!JNT:CO(K1F[P)I(G8YK+9
M2GT5 TP2[/4Q:]0'+/SXG3[>%G@X[4IN98W4D&82_D9BR)0V\V0'H'T7:.5\
MUYP:Y]7JSTKHW39T(+5:Z^4)UP&>+3:W,D0]PY*XD\I!AD+>\,')2\TMYC1'
M6W-;6C:=DB+G5;')_61#NEG^E1M<_KE'B(CV5LY=BA%LU=*3+MUKIR/T@(CN
M066BHPC0"VB4EYY^-"D*CQ_I.*V\XV)BF<N&3 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# Q"N7<O.?('[^V4IVQ+XF\BN?VC8KG$:'NT6FYTE[J+T0<ZY%'HN2GZJ.7+
MD:94^[-EMHB1T29SC,=9J(F5%&]?\OKD!7X/+X+<4IW"7Y^J1P9S.M$X)+HL
MXM8(%A8CNUW1.=614>95I3L^26:&?.VEMW27$N(5L:\_)?M@ZQYO38BU6L3-
M2E%Z>?(UHNQ.K@LA^0N<_P";#>PS"#R%1I#\0#6*U/B;;E:1IID@ZW';_P!+
MO6$J>*)'?8/E>@UB@:T#,!:]*YS'Z578+M(;@2:F.*/7&<.$&A!5^*9K-K*G
MN=%F'=/LI:C%87RSI$=UQG;A=LRK&O3GF$N)#6275'G:F'8(MN7&?SJ#(JU#
M.E0A2T2:G,-:1)C1#MB$#ER=*';E0):)41:I.TSX2I K)<Y#VIQ<3SNG=))J
MM,$3=KD9HHH2\&C;L"#E=BF)QU.H3)-V(78'Q ;VTZ%R"#TQU3<>(W(DKTS@
MVS=*X3]<\6$F;8$FE3R)51N$[G\EY%8,.0SEVB5U-@C5>I/IC_\ [TF#CC$\
M8.:AZ=W.-")\%KYI$9:,)4J?TKV-QSD]E.U.Y+MC!FO5%FTSXHFMOV"0Y,E"
M9YR#21\ *_-*$;L0%#UNL168ZX[FUM-Z?^J\TVH1C,ND;]M\ KEG.5@S8"L5
MP(6J8#1A@*^4#F3UQU4?RD&#V(<GE)IE>[R-2B*J*W(FN.N-PD2G&'TMEVRJ
MF_7_ !YHA%!SEVP;990JX$MUB95YVCD233K96:.]7YL6,J0RQ9K%:+9&B!H/
MU-O$U-2-LZVF,]M VR^Q?K_BYJ6T/%D+#,($;/8J?682*T11)NQ^L&ZX((1J
M8V\EO]017H5M'F8\IG?X5^NO[*I<_ M//MDJ64&$,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@0UKT3P7< 85WV3FC8PQ/Z8+&D'[F!CPI
M1#B_YY^]V*F4_.;80[S']-$/S[YE)T*_!N_B?I_)O"U**2/OWQ*)I@7HA'U5
MPF-1;%8B-1"VQ72*RL$0M8ED7)(5IDBU/7'T?8C'(3NH:MID+:F,+0A27F]J
M&W*ZJ;2?SOTCP/K=OM= YCUZ@7VZ45I+USK-5L8\R7JZ%+BM_*<B0WG7!KJ'
M)K*5-N_*M&W$Z5K7QU@J8XK4YY[-\F=:F"AW,O1_%[V0.')E9#PJOT.LEY9(
M_ K)6Z2A,*/$(..OS4U$#/)H0G6]NP(,E]'S-L.J0)QRCC"X3'J#SG7J-6^F
MGNW\O"\\N-.LO0JI=BES!0*Q8Z)3:ZNWVNXA3,F8U!(UJO55O9*7-:6J.S!U
M]=2M-_RL%3P\UH7OV]X_YBY&:Z!Z5XQ4G)K@-F)HU?Z_%U*>LX$5:*TRPK<W
M:77K%7#L*= 0G>U3(LIIQG2TK3O8J5/F^]/%PZ#;"D_U!Q*(-HEC&4^XD)%_
M -0JY;#,PH/&5HK*7+TS%/3)P28RF)M7U_J174[3K;:M:&W+DD.%Z<\Z$I<V
M -[ER@C-'".1V";&@7RMS7HX#OQAFO<0.+1&(N[V'ZT=DMPZ]*U\6"TAQ+<9
M3BE:UL5/)$DS[B?A0>(_4$WUGPB,!W89%20;=Z( 2)>L\7;:7P$<C^+_  DD
MLEQU*-,-K4XI:M)3K:OV8-N7*68 TC ,#H!<7+8GC"D**1'3HR].QIL"<PW)
MB2X[B?Y+C$B.ZE:%:_9M.];PCNX# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&,/0?/'"^AFR*K;+DK,/V
MR/;#\)JX.1'YDNWB*E38@R?!5(4N"-L4'F0V+#VPF-+TY 7J&^VMR1\Y8F8X
M*D,XYQL-:DGR)M9Z\Q.IBKI)+V6TPWS:[\KG]@IE2%S8L;\OC:_+Z-;)>AL#
M\.E2M.ID_!QW_2[%S[(\MW"O'IFPS7[C*HKAUPWT*WVF&6N@F/+L2B!VM6N[
M1[E'?(-S#%9 S:8,^K#D[W#@1(+;*TI9TI&RW*F_^CORN7AAUUUW\K?L$W1:
MDG:M=([A!8H=8)U]W7*=*D*)QB%%BV&>X3<%);DC]NZ2XXWO2=;T-TN\7\F^
M8P,(=23A":$K5I^@'"\]+=&ECP%@MFJE%Y^NPBPL^>W(,WF;3TH@.+0I[2M+
M^LEG4I7U\%SQ52Y><_.)JF5%1,TFL<ZYR7OB@NPEVA5NHCI%XN\<L;#*G-K1
M#&L"+F-:CCV8ST9P:IG\$UM+6W&%"Y<XS@OE+C!@:>C,T^@2*Y.HA=31*UPQ
M,!PZ)&=0KM,L9N,5(-HF'RK=\L&TRW][>(S&_K;VX]&TI)+F7/;^'^4KU<#%
M@O$6A6:Q'K^S&,Q39\1)40OZ:$*I06MRHRI2);I4+4H6UC16U?&*]-D2VF=/
MO[=P7*GPO"OG. /ACF:N6VB+J,\[,79"WYJ1+BFKBQ5K.3*MOMSY=LHR+U._
M(B6W-2Q"M,*C+1N,SM!=TJR=\;</L9DM8BHVRNGS=S*WXD88MIJ%-?LQ?FC7
M*I$IM4.2PW%BQJ\AR7$C,I;CPC;[I-A#<U?UM#=*[:'YEXMS&P0[#0J;$K#@
MN64GAPXIQV/7 DXS4*90R$L,"2K\ -?=J="'0];:2G2&D.:3K7U7/F),S/%/
M>$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@:..@_;&WU;
MLON(2COE&@4SK=%N4[B?,(8]!^S\/ZAZ$)\GN?H:W7\$X2BZ-4OIUVXL!DH@
ML[B+?'F3<9;R=3M+V=-]1&B1U>,>I]"MG4[-T?IW#A??.D^BO!O?+?S[FGZB
M>I]6YCY#Z!6"@Q;+9OZ-P+V[I,2K%8Z2TR%#B(^C"@)^HT.4^Z3=%5%U4_5.
M_DGRSU3S]V?UA:K2<KARB=V[1TGKU1<#],Z[.EB?U]889:.!)<>L#:>15:>+
MC-.ZDF@F_P P*.*3J1\4Z^.B991,1SAJAIOVJIM9\[=@\U=D]&< C=(/5+R7
M6*%(B]*OTZSU"5YZLEJDD+LS9K>8'=$H$*]\]Z*1!P*D!0S70\:?,W'VM)>;
MI1N<[F)B&S'W?X,.>H:GSBF\O-T'G=>Y[QSTIR> ",AIZ@<:#V;B:N3U*&-&
M!8ZHL>OUA24;DQODUK<)/TVD_']F&<<JX\V.5 ^W"<YFYT1H?W?G$[EL?WIY
M%[!R=@HY-1-YYQ[S.9J(L;Y[.%=R7HDVV )L!RMU]7U-?+!:@1Y"=/H7K9=W
M\U/U=63]KKMMC@7FDF>OLTNKG/>EA]<5^^\V[%VQF^@ZQ:+]W.Y2 -.IIJ*Y
MSWCE\#-]5AHV3KO^B-OQ'G"&E_,W@WQ]$;AOM!]-@'^1V87UOC=6Z-S5G[>%
M7NH^G@CT:N7'A7E4Q5C70*8^$4EN8)1=+[R@38JJ\OZJ!92%,8<4MN1(<V-\
M?\_5/7#OMV]QH'F7G?GVW7:CO2N7^J?/'<1=EA]'[3?A1^I<?[L(ZT>%P:CT
M!G0GDI J)%ZA0Q%=_P#G&F5OZ[GPVI6]DG*+N.3;[8[36*<+<.6ZQ@:J%9=9
M8>,6,N/!BVGI"_IQV7"!.1%B(=?<_DH3M>MJW^S7QPPK3+S,AEJ1'=;?8?;0
M\R\RM+K+S+J=+;=:<1M2'&W$*UM*M;WK>M_'6!]ZWK?[=;UO7QWKXZW\?VIW
MO6]?L_\ '6]?#?\ ]W _<!@,!@,!@,#\UO6_C\-ZW\-[UOX;^/PWK]F];^'_
M (ZW@?N P& P& P*-*L=>@FQ%9FG@T.R6"*6F@:_**08YLW" :';.RQ IU]$
M\E%"Z+Q-RW&6UHC?BF?J;3]1'S!6<"P9'5N71(=M(2NDT&- H,UH;>YTBXUU
MF'2B#[B66(%MDN$4LUR:\ZO24-3%,K4K>M:U\=X6I=DMTGG0"J1;V=OU*"T>
M<B&["N1:U AM4F-D=?$>Y%L4R>R(D(GZW_H=H>WIW_[WXX2IX>:[8DN(0B19
M\"5'FP9L=F7#F1'FY,27$DMI>CRHLAE2V7X[[*]+0M&]I4G>MZWO6\#L8%'(
M6*OB2($.5.AQA>U3)@ZL"B!.%"(V,@/%S3D^ !@R7VY)B9!"#9,QYJ.EQ;46
M.XZK6FT*5H*Q@4:!8Z\5*'@8L\&)&JM(@1+.'@%(,PI7)10=',#(QX?'?<EB
M)!$3+:E,(D(;4]&<0XC6T*TK85G 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8&N>3X_ZW!ZHSV2#T^I6^S66V@KETJOW&MN" 1 A29MKF<R$UHQ6F%6%NO<
MXU:4M#V"BB#FT04+^HAU]]:C=Q5+<)>".@/&"-I8[:))W K;*9VN18[+SH2^
MXUZ'HSUW37K=^!!O@TDJ@*%W- Z*.F.ORV18B#$U*VVSK>ANCV= %X&N5*7U
M>/7+A4S@WHLNM3G6K5L^C9K\#W8OURX1KPQ$C3?S@K>QY^9#FEVGD.;=>5M4
M1QK?RZ&Z%W#_ !]U&LW:J]@@]#KMANM%Z.?N%6Y\W7HE:YL+&=2>MB^MCA!!
M^+8;977S4J^//*=C/J1+C@!S;S*GER'5C=%4G7IW$^@6+H%GNE#M54!S+MSR
MO\\78[&!?,6_E* 9BRD'+7RE[YG!:#$]%G^ON-,;0QHF,AR'52&D?ADF8F/-
M$,OQ69'\$5PFL7H>B&-ZI:KG2K.1!C(LFF@KJ(L4(PE=;AAI-3M!R+,NA=UM
M,B&PP^Y*3*VXS/;1*27=K:T0'@Z[U4D1)1>P1+,>EV;E$X)T8X FB;[3P_*J
M[;:T,<>;#E':ST8ANOWPH)8@%XK81B XAQ<9Z1]53HW*O3_&M_ E:Q!.6#F)
MVBK)T=71AL6OG!)^T0N3$YUAHI5HL^^7^>RV>\6 I8;4^Y\CQ&2N+!;D(AL/
M_C!.38YADP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP-61SS5Z1G7Z^="%E-BGY=^M)*'";MHQ)PK5+9?A[I892#((?52U3@EN<4&I
MQ"*"9AV6\Y"D,PG1S>UJEF[A],>3.^ULYT(Z$NUA-'>G-/!YEL>ZW:ZR?'G*
MUS+D= Y-U.S[$K5&,1JA* VLK*KL-*84R>6:^JB0E7U(DU-T<%_T[@GI4=>>
M<F+7UNXSA+LQVY7_ /+;T5(18EU>Z6=MY81H.8)1!FZ&4H>Q-6A#H4-V$.B,
M2G6HS4E[4S=29Q\H7GU[SK9^I]-M)Z3'#1:U8]^;:HX0B&IXNS)H'+>F67KO
M0V8TT9'C$1LVVF5B16M1Y3;NXK&W4NM+0C!$U"E<&X[Z3K/0@YSK_3["=#A*
M]%U$A0;2^9K\UF748 R32CT<K*:GF)X*VR9I!!QZ&X0FHCQ=.S?AMZ/L3,5H
MQ\WXH[M. QZN\5H<$4UU^M^F&]/SYA2*[Z$.)U>+M9CXYP0F.8#TGJE>CR [
M&]*_,'3TJ:_IIZ!%2LNZ$D4[@7JB%8:+*.==Z JM,I@E# F7=?Q\L#< Q("\
M9D$9_P"?29-GJ/11E=TPJ.XY-0-65(KC0(2G6-QR3,+-IOE/TG7JT*#0[J<J
M<.N<A"U\"*$]HO<GZ?5'(E!=.74Y-0MZ=98HVTE+H5BQ)3S\.6MV$AV-I"E-
M-%N$E^8 /<C=EZN>M5CZ.%4CFU8I8JQVTC<B]1M'79YF^6&Z]2J?+[Z,JVJP
M'$Q2(&'$'LQ(L33#*X>O@J.XM9)I(?<^1=4L&^36@0@+U2R<_IW1:J7C$/TS
M492[3?1%6@#^Q4T=::_>:#$MM477I<5J$1AR(VAIZ:E"U;3]"0(F%G<?Y1ZK
M!]-I)[IUM9*-CU1YU_L(;H!A%%L-;<XL,JVN95SB+(H;4J\0#=A:6<2=CQHC
MST./O7S?"<[!C"9BM$:53S7Z5I-@4*K1PL/K2.K%+)4SF^ZWV8/IPPOZ9OW6
M;Z<L=)(OSF.DHZ7R:UCJ^P+(N/,B9XY_;/X9,C<]99F)8J>P>8_<?G^B.CD/
M-?4NKA^4;7LI3AKA#H.X#-D[%5JQQKL8[Z40<1@R*IQ6E@WNA4#33OTDWDE)
MCI1'1K3V&HG"M8BUI2>4_<4']_86!ZGZ%E^8Q_2ZU3(8XP8ZH[?I?F8OT-7?
M^@68DZ_"D$)/<*_:!L;F >2N8I]V@2WGMR$+3ME0O"O*W0J5&^Y_3.H!;(1N
M?:ND\WKMX/BGJ,2L/00I"X<=X9/F7WS'+EEI=;*,B^E=ZM9I^N=1E/(E)57H
M43;NYJ4_2R%X3%+*75/N3])M_?BH*?ZQY56SG8_0@83/+] ZIHA8^<EO47)3
MO,H?,Z++KZPW&(W-^.UBV-#SHY2UG8I=B)OZK#ORPA^.G!?5EY;]Q59GL(ZB
MWGT, C&M=&$<ZZ29O77+2VV@]V?FMA\VW-KEIH,Y#I[WE;DU=+0+2,3*D[Z[
M(D*C%''D$'Y<6EX^=>/O]%,#4WW3;^@U3DEBN/L?GE"1Y)!D^T78#*[2?(@_
M7M7I]^Y-59G-^B$(M?1:J=TC=YC]$-CH*UL0#-1@Q9[+.Y6V%C\:O2[^CL:H
MWW23FN=VZT6_JL#H]DG2K3?!U0LG50_+^!="D=OJYQZ=7Z>S7DC_ $!RM7GB
MLIK4:JDVV(3!J5-G?20\2=G1(7AP\E*Y]Y]]O\OZY3-THWZ6K?":SZ-[ET8F
M &73HMAG6L+T/TU,[(&L]I&WYHX@X&-<=+[I12M2OQ*X)2)**PU:DDU$F:7C
M,>5TF7JD3WO?KKU2XCZCW*O0;ZWYT.5ZEU?K?4:>'I-&ISM#D>B/,(7].5X0
M-$7'IY42;EP.LQ(NBR(D]L>A0ME.U9$_&--/'G_TB49PO[@IJ95'NA=3]6_@
M8#_+!9 =2NF]JK_X'G<5CU8]T*JS9XB*!?NEU'Q;OS(4Y;)#3!<V[7'R#3L9
M[ZBY%6\?*O'B66_8>&_<%Z9Y[\DPJ'T\N&ZA6_-9&G=A<<Z[;^-%H?J,M1N;
MC*=Z#LA>MU4K+ZM4>:6X'8I)&FSXT6!8=%VG'F7?II:;)$X1,\K^B3I/FWU:
MGROZQJDKMO3"/HKKW4NIV'G5OKO8"0C5/H[O4II'E5=H,HV-GB>4"=\[2RP3
M@C([<I&I#[#)!#J(LR.2XN)\D!$_.GW+'JAUL40M@0U?.@#> 1 -OK'J;O53
MJ/.:37ZAS$1U?G'-ZEMUDT,O<6_5\\;BW<F1(%;&.)ZCDWOCK<79;POIZ+]\
MS>8_>U)ZER'I'<^\V"YR!MKA"^O@4=CM9KGQOFL7P]SRA25A.<2@XZJ(LI#V
M%6R%BW+3%C3M0Y;C^GTIDOP]DRG&JB/%_9C;T3[:?J:=V_T+T/F]V.5*64-^
MU.H\+Z&)]*]2&'V.A][XYYY#\>"31KS4]^I5>G=-Y004;@QW7A1$?^7H=8EQ
MF=0V2[XJ+Z,W?-O _9E0]%>D+EW;NMBMG.+\Q=&>;#AMQW/J@2'8K/!*4%P)
MS\B)0J@V;E]40^'?<'2&8!=2_P 5(1*?4AV.9F8J*:NF_M@^E3PBG<,>Y7RG
MD&N2>?>'\O,]RYZ9 V0)ZU+5KV=P#K=MZET =:**]^ Z)2JEQPI8X(BU"+$P
M3L-RFLJFO14S%2(Z;XX]?\,IKU]O_OBOMZ^>/,]?!T8WT?A7JJ!U4W^5V6JU
MP3>ZL$[+TNY2[I7_ -9<POO/*E;+T.MC)=P _6)5>"SI;X^)'U"CQM:K.Z-T
MSY3"&!'AC[J%*H- YASCJM'Y=7*#Y2A<+&-<I[?TX-7VS4?E0\>(.1*Y8A!,
M4)N]6Z? 6[H^-@CU28"T*^E]-YZ"P7=A=SS9,7?RW[GA6+IT&L7Z[WBC+[3S
MFRU=QSV#USGQZZ^8:YSZ/6G?/$6;%'%27)NCB>AM)LA2\PY,DO<H[2X<V>RB
M6MI@D98^(\T!,>#_ +GY6]\ZL5[]  K5T'GU)OJJ;WB7U>V2J]SVW6SPE:.!
M@(PC@;]'9KI&S5SOAZ6>(733C!,V-([4]&^9&H+)=V%:1I_VS(JW"?;H#PB3
MY/)Z"4M7H(U?8,MXQ=^TVU=AK7-IU^ 3;4 J?9ZBT$ND@Q!JT8BL$^1ENO)W
M);BS)*F$_329O'=?DP4I7A#[JP.QE;(+[<"HG7+O4>4HNO>T]NMEG!%3W/O(
M%BXB;AW'AOZ$B5?HE@L73_T^4BVF?M1&"R*5*0A#R519IJ<L.6G_ &GL'Y,^
MX[\*$[&[E8:15#7955CH_.3'I7I'5;/1_,1^G\;EWRQ5GL)JO03ML[-*ZORD
MR_7=R&F-  -YFQF)B$-IBMDW8\F6OA/BGKCD9?O,SU1V,SU:1;[BB=35O6M5
MAJC,1NR7LBL[3@,T7%)\WAE:T<#0)(%#ZQD9T3K<1EOXO2)AG*<9^+8=ADP&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P&!JKN9/TT-F:#5%CJ86S<YZ[ZCO!RSEJC?+C22_.;U;K%*X\(K[M
M?%6MN\37Z]=8489!AC3OZ4?'N/SAOX>$AB0;T7GR&\^S>D/=JBWP"4Y=$>YE
M;V>< 2M94U>J_99$ 4UR^PQK;%J#7)2YTD.DRY1^$V9)ZA&=,LHAP([3S3@F
M,8JD'5PS[NY_02ULJD:]W\Q=;#5H9@+T2@?EYX!"C>=.#HN/4X\1D2X7U8(-
MR!V)B.(9%N0)Y#6T-#Y$A?S2!^-TG.PS/7)*#YP,C9I!BXDZC;*_T&Q5ZGG]
M5@0S;/1'F0+ LI^A7,54'6[D)XFNR3T?F J(W"EL$'6HJ(^MQUD_%$-FO7OL
M&0?)BTV^1*L=7YN())F\QF$:E27*T7]*!3UT"!JA0KT=E6"\%P%#=,CT1IRF
MA1UQ^*U&89U*@E_%*3]G]VL&$F'W&Y$.*?Z(2DU$-S"#^23AM7Z]QVG5.M03
M9&0Y9/R>W<_-6HVB:OZ9!U$=AQ/T4Q7F9)/Q4CCUG]KVKJ7)#W8I!RJ4]B^W
M8->:'4Z(8;'P9Q#G]H>@";6;,<^&1RO.0MA'0M S@::2C+E.N)FE'=OQ4(+.
MVM.+J";G[.JUC/5W:^D6W\%UJWKI:S_*($P+>1QSTE:8KU6M-V&"A@^B\\I7
MGM\(3!%T;9U(?F2652ICX[8E0_%=5QL7K*H]?[4[6Y73K?01QVZ7L'7HW/JU
M-:G5H3P'D"*-0>;6J8(;'L_G75Y=E<FH6DJ3VX,4E+.ERFOQ!(VUU6_2N@^[
M2T02:.0Y F.'>$UZ6/G\BF3&K3&.=D]"4N5T8K&W"IMQ2FK\PK5,L2AL(<%>
MD*G;TY&9_%IC,1?Q4VNW/WI;84&<B1::;%2]'K;S1[D%<DD2OY;R3KEL*=$B
M?CQ=7GP(%IZ=3ZZ*&0R <=)@BS>V)L%))Q#T6E8KWY).]/E+N7-72;9.9#[1
MQ'K\@-7R510]R^G]28ZZ;EA;58)LUH@6C$6JF6@O-1I9)F*0@-N_0;_T+FFQ
M-+!HG?\ V=TL;1+Z+I<P.-Z1"IUBY_3HE#8,U>:#.7 U6+XST?HZ9+L>F?I.
MB!(EMK\GZ[#9E9I$5/XWZ>X[(K'@EGB?1_572.BTEJX ;)0.>CA\R3=UGN6[
MKLRP6 7R#@[\D%%E'5ZDBPSW6+;;D(F,1U?C4A=MQ'514(D/$F,8CJC IU?W
MBQ./-2:B9&LUF!;ZI2M@.4(LS/7NMT L(@@I]F=3*=_0'&NT03+LEDIM<!(]
M YQ2IL7:4-3"UBZ5/7[90:K54V9O$63))=,&W?J]GYT',E(<43<O51RIB!3<
MB('ITD$Y%%4>/ (-#W_KP2*4:=VMU/X8?BYJ1W_TU;.I$:#;X;D$^2X3UNUE
MN2P*&SH75B@6B\.E<ZDL7%@@LVHW9;->3D><+D2%.,.MHCZ3&W&0]/$Q%7#M
M2KU[AKU4,E=0"^F5AK(Z&K [DDHF7 M4(_Q** K5=E#!]S)R+/U8#8[2S')&
M(!(9!?'LO/-,L1Y3S@_&9?<:T>U*]9.E28+G23M=!6KHMZ: VGFM=)$)%;F7
MCB3U3H52-!H[$ ]&!\K.VIYJ**<G3)1F%IA,G:F-QWQ^/NI=PZ+[&Z'5^_1A
MK77^426@/19_GC=4XNE1RXAQ%]O*()"RD;"!/;IUO8IH,7H.'F(%3"K,Y+R6
MY,I_<:$*QBG9.]+]I@B'2FZ;2++]6%;++)X[7U\MEE*]TZMDKWT'5AL_0K9-
M?0_0#E;J44:0#COG%I*25MM-19>I:HT$?BDSG]U];B.O4.H]":L5QI$DKJ":
M-"N7Q*T]*0=Y%4+;(LUAL38R;2AU,HU_=+A$#F)@RP//.Q?E65U'E:43\:T1
MHYU;W9;#O085>J%KH0&+:2!.K3+!S<>:.PA<#G/HV>FD*>E@Z]724.5?:)26
MTSH7YTA4>P*88*ON/H=AEK%=7/R_IV\]Q.$KW"Z!3D1N$>B!$,;"H6Q-"HUB
M,WCC:^1N5:WS79,#H=J.4\3*)NIDMS%#)J)<17X;6EQEDFJ]T,5P][HYMR>H
M4"CA+9)N("C4&NQH=@Y(P8!)K\[B5<-V;KYVYH<&QC'7('<2$X;,K>Y3:Y$=
MI:UP_EWLJHOXS.J7O6!/U_).V3E_.(4N?SV=P23&U98-:L4RP7ZUD:YTN!=F
MH9FEU"2)H]Z#.#J_)!(DE $&1)GO(0F9O:6XA(KC/%3:WU#V],Z"['Z&+(4W
MFDCI-B#'Y%&Y-9[O<J4P-/7-F@P06I- ;K]GYO?Z[ %.$CL!=FD"):U_7>'M
MS$?E\6L:ZNE7[![7KZ;#$)6#HY2LUVZSQ=@.$>/B3MV: VWTQW"*1M-'B00K
M2+O%H'%PE04)ACAY%'X0VY*6B>Y%U U3\71E7/WD6IYXV9KA&>S)LKE'$T'7
M,8XJ:5HKW(CEI$=;+.#S6[ (M12X#1D:6):E-Q!DLA)@+:4ZAM;$/QB4[1K]
MZ,=X_=SDMBYQ>H1^G5P380#?)G78W-:))Z5%$6\AR%A(9[7;4!.9J=)PI;;Q
MA4V4G2M,?.K\J34TOHPSYC-]U%0U7H=JKEH%T^!>>='W4&JG=1EXM54=] 5"
MZEKC(,P09$%4K'$D2)\8E7I]D;2S58JM-#7/F3(4:_%)#G2??P:E! PWG[HE
ML$ Y#.L5D12B)"=&"].K=??*CJT"AB.BV K:.)6>KFAQMA(HN^N$<'R=LNJ9
M=5A*QM=X;JGL\-8^4@[Y-K4D[VSKA_FS0,52V 0ZA5FFP:U>"?4PT.PNQ[B>
MJA2D52UP]K((0['+&P;:V6=H>T^*Q4;NDGUQTR;=.9CX]["@"_2G!!^( YU#
MB@@'( O6^;-4P[4>BS6Y<:]$>F420079QOU9*H,5R8VMD>F$G\P$;8U29UDQ
MZS&=8ZRKDXR4,IM;H!^[UIQNBLV-GIENJ%1Y<]5><ZG$27TX$2RE"9V(]L>S
M&F+3'WIIUIQKZBB15:H<!SO8_)HUC$UT;>+48*7^_7.L,F.;0C,'IA"T^E.I
MC+)"Z-<QT6)&YT(I/#Q==)5E?S0=3FI2&VMS]-H'-%_&5QR[!]P)N"-<CG"#
MLEGGE?D$DIXU6M*GW9? ;QTPVXRC<IS0]M?8@X>IIA_Z;Z$*8ZSMQ<]UJ>P/
MQ4:T=(]HW*_DF8U8ZGSWGM<N_-2TB,,H<<L2(PFS=QJ-MJFG?T>EH[0K0RX)
M-.;'3#4X?!>2X_/AN-RXD81&-*B#OON60P!K<.O&ZP2EQZ"!/L2>5HFUOFU8
ME'^&B6+I6;,4E.-WBU$J]8+2^8%2)<O\D7 VIYIA,%*BH_'BS_XB3Z$6YH"D
M=3BKC7F-.M(<NXX,;"NE(U?MQT$"L3HIE;D:"[:*\.B$E(9^5C2I6_I)0W\J
M$F9J]$KX0P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M>%YST)12YQ$E"B1PUU$1,IIR2K2U[:^"21$5KSAC36/:7HO\.5CP^/F;2*K
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MDMI>C2XDJ.MQB3&D,KTM#B%*2M.];UO>MX':P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MW&<', *O=@=VM >H!JD0;ACHAC9#4=M,I+Z51-I<+&21#?A>@68QSHLLM$;
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M1&%1H,=UYB+"!LF4PF$HWI/T8Z?@E.OY.B3-RD["& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MY^-GA]?%<MG<)W;K4DDS$LZ\,F P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M1K>OAO2?V?R?CK]G[,!M*5;UM24[VGX_+O>M;VGYM?!7PWO]NOCK]F\#ZP&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MM8_OF6JF<-8ZC;N8<KKUF/>N.ATRI5 _>2-=9(>/N9<9I'I [U"03+Z;;5V
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M;:XQ1;O2!WGJDTVBVPO,7U451N$$2-._,.9F^G&J4&Z"Y!JS*E'AK'("T\9
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MA6X\R;J*E#DAJ0TR-LN=?N/AL@C2XX,R3L4>\!H4P#%#5FT3SYHX;E55H'5
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MLMW97A]PH(WGW22MA"7LF(CB% A,6-"'Q9(B!IF&G4=:W]N)>4I7S?+HE?\
M*&#?HOT3SZG\JOI.[T+I,7K_ !J9Z$G@@-+;$QJ/6><SN7= Z*,IQ%@W.E6.
ME%.2VXD,BSB.G)[)Q(Z3IU3<M41LM1=+FYAZLZET'MAKE2)=1<AVWJ-4Z/R
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M+TF;:(K"K>JU]:$^.N>R>;U_IO=;Y3+,YW&)&].#3M6A\5D__NQV(R'N%8@
M3Y,M-;F;T-:FN+>7M"U0FOK]DL2;A0H_"0!;GG:.IGIA"U\-C^N;)-Z?T8GU
MB@44D;>:O94]499YR9PHC(.)<A'5!AH1X"&5,=83%:@,NQZ5J@[K9WIQP68
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M-M#9&G^B;_[!N/DOM'&+\V'E1G6A_)[-3924KC:;E27VOGWO;+C>$_KU]_\
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MYB*]?JNCC/AFM<L]%6#U-;.V=R[[V"?S0GQ>IF^Q%.>N1.<<D,7B/T,C2*M
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M=*GDUQ@G/]QU3I6_B[)VSN2YM/S;W\-N*W_X[PZ][Y1Z0SH=[KZ/MOW4NO\
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M,ZM9D#-0M;,9H^1,%=(%+7M[2]OH37/+C415,^L,F P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P/,K]EMIL?\
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M2PE*X6T2"XXQ,7*R:[[ROL!NRDC?,HR^3<DE1@_4^EG++#&EJK7Z<0YH*O\
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M8/A$=QY,F?&C1F$$O2F6.&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M%2!WH'D\VVS+/N7N!JN1:Y&MCI>0=5.3MC41#.Y&WM?)\GS?LPNW+E+*W"&
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M3,SAKS;2\,& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M TLP9IS[&Y$<3)%1W'F429T=2U?3)LG7HCCS_P#>$X=T87QL)9P?721Z\0N
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M P& P& P& P& P& P/,S]F?_ *LO\01_S)\B_P _L>'7N?#'T^STS8<C 8#
M8# \S/\ "S?[EGJ?_N$>A?\ 4G.<.O>^7M#TS8<C 8# 8$-3?0?'()J^UQ=Z
M&2#O+S/,J]T 6/8(DI-5-]B-QZ]SD:4_ PY#:)=B*RFT:0A2U1D*TY(TTWO2
MMEJ4RX0P(*E^F>$0:CVR^3.E 8U2\Y&['7.VF7D$4-<^.5((,L9\:7C[@_C9
M$B&&,Q7D?A6I&I'UDH9VXOXIT6I_E-L25'G18TR(ZEZ++CLRHSR?CI+L>0VE
MUEU.E:TK27&U:WKXZUO".L-)QRC4AV.R083&($1BTDAA$4ZX^+F/09#T9DE&
MBNRA[SK&U1Y3:51Y3.TNLK6VI*MA'5T[;S6@6813+$;(+MIN"V6B5JMU2X7<
MW&".D/REJQ&QM) V&56ZTZ3TJ.DD13%@*>;<3IW>VW-)+$3*X^@=!J7+:H0N
MUX)/":V,E!8$F7%$F3TQ<^QG1M9 CX(6NCRQLI/+GS$6(PQ&C/.N//IUI/[<
M)Q5L <@64*./C4$VAY6*W,BMF@9JM%4,N?'Y4SP-D'BCHJ1KX?RF949EY/\
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MC&KQML2PR8# A@1VT*0Z]*XN2J=ZJUF<KMGME6*6,4*9K5\KE*-UFO6PK52
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M0M!;<[9Z7)A/-M0_D_$.+:6E*-[2K6A4HNE>S/-@>27%VKK-)J9^NSN;C;$
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MZ4^Z7RGRA(]Q78CX,LG,JWR0)Z"MO$:MS;OH2]/\^EA1UO.TJN]=+]A+5_\
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M_2/.JUUXL<] FI]6%N00MIG6_P!"]3H'H4/!D!H=S%V:9'$HI,%N1";E-$3
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MTWXY*Q=^I=-[Y>_2_GH/U"8H<5KW7[UJR\WIG-[ENAAZE&\HWG0#IL;J1"!
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M'QUE;.^#U771ZYC*%(9(J9&.DJ+Z-F6MZW\?AO6_AO>M_#?Q^&]?LWK?P_\
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MNT"';0-@K8S1<G.!S4-+T0C#WY*T_%U#2OG22XC*XX(Z@[]!\VZ;(Z-9J[W
MQ7@]WZO.NJ8ET@7NJ7_EMO([$^>.>\PY3'M$UT#T&H/% B#!%P<(0WL88D3"
M<YN:TZL:3">O7PWLYWGHBO<9KQDL1,GI<>P&:S;BU7LU4@-U:PNA"PE@1U7B
MCQE$BVI@1I"7+"VS$8>5)7#G::^C@QKS8A1>!^PK .B&+C=NQ1K839M_ZCB
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M'H;ELOME[HKH[L59LO8+V.J5:33+20=(J#^,Z9U -?P1H58IOXBJ3K/49#:
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MX1I"Z!Z1[E6J][4YPSTTU'N/0;1Z+-^9KEM@.LARVK\3C%1?9 H5QP?N#O\
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M*++^DB1'F(:_$L-O?33+B..Q)24?/\-.-+4VO6OBG>];UO#+NX&+,WV!R()
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M?3I$%"H0R9&B+>8<ENL,K4X@L8S*YZ[Z+Y9;.*%^\UFPP;)3*[1I-ZL4>LE
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MMS4"-3&!\C<K;&U&8JV!9CRUW3HH;I!R^1>PR;';Z-YNKP+4GJS@T^FL<_\
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MT.?1=4ASZ:TJ^'RJUO8F)CCHF'"&!^;WI.MJ5O6M:UO>][W\-:UK]N][WO\
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M_P#5E_B"/^9/D7^?V/#KW/ACZ?9Z9L.1@,!@,!@>9G^%F_W+/4__ '"/0O\
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M.AV[J8"@&Q7/BE/"4RC3.A=*B6:HUIN<FP\ &=EG=@JXHOT51B7S;1HBFO\
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MSL0RI I9R;(CC(C[$),F6Z]MO;B]JPLY3/%E9ADP& P& P& P& P& P& P&
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MIUO<5]6FW?E5O6L(M977.4(39EKZ=SU"*7MG5Q6JZ5M*:GN1.>%Q]696R6M
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MDNPY2(Q$<_)AOJC2V%M.:2O>T.(4G?P5K>L(K6 P& P& P& P& P& P& P&
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M3J1SW57O5<^5U>P+M,T%9$2PW,!R1SOT8B8.R;\F8VX^C;>%W<O&CK=B\(=
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M)!]$BT;0277SZOGAEA)%<5QV9])W:92$QA.5Q38OADP& P& P& P& P& P&
MP&!YF?LS_P#5E_B"/^9/D7^?V/#KW/ACZ?9Z9L.1@,!@,!@>9G^%F_W+/4__
M '"/0O\ J3G.'7O?+VAZ9L.1@,!@,#$_JGF1'3SW4B<\^,T+Z7%\N0Y 4E7]
M%8L>/YW[%8.HD6)J'9[;!)BXQ3FH*4*;0F(IO;BOK:5]/1J)I(?(^7F^5[L@
ME@R$(56QW_KW0W(;(:9 )CB?1K\Y;Q(V ZDHZ-0,$Q"4YN7\8_U)<IQMY&V=
M:<0LDS?JFW"-=/3/&_4+^]T^S0^HT,)>>J3NU!";K] .%:P"Y[UKC7-.+1V!
M@_=TA$IMPKXGD8HDN0](3!F2Y,IG\.TU]%2#<91'HI=U\#F+&4=/C>FQX)(?
M=)U[!0]CK*(@R2"^A<[NT()8"E4MH*R?DZ6:2ZTIR#*BOM378TM'QU%VP\-R
M:S'E;\RY9P'D *Z$>:5#C]KJEW+L454PH0,%Z,S.-5,0'*=,E7UUFO"NBO1#
M&T%6RKSB1C#&E(UO:M$O69\Y0W3OM_[J$,Z+WT:/8H\9GFX3G!NP5*$];JG3
M^?>F+%Z/A@9A8?*'0Y*H\RQ[$0E08HYF+%@0U_14IGY=EW*>2^WNZFK4437;
MX*#%*!6>;1(NQP0]61=HLO.>OF^JM2[+(IUJ!6- DN]8YB/A%FMRXA%Q,Y+K
MFTK8=&Y.-Q\RO3_-%7\^4^!RZ'%#P8$%>[J'O]R#5V0TQ/DILE$ER+]&O8BU
M5FR2T3@TYTRN9%VSI*'V5_(\T9O6T32? ,*<D@\6N@BR&R$SMA"=:['28$ZR
M&2G7N 5/ABCQV:U,CMRSD=BL?C)KK:&D2T/?00EE*-*PNYT+'X(+&PDP#^O:
MO*B6(1VRM6Q9JE29ZYP'KMKXY<M(C)_/DI>D#B'(M1I*).W&9D8F[OX-K;U]
M0NYF=RGER>8RNJNLD(LN)T;JYOI4.##':&L FS==J@>0)^FB0\U)=7/K[TMQ
M]"6=.N2U;VCY_F6HS,VES"& P& P& P& P& P& P& P& P&!JU]"B^_<6]TU
MGUES?S7?_3_/['Y/G>=K#6N06WDX'H%)MHGKJ>E!CY 3V*^\T!&*B?%D9,7;
MT$D[,ARXJ=.1E-O)<0;BIQVS-:JUY) =SO\ ZS]-^LNK<!N'FNK]!Y!YTXGS
M_GW3;1S6Q]),O<B.=LM=LN1B+R>Y= J5? 2IO5XT$:RHL_-D_@WGG6F$;:2L
M95$1C$VV888,"(/0?/2G6^!]OY2#F0AYKIO(.E<]#SR7UM#H)2Z4PU6Q\R?N
M.V[(_!1I9)"W?D2I?TT[^76]_#6%B:FVEB^G_;?3/M\D_ T?[;G?:STRT^8A
MGEJ5U"P=7\K+X2!..T.#S0QT*58@W<B?0IU &MMO$V=QZPHM+CH0UJ$V\YM*
M#I^.[=<5=M^ $:H.#"B%NI?6*$CAJWT)VA+RH,-F*IU*-[5M"7-M?'6M[W\/
MCAR5; 8&LCU$%[ORWV7P_P!;<N\\7;TU30WG+M_GF[4?E=KYA7>CU@O?NB<6
MZ+5;C'@=<NO.ZN?JSNN:3($U+!5$Z(\^PXEAYO:_D-XU..V9K5P>:Q'>^O>V
M>H>M>G><KQYBHK?E_FWG2H4_K-LY;8>C7"Q!NI=#Z79[6D;R"\='K0&HC(ME
MA08RI134Z;)VZK4=MMO2EB:C';$W-MGV&# 8# 8# A+T>CI3O"^G,\=E%X/3
MGZO*8I<X P*DFH)I]UAEF:+CG&9(=Z;#:6MQ"9+;C.]I_EI5K]FRQ5Z\& -R
MKGNBGQ[^YSFU]5MRW+#UZM &;6NHE]#^8"2',2E.-U[34,1(GWV0(E6IL1,E
M.JD39&VH\GXZ9B[;-?C/%VJZ+]HS[_RD.:Z-?XW-9HX6^.LK',;!")OQ)?6+
MZJ^5#JD.:7T:!GX/']@1P0^72S_IOG)(;V02\RX/QKJIG'N<>G&J?Y]YHHOW
M>D5<=3//-.ZC92$JO[Z#&EUBM>N6NMQG;@9A%C#XU5OB4EMB:TI[6X4F(Y"7
MI+\AS8F8UGS_ /"@!>E>FAO3?.X3J5LZF-Z-9^@^> D^G@=\]_=_/YU,X.Z:
MZ\F_@X3,@Q#NZ^HB34J<IA++T>(Q 7#V@;^+WLM1K7!+'=I/L!N_=3US3?5_
MSY!0DGE[0.#57N)JXUOA,ER5*FOSH^YBNQM]F_$ZA-R'/QBIJ1R4-["[F*V2
M*K6DL]PC=KI_G_G-1HG[U[Q="4B&+MG0AY9+EX 2_P!*GS:; :'UL=%D&VBM
MRCQ!?X:$F! A?C&W9+K4".\E1(JV,JE^VQM+G=+N5ZO%/L"AA%RQPCZJ$,YO
M3!M7\H<_Z"P6DQ&X*FAT8IZ3KY03/F?B75?A"DR,CX1TQELE_&Z9$,7'NICR
M+5[](K%\G]"[":"7,M7PY%4*V\8H'4+?JQCQ&H]:'/'#3_):&2AC)\,4A9&=
M(COK;?;^93[9-+82G6_7Y*G\],=QB]D;/TJT\2O2'F1]#B<I"4+G*BAJ^W'K
M,A]Q]B)>1-B$)FR/A)<?<C:'JAH<844UAK\?)>8PS[<L-#@EJ/(ZQ(Z 7HY
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M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MX953 UD(]91J1S/H@_73P9'K,?U9W#GD$<?DURURZ6(7V/ICM/;N0VR]2Y5
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M*5:WI24JUO6T[TK6MZWK?^76];_9O6\#Z^'_ /+_ "8# 8# 8# 8# 8# 8#
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M!@,!@0]![G02]QZ300;YDS:N2R^=0[N/B@R$6- <Z?,EQ*XL>8+M#0AYN-J
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MF,:O%L9PR8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M/00=DNOG:U=1(W.U3EQFI<F,4N@'I'THDW;4B8R_"3I]3C2M?*3=SZME^&3
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M 8# 8# \S/\ "S?[EGJ?_N$>A?\ 4G.<.O>^7M#TS8<C 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8'F9^S/\ ]67^((_YD^1?Y_8\.O<^&/I]GIFPY& P& P&!YF?X6;_ '+/
M4_\ W"/0O^I.<X=>]\O:'IFPY& P& P& P& P& P& P& P& P& P& P& P&
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M:?E.NZ:^HXI6Q.4SQ9480P& P& P& P& P& P& P& P& P& P& P& P& P&
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M7C_M#?50;@BQV ?Q0'T.QD:-6:5?A@LIRZ&4N',[C&M [=RK=BTH?-2'.#I
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M?>'6'GM.6#GLM2Y32HE@DP5.2-J^M%0U]=&U.)UK9(GFQ:O?CGT79+A,*#F
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MT?LO,%>?**+ZEU#1BU<U[<7M-GIG%:QT6\VF\TJM4N?36)-3#T4P-KX218[
MY'?U%%M(6A;49R2PXYJ8DD1$H>+=M]RV.WR0(*KW_GDLB !U^T-R^<QK<%Y[
M=HO3_.M:-V:D/N<G@5R=6S=4M-S(C]2+?<?JCX:94AH>N,XQHM8^/=5X.O7
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M6!_G^"I/WF<X_O I']:P/\_P5)^\SG']X%(_K6!_G^"I/WF<X_O I']:P/\
M/\%2?O,YQ_>!2/ZU@?Y_@J3]YG./[P*1_6L#_/\ !4G[S.<?W@4C^M8'^?X*
MD_>9SC^\"D?UK _S_!4G[S.<?W@4C^M8'^?X*D_>9SC^\"D?UK _S_!4G[S.
M<?W@4C^M8'^?X*D_>9SC^\"D?UK _P _P5)^\SG']X%(_K6!_G^"I/WF<X_O
M I']:P/\_P %2?O,YQ_>!2/ZU@?Y_@J3]YG./[P*1_6L#_/\%2?O,YQ_>!2/
MZU@?Y_@J3]YG./[P*1_6L#_/\%2?O,YQ_>!2/ZU@?Y_@J3]YG./[P*1_6L#_
M #_!4G[S.<?W@4C^M8'^?X*D_>9SC^\"D?UK _S_  5)^\SG']X%(_K6!_G^
M"I?F^F\VU_EZ%1]?'?PU\;8!U\=_Y?A^V?\ Y?AK!4OS]Y_-?[PZ-_6T!_\
M1#!4G[S^:_WAT;^MH#_Z(8*D_>?S7^\.C?UM ?\ T0P5)^\_FO\ >'1OZV@/
M_HA@J3]Y_-?[PZ-_6T!_]$,%2J0J[TL[,2/"6ZL&9ZFW'DP11\40F*::^&W7
M4QHDMY[;;6E:^97R_!/Q_;A%SX# 8# 8# 8# 8# 8# 8# 8# LQWH_/&'76'
MKY3&7F7'&7F7;0#;=:>:7MMUIUM<[2VW&W$[2I.]:WK>OAO!4N/]YG./[P*1
M_6L#_/\ "U)^\SG']X%(_K6!_G^"I/WF<X_O I']:P/\_P %2?O,YQ_>!2/Z
MU@?Y_@J3]YG./[P*1_6L#_/\%2?O,YQ_>!2/ZU@?Y_@J3]YG./[P*1_6L#_/
M\%2?O,YQ_>!2/ZU@?Y_@J3]YG./[P*1_6L#_ #_!4G[S.<?W@4C^M8'^?X*D
M_>9SC^\"D?UK _S_  5)^\SG']X%(_K6!_G^"I/WF<X_O I']:P/\_P5)^\S
MG']X%(_K6!_G^"I/WF<X_O I']:P/\_P5)^\SG']X%(_K6!_G^"I/WF<X_O
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M *LO\01_S)\B_P _L>'7N?#'T^STS8<C 8# 8# \S/\ "S?[EGJ?_N$>A?\
M4G.<.O>^7M#TS8<C A#BU4JSO'^6.NUJON..<]ISCCBPPY2W''*_ 6M:U*C;
M4I:U;WO>]_MWO>%GC*3?TA4_]EZ[_0@W^;80_2%3_P!EZ[_0@W^;8#](5/\
MV7KO]"#?YM@/TA4_]EZ[_0@W^;8#](5/_9>N_P!"#?YM@/TA4_\ 9>N_T(-_
MFV _2%3_ -EZ[_0@W^;8#](5/_9>N_T(-_FV _2%3_V7KO\ 0@W^;8#](5/_
M &7KO]"#?YM@/TA4_P#9>N_T(-_FV _2%3_V7KO]"#?YM@/TA4_]EZ[_ $(-
M_FV _2%3_P!EZ[_0@W^;8#](5/\ V7KO]"#?YM@/TA4_]EZ[_0@W^;8#](5/
M_9>N_P!"#?YM@/TA4_\ 9>N_T(-_FV _2%3_ -EZ[_0@W^;8#](5/_9>N_T(
M-_FV _2%3_V7KO\ 0@W^;8#](5/_ &7KO]"#?YM@/TA4_P#9>N_T(-_FV!%-
M^J54U=^'I_3%=^5=_L:5I_)!GP4G]T?2-_#>OPO[=?'6%CA*4OT73O\ 9.L_
MT"+_ )K@N3]%T[_9.L_T"+_FN"Y/T73O]DZS_0(O^:X+D_1=._V3K/\ 0(O^
M:X+D_1=._P!DZS_0(O\ FN"Y1=<:\ %=*X3(%@PXV1NX7!K;\ 9"AO;;7RRZ
MJ6W]6.PVY\BU(3O>OC\-[3K_ -F#RE.^$,!@,!@,!@,!@,!@,!@,!@,"!>%5
M:L2./\[>?K@%YYVLP7'770XYQQQQSYUN.+6J/M2UK6K>][WOX[WOX[PL\4L?
MI"I_[+UW^A!O\VPA^D*G_LO7?Z$&_P VP'Z0J?\ LO7?Z$&_S; ?I"I_[+UW
M^A!O\VP'Z0J?^R]=_H0;_-L!^D*G_LO7?Z$&_P VP'Z0J?\ LO7?Z$&_S; ?
MI"I_[+UW^A!O\VP'Z0J?^R]=_H0;_-L!^D*G_LO7?Z$&_P VP'Z0J?\ LO7?
MZ$&_S; ?I"I_[+UW^A!O\VP'Z0J?^R]=_H0;_-L!^D*G_LO7?Z$&_P VP'Z0
MJ?\ LO7?Z$&_S; ?I"I_[+UW^A!O\VP'Z0J?^R]=_H0;_-L!^D*G_LO7?Z$&
M_P VP'Z0J?\ LO7?Z$&_S; ?I"I_[+UW^A!O\VP'Z0J?^R]=_H0;_-L!^D*G
M_LO7?Z$&_P VP'Z0J?\ LO7?Z$&_S; BOHM1J?ZDXHC],5WY5]4EZ6G\D&;T
MK2>2]57KXZ_"_#?P4G6\+"4/T73O]DZS_0(O^:X+D_1=._V3K/\ 0(O^:X+D
M_1=._P!DZS_0(O\ FN"Y/T73O]DZS_0(O^:X+D_1=._V3K/] B_YK@N4;72N
M5X7=N%RA@$*.E?O.--:DP1<&)(TVOBW7/G;T]'8;<TA?RZ^.OC\-_#!Y2F_"
M& P& P& P& P& P& P& P/,S]F?_ *LO\01_S)\B_P _L>'7N?#'T^STS8<C
M 8# 8# \S/\ "S?[EGJ?_N$>A?\ 4G.<.O>^7M#TS8<C C#B7_TF^4__ %.J
M9_\ DZ.PL\92?A# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8$47__ /#CAO\
M]4"Q_P#UHNDX6.$I7PA@,!@,"(.@?_3$X1_^.=N_^M7>,+'FE_"& P& P& P
M& P& P& P& P&!$?!/\ Z37./_Q6'?YBL+/%+F$,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@15T7_P#";B/_ -569_\ 6CZMA4JX0P& P&!%70O_ ,+^%_\
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M 8# 8# 8# 8# 8# 8# 8# 8# 8# BKHO_P"$W$?_ *JLS_ZT?5L*E7"& P&
MP(JZ%_\ A?PO_P"JB8_^LMUW"QYI5PA@,!@,!@,!@,!@,!@,!@,#S,_9G_ZL
MO\01_P R?(O\_L>'7N?#'T^STS8<C 8# 8# \S/\+-_N6>I_^X1Z%_U)SG#K
MWOE[0],V'(P-%@/J7WAZS+F<LI4?[/YIGF\T/18XTGZ ]#JO0^$^^H-0XUV
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M*_#LEB]%^C H"6>B.$F902,8)46,/?+QG0TQ+D9+FWD*B/:VG6VE_*U*P_\
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M/]U'VHO_ #;]6_X:8U*[?.3]2_?Q_NH^U%_YM^K?\-,:E=OG*/>BVW[WH6"
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M6AQ<Q:Y"'D(;3MO2M_'6R3LK\;ML^PP8# 8# 8# 8# 8# 8# 8# \S/V9_\
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MGB6M?'>]_'?_ -W!?9Y3X]WW^YK^*F_XN?MP?U"/?X)X+[/*?'N?N:_BIO\
MBY^W!_4(]_@G@OL\I\>Y^YK^*F_XN?MP?U"/?X)X+[/*?'N?N:_BIO\ BY^W
M!_4(]_@G@OL\I\>Y^YK^*F_XN?MP?U"/?X)X+[/*?'N?N:_BIO\ BY^W!_4(
M]_@G@OL\I\>Y^YK^*F_XN?MP?U"/?X)X+[/*?'N?N:_BIO\ BY^W!_4(]_@G
M@OL\I\>Y^YK^*F_XN?MP?U"/?X)X+[/*?'N?N:_BIO\ BY^W!_4(]_@G@OL\
MI\>Y^YK^*F_XN?MP?U"/?X)X+[/*?'N?N:_BIO\ BY^W!_4(]_@G@OL\I\>Y
M^YK^*F_XN?MP?U"/?X)X+[/*?'N?N:_BIO\ BY^W!_4(]_@G@OL\I\>Y^YK^
M*F_XN?MP?U"/?X)X+[/*?'N?N:_BIO\ BY^W!_4(]_@G@OL\I\>Y^YK^*F_X
MN?MP?U"/?X)X+[/*?'N?N:_BIO\ BY^W!_4(]_@G@OL\I\>Y^YK^*F_XN?MP
M?U"/?X)X+[/*?'N?N:_BIO\ BY^W!_4(]_@G@OL\I\>Y^YK^*F_XN?MP?U"/
M?X)X+[/*?'N?N:_BIO\ BY^W!_4(]_@G@OL\I\>Y^YK^*F_XN?MP?U"/?X)X
M+[/*?'N?N:_BIO\ BY^W!_4(]_@G@OL\I\>Y^YK^*F_XN?MP?U"/?X)X+[/*
M?'N?N:_BIO\ BY^W!_4(]_@G@OL\I\>Y^YK^*F_XN?MP?U"/?X)X+[/*?'N?
MN:_BIO\ BY^W!_4(]_@G@OL\I\>Y^YK^*F_XN?MP?U"/?X)X+[/*?'N?N:_B
MIO\ BY^W!_4(]_@G@OL\I\>Y^YK^*F_XN?MP?U"/?X)X+[/*?'N?N:_BIO\
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MT]4Z.6998G'9S.I$YP<*A1V4L0(2I,E;#?SN.O/R7GWW3&>4YS<MBF&3 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
B8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g282574g08x65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g08x65.jpg
M_]C_X0F"17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,CHP-#HP,2 P,SHP,CHT,P   Z !
M  ,    !__\  * "  0    !   !Z: #  0    !    5@         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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M 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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MIUVX_P#PRK^GC?\ <>K[[?\ TNE*1&EZT-;DNA*!]7":L^GAQ_UFO^TNJ?\
M<[*_[?M_\FBXG4>I.R\=KLW)+3=6"#=8007M!!]ZGZ>-_P!QJOOM_P#2Z)BU
MX_VJB,>L'U:X,V_OM_X=-B96/7U[E=*6/A/ZOIV@TAU/JD?T[*_[?M_\FG_:
M75/^YV5_V_;_ .30FWL@?J]/W6_^ET_K,_[CT_=;_P"ETWBE^_\ C)EX(?YL
M?9%)^TNJ?]SLK_M^W_R:ZKZD9.3D4YAR+K+RVQ@:;7N? V_F^HYVU<CZS/\
MN/3]UO\ Z776?49X?3FQ6RN+&?0W:^SOZC[58Y0DYHW*]^_9I?$XQ'*9"(5\
MNM1_?B__T/3'8A+G'U(W$F(\2F.$3S9/R5I)1?J_Y6S?K?Y<+4.""02^2TR#
MM&AC;N']ER?[$?\ 2?@K227ZO^5J_6_RX6K]B/\ I/P0;NG-N>&B^'5B7-@$
MPX^TD;OY"T%4I^R?M"_TY^T0WU9F.&_1_L>EO0E[5:[?X2Z/OV.'?_ :_P"Q
M?^'_ .C_ .9)?L7_ (?_ */_ )DM-),_H_\ +C9/Z7_+@<O]EUTO:Y^2&P9
M< )V^X_G*K7]6V.;[,O<![20P'4:'\]7^K?8O39]LW^G[XV\3L=NG_A/3W^C
M_P"!JW1Z'I_H(VSK'C^=O_.W_O[D)?=M+_[M=#[[KP^%_P VX_\ S9_[LG_,
M'_DDA]68$#)('$!@&G^<MQ)-_HG\O<7?T_\ E[3SMWU=HN;76,]H+7.(]K23
MOVMCZ?\ P#U'_F=_W</_ &V/_)J_@?LC[0[T?YR3&_Z.[=[_ $/\'_HOYGV?
MS?IK50/W.]=_^J,D?])5Z=M?\R\W_P SO^[A_P"VQ_Y-)OU6KQ[:[+,X-VO#
M@', G8?4CZ?\E=(J?4_L7H#[;_-^[;X;MEG]C^;]39ZGY_\ +0'W*]/_ %(H
M_P"DZ-[?]1><9]1&.'LZCN#3M)%0.H[?SBE_S"_[OG_MH?\ I1=/B_9_2'V>
M-G?G=,?X7=^D]7]_U?TB,A_0?Y>ZS?\ #'\ON[R)^H8:"YW4" -234( _P"W
M%J]!Z31T5M]9RVWF]X.H#""T-9MC>[]]BU;]GH6;YV;7;HYB-5EXO[$^T-V3
MZD:>K.WAVS^<]N_^?V?]>4F'[KQCV_GUKY_^Z8.:_P!)>S+W_P":TXOYG][T
M_P WZ_F?_]G_[1%J4&AO=&]S:&]P(#,N,  X0DE-! 0      !H< 5H  QLE
M1QP"   "<]@< @4 !F<P.'@V-3A"24T$)0      $/"CMV ;HQ1S98WR\R9\
MR!TX0DE-!#H      .4    0     0      "W!R:6YT3W5T<'5T    !0
M  !0<W138F]O; $     26YT965N=6T     26YT90    !#;')M    #W!R
M:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $
M  ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U
M '        IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN
M4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2
M<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O
M;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP
M $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B
M;V]L      !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U
M8D!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M          !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M              !2<VQT56YT1B-0>&Q <L            IV96-T;W)$871A
M8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&
M(U)L=                %1O<"!5;G1&(U)L=                %-C;"!5
M;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC
M<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M    #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<
M     #A"24T#[0      $ $L     0 " 2P    !  (X0DE-!"8       X
M            /X   #A"24T$#0      !    !XX0DE-!!D       0    >
M.$))30/S       )           ! #A"24TG$       "@ !          (X
M0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M  $ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE- _@
M     '   /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H
M /____________________________\#Z   .$))300(       0     0
M D    )      #A"24T$'@      !      X0DE-!!H      T$    &
M          !6   !Z0    8 9P P #@ >  V #4    !
M          $              >D   !6                      $
M                    $     $       !N=6QL     @    9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   !6     %)G:'1L;VYG   !Z0    9S
M;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E
M241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0
M  Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0
M  I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !2
M8W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T
M;VUL;VYG    5@    !29VAT;&]N9P   >D    #=7)L5$585     $
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M!!$       $! #A"24T$%       !     ,X0DE-! P     "&@    !
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M1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$
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M(^T.]'^<DQO^CNW>_P!#_!_Z+^9]G\WZ:U4#]SO7?_JC)'_25>G;7_,O-_\
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M]:^?_NF#FO\ 27LR]_\ FM.+^9_>]/\ -^OYG__9.$))300A      !5
M 0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    $P!! &0
M;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ $, 4P V     0 X0DE-! 8
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M P,# P,# P,# P,# P/_P  1" !6 >D# 1$  A$! Q$!_]T !  ^_\0!H@
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MCOG+_P [?IO_ -%?7?\ V:>_?\$G[J_\I.V?]DK?];NO?\ ']V[_ )0.8/\
MN8I_VR=>_P"'COG+_P [?IO_ -%?7?\ V:>_?\$G[J_\I.V?]DK?];NO?\ '
M]V[_ )0.8/\ N8I_VR=>_P"'COG+_P [?IO_ -%?7?\ V:>_?\$G[J_\I.V?
M]DK?];NO?\ ']V[_ )0.8/\ N8I_VR=>_P"'COG+_P [?IO_ -%?7?\ V:>_
M?\$G[J_\I.V?]DK?];NO?\ ']V[_ )0.8/\ N8I_VR=>_P"'COG+_P [?IO_
M -%?7?\ V:>_?\$G[J_\I.V?]DK?];NO?\ ']V[_ )0.8/\ N8I_VR=>_P"'
MCOG+_P [?IO_ -%?7?\ V:>_?\$G[J_\I.V?]DK?];NO?\ ']V[_ )0.8/\
MN8I_VR=>_P"'COG+_P [?IO_ -%?7?\ V:>_?\$G[J_\I.V?]DK?];NO?\ '
M]V[_ )0.8/\ N8I_VR=>_P"'COG+_P [?IO_ -%?7?\ V:>_?\$G[J_\I.V?
M]DK?];NO?\ ']V[_ )0.8/\ N8I_VR=>_P"'COG+_P [?IO_ -%?7?\ V:>_
M?\$G[J_\I.V?]DK?];NO?\ ']V[_ )0.8/\ N8I_VR=>_P"'COG+_P [?IO_
M -%?7?\ V:>_?\$G[J_\I.V?]DK?];NO?\ ']V[_ )0.8/\ N8I_VR=>_P"'
MCOG+_P [?IO_ -%?7?\ V:>_?\$G[J_\I.V?]DK?];NO?\ ']V[_ )0.8/\
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M)U[_ (>.^<O_ #M^F_\ T5]=_P#9I[]_P2?NK_RD[9_V2M_UNZ]_P ?W;O\
ME Y@_P"YBG_;)U[_ (>.^<O_ #M^F_\ T5]=_P#9I[]_P2?NK_RD[9_V2M_U
MNZ]_P ?W;O\ E Y@_P"YBG_;)U[_ (>.^<O_ #M^F_\ T5]=_P#9I[]_P2?N
MK_RD[9_V2M_UNZ]_P ?W;O\ E Y@_P"YBG_;)U[_ (>.^<O_ #M^F_\ T5]=
M_P#9I[]_P2?NK_RD[9_V2M_UNZ]_P ?W;O\ E Y@_P"YBG_;)U[_ (>.^<O_
M #M^F_\ T5]=_P#9I[]_P2?NK_RD[9_V2M_UNZ]_P ?W;O\ E Y@_P"YBG_;
M)U[_ (>.^<O_ #M^F_\ T5]=_P#9I[]_P2?NK_RD[9_V2M_UNZ]_P ?W;O\
ME Y@_P"YBG_;)U[_ (>.^<O_ #M^F_\ T5]=_P#9I[]_P2?NK_RD[9_V2M_U
MNZ]_P ?W;O\ E Y@_P"YBG_;)U[_ (>.^<O_ #M^F_\ T5]=_P#9I[]_P2?N
MK_RD[9_V2M_UNZ]_P ?W;O\ E Y@_P"YBG_;)TK>O_YN_P U]Q=B];;:RF6Z
MA;%;G[)Z]VOEEINM:VGJ6Q.Y-Y83!Y1:6H.\)13U+4%?((Y"CA'LVDVM[,]D
M^\7[FWF][+97<VWFUGO((G"VY5M,LJ1FA,K4H&KP_9Q!'S3]Q+[N^T\I\W;Q
M96._"^LMHOKB+5N",OBV]I--'J7Z4:EUHNI:BHJ*BM>E-WK_ #8OF7L#O7N_
M8&V\KU-'MO8?<'96R]NQY#KBLK<@F!VOO#+X7$)7UJ[NIUK*U:"CC$LHCC$C
MW;2M[!9S9]X/W*VCFOFC:+"?;Q96FXW,,>JW+-HBF=$U-XHJ=*BIH*G/1/[;
M?<?^[]S1[;>W/,^[V6^'=]SV';[N<I?HB&:XM8II2B&U;2FMVTKJ;2*"II7H
M+/\ AX[YR_\ .WZ;_P#17UW_ -FGL@_X)/W5_P"4G;/^R5O^MW0T_P" #^[=
M_P H','_ ',4_P"V3KW_  \=\Y?^=OTW_P"BOKO_ +-/?O\ @D_=7_E)VS_L
ME;_K=U[_ ( /[MW_ "@<P?\ <Q3_ +9.O?\ #QWSE_YV_3?_ **^N_\ LT]^
M_P""3]U?^4G;/^R5O^MW7O\ @ _NW?\ *!S!_P!S%/\ MDZ]_P /'?.7_G;]
M-_\ HKZ[_P"S3W[_ ()/W5_Y2=L_[)6_ZW=>_P" #^[=_P H','_ ',4_P"V
M3KW_  \=\Y?^=OTW_P"BOKO_ +-/?O\ @D_=7_E)VS_LE;_K=U[_ ( /[MW_
M "@<P?\ <Q3_ +9.O?\ #QWSE_YV_3?_ **^N_\ LT]^_P""3]U?^4G;/^R5
MO^MW7O\ @ _NW?\ *!S!_P!S%/\ MDZ]_P /'?.7_G;]-_\ HKZ[_P"S3W[_
M ()/W5_Y2=L_[)6_ZW=>_P" #^[=_P H','_ ',4_P"V3KW_  \=\Y?^=OTW
M_P"BOKO_ +-/?O\ @D_=7_E)VS_LE;_K=U[_ ( /[MW_ "@<P?\ <Q3_ +9.
MO?\ #QWSE_YV_3?_ **^N_\ LT]^_P""3]U?^4G;/^R5O^MW7O\ @ _NW?\
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MYBG_ &R=>_X>.^<O_.WZ;_\ 17UW_P!FGOW_  2?NK_RD[9_V2M_UNZ]_P
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MOW$_Z8'>?^R2;_H'KW^OI[&_^%HY5_[F5K_ULZ]_LH_RU_[Q:^0G_HJ-W?\
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M *V=>_V4/Y<?]XL?(7_T4^[O_K=[]_K=>XG_ $P.\_\ 9)-_T#U[_7W]BO\
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M?V*_\+5RK_W,[7_K9U[_ &4/Y<?]XL?(7_T4^[O_ *W>_?ZW/N+_ -,#O/\
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M?V*_\+5RK_W,[7_K9U[_ &4/Y<?]XL?(7_T4^[O_ *W>_?ZW/N+_ -,#O/\
MV22_] ]>_P!??V*_\+5RK_W,[7_K9TM^KOB=\K<?VOU'D<A\8N_:#'8SMSJS
M)Y+(5G5F[(*/'XW'=@;<K<AD*VHDQPCIJ*@HX'FFD8A8XT9F( )]FVP>WGN!
M%S#R[-/R-N\<$>XVKLS6LP552>-F+'3@  DDX R2 ">@WSG[X>R-UR1SU:6O
MO'RQ+=S;%N4<:+N-LSO))8SHB(H>K.[L%51EF( R>EC\D_BO\I,]\D_D9GL%
M\:N]LU@LYWSV[F<'FL5UENBNQ69P^3WYG:S&Y;%UT% \%;CLC1S)+!-&2DD;
MAE)!]F'.W(//MWSMSG=VG)&[2VDN[7;HZ6LK(Z-<2,KHP6C*P(*D8(((Z(?:
M+WK]E]L]H_:?;-R]WN6K?<K;EG:XIH9-PMTDBECLH4DBD0O5)(W!5U(!5@0<
MCH%_]E"^7/\ WBQ\A/\ T5&[?_K=[#/^MU[B?],#O/\ V23?] ]2#_K\>Q7_
M (6KE7_N96W_ $'U[_90OES_ -XL?(3_ -%1NW_ZW>_?ZW7N)_TP.\_]DDW_
M $#U[_7X]BO_  M7*O\ W,K;_H/KW^RA?+G_ +Q8^0G_ **C=O\ ];O?O];K
MW$_Z8'>?^R2;_H'KW^OQ[%?^%JY5_P"YE;?]!]>_V4+Y<_\ >+'R$_\ 14;M
M_P#K=[]_K=>XG_3 [S_V23?] ]>_U^/8K_PM7*O_ ',K;_H/KW^RA?+G_O%C
MY"?^BHW;_P#6[W[_ %NO<3_I@=Y_[))O^@>O?Z_'L5_X6KE7_N96W_0?7O\
M90OES_WBQ\A/_14;M_\ K=[]_K=>XG_3 [S_ -DDW_0/7O\ 7X]BO_"U<J_]
MS*V_Z#Z]_LH7RY_[Q8^0G_HJ-V__ %N]^_UNO<3_ *8'>?\ LDF_Z!Z]_K\>
MQ7_A:N5?^YE;?]!]>_V4+Y<_]XL?(3_T5&[?_K=[]_K=>XG_ $P.\_\ 9)-_
MT#U[_7X]BO\ PM7*O_<RMO\ H/KW^RA?+G_O%CY"?^BHW;_];O?O];KW$_Z8
M'>?^R2;_ *!Z]_K\>Q7_ (6KE7_N96W_ $'T:#XK_&+Y,[=R/R5DW#\=>[<
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M] ]5_P!?CV*_\+5RK_W,K;_H/KW^RA?+G_O%CY"?^BHW;_\ 6[W[_6Y]Q?\
MI@=Y_P"R27_H'KW^OQ[%?^%JY5_[F5M_T'U[_90OES_WBQ\A/_14;M_^MWOW
M^MS[B_\ 3 [S_P!DDO\ T#U[_7X]BO\ PM7*O_<RMO\ H/KW^RA?+G_O%CY"
M?^BHW;_];O?O];GW%_Z8'>?^R27_ *!Z]_K\>Q7_ (6KE7_N96W_ $'U[_90
MOES_ -XL?(3_ -%1NW_ZW>_?ZW/N+_TP.\_]DDO_ $#U[_7X]BO_  M7*O\
MW,K;_H/KW^RA?+G_ +Q8^0G_ **C=O\ ];O?O];GW%_Z8'>?^R27_H'KW^OQ
M[%?^%JY5_P"YE;?]!]>_V4+Y<_\ >+'R$_\ 14;M_P#K=[]_K<^XO_3 [S_V
M22_] ]>_U^/8K_PM7*O_ ',K;_H/KW^RA?+G_O%CY"?^BHW;_P#6[W[_ %N?
M<7_I@=Y_[))?^@>O?Z_'L5_X6KE7_N96W_0?7O\ 90OES_WBQ\A/_14;M_\
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M5R_ _C&8N2 !_%<AR2; #_*?J3[]]3=?\I<W^]O_ )^O?16/_*!;_P#.*/\
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M:G SCH_]H-MVJ6#W(\;:+-]/-%PJZK>%M*_36ITKJ0Z5!)(444$DTJ3T6_\
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MC_Z_^]_O/=O^CU??]E,__6SJO]7^6?\ ID]G_P"R"S_ZT=>_OGOS_GXO9?\
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MF@KZT'2^';[.WF>>"V196 !(50<%CQ KQ=CDTJQH!4]8^U/^90/_ .)/P?\
M[S&7]E',_P#RI[_]+2+_ *LR="/DK_E?D_Z4LW_:3%T53W%O4W=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=(SY,_\"^C/_$ ;8_\
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M;"_YF#UW_P")$V%_[U^&]F.R?\EW8/\ I86W_5^/HGYF_P"56YK_ .E3>_\
M:++T6GY!?]E ]]_^)J[2_P#>VS7L*\\?\KQSM_TM[S_M(DZECVM_Z=;[8_\
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MW[^H^Y_\IL'['_S=>_UQ=G_Y0+G]J?Y^O?Z%]Q_\[?"?\D5__7KW[^H^Y_\
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MF6\C\-H>V-X88PCZF'>#&2=/;0CSKT$G_#<O;_\ S\#K?_SEW/\ _4?L+_\
M ^<V_P#1^V[]DW_0/0[_ ."UY"_Z9;=_]ZM_^@NO?\-R]O\ _/P.M_\ SEW/
M_P#4?OW_  /G-O\ T?MN_9-_T#U[_@M>0O\ IEMW_P!ZM_\ H+KW_#<O;_\
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M_0/7O^"UY"_Z9;=_]ZM_^@NO?\-R]O\ _/P.M_\ SEW/_P#4?OW_  /G-O\
MT?MN_9-_T#U[_@M>0O\ IEMW_P!ZM_\ H+KW_#<O;_\ S\#K?_SEW/\ _4?O
MW_ ^<V_]'[;OV3?] ]>_X+7D+_IEMW_WJW_Z"Z>MM?R]^V<+N?:N<J=^==S4
MV"W3MK.U4,%-N43STN%SM!E*F"G,E((Q4304C*FHA=9%^+^U>W>PG-5GN6V7
MLF^;>8X+J&1@!-4K'(KD"JTJ0I KBO'HNWC[U7(VX;-O>VP\L;LLUS97$*DM
M;Z0TT+QJ6HU=(+ FF: TST$79_\ *V[PWQV?V7OC&=E=4T6,WKV#O+=V-HJZ
MDW<U?1X_<>X<AEZ.DKFIZ%J=JRGIZM4E,9*%P=)M;V3<Q?=QYOWCF+F'>+?F
M#;4M[R^GG16$^I5EE9U#46FH!@#3%>'0WY-^^A[<<N<F\G\N7G*&]R7FW;5:
M6LCHUKH=[>!(G9-3ZM#,I*Z@#0BN>D/_ ,-']^_\_3Z?_P#./>G_ -0>R?\
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&O?NO=?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g282574g13a85.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g13a85.jpg
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M6(*7U0H7)39#8H6BL;7!T28T15-68W.$E;/4_\0 '@$!  (" P$! 0
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MX%UT _,D>V2$?F?P_?\ HHE_D/Q6'3.1MPF$]VRHR#WTW#8CQPGO[G$M%_\
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M<I?]X_#Y!7,^Z/C\RLZR*DF$3")A$PB81<*4E*5*4H)2D%2E*("4I [*E$]
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MS2"US2-PYI&X(((((.Q'4+1.]CXWN8]KF/8YS'L>TM>Q[20YKFD M<T@AS2
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MYL8=(YC77SHZ:%K]3!IZ]'DC064M)) \[J^RIY]TCH%V0ZI;SI  \ZSY0$@
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MQO&;_97Q _X3S?\ R2\B?&-X3U *3XD.$B#\B.2]2(/1Z/\ [5^_']X>A/\
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MD(W.KT$RWN8\+5ZV!1VUQ;S7;!^B8IKLN3ZJLJI5REV-3Q*>P)C+,Q4.4[^
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M^PC+^]4+QX1,(M?'BTT%59?U^_06>H.P);K;@H3]5FZA,=17ED= ?2%:R$)
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MK:A[*0M*DD?,'"*LV\^%;1]C^(F:P\]IUHX%K2U&09M$XZ05#U*QUQMV*DJ
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5(F$3")A$PB81,(F$3")A$PB81?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g282574g13b96.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g13b96.jpg
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MLC;DJ44LT43S8QEM_@S,?&Q[X)*ESPXX[<;!0W.\+R%,(F$3")A$PBH/S?\
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M:E <(*5.!LEFW.X$101/?LX@-/6)\1?B"V_Q%;_+V[8G'(5/$+T+4=7;?4Y
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MS!2D>V>PS8EKA;N&Q.R0 .= Z!CM_#;MO0\EWAJWAKPAT_4LUQ#G=1QMU3J
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M=BC?I68W16*ERK*Z"Q7GC=LYDL,K'QO:>SFD+SDZ^),(J#\W_P!)FP?U=/\
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MI2I2@E(*E*(2E*02I2B>@ !ZDD^@ ]2?091SFM:7.(:UH+G.<0&M:!N22>@
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M.3-1[V1WQ$V#P2720&U7C?,+3_W]'A _SA^,O]OM_P"[SN_])O#_ /Q;A?\
MBV_LO(/ZOO&O_+/5G_+7_P#4G]_1X0/\X?C+_;[?^[Q_2;P__P 6X7_BV_LG
M]7WC7_EGJS_EK_\ J3^_H\('^</QE_M]O_=X_I-X?_XMPO\ Q;?V3^K[QK_R
MSU9_RU__ %)_?T>$#_.'XR_V^W_N\?TF\/\ _%N%_P"+;^R?U?>-?^6>K/\
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MYX8SE\[U3Q#U#JS":2TU>\QI:?T5C78[!X?$UG4Z3))W^)>RMMCI9GV\QDI
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MW,9).YW)WW7YT-:9UVJ-8ZKU*XDG4&I,WFOK;@@93)6;K1L>HY6SAH;_ '0
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M8:<Z]TL%85(7Z>O\FPEQ9Z^B<H3L"?4J@;D#UJZ*4A*0E("4I 2E('0  Z
M'H !Z #V&0*=><(F$3")A$PB81,(L9<UK=Q56%8[T$S8KS 41V&W%))9=Z_%
MIT(='YH&5!V(/J.ZH1N"/6J7OLNQGWH[R"V]'=<9=0?=#K2RAQ!_-*TD'\QD
MZ@7JPB81<)GVHO!ZZ^^UWGBCA_S&^;C:GNZF6_1FZ@L+_1RWD%(*B+&J9<IW
M7E>1IE5-6,]EZ:D*Q!\HW1SJ]ZAK2G%_8WFQXS,%C>C+D##YA:?L"?\ 2*S'
M57O<0UAJ5V=7S#?:'Y!W%-ES$YGA-E+ %K$OGU#I<2/ZRXRU*WZ:QT(<0-Z=
M^5F2CC:'22-R-Z381U21Q%9BZMBJ81,(F$3")A%M^AZO'W/:ZO6Y5W"UYFQ$
M]1LY[D-ML+@UDRQ9@1?O&PJ*YRVN7HC=/1Q[&WJ:^3<SX$:;:UL5UV:QR&+I
M,R-Z"F^S'4;-XI\:4Q@;Q0R3-B9XTU>$SV'1BO6;-8@B?8EB9)/"QSI&\)J/
M+RX'#7,K#C[&3?5-8"I6;.YW+8MP59+,WFM:[:;2H1S.O9"6M2NV8:%:S+!3
MM3,9!)*<OPV\@)G4T*O^ZGG[Y,D0Z^ZLZ_5KR!8?W0-AXXJ-:V&IO)D<T^W7
M=_K<]$.A^;F*:0S.+\M#=/;NPN:DT?E?$KQPB!SK0?X<5B:&E9BE^E;>(@IV
MX+,C/-[]FU3E;'5\20MY9.:0"O8=%TZ#BKIIU>]8LB[''CC"9K-"I9S&/LUO
MX:QFJ+N5QEVA#)Y]A<=C<I7=/D?!@#R^OX4+G7J3)\8WP+N!U#:=HD.U;#NI
M0=0N[BJ3:5#SE30;?2W-W#L-ADHLP-?EJ9A4D*NJ)K"IUO;[/74,5*+]"ZI<
M(TOD/H^]><86NH18^S8@$]=SH*F0K6;,<UIXF JR%L5:.*O*WQ;$]V&JP"T#
M ?K=Q'P?TUA\1%'<DCS5C-T*-PT[L;;N2PEZC0FK8R%U0G)P!\^0GLWH)17I
M4L3:R,Q=C7-N-\5W VXV_&E/R/6!J2U<6MM%8I5-/1I*JBOJ=KL(MY&GR BN
MG(LYN@;U1QZN,\JT3;4<*(([K^P5#3Z+3&0GPU?,0\KVV)YXVUBUS'FO%!>E
MCM,E=M%()I<7E*K8&N\<6*L<88YUNN'5M<1L'1U7>TM;YXGT:=*:2^U[)8A=
MM7<-5FQ\M:/FLUS4@U+I[(2W)6"H:60L3&1D>,NOC]L_PX<NU<K8H-CK342?
MJ]!?;3:P5VU4Y)3KVMPYUA:W,9+$MU,FM1"JK5Z).;7\I8+KWXD%Z1.<BQ9%
M9=(9^"2W%-2$<M&K;O3QFQ7+A4I1R33V6ALC@^$1P3NCE!\.9T3HXG/E,;'V
M5N*>B;D6,L5<J^:ME\ECL/3L-IVVQ')Y2>O6J49720L,5HSW*;)J[F^-6;:C
MGL,CKMFEB]EEX?=QU^FY"M]DG:[6?W/X]@W)@P]BU^ZFV=U3;/I.M7U/$CU]
MNMX_<4C>*_[TG1VIC+$UE^N2VMV/9.UETVE<A4KY:>Y)4A^BF2A\4=RI9DFL
MU[N-IVJ\;8;#G'S5^3B\>5C9&MD8^$ N9,Z&VKQ,P>2O:9I8JOE+?\2RU3%8
MGQ>2H05*%_%9_*XZ]-):I-9_\1BT_9-2O(^"22O)':+FLEJLM_7J_#6M[1_<
MP:9WNUK97)<VWJV6;/2F6VJ5ZG521I>PRWX^W22YQ]%GV%VBQW!UJ$N!!TS:
M9II7WJY4$WTM/4[OT*UN3GA?F9)X&MFQK6MK/@-9C[;WMOOYL3'+-9$V0<(C
M%%CKTGFSW0F)09?7>6Q!U<Z33E.W#I."E;D?4S[WOOQWA?E@QL,<N$BY=235
MJV/=5PC'V&V+&=Q%?S^-ED6!C-BX3L:7087(M?=QMGH)-)K4Z8]KT)RU:I;F
M]3\:=2WTRODS(=$-?:7%B6#]R[7V+EW80*N/2+:=>L(\-O3DU?%QY:*RR[5?
M6IR2.J1F=M:S9 =+6MRPODBJ^:-='',ZPZ*8VI8H&5BUSIF?7B]?U;^I+&E[
M6/EQ&2BR&5KP,R=AE-]^CCCX=>_CH+,4$V0.3>V::K'199JMQ]:Q;EOM>R.M
M+"&=;7H*81,(F$3")A%G-9URXW#8J/5=>A.6-[L=K I:F$U^W)L+*2W$BM>8
M^B$*==3\1U?3;384ZXI*$*4/LQ]"WE;]/&T8G3W+]F&I5A;WDGL2-BC;OV +
MG#F<=FM;NYQ !*XK.9K&Z;PV5U!F++*>*PN/MY/(VI/LP4Z4#[$[]N[G".-P
M9&W=\CRUC 7. /:^X:XRJN'.,-,XVIRAR/J],Q$E2T(^']Y6[ZES;NV4@_K)
M59V\F;.^&HGX27TL@^1M(&S+2>G:VE-.8G3]7E<S'5&12RM'+YQ:>3+<LD=P
M;%J2:;8_9#PSLT+\^W$O7.0XDZ[U-K;)<S)L[DI;$%=SN?S''1!M;%X]KAT+
M:..AK5>8;>(Z)TI^L]Q,G9V)=%3"*8>(*<R+2;=.)[:KF/EHY(]Y<L$+4D_B
MU&2XA8_"2DY&\]A\?G\5>P=2?A\]/GXJP^1J5,(F$3")A$PB81,(F$5:.5:$
MUMZ+1E'42Y275$#]5$YH)3)3Z>WQ4EN0"3VM;CW7H@]2L/3;U?E_W43QUW]:
MB[+U8F$6B\F<>Z_RMH6T<>[0P7J7::I^MDJ0E*GX;Y*7H%G$\X*$SJJ>U%LH
M*UA2$RXK)6E2 I)X746"HZFPF2P619S5,E6? \@ OA?T?!9BYMP)JT[8YX20
M0)(V[@C<'M>AM8YCA_JW ZQP,OA9/ Y"*["UQ<(K,0WCMT;'*0YU6_4DGI6F
MM(<Z">0-+7;.'52Y3XUV3B'?]FX[VN/\&XUNQ<B+>0E:8UC#6 ]76\$K 4N!
M:P7&)T12@%AI]+;R6WT.MHUJZDT_D-+9O(8+)Q\EO'SNB+@"(YXCL^"U"3U,
M-F%S)HB?K!KPUX:]KFC?[H'6^$XC:0P>LM/S>+C<W398;&YS73TK+28KN.MA
MO1MNA:9+5L ?5,D1?&71/8]T?9P:[@F$3")A$PBRE-<3:&RC6U>F N7%#X;1
M9U-5>0%ID1W8KS<JINX5C536G&'W4%J;"D-@J#B4AQ"%IFKV)*LS)XA$9&<V
MPF@@LQ$/8YC@^"S'+!(TM<X<LD;V]=P-P"/DOT:^2JRTK)L"&8QESJERYC[+
M712LFC=#=Q\]6Y7>V2-C@^">-Q +22QSFF1&N<N5&I29_P"EK[T]#DY]N?+K
M*.;/9DSMA?VWYQB;,K'Y3$ZMV>9.OM>GLNHF:Q:V-G-UQ^J?LYZY'+#4N;$G
MB^?.=*'2O$LD-:25KY;;K_B-DDA<]LL-U\EJI*UPDI3S3R4W0.GE+^KOX>Z.
M? :WT+&RLYM>-U:&WD*]=\5?&1X;P)((+<<4E>UB8*^.R==['09>G5J092.Y
M'4KMB^ \O<BF&8 V1UN,Y51*.8EFNIV';6K@4%AJL.)>26:]N3?IC:U:3:)E
MRZ>GO(JELP0Y\O$B(8C^G\OX?A"XX,,$=:0-BKM,\$566C'':>V(/M!E.>2J
MTV72N$!;$'<D<8;] T1I83BR<4QTS+DV0@+[5Z1E.Y8R5;,3S8Z%]ET.-,N5
MJ09%[*$=:-UP26"SQ)YW2>JFY:Y(UYRL<I=OMZ\4S%'&JF&7&E0Z]K6[^#M-
M+\I!=:<A,NP]@KHUJ9"(X?DR3*,QV0B?/1)MK9[,5'0NKY"Q%YNRJR!H<TQP
MMIVHKM;PXG-,;3';A9/S!@<]YD\0N$LH???T7I7)MMMOX.E9-Z7(37)'L>)[
M+\KC;&(O^-88]L[V3XVU+3$9D\.*+P? 9&ZM7=%][G-G*<AB=&E[C83FK'7F
M-5DFQCUUB\**-6;-2L1(LF="D2(#K=/N>V50GP'8UB:[8KB$99CSY#:Y7:CS
M;VRLDR$TK9JC:+_&;%,[S5D%RLV-CY8WNB+:^0O0"6)S)?"MV(_$Y97@_.S0
M&CXY*\D.#K5W5LG)F(O-9;55AR$MO$WY)IHZ]B*.RQ][!8:X:UADM7SG%T9Q
M")*T3FXZ7RKR!.JMGI9FQ/2J_<K6UNMD0_"K')-C8WMG3W5TY]X*@FQAQ[:W
MU^BLK*! E18$V;35<F3&<=@QE-PR9S*RP7:TEMSXLA//9N!T<)?--9GKV;)\
M8Q^-&RQ8J59IHHI&12R5X'O8XQ,(^F'1NFJ]W$WX,6R*U@J=.ABG1V+C8JM;
M'5+M"@TUA8%6>6E2R60JU;-F&:S!7O6XHIFLL2A_JI.3=UU]YEZNM8RQ'U61
MI#$2UHZ"_K6]4EV;MU*I4U-[5V59\K*MGY-A)48A?D2I<UUUY:ILKXU*V9R-
M1S70SL/)1=C6QSU:EJ$47S.L/K^!:@F@Y'SN?*\F/G>^21SG$R/YI+^DL!DH
MY([-.5IES,>H))J>0R6-MOS,-1E"&^;N.N5;?C0TXXJT0$XCCB@@8QC1!#R?
M*.0MR31S];1=O-4-E KZR55,QH#,3Y&KL+2UAQXK;45'R"4V%Y=2GU0#&<F.
M6UD)JY")TE+MGTMD!6EIBRYM6:*&%\#61-9X4$L\\;&!K!X0$MJR]QB+#(;$
MPD+Q*\.E.F,$<A6RKL>Q^1J6;-N&Y)-9DG\YMUJ=2>69[YG><DUL?0BC%D2M
M@;2J^ V(UXBS3,XY<\F$3")A$PB81<Q'V9?AR<?ERO$-M< ICQ1.I.-6)+9'
MQY2TNP=@VIM*@.VHS2I%!6.@K2X^[=K4A#D2(ZK*KR>=!.DEDUUDX=HXO&IZ
M?9(W[<IYH;V2:"/LQ#GI5W G>1ULD Q1N.MSRY>-#(J\'!S3]L.FG\URFMY8
M'_\ E0-<RUB,"\M/229XBR]Z,@%L3,8T.<VQ/&.:#,MEK*3"+R 5$)2"5$@
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M:Q@V8QK6-#1E\^I<<F$4E<9:V;F[382&R8%.IN0KS#]1Z;V3$9]?100I)D.
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ME]M#K2T_@MMP*0H?D0?7"*,+OB>CGE;U6Z[3OJ[/PT@R814?7_ .+2ZUV?\
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MA$PB81,(F$3")A$PB81,(F$3")A%\LN!!GH^%.AQ9C?^1*CM2$#O\$NH6!_
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K  >@  ]  /89157G")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g282574g28x28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g28x28.jpg
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M 0$! 0$! 0$!_\  $0@ (  = P$1  (1 0,1 ?_$ !D   ,  P
M      <)"@4&"/_$ "40  (" P$  0,% 0        0% P8! @<("0 3%!$2
M%187,O_$ !<! 0$! 0                (!  /_Q  F$0$  0,# P0# 0
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M=*XZK]C,:SQ:%Z3$)QU^^VL97VRLDNJ;-TFPWOGV[UG5A,;FY._^;]RMC\Y
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'($!^YK__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g282574g31z78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g31z78.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ H@'R P$1  (1 0,1 ?_$ ,T  0 " @,! 0$!
M       '" 8) P0%"@(!"P$! 0$  @,! 0$           @'!@D#! 4""@$0
M   & @$!!04%!04( @,   (#! 4&!P$(  D1$A,4EQ76&%@9(=065G@BM387
M.2.V-W>W,20EEE?7N HR-4$S-!$  0(#! 8%! T* P<% 0    $" P0%$08'
M%Q+3E-15E2%45G88T=(3"#%!(K*S%+0UM<4V-TA1,B,S%76&AS@90I/589%2
M0S1$)7&!4R06"?_:  P# 0 "$0,1 #\ ^_C@#@#@#@#@#@#@#@#@#@$"Q;:7
M6Z<7A/=9X?>M4R786KFE,_6)2C-.(\OLV',BHID.+=WV&IUPWU"V@!)6[Q3A
M$^&0)>G"9D(CB\" PQ^WHT[C;_L!$G39*H<S#56N9!;>Q<,;)DUOTSI^N8LS
ME/TAE,VB3$:Y2-K0M34H*,-!Y81^,G% P#)AI81 6%A$TB]D0N(6)"'A/(87
M/8NP32(/Z0"@I*^1>4M*1\8'A,6K)3JBT[FTKBC@!-++,P$>,""'/;C &4<
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M)0ZSA#>&JB*:OR%*V/DP26742:4/+:A"2%"WNL@)>@.SBA1A3EX**..&67@
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M,8QG.>?N'B!<.-$;!@UND/BO<B-:DY+JJJJV(B(D2U55>A$3I53Q1\$L9Y6
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M/[N>2'9K34)*!,'8+60*=J7"<VL@-KU7@EM<A^:R)P0%8?\ N(UPLKCNTTO
M3,^,/[?VQ=K,3#_CM&VV6UHR*QN['7JY3/[N=%YV&TBD;0^1^0WEJL_,,F,P
M=)&1YLRI'1HD)N )"L&OC:N>ST;L9@MO(#WCP&9[I!>/]@ ]C,3#_CM&VV6U
MHR*QN['7JY3/[N=5QOG15XCSK$7:YM3'2*/HBAO<8<;$IY;'G@:?"() G5E4
MO!K:X")"VI\ R<4/(<)R^SL[@>QF)A_QVC;;+:T9%8W=CKU<IG]W.-[O/1"2
MKF!SD=PZD/[E%!=^+.#W8-..JZ-#\/PN\P*USN>>S"\+]GM3B+SW?L_V<9B8
M?\=HVVRVM&16-W8Z]7*9_=S(L[1:>"PZ8%L3K4+#W_\ =8S;E79P[_[D4V_\
M4QF0?[__ ,/( 1_:]_\ L0!!_P#'&,<9B8?\=HVVRVM&16-W8Z]7*9_=SP7.
M^=%7IQ;7AXN;4QV=V=I7L#0Z.=B4\O<6IB=2@$.;*VKE3P:I0M+D06$!Z8H0
M23@!Q@8<XQQF)A_QVC;;+:T9%8W=CKU<IG]W,B3[4:A)#U"I+L=K<F5*RTI*
MI2GM^L23U)2( RT12@XN0A,.+2%F""4$6<X+"+. ]F,YXS$P_P".T;;9;6C(
MK&[L=>KE,_NYPXV?TZP%T!C8?6C 'P0QO0<6U5N O S$H$)@G0/X@[' 0T10
M2<Y-[^<E!P#/[.,8XS$P_P".T;;9;6C(K&[L=>KE,_NYX;C?.BKPK:%[O<VI
MCHN8&U<S,*UQL2GERMD9W-)A Y-30H4O!IS:VN"'&"3R"<@*-*_8&'(?LXS$
MP_X[1MMEM:,BL;NQUZN4S^[F0)=I=/T)IQZ'8S6Q&<H)2)SSDMNU>G-/3MY8
MR4!!QA,A ,PE$4,020BSD)8<YP'&,9XS$P_X[1MMEM:,BL;NQUZN4S^[G"FV
M=TW1A; I-A=9DH61.:D9@IK9JP@+2E.++*.3-F"G\.$"<THD 1 *[@1!!C&<
M=F,<9B8?\=HVVRVM&16-W8Z]7*9_=SM(MJM1&Y.!&W[(:X($A8C1EI45PUDE
M3EC/.,4'B 01(@%!$<>:(8\XQVB&+.<_;G.>,Q,/^.T;;9;6C(K&[L=>KE,_
MNYVOBXU1^9S7KUHK?WEXS$P_X[1MMEM:,BL;NQUZN4S^[CXN-4?F<UZ]:*W]
MY>,Q,/\ CM&VV6UHR*QN['7JY3/[N/BXU1^9S7KUHK?WEXS$P_X[1MMEM:,B
ML;NQUZN4S^[CXN-4?F<UZ]:*W]Y>,Q,/^.T;;9;6C(K&[L=>KE,_NX^+C5'Y
MG->O6BM_>7C,3#_CM&VV6UHR*QN['7JY3/[N/BXU1^9S7KUHK?WEXS$P_P".
MT;;9;6C(K&[L=>KE,_NX^+C5'YG->O6BM_>7C,3#_CM&VV6UHR*QN['7JY3/
M[N=UNVGUB>'! T-&QU#NCJZ+$K<V-C=;]?+G!Q<%QX$R) @1)I":I6+%BDT)
M91181#,&+ 0XSG.,<\D&_P!<69C,EY>M4F),1'(UK6SDNYSG.6QK6M2(JJY5
M5$1$2U5Z$/7F\%<9)"5BST]=*\T&2@PW1(D2)2YYC(;&(KGO>]T!&M8UJ*YS
MG*B-1%551$)XYRTS,U2; P>%6!U%ZS8I[#XM-V,&ITE7@9I='VF2M05R>S#"
MTZT+<\I%J0*L@M08$!F =\(1BQC.,9SVX9>"D4FMXW2,G6967FY-+N17:$:&
MR*S22:L1VB]KFZ2(JHBV6I:OY2Q;D7HO-='U0JO5;J5&>IE46_<M#6-*3$66
MBJQU.M<STD%['Z#E:U5;;8JM153H0FWX6]9?ETHGTBK_ -W^:%EWA_P*C;%+
M:HP[/7&[MC>KFT_O ^%O67Y=*)](J_\ =_C+O#_@5&V*6U0SUQN[8WJYM/[P
M/A;UE^72B?2*O_=_C+O#_@5&V*6U0SUQN[8WJYM/[P/A;UE^72B?2*O_ '?X
MR[P_X%1MBEM4,]<;NV-ZN;3^\#X6]9?ETHGTBK_W?XR[P_X%1MBEM4,]<;NV
M-ZN;3^\#X6]9?ETHGTBK_P!W^,N\/^!4;8I;5#/7&[MC>KFT_O ^%O67Y=*)
M](J_]W^,N\/^!4;8I;5#/7&[MC>KFT_O ^%O67Y=*)](J_\ =_C+O#_@5&V*
M6U0SUQN[8WJYM/[P/A;UE^72B?2*O_=_C+O#_@5&V*6U0SUQN[8WJYM/[P/A
M;UE^72B?2*O_ '?XR[P_X%1MBEM4,]<;NV-ZN;3^\#X6]9?ETHGTBK_W?XR[
MP_X%1MBEM4,]<;NV-ZN;3^\#X6]9?ETHGTBK_P!W^,N\/^!4;8I;5#/7&[MC
M>KFT_O ^%O67Y=*)](J_]W^,N\/^!4;8I;5#/7&[MC>KFT_O ^%O67Y=*)](
MJ_\ =_C+O#_@5&V*6U0SUQN[8WJYM/[P/A;UE^72B?2*O_=_C+O#_@5&V*6U
M0SUQN[8WJYM/[P/A;UE^72B?2*O_ '?XR[P_X%1MBEM4,]<;NV-ZN;3^\#X6
M]9?ETHGTBK_W?XR[P_X%1MBEM4,]<;NV-ZN;3^\#X6]9?ETHGTBK_P!W^,N\
M/^!4;8I;5#/7&[MC>KFT_O ^%O67Y=*)](J_]W^,N\/^!4;8I;5#/7&[MC>K
MFT_O ^%O67Y=*)](J_\ =_C+O#_@5&V*6U0SUQN[8WJYM/[P/A;UE^72B?2*
MO_=_C+O#_@5&V*6U0SUQN[8WJYM/[P/A;UE^72B?2*O_ '?XR[P_X%1MBEM4
M,]<;NV-ZN;3^\#X6]9?ETHGTBK_W?XR[P_X%1MBEM4,]<;NV-ZN;3^\#X6]9
M?ETHGTBK_P!W^,N\/^!4;8I;5#/7&[MC>KFT_O ^%O67Y=*)](J_]W^,N\/^
M!4;8I;5#/7&[MC>KFT_O ^%O67Y=*)](J_\ =_C+O#_@5&V*6U0SUQN[8WJY
MM/[P/A;UE^72B?2*O_=_C+O#_@5&V*6U0SUQN[8WJYM/[P5 W5H^E8'6<'D$
M&J"KH8_%WM3:4M[B=?Q..NY:53,$@5*8#DSM*-:$A0$.,#!@?='C'VXSS+,7
M;H73HUVY6=H]+ITI.I5Y)$B09:#">B+&2U--C&NL7VTML7VRC?5@Q0Q,O7?V
MHTB]-XJ[4J2Z[%6<L":GYJ8@JYLJY6N6'&BO8KFK^:NC:GM&ZWE"$/#@#@#@
M&IRY(%!;$ZFB%DL"%Q.=,R71-*Z)FB8QQGD[8G<R-@'1(2XD('M&N2DKR4JX
MXH)P08,"6<,.,]@Q8SA55HM'KN/"2E;E):<E6W11Z,CPF16(]*BK4<C8C7(C
MD1SD1R):B.5+;%4LB[E[+TW.]3%]3NC4ZA2JE$Q/6$Z+)S$:6BNA.H;7K#=$
M@O8Y8:N8QRL5=%7,:JI:U%2=?A;UE^72B?2*O_=_FB9=X?\  J-L4MJC"\]<
M;NV-ZN;3^\#X6]9?ETHGTBK_ -W^,N\/^!4;8I;5#/7&[MC>KFT_O ^%O67Y
M=*)](J_]W^,N\/\ @5&V*6U0SUQN[8WJYM/[P/A;UE^72B?2*O\ W?XR[P_X
M%1MBEM4,]<;NV-ZN;3^\#X6]9?ETHGTBK_W?XR[P_P"!4;8I;5#/7&[MC>KF
MT_O ^%O67Y=*)](J_P#=_C+O#_@5&V*6U0SUQN[8WJYM/[P/A;UE^72B?2*O
M_=_C+O#_ (%1MBEM4,]<;NV-ZN;3^\#X6]9?ETHGTBK_ -W^,N\/^!4;8I;5
M#/7&[MC>KFT_O ^%O67Y=*)](J_]W^,N\/\ @5&V*6U0SUQN[8WJYM/[P/A;
MUE^72B?2*O\ W?XR[P_X%1MBEM4,]<;NV-ZN;3^\#X6]9?ETHGTBK_W?XR[P
M_P"!4;8I;5#/7&[MC>KFT_O ^%O67Y=*)](J_P#=_C+O#_@5&V*6U0SUQN[8
MWJYM/[P/A;UE^72B?2*O_=_C+O#_ (%1MBEM4,]<;NV-ZN;3^\#X6]9?ETHG
MTBK_ -W^,N\/^!4;8I;5#/7&[MC>KFT_O ^%O67Y=*)](J_]W^,N\/\ @5&V
M*6U0SUQN[8WJYM/[P/A;UE^72B?2*O\ W?XR[P_X%1MBEM4,]<;NV-ZN;3^\
M#X6]9?ETHGTBK_W?XR[P_P"!4;8I;5#/7&[MC>KFT_O ^%O67Y=*)](J_P#=
M_C+O#_@5&V*6U0SUQN[8WJYM/[P/A;UE^72B?2*O_=_C+O#_ (%1MBEM4,]<
M;NV-ZN;3^\#X6]9?ETHGTBK_ -W^,N\/^!4;8I;5#/7&[MC>KFT_O ^%O67Y
M=*)](J_]W^,N\/\ @5&V*6U0SUQN[8WJYM/[P/A;UE^72B?2*O\ W?XR[P_X
M%1MBEM4,]<;NV-ZN;3^\#X6]9?ETHGTBK_W?XR[P_P"!4;8I;5#/7&[MC>KF
MT_O ^%O67Y=*)](J_P#=_C+O#_@5&V*6U0SUQN[8WJYM/[P/A;UE^72B?2*O
M_=_C+O#_ (%1MBEM4,]<;NV-ZN;3^\#X6]9?ETHGTBK_ -W^,N\/^!4;8I;5
M#/7&[MC>KFT_O ^%O67Y=*)](J_]W^,N\/\ @5&V*6U0SUQN[8WJYM/[P5'V
M[I2FJ_;->WV!5)64(?![8T0@&\Q&!16-.HD*B0*S%"(3BS-2)6)(>8G+$,O(
M^X(0 YSC.<8[,MQ4NE=6B2-&G*-3*?*3BWCD&Z<&7@PGZ*Q'*K=)C&NT55$5
M4ML6Q/R%%^K?B;B1>ZKWJI5Z[P5RITM+B5J(D&;GIJ9A(]L%B-?Z.-%>S3:C
MG(CK+41RHB]*FZ;E!D0&LRTOZEE:_I#E7^IX>8[._?O)=VHWRI"J*3_1G5^_
M\K]'*6[YL1*XX X X X X X X X X X X X X X X X X X X X X X X X
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MT]Z^X%<^"A&UGFQ$KFLRTOZEE:_I#E7^IX>8[._?O)=VHWRI"J*3_1G5^_\
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MZI!'Z!"O_(A5S'?Q ?P=]9%4?@C_ )J?4);_ )L1*XX X X X X X X X X
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M[JO+4 >#JW2JBW-88Z@7*@+=[^3U-%K2UL8;;N.UM?=3I!&K\=;-L^J9')(
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MWE,;E2GR:E%@SL"9D01X"!5:-]1K3>4Q"Q+ 0VVK:X16%<*KDD4KF586_7S
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M@%E5780S'RE*YL>0I+#KNVF*)SB(R)JD4P4IBTJUH;3?(ED&9*%@S!I@%UN
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M]G/]IW70X[(>Z2U/JVMVV"5A/6F",KIJ1L [7\PO4V7OMA/4BD">RWY44E<
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MMYS'Z=BT*07C&U<^K[6_2:LXC*%]?+P1M;;6D6T#EM5#YG)(ZFE>%1D%FTS
MWM[DT$*L*26\"CN*3!# $(%TM5Z)N"K97LA9MXSVO9G.]C+)A]@JVRL(<_Q&
M(05%$J>K^J$,2;QR>4REZDPB$\&PH,=#Q(A+#3Q#PC2AR$@L"XO ' */;U?P
MOKS^KR@OWXX\QW&CYHHW>6G^_>51ZIWVGO7W KGP4(VL\V(E<UF6E_4LK7](
M<J_U/#S'9W[]Y+NU&^5(512?Z,ZOW_E?HY2W?-B)7' ' ' ' ' ' ' ' ' '
M ' ' ' ' ' ' ' ' ' ' ' ' ' ' (<OJ\(7KS64@LV;J>Q TE8);&DDTH#E
M)7Y2$>&N/- #.WQ%J\T&>\+LR$@@!AQG866/..*WSO?2;CW?CW@J[OT,)+&,
M14TXL1?S(3+?9<Y?;]AK4<]?<M531\*,+[RXOWWE+D789;-S#M*+%<BK#EH#
M53TLQ%5/89#1>A+45[U9#9:][47Y"KLN29WU9$BLV=+?,O+ZISY=&4(?L]B9
MR!#"UQ]H*'G.2&UK3B[@,9[1F"[QIF1&F#&+K$O;>JJWSKT>\%8?I349W0U/
MS8;$_,AL3VF,3H3VU6USE5RJJ_T.898<7;PHN7)W(NM#T*;*,]T];/21XSK/
M2S$54_.B17=*^TU-%C$:QC6I%'.-G/C)8?#)98,D:X=!HX\RV5/9AY31'H^W
MJ71W<3$R4]<I"D0I"S3SO+HDIIQF<8[ %%B%GL"'.>>]3:94*Q.PZ;2H,68J
M$551D.&U7/=8BN6QJ6JMC455_(B*J]"'QZ_>"AW6I$:OWDFY>1HDNB+%CQWM
MAPH:.<UC=)[E1J:3W-:VU>ESD:G2J(9-'J:MF6S9[K:,5Q-)!8,;$\ ?X6T1
MUS7R9G,CZO#>]EN#,F3F+TIC6O%@@X(@8$ X6 9QWLXQGW9.[-X:C5(M$D)*
M:C5B!I^D@LAN=%9Z-=%^DQ$TD5KO<NM3H7H]D^/5<0+CT.[LO>ZLU>GRMUIM
M(2P)N+'ALEXJ1VZ<%617.1CDB,M>Q46Q6HKO815/):JWL!\;AN[/"Y,YMA<M
M:(&-<B95ZA,":OV%&66*C-+($$+\Y^5,P2ES_:CR'LP'MSC&?7EZ)6)J#\8E
MI6/$@),,@:36.5/3Q+="%:B?K'6+HM]E;/8/>G;VW7ILVDC/U"3@SBR,6=1C
MXK&N64@Z/I9E$5?U,/2;IQ/S41;56RTS.P=<K]JAI"_6335EPAA&<4F]NR2&
MOK8R!5'BR A*:[J$06XE4H%C/AE#,"8/L_9QGGTZQ<N]UWY?XW6Z9/2LHJHG
MI(D&(UEJ^PBO5NBBK[2*MJ^T<?NMBSAA?>>6F71O!1ZC4T:KO0R\W!B1M%O2
MYR0FO6(K6_XG(U6I[:H0OSC)H1^RS#"C &E#&6:6,)A9A8L@,+,!G @# ,.<
M" , L=N,X^W&>?ZURM5'-54<BVHJ>T?E[&1&+#B(CF.145%2U%1?914]M%]M
M#Z<>G1NF"_HB"K[#<B_YPPEL!W5JDP 3)_&$F"R"GTKO9P(U_; Y 6Y QVY-
M[0J@YS@PT!/8+@5BPE]*8EWJY$3_ /4RD/\ .5>F9A)T)$3\L1G0D5/;Z(B?
MG.1O2#ZX_JTNPEO"M^;GP5RZJ<=;6-1520F7VN6 OY($3I=+.Z$;[J OYD-T
M39WR@R'AP"#]G++?:6ULV$N*+)&A?)JFHZV++CB%_(6*F):^P2!/\I:$CTE;
ME[4X*6A2X-18%)9"I,<,D0L -+%G \ :XYMLYNU#UNL]-A'!9I=MUTA;^Q4O
ME=6Z\NLEB$>00=QI%E8ZRB$ EFS4&>'5C;9!<8,/4C4OPEPV]*F+*;4I[GA2
MW =*4[YW]'[#US;7"/-#*Z2"<::59M%18ZF=7$BB+%VH9XWE\A+OLJ7;P(L]
MSR&KY>E<4")@CCPE]F)O#7'!]IHUJ4#B6;P[,0]AO*%V*"O85LXBO+7FK*]K
M^8TY,6FL*ZA>SNU+QKY55Z&V6VVXXMNQU9/L>$D5D)&PZ)O@90WGMCF6SB=D
MA#8!QCVMW15VHS:G,,UUR5V<EV]DNN4JV*64Y.ET.6PU%H^AV]*>&2GFR[D6
M&&W(VN>B6%:WJ90X-@R $.0@$^<]GIP(LN3J97Q M/\ %SLKA!7>\*IIC:JV
M[1K*-4+,I1&)RWZDVC,ZL?IDX35==,;:J$JZ?/$!/*)1G#E,E+4NI8T.%Q+.
MO+6 =\5OW]1NS749LJ"3"F%53-74UT9KV;TV_P (D;K;<Z/V*U4Z9%$.2^-3
MM!8S0U1%2U(I@B5QA$*-NHGUY;UB$\XDLTLU.!AL(W9FNFU32@2N+1F2PVU]
MB^LXQT,D\@_AD\MW>CG5%V?/I^@UK@F=?9BI!?;0_J0-!*=(2M3*(XO&8>,L
MXL) %Q=[P7+^(>E,C8)K4\/NQ9O&<T+IM(XE(7ZK6^2NG3?WX:Y@M9H3B<1J
M0N05I:I:7'6Y0^EC&X&HRU)QH?$P8!!"/?7;.4G533<3CL9>;?6+]]V^<67
M*85V##IIG2C9A@UL9W2#5N^["5HH8VF:.\D3KY6',E>#HXJ(,:$N3QJ0.B("
MVFP&TM[U=K)K!,/Y3F0_878J8T36TG@(VMNLT--S:PH:X3:QV7+6AL&"L\U=
MXL&,.;"U9!(DZ)2]G(S,F*2.T@\"F]T=13<776+T<GLVLJN9IA>LVL^CV(4W
MB[]&5T$<R[+AT9J'<NVXA#;;L4J.ZJ,<<FB1+8+=[52+VZ1JFT*9V3I7<L*(
M"3W[</:IHMJT)$.2:['4A3W4(USTB4U*WUU-?YQ3AFV&.ULBRBP!V&IM]2QL
M,@@<DV!]ME-I$94)U4;8UWC&X-$ ].!'\ ZC&V*VG+&VVD5!.,AU]9=:]JK_
M "F=% FV$*H6JI5M=9954(23HV\9PZ64\3:/,"QF?@8BS.:ED00GD 3) &)>
M 9M<CQU!&2P^G9'TVW.KRIQM/;22LTL50S6BS_PI(8JX:(;:6NV1Z0,2'<="
M;+(&B<*P<3FH8U:8:QU$PNH\X]@*T;\!VHGO)M9)['L";,]'NLHUWKR]MN:@
MES.UU\U,Z^-0S5S-RQ%-8Z6V'"\5BR42N<VO4J<D#&&$HBLL<H1B($(]O,4.
MH&,ZHSB]+'WIU[L*[[*HV=JK3Z84TN2*L],PE_AH8(T6?<&LKV;'5RE]LNPS
M)U&"#"@%,DBP6SF.F$ZO)B0&0!P$#I,^P>X]7$[VO[S;E-3S!O45J35?7Y!*
M*BL1I8:;77NOU7A+&_3%Y,V*?,2:OXDUV^4:5&VQ''CWJ5EGC YHB7DM.V 7
M[U+MJU)N\;)U5<3U!YS,-:[I:*L-M*MXLY0>+SY%(Z3J6YTHET*<I9/!0^:1
M0-HY:G-"4\KRC2TJ9>'RWGLH4H%Q^ . . . 4>WJ_A?7G]7E!?OQQYCN-'S1
M1N\M/]^\JCU3OM/>ON!7/@H1M9YL1*YK,M+^I96OZ0Y5_J>'F.SOW[R7=J-\
MJ0JBD_T9U?O_ "OT<I;OFQ$KC@%<=A-FXAKF96:!_AMIV#([=EKM"X)$*BA@
MYO*'5X8H;(I\\#$VA7MH4Z!OB\66J##A&=F/#QC&,YSC@$BM5KP]5'X<^21:
M&MELV31P;7$++5M$1FB5SE92HQDC3FPK',PPB3K#$"@H*(L9IHCDQP ]X10\
M8 R!7.82@DB:&KIC%D4O6I"7!'%%<@:4TD5H%*D2).M3,1RL#H>D/6 R4 P!
M60"-QD.,Y%CLX!^6B>0>0)I L89G%'M)$UJUME2IHD30Y)HTXMQ&%+@@D!Z-
M8<4S+4";.##BE.2S"@9[PL8Q]O /,!:U7&113.R[)@(X.C"2-7,@3&/"BB4*
MG!64XE,BPXY:" GX4%]S(CL8%WP]G;VX[0/<52^)H76/L2Z41U&]RPM6;%6=
M4]MJ=UDQ3>F L7F1]O.4@5O):)(8$T[*8!F"RQ8$+L#GMX!Y@YPWDS5RA:MM
M=D/LR+1Z4CE*T#:GB2K$D?WN.HV!(X#<_/CD2=6RX&<2-* GPE:?PS3#!B++
M ]-@E\3E;+F21>41V21W!BXK+\P/;:\,N#6P\U,Y%Y=&Y2I0^(WJ2!EGX\3M
M*& 01]F<9QP"L!>\NOCD30KW%Y@BDL%O^5V/%&.PB5*9AC$4/JZNK L:2N,U
MS*C&-R8FX#?7*U. 1B? LFF%&9QY<?B\ LLNGD';$<;<7*9Q1O;YDI;4407+
MI$T)$<J6/!0#VA)&U1ZPLA\4NI!@1IBTHC1G@%C(,"QG@&2C4$ .)3C/) H4
M!-&00,P 3CPD=S)PB2LBP,P).# ][(<9P'O8[?\ ;C@&$S*PV:'Q=1* )E\K
M 6D(<$3+$1M+B^O2 QU:6D]:S)EKJV(UJ1O/>DXU!GF @++'C[<B$ (@*PHM
MZZM.GV(*YLTE80E6?L76+C)G3V0%B:U>M419IE,Y L$G<3UWL5S:WD(4/<)&
MH$86+!A8,=W.0)1UGV,8=F*8AMVMD4D%=L%@1\B;19CG+W7BZ1JX [)R'.-2
MY>37\UF[4RDNS.M),/1*E92YM58-3*2@#+[PP,D@UV1V?6K<U3M+>YE.M+%U
MJ:]/)XD)C*]E6?&%,J9C&(U,K/4F%I$*;(#\FEE8R,6.YWP_;P#/"9S"5"N4
M($\QBQZZ#E@-FJ(F0-)JN(%&(LN0#)0F K$='RQMV,GXRK"3C).._P#_ !^W
M@'73V)7ZN+I9NEG,.4PM<G7*D4O3R9E.BZQ*V)W!6Y*4K^6M$TJ$[>E:51IX
MP&Y"46F-$+.,%CS@#L()S"758)O:YC%G)>".M\O&A02!I6+ 1-VP9EJE DR=
M68<&.N>"A^76Y#Y8[NY[@\]F> =#^9U;=IF/YA0?M)DJ"%G8_%C#VE3%T3EK
M&R)F?\0_8DKBD. :0@SV*CBQ8$ &0YQG@'F9M>)(3+",E:G\ ,]=35H@ZV3S
MQ>PQR-2!P?(;!I@WN49=5+R,M2TG&3PEIQE6%&I&\(E1("1EA)./ ]9_L"*Q
M\]Z:C'9 Y2QDB3E-AP-J<V@Z<.$?;0'8$M;8ZJ<4:LTA4K)\L2>9X242D6 "
M-#]N< <2.R(<=B#IG5]:HO(;#:D[I%8;*'AE:I@Y^(VE.BM C8\N1QSDXM*8
MS/FP(Q*0$Y +/?R''>R!ZI<TAQTB+AY4LC)LM.0+74J+EOK6.1&M;:NRUN+D
M6R!59<QH$#F'*<X[!62RC\>&+.!_9P#0GUA(]<H9W!Y.\JA+J0$W8:8:0VDJ
M"T+#,!$Y4/Y$D[3#2C']Z*)\5&?GPP&H2,E%@[Z=0,R(_6BD;U)69.H33M.Z
M*LT("-14;#CV6Q$B]*HL2(B6L=T(L-NBU+6/5W;S_P#SKJ^&ZW5JE#IL-(6)
MZ1O2SCHBM5\>4TM& Z6Z$5($%7:,9GNE;'B)$>[1C06LTP\E([*!P#9=H8Q,
M<(@^PFQ\KL=KIX#%%2Z3K*Q7=DDK_ABLFU"%'M!Y9&Z'M3O(37Z/0ML4X*&0
M7_8^T<&"_8",0-PPEE)2ETJL7UJ$[#IJ0I?XE*S+V18GHYF:1=)[&P6/B+$A
MP6NL5J>Y])I+T(JI'_K-5*I7BO'=7"2B4B-7W3,\M7J$A"C2\#TTA37-T(4:
M)-1(4!(,>;B0U<CW>[] K&^Z5J.OBM\"([,6SMM3\@;W5CN7I^WA<D3F+*W.
M2%C%:,!969JEXFUM?D:!W3Y325C3.)Q"PDLXLU?D P!SC(<:S%T*=?BHXAW;
MC,B2M3N?/3D*,QKFL^-2[&,C:+8B->ED5C8CFO:CD6)8J)[!,\OZ6NX/T/ R
M_LK%@5*[^*5'I4S*Q8D-\;]G3L6+%E?21(+GPG:4O&B0&/A/<QS8*.:Y46U>
M>3I*[E%-UIL)5P4;;'-CMW-79[((BE%CO0BT$*B0,UEQ_N! '&$IDA)\X2//
M=R;YH0P@ 5DKM_4]#HT_=J1OC0=%DE6KTTN8B04_Y$TU8C)F'_Z>D331>BW3
M541&JT\='CWKHU_ZQA7?-8D:K72PYO%)0)IW_>4Y[8$6GQ[;?SD@+Z)R):C?
M1HU7.>C[,9ED5M.M+4ZD\]NQ._1C6R<P2[&2-I)HO&D8;!GDB=",U:&!,3DI
MP)U?"U&##$B](3W4819SDT&!8YZ-0I]?H=?OO5[T-C0+DS4I.LAI&=9#F(\1
MZ?%?00W+[MZ+:K(C$]PG^)+3[%$K=R[WW*PBNSAV^5G,7:;4Z1&F'2C$=&D9
M*!#7]HK.QH;?T4%6Z+8L&*ZV*J6(QUA\_P#R0CM$' )RUKC]MR6\*[;J..4H
M[+ _IEK ZDC$4E90I.\8Y.[T=@LX 8\C;?%RO ,!H#TN1D^&;DS!0^7W!DKS
M3][I&!=!7,KZ1T=#>G0D.SI<^(MB_HFMM](BHJ.9:W1=I:*Y;C35\/J+A?6)
MS%%K(ER5E',CPE1%=&5_1#A04M15F'Q-'T"HYJLBHV)IL1BO;]FB(*L"-(!P
M.(4KP)B K5"5.-(E/5A*!A2<F2FJ%9B8@T[ A +$::( <XQD8LX[<]JT)(J0
MFI'5KHR-325$L176=*HBJJHBK["*JV)T6K[)_-O,NEW3,1THU[)57N5C7.1[
MFLM711SD:Q'.1+$5R-:BKTHU+;$[//(> \E_8&*5L3U%I2RM$EC,E:')@D<<
M?VU&\L3^Q/*,YN=V5Z:'$E2WNK0ZMZDPA2F/+,)/),$ 81!%G&0(,L2M]6+J
M)S&[+BM*6'FD!#6>SI EB+NOI_SK'X2DX&1Y&X5X2Y1<&2C^Z)&!2V]I9G?3
MYR'(&.8IG25S/B%ZAK365P_#31&T\#M0$8K-4VL334P%CC#C8G*0I!MC:76*
M=D4F-9Z0T V0A*=Y<9!8#,8 P@,+Z?44=@T,3 M>D9VYL0D#Z?"$D&C;A&KU
M@T,4M1:XAV4)6=7%'F-MJZT2QM3<J/"0<>[*C&XD8Q+!8 S.%PS56H%=2U?3
M=/5:B)8+'?$\:;:IB==X3TI+)C5MERQYL)_+1'HW2''V!&XZY-![JF+.<W94
M\%DG8,3'JCR@(AJ1@T'W9H.EK>6T+KX]QB1TM&;P15U/X-4[XZ5=$]G8ZT7B
M\M<\C11#LRLQDK7NQ;P\%G8&B<7A-AQR(X\HM2$"0KJ@FB56SMFV;NRLZ!8;
M2_F;3\?;+C>JSC+C9&;/MJ3Q'7^G%JN1M\>7RP;JN=C&MC0O"H62F9M2#,,4
MI&]$H-( [MG4'KI8TFUMC2]RA46*K/8!YV^@M5Q@$#9DMGV?[/LQZ73E2R8;
MQ.[J8GL2U5LX7N;3DA8NDI8%:U2< Y66I R*\/A,M&<U]K!L,P538LQF<=G-
MQUO6=H0ULEY!K=72F)UC+)JP&O[,XL<>DS6*^$34D&%0E>%B9W6!0A.)(<<D
M =,>OFF,]8F&E2:HU\DC)K^9Y6,URT1N#*,TJ:^(SR3DS*Q-)&%E=F2)M&<6
MH 2!)EP3C, ;@TL8\9 BV][LTT0TW>=9RB(0.VX9K*KJZ'V30*6'L*MMB:A8
M;6[E7:%DC4C0MT4$1$$LO8ER-0VB&2S*"BRRS"%J?!18$L1VH=,4->RD4<KO
M6\RL11":5A/%Z:.UPY1);!G=U7.EC0.<NYJ94WN4;>'U>J5/K<YG&$*EAYIJ
ML S1C%D# :TTHU$A]E3;:E# ZLF4\G,X,N./7"\QB!N2^ MAM:0J!H4-?35(
MU@-;(<UQJ&Y4(CL*1B2X<UW@F@)4##D#.(I56ET4FC]-89"M=&*<3^2S* OK
MTP-U?HW63323'Y?+'B!N$80^;ELK5I_.R%" 'GG,XO!ZX!HPX'@##D.IW3U9
M6)ZH=JHC59F8X\_-%U2"JFN&ULU@8'UB1Y0L%E.L71)4ZEH,9&97Y)$XFE%E
MI6TSRA0PIA>%D#FK<G0V;M\*WQ@+/0I!5J,\9L.*[!*X['X2\/0[-A:-''Y,
MY.$F;X^^,UA2. R0MK,,<B4LC"VJA-BC "\C3< ]Z&4=IKJB[/3Y4%&T+5%@
MO+'*1 ;ZO@M;PVRYFV%I#)L\Q*/!1$,;LZ(E1<2PK+:P' 0%^0 9W2RT^!E@
M<AM2:?360RY5*JGI0-C[:5ZS9M"(S>.P,RP+@A;;'T21.V3Z-J1KU$U31QE:
MR$9^1X6DD%MY9?BY+3E9"!V=,3J,54,UJ==:D8:3K$J>7#'4D&CT:CT62 D5
M?6W-:TE\@/;XSVMZE7*)+#5*_*LP0U:HL\!BC/C9'C %J> . . . 4>WJ_A?
M7G]7E!?OQQYCN-'S11N\M/\ ?O*H]4[[3WK[@5SX*$;6>;$2N:S+2_J65K^D
M.5?ZGAYCL[]^\EW:C?*D*HI/]&=7[_ROT<I;OFQ$KC@&LOJ+T38%PO&I<BAM
M76];3'4-RS:6SR-41L>Y:L6F4R2&B+/@#0X1VU6&X*-D*,@B4RE%A<D1R @2
MM%DTLTLXG(RQ 5FV0T(ENP;9NK8(=?D ;.L#I$4YK/JFHMN91"P;<KC8:*K-
MY9&[, K9=I;-')ME+/*+%KE8=,1OAV7!R3 69<#3TAY@ *L*9*R/'4NEI\D'
M5TT(;NHNCE=55LF5PL_:YCN!JU7C&L;=-)C'']>*TD&IL>[JIZ,.;V?QB$0$
MSPD7'LHBT@P,0L.AME*BHC8VS;CA""D<6+1?3RHQU"ZI=7(+2<<M&%;;N:R=
M@88_K[A9'8SJ!#V&Q@A;G&RG-8Z#CYJQ(\C))SD@T#,:GIV3WI%F^?5"PKYH
MIKK?BT[*V/%J;\'#G7%C3BRM86=LCUBZL*+^#-]>I;#JK*ER9A=F]Y</Q"@>
MUT@/PO/<2!86@6V@^G=@U!;6H#[2=/7&8"*1"!5W;$@V+4Z;S""L5(L]OW)9
M:>+N""NY0V2ZN+RILV=*Q1)16#*=$!IG=O:UXE29N+4M8$D[PZ;63L78-Y90
MP=AF5=6C1VCM9*VM]>&$E!(RZDWADMP7"P.K6Z+"AB;":H>/%SXH,%+\FB3%
M9&;V@X!9W6W7/%.69NFF3P&)1"E[CMJ RZNX?'$<?1Q!<TD:U4[6L[5"A3.
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MUK8]7D5+SJA[=HJ80B*B7($"5PV9LJPIP\K6T$]32HQ)'!+B2_)MZQ.F)<
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MQ<28_P#!2T31J<Q#=T3$9B_]&QR?\F ]+8ZI;Z2,U(?0R$[TNZ/E7G6H. .
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MAAQJON9$8+(A9SD#R@Z(U "Y06V&2VP%G+M@R_@48&<Y!1'\^3D"I$?;ID-
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MDN[4;Y4A5%)_HSJ_?^5^CE+;FFE$%&'GF%DDDEC-..-&$LHHHL.1F&&&#S@
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MWG0P,NQ2[R*2V>GM9H-LN7**\>2'^VYS["@2DEH/0Q$5IW<G(L*V2V1],<?
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M ' ' ' ' ' ' ' ' */;U?POKS^KR@OWXX\QW&CYHHW>6G^_>51ZIWVGO7W
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MG *K0S%OD5@2*8W*HALJLZR&EJM2US)JE*D!S&6U$.!C,6K797JS\&)@+M\
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M1C(BHY5<J6)9I)_[6K[1LF#>"-Y<)8UY[S7MJ-WOV=%N95Y5B0*G+1XCHT:
MU8;4AM=I+I:#DZ/;L2SI-[W*=.O,< < < < < < < < < < < < < < < <
M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
<< < < < < < < < < < < < < < < < < __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g282574g41k86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g41k86.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 00!2 P$1  (1 0,1 ?_$ +8   ,! 0$! 0
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M4G8,,U!S8:C=$*ZZ6BGLBJV9R!F\9+-)9BL4YD 1:ND%$5$T4# HF"E=$_\
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M1A#^(XW$^@I6/=/5GBE.XRGF;%>$8)I9<LWRN4*$?R!(I@^L+XC0K^1425<
MS8H "CEXN5NB=0Q4R&\"91,;H4.O,9W3O/:NR;%,ENR_MK"RDD"*TK=/4Y!/
M2H[68Z D@ Z $G05FVQ>.-]\F923"[!Q5YE<G%"99$MT+]$8(7K=NQ47J(4%
MB-6( U)TJ=P-BL);!=Y VP&5<E5NO:X:>8@"MZ\RL\HY+#7_ "I<V9266V0[
M,$3G5"+]\$DD+A0G0IXB-5(4IQ Y,!^(3A;WCQWK-]BMK_"+XE/<[,>HGXE.
M9D-^]'):/?14IL!C.0C)-FYCY%@\6>.&;YB]1.V=LW3=6-,DNV<MU#$.0P"4
MQ3" AT'CXA.%O>/'>LWV*?"+XE/<[,>I'^)29NU7LOB#3+)>W6H%LRG$GUH@
MLEN\K:JY4>.GKRN/*G<#-!G*",F/I"J$G#(.(Q0$/)3!:03EE^@>( %\0G"W
MO'CO6;[%/A%\2GN=E_4C_$I[/_<S5#]X?$7Y.^^O\MX/_ _[3^%_A']U_"OO
M?/9_]EXH]X<1^7[_ /,Q_=?2]+R_4]/ZM8Y\.//7NAN#\Y[+^2F^^^CZ/H_Q
M/NOKU*'M_JW8L1YAV ;(JHJH4^^K61& !%8DD.)K^\4D:9?8]00%O+0+%Z\+
M#2QTNGJZ3%%,_7SA\NJ7E[BW([1W?N"-"I2SOS,(M"']@NF+V]TA\DD2LPMY
MROW,W0IUZ_-OG\/7.>'Y X\VE-(K++D<4+<SZ@Q_JM@@CO+&0>E%.Z(;RU#_
M )BV[QUT[OS^&^:.J3]'%*:EV@<-361=MH*^IME@JN&(B8M4[(=#E;C+341)
MUFKPP+%^P]>/))5X4@^P="/6 1^P RG\(6S;W<7+4&>56_2L-#)/*_R=Y)&\
M,$>OTF9VD ^58G_U@I_<*Y&QNS^ +K:KNOZ[N2XAM8(^PMW4,L=S<S:'YB)&
ML)/R/<1Z?XCN#ZQI\T?6SZ=>'?DSSARV^OS]480_B.-Q/H*5CW3U9XI70/>?
MPQ+9"UMK^1X)JX?/<,6PTQ,MT ,H*=,M+5.'G) $"=3JFC99M&*G, ""+4%U
M#"!2F'D/_&;LR[W#QO;[CL$9Y\+=]Y(!VZ6\ZB.5]!Y>AUA8GYJ=;'0 U8=_
M;=Y(L-H\S7>S<I(D5MN2P[J%FT&MY;,9H(^H]@$D37*J-?/E[I!JS 5*9RJF
MKXJ.*5H58QY)6&K6^[N7*<+4Z@W0;JR[Q!90DU;)43$KM)@TT_#Z?8);P*N5
M" 8 :1K5PY/U!,J:F0XO;USD,7>9N5A!B;-0#(P)$D\G9#;1 >E+)HSD:_LX
M4DE;T0K8EG-WV6(SF.VS AN<_D'9A$C &&UB[;B]G)]""+58U)&LMQ+#"NA=
MG1D'_P F,Z_Y?(_-G^.+[B3_ '0_X8^X?E%_-_D??>2.^$[?7[N3^FOU#R?\
MW^7>3[[_ &^M4-OCZXM_?0_UK^D>4_\ 6_SCTOR_^?E_AU0QM9J7!;'1T//0
M\^ICS,5+:2;6D9%:1[:61&+F&RS6;I-T@'G5A;:%8VSA1)XP<E.3PJGZ 9-1
MPBO83RKQ+8\CVT-_9W!Q^\;)'6VNU02#HD!62VN8F\V>UF!*R1."-&;0%6D2
M2HG@?G[*<.7EQBLC:#+\=9*2-KW'O(T1[V%@T-Y9SI^TM+ZW95:*>,@ZJNI#
MI%)%-UL'VW]L*];%WM;UN.,6=H3U@KB.S$O=-E)E-5<7LM48-\9*]U6$>H'1
M$L9(IN5$5RJF25! Z2"%<'(/AQY7Q^6:;&[;/LI0=9L)O:K=Y 3U26\3:74$
M;#ITAE#E6#E'[LK''<KQ'XR>!<O@%MLSO(>W"0]V,K;&QO(H2%Z(KN= ;&ZF
M1@^MS;M&KH8Q)'WJO++]PUVF-O<H3+-&TT]OAZK&6*60LU[?QPNT$"CU7]7U
M**?N["_> 0/Z(JR;-LH80 7! ZF#G9OA-Y>W/>HF5LUP^*+>?-=.G4!\O1 C
M-*S?1#"-">PR+VD<<C^/OP][(QLDF"R+[BSH7]G;6,<G0S'T>\NI42W1-?2*
M-+(HU(B8Z T\:Q:R8WU2QBQQKCIJLJ4RWK2SV:1!,TY;[$J@D@YF951( 32*
M":)4FS9, 1;($*4OB,)U#V<<8\9;;XJVQ'MO;J,1U=<TSZ=[<3$ -(Y'8.P!
M40>:B@ :GJ9J1N;N;-Y\\;VEWGO"158+W5M;1Z]Q:6X8LL,0/:>TEI)&\^1R
M6.B]**H/ZQI\T?6SZ=>'?DSSAS8E:@HPA_$<;B?04K'NGJSQ2G[R<9'34;(0
M\PP9RD3+,7<9*1D@W2>,)&.?H*-7K!\T<$40=,W;94R:J9RF(<AA*(" CSX7
M-M;7MM)9WD:2VDR,CHX#*Z,"K*RG4,K*2&!!!!(-=JRO;S&WD.1QTLD&0MY4
MDBDC8I)'(C!D='4AE=& 96!!4@$'45-EMMV:;_#V&6N.JYV5OJ$@LJ^^+*:F
M&41:ZVJL9159C 2TLHRA)^#;]!\@'#EL^2()4NCDP"L:MSEKP;9^SR$N8XL*
M7>(D8M[%)(L<\).I*Q22%8Y8Q\WK=)5&B:2D%S<UP!_<;VGD<1;[=YU$F/W#
M"H3]2AB>6UN   'GBB#S03-\_NXY(6(:36!2(PO:+[>.ZS^83BT=<+V9P59N
M!O6B4;$0ZOFF.)4U)Q],1T65$P)""ARNB^6 AXC$$Q1&/EKX>>:I[P6J;<O^
M\!'IA(XSKKV&5I$33L[2''3V:D:BI<WWB\\-5KCS?2;RQ0A*M]T9)91IIVB%
M(I)=>T%08CU:'0, VCUM4.VY8H:VU#+.SJU/%QCY0'V)-?<>(J_%=C1^=0CG
MUM)'=G='LEF2<HHJF<*+/7+ATV3</)!^H1/RYT<4>&_(V>6L]V<G-9]YCSU6
M&*M ?8K-B=>\?JU[Z8,%8N6D=W19)KBX8+TU<<]>,O$9' 9#8/"*Y'N<L.C*
MY[($?J>20 KW480*+>V*EU$:I#''%(\5M:6B,_6X[DQ:KIHXI1Q2CBE83L7E
MUKA_"V9;M&S=6;W.BXDR%>:U$V%\V!)Y,UJHS4U")NXL'[!^\8.I*.(0Y$CI
MG5+XBD.4WL@I4KL]C/NI=W'5?"5UO>QFA4)C-]>6.:*96Y^4MU#OT5::2K=Z
M(R&S-8'&-E8D0,E)OS@W3=K$4342.)BF#P@I6XUS3?N]U;;&^[I1.UG;6)G#
M)&-6>*+._7M-_6KBM18K4M=NBSKQL,@W:/P4H4?U7 XF$"G]C[<>BE-/[1^Z
M]WW$U"K&5<[V.@IY1D;]=*HHU@$F59]8LXB50;PIBP"DFY.+]<CKR@%$I"J^
M$O0GB\0F4IK'%*.*4<4HXI1Q2CBE'%*BJW/A] [)WJ-UV?<;O5NI>*V&.L)C
MCM[74,COG"ES'#6#E/5Q4L>5.X22$>:+=22X^8@BU\_Q")_-, &4K]_BU^J]
M_O!9>_$NTO[$.*4?%K]5[_>"R]^)=I?V(<4KE/96J]H*NVS5=WVZ<GWFZY14
MV=QBE=6-F8YC9-65$"2\T7S57(N/J?&"Z+8B,B ""ZKCPF$?!X/$8%*OZXI1
MQ2CBE'%*.*4<4HXI4>_>@^>_/?HYQ][GNN*4I_BE'%*VK6SYQ6 OTU8L_P!<
/P7%*O^XI1Q2CBE'%*__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g282574g48v36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g48v36.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 00!- P$1  (1 0,1 ?_$ )$   (" P$!
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MK\8<Z;=,4VJ9B$.L"1%%_C*)OT*4I=)9WDN7Y!^/!?W$\F.L8NS:122&06\
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M(3-\$BJ2C[O6I]P!Y:*2_P 8+9G"A=A[HQ;2B5KH)IN$ANU6\*;>Z85%L?N
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M(-%51U^NI9B269V)=V)9F+$DQSY5ROD7..0W?*^67DU_R&^E,DT\I!9V/3X
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?<4HXI6H7_P#\79O^H=_\.*5M_%*.*4<4HXI1Q2O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g282574g59s99.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g59s99.jpg
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M 0$! 0$! 0$! ?_  !$( "  )0,!$0 "$0$#$0'_Q  7  $! 0$
M       )" <*_\0 )1   04! 0$  @(" P      ! (#!08' 0@)$Q0 $A$5
M4Y+1_\0 %P$! 0$!                 @$# /_$ "<1  $# 0<% 0$!
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M'SGJF,U7XHMYQI.XU/'[%IM(]#0E1Y*21#E@E"BM#O S20:Q!M2%LEH8PO\
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G^(2%R2L[J0^.?L+Z1^NE"B.I9_,I?&&>()<XXGCA*RT8#K7E?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g282574g74j57.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g74j57.jpg
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M_\0 '  !  (# 0$!              <(!@D* P4$_\0 *A   00# 0 !! ,
M 04     ! ,%!@<! @@ "1$2$Q05%B$B"A<E,4'_Q  7 0$! 0$
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M6)BD3W$AWQ45)H>W-@ D;4@_X8S'%!F=U26-Q6'=P#@AQ&FHG-2MO$33X0>
MCZTK8K2D8.]V5;LZB]<0..H87>)5+W@-E:!,J;?8,+J08JG^TY'KYT$:VH/4
MAS=CE4 &T0HU=%!0"ME(] W?T;*PY3$J+=:=YC12*6!GU]"NL8N>W]5$MM&L
M^OZ-T3'>*WA"ZGVN"<LN1P9IDZAX2'#J$4(]"2H"M)9R]%EN\^G?(MH'%8X
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( \ \ \!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g282574g77n77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g77n77.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1CJ4&AO=&]S:&]P(#,N,  X0DE-! 0
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M:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M    "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O
M9@    EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN
M=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M    4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L
M<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M     $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M            1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M     $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
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M8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P
M.$))30/M       0 [_^-0 "  $#O_XU  (  3A"24T$)@      #@
M       _@   .$))30/R       *  #_______\  #A"24T$#0      !
M '@X0DE-!!D       0    >.$))30/S       )           ! #A"24TG
M$       "@ !          $X0DE- _0      !( -0    $ +0    8
M  $X0DE- _<      !P  /____________________________\#Z   .$))
M300(       0     0   D    )      #A"24T$'@      !      X0DE-
M!!H      S4    &              $/   "A          !
M              $              H0   $/                      $
M                        $     $       !N=6QL     @    9B;W5N
M9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,
M969T;&]N9P          0G1O;6QO;F<   $/     %)G:'1L;VYG   "A
M  9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L
M:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU
M;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU
M;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M  !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M $)T;VUL;VYG   !#P    !29VAT;&]N9P   H0    #=7)L5$585     $
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M8\AK6M&KGO>[VM:U9>-];.@9-]5->26G(=LQ[+:K:JK73M#,7*OJKQLE[_\
M!>A;9ZO^#5+IV&[ZRNIZWU5D]/(]3I72W0ZOTW?S/4<YGN9D9E]?Z7'J?^AP
M*K/^Y?J7+<ZAT_"ZEA78&?2W(Q<ANVVIW!'/;W->UWOKL9[ZW_I*TE-A)9'U
M9R;[>G/Q<FQUV3TV^W"NM?\ 3?Z+MN/?;+G[K<C#=C9%KO\ 26I?6G)NJZ0[
M&QK/2R^HV5X.,\3N:_(<*7WU^G[]^)CNNS/_ $'24\[UFU^5B7?7(D[>FWU#
MH@:Y[1Z#+F4YV2X,L].W]L,==4SV;/V?]E?_ (2Q=RN?^L.)CC Z7T''J:*<
MG+QJ&53 ;1B']H6C][;]FP/0_P"N5KH$E*22224I))))2DDDDE*22224I))9
M72_K+TWJN59CXGJ0T/=1>YL4Y#*W>A?=@WC<S(JIN<VJS_K?^"MKL24ZJ222
M2G__T/54/(HKR:+,>T;JKF.K>/%KAM=_T2B*-EC*F.LL<&5L!<][C  &KG.<
M?HM:DIQ_JKDO;TROI.7M9U+I+&8N54'3(K'IX^97(8YV/F4M]:M^S_2T?SM%
MJVER.13U#ZVG&ZCTP#I&-2[?A=6L8XYEC0YI#\;%#J65].RVA_LZ@Z[[55LL
M_9_\U:@9'7_K5]5\O_LB%74>B. _RKCUFJQA)#8R
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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>&S)HFJZ<.':_Q(Z[.';APZ7V4<+JJ;S+P\/#S__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g282574g82m13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g82m13.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_X0-S:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-33I/
M<FEG:6YA;$1O8W5M96YT240](GAM<"YD:60Z.#E!-4)#-C,S1$(Y13 Q,3@V
M138Y,3,S-C(Q-44T038B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z1D(P
M.#E"-CE"0C$R,3%%0SA&1C9%-40U14$Q,SE%0C@B('AM<$U-.DEN<W1A;F-E
M240](GAM<"YI:60Z1D(P.#E"-CA"0C$R,3%%0SA&1C9%-40U14$Q,SE%0C@B
M('AM<#I#<F5A=&]R5&]O;#TB061O8F4@26Y$97-I9VX@,3<N," H5VEN9&]W
M<RDB/B \>&UP34TZ1&5R:79E9$9R;VT@<W12968Z:6YS=&%N8V5)1#TB=75I
M9#HW8C,R,#)F9BTY,F%E+30S,S8M.&5D-RUA,#8Q96,V9#5A,SDB('-T4F5F
M.F1O8W5M96YT240](GAM<"YI9#HT.#1F-V8T,2TX,F8S+3DU-#<M8C5D9BUE
M968Q8C<W8C=A-S<B+SX@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@
M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
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M(T^]E$#T7HWWC]I81"T62\KB;OV_.B:/Y:K9RN'H:S8K458,Z]I:W2;S-?\
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M*?V:+./=;+,7.?1[(]-N?6O#WA2FCC!9U.K<Z]I3F&,[D%J272ZTYTMG9YK
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M"!H248 ^F@^F$UW5)]:H$B7-$SDS;$$CG&_:U,,L?4;,0N8/Q"I2LX6UH?7
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MSS&65TD#!_*?+_\ @KRM1'N35_*[]W\@87^E]O\ #@=E7"88O>%4B71&,+9
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M:RCG>N8@8VP]2E&I0DG.#@M4)FY,6(]8#6C/&9KSCY;D=A],3VJ:YF-\6H1
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M.VIKWHP.VU!L)J\IU-UM&GWHQT(&282Y&:^/T&O),3EB"=OU,#LL.];]0Z]
MZ?X:CGWHM?/P^R??3FB"VN3Q]U(/O1P;@AT *!:X?!]6K1!!KTT48,0-:^ST
MP*@6WH"AI3"D20LQ"E,0HC"TQ(!HT1OT_P J-*,(-"3I3/I"O<6#T!OX@>NO
MT=>@<38T-3*B VL[8WM+<6-0:! V(DR!$ Q6>8I5& 2I2RB C4J3AF&;T'U&
M,>Q;]=[WO IZ")Q9J(*2M<:C[:F(-*/)3H&9N1D$G$+3G(DXHI.F+++-)<5!
MB@(M:UL)PQ#U^EO>]AWE+,T+2'-,L:FU6F>@;*>4ZE"E/(=B]I@(]EN91I0R
MUX-I"PE>ANAZ^,.@_P#;K6L#\2,C,WHC6U T-B)N.*"0<@2($B9$:2!&2W@)
M-2DE (,* @3ED:#L.]:)+"#_ +0ZUH.P8@0G(1M9R)(:VF)=H3&XQ,2-"8B$
M5\ D8T@@;3B2B(_0V7L/LV#[/3TP./34UZ+$3IM0:*$N Z"*TC3_ !B<BU %
M9;B('Q^W:X"LH)NCO3Y-&!T+6_76MX +4U@+3% ;4 "D:LUP2%A1IPEI5YPE
M SEJ8&B]!(5FC6&[$8'6ABV:/>]_I"]0ZB6-QU$X*W9$P,J1T7J_KUSDE:D*
M=P6KM)1H=+5:PH@"A2K^B,$3\@Q"'\0M@]?;OTP.!-$8HB">!'&(\D J4J%B
MD*9E;2 J%:M6F<%2H\)28&CE*E>B)/,&+U$,XH ][V((=Z"LJ$:17M.)4E3J
M1)% %B3:@@H[:566 PLM4GV8$6R5 "S1!T,/H+6A;UK?IO>!3'&,QQX2N2%W
MC[(Z(G@T@]W1N+4@7)74]*602F.<DZD@TI<:G*2E!+$;H6P!+#K7IH.O0(Q#
M0\&%<+S<BQ*%Q=G:M:WK,F.N"!G51EE;JNEEBR^-O3,C-;A*43\%?92LH1NC
MMEEDIR=% +%H8AES<82HX,3([*FQ:Z,S4Y+612):S*W!O2+%30L$'0!*VQ0H
M),-0*1 UK6S"M@'O6O3UPCN 1HRS%9Q:1, Y?L&UQH""@F+-E$A3E[5CT'0E
M&RTX- #[][] :T'7V?9@== SM#4VDLK6U-S:SIR1IR&E A3(VTE.9L8C""4"
M<HM*629LP6Q!T#0=[%OUU]N\#I((K&&I,G1M<;86U&DVD$E2(&=O1IDPD!QZ
ME").0G3EE$[1*%1IA6PZU\8S!"#Z;%O>PYU$?8%;NBD"IC:%+\VD&I6Y[4-J
M(YW0)C]BV<G1.1A(EJ4@[8M^X !A"+UWZZP.1R9&9Z^B^^&AL=ONU:2YMWWD
M@2KON]Q3Z%I.X(OJBC?I5I&A[]AI?M,#Z[]-Z]<#D+:FLD: PIM0%&-2<U&U
MC+1IP#;4AX2 'I4 @EZ$C3G 3%Z& OVA%HL.MZ_1UZ!T-1:,:6+W#4<8=+W4
M>C71=IH;]+'(W2$YLT8O4_3_ #+!Z;5!B?U,$+?P&"+_ .T6];#D61N.N"-<
MWN# RKD#FF3(W)"L:D*E&X)$6O1&E7)CB!DJTR37V% ,"()?_P!.M8'761")
MN*,QN<(Q'5S>: \LU"L96U4C,+4C2FJ0&)3TPR!@4&(2!#UL/H,1(-[]=@#Z
M#-5?3>@":!0%$D">4DVWE':3$Z-+0"$ 8D0#- ]X$@AE!WLO6_9O8=;]/LU@
M=1E8&*-H]M\=96EA0"/.5"0LK:C:T8E*C>A'J-ID))!.SSQ:UL8_;[A;_AWO
M ^"XY'B7-2]$L+,4\K34ZA8[%M:$#FK/1ICD20Y2O"1I4>:E1J3"2Q#'O8"C
M!!UO01;UL.RWM+4T!5 :FQO; +ERES6@;T:9$%8Y+1:&L<%04Q96E"Y6/6MF
MFC]3#-Z]1;W@?&V5GV08EVTMFTQSAIV.3[0)=D&NNEH'+3F83\7QC<-.)85'
MS;ULSY@Z'Z^[6MX'9^A1?6Z<OHTOWCI+M#I?].5];I%LW1^T>E7L^?Z79^M#
M^/W>SWZ]?3UP.MIE9@MY+0%I; M2<:<Q.V:0)=-Y TBDM:E&2BT5],4-,L*"
M:7L(=; :'0M>@M:W@%;(S+_K_KFAL6?>J,IN=/JT"51]Y-Y&U B4"_YBA_6(
MR1*S=A*,]P [-'Z:_2WZA%\)H^&0F;VG/TY0WF16G9!5FJE;VC:E1T6> 5;7
M53GH(FK+;R5S<V+6"M49IVA&F&F*#SO4?Q[ 6 N;C'1+ 4"$ %A8$20('$PP
MYP %,2$"XTTDM,::L#H&M*3#4Y0"Q"'[MB '0=_9K6L(I[;&8XS$-R5HC[(U
M)6?ZK[I3-K4@0D-?UON^L^[B4I!1:+ZOW;^7XM!^3UW[O7 B@VBF19=S!=+H
M^.:\R$1B3L5=P0+;&F^)0MWGRI ?84W2&-[*FD+M+98F:B$HSEJT\E(F&IT0
M4 2Q0,9<Z8304B1$JE2XE(E*6K@IP+5A2<HM4L D"8%*!4H"#1J@*8)H]%Z'
MO>@:%OT]/7>$=-J86-B L+9&5I9P.*PYQ< -3<C;P+G!3Z?4+U@4A).E*Q1Z
M:]YH_<,?I]N]X%._!,,^G9T?X1C'TD>5F+V!+]P-7T[&N--&>:L9R/I/B;%9
MIQ@AB,)T 8A"WO>_7>!5]M#5L+F#;8W[ ]B$)Y!M$FV%W$-&4WB$YA^/T7B$
M@( 1O9OO]20!!_VZUK H^H1"PM;:QAB$7"RLZLMP:&?3 TZ:VI>48,XI:VM^
MDGTB%66:8(032@!&$0M[UOUWO!FJR<U-BGZ[ZAN0*/O,@M*Y?,C3F_>"8G1H
M24Z[WEB^K(*">/00&>X(=#%Z:^W>!\*V9H</J/KVIM6_5@1%JOJT*53]26VJ
MAKFXM1\Q0_F @6F".(T+UT4:+8P^@M[W@5+ 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M]I&VDL@?PN:]6.4G/UFM#@]-QYC>I)2?2$#TET%-HS6O>,>]B63>98YBXO\
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MZ]^][P2R;S+&W?%_DDWK>M>8VQ@[WK>M"_N5<E;]-^GV;]-QGTWZ9-5[N/\
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M:U_JS\97ZUE_[:8/P^9^*OS6O]6?C*_6LO\ VTP?A\S\5?FM?ZL_&5^M9?\
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M;WO#K[GV<?DV:L.1@,!@,!@:S/Y6;_!9U/\ \A'0O\R5SAU][[O2-F;#D8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# UF?#/_ +LOY@C_ %)U%_'N/#K[GV<?E_#9FPY& P&
MP&!K,_E9O\%G4_\ R$="_P R5SAU][[O2-F;#D8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# U
MF?#/_NR_F"/]2=1?Q[CPZ^Y]G'Y?PV9L.1@,!@,!@:S/Y6;_  6=3_\ (1T+
M_,E<X=?>^[TC9FPY& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M TDT A ,+'H0=[UO6$57 XCSR4Q)BA2<4G() (PX\\P!1)18=>HAF&&;"
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M'A6ZSDL:BXN&YQRGTDCI'M?EV%,$%DD5LZRQV15C4/[OL]J;FQS;&A \.('
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MUO;N:5#@X43949N2U(_?-:N[V<:HDCTQ7D@E@;+/<I4H/&8YB5N*DM:/81&
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MPT!&ZSQ[<]MF=6;/!W0EL7MX^N<>F+OA?W#;5@\^QRS9K$F= <VA6O"J/C=
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ML6HAN. 8!T]LJ=R%1Z?V[^1(F.]?LUO*QPX]W+'1B+XDNO\ J6TH_P!;<O\
M=K^Q/';G&EA(D$Y>&..1^)MDLK>SH2BG=52]KCS W-+4-* (ER PTE*  ])2
MA&>IAF][-<^,F+Q^VO/OP@>6_J6[E=OH?(59,>E#,[<RNW85&S)N@L,K\E+5
M=0V78U37PSJ$\3:&-(]KHX^1I$LV(S1AA) Q;]V@"^R->YPXS';XX7SX-O(M
MW9V7U/T1%>L)DRKZ\7\Z5-T]1U?MM>P^)K8'!KUF\L70)O<WID96]]?E'[ND
MS?OWKCS]C 8$W>]F"$+=3W./'C)C?+:"PY& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P-9GPS_[LOY@C_4G47\>X\.ON?9Q^7\-F
M;#D8# 8# 8&LS^5F_P %G4__ "$="_S)7.'7WON](V9L.1@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@4.3(%#K&Y UI- VK<F-V0)
MM&C]A>U"Q H3DZ,'Z"]@/D,UZ[]-^FL#3UE?@D[B=/'MX^J2A4CK&ONC*B;.
MDN:^H'-NG"HUD=^0NJ;+>I7/FIAD1<=T.0N3.A*2GIT6TR86SUR@(3=;#[MQ
MWGN<>ZWI?[LYK9\7G8J"X?*O+.3YE$J+0='<4\H<\\B3-JFSFT2:+O5"1E-'
MY R.>VAG$XP1(XQ]&-H0NR4T\Y-]3I2 (!%Z]&&9SF)+-)<HBX_\:?0=3]P\
MD=@3KENBN0Z6HNA[^A%\-JKJZ4="V7)9))X 2VF6O/)K,&DM@6,KVK3F"T06
MN&8WI-*%"Y0/9A9)!;REXWC+;;4*>&?F$,C\D70Q,7L"+VWPQXQ[)OU!Q.]0
MYX0RF$I;#[;6,4_EC:RR5O/6,LA5U-7Y)S0=M(,04"IS^P7J9K!SOTS/W7?T
M>YOEG@/D'MGE9;5/CG>H)$K3L21%1BPYM+Y8HA;Y%JC6LCU^)%%</Y+0]EM<
MV=G$*-"6K$G&:B1J3SD^P*0%&EUCA>,N>6S&KA.H^Z^/>-9[0T7X$Y0@!E21
M*,K.?J^C'5#]-P7U8#D^J%%FNUT6#(:F8!QZ2NQ!1:\+N-.X:/6':)^(E.G*
M!HO+LY<LYK%X%8]YU+T!VEYH;KY8KVLK2AG#[I1-!\<T/*G7H&;7#-2I(@DK
M+*K:?Z]C##^)SU,A2HF\E,VE"6%MFOTC"=) C-C6>-D]N73.[WRJ>07^^\R0
M65V3&8,U=,/=-M,DE$*: OC17S/;CI$RW4Z( $Z.3S($C TR10% >:8I./\
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M6[QY6^0Y[6QN3($+H1KZ5=MH?&X],882(96S"A>T0M:]<+99I=TK80P& P&
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MS!I8$D@--<RCQA4BVH]RC0Q:,V+UWA<VS%NBH;Y?YKW<!'0>^?J5_?PFT?\
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M^W(&U.I7IV!.5MU"6(D2M$0$DX>R]:UH9M0_1_#<(K253.;39'4LP=9=#VB
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MXO68#9:SI'I\@6V6+!,D[!&$<?AZ%V=8MM-H3TSQY W-364><0:2D)(2)@B
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MQXSSGIR<-@>P9;>BN3SYM8*K:#8LBIL$H'75*U()5 %;:T2>R6?_ /$G=P=
M/+@L)C"_3=I#\P?IQ9-<39&$L[%Z$B[HEB#??HWQ@,O&X>9IE;RB)Q%5J!T3
M"9] $)/<JL3)%D\5)D%9R6<J*J?!'%DQEPDFR'CZ-,F9G8@P=LWQT^)^Z29#
MTAT$\VVCH^-O%B[;IEU%VFRB=Z<WS[%[,"QT*UU ;!ZY87J\!M<#.&M)GSD]
M+C3"7"0+DC 8$(OIM*S #$QGRB4H):W4T)L;F^2=@R21QF,V:UU34S:SU"[T
MXZPI#T,_HI6C<6F\6%(SR&5+$]L#2(7!F<XB[J&AG.WM(H+2IRQKU9,37M=:
M^+MM\K?D(LMLZ%54ZLXB)9QU?413+ %<5FZ<NCX;;37(;:(DC Y3"4M-XS62
MK8BU%,[DSB3Z:A@0B$Z?*9H232>*2N-XD^BZ(\@<H=YQ9P%LILVH1*H=)'"*
M*4T*<)'RK1DG$2@TAA[:L [Q+3Q]TI1'FGE:1(RM&EFG:,/,)RVGQU8,TI64
MM-DO&\3:[\M$M:Y]A^50AWFCF. ODZ9FABF=X1]P9XHK4PD+&R.4A6H$Z]8H
M5MRX9!QZK:0";1A'TSJW>ORBZA])=>3J0M5%Q*4V>ZRN$5]UDZM-@5]_=CC,
MBM&:T?UI97/4-=['3W.ICD46Q6(1B$-:^5((NC2&+%T@+-,$B3_3DF$QQW^7
M]GH7);6MYDL7Q\,TR4-D'<;E-F[3=D39SVMUC:F=H>=I!.BX@T2!0!8:H):9
M>R*SD(T:D)BTA$(6Q&%Z%K#.)BL1*DMBZ^H;H;8&Q].2R'URN1>09\*D-8,]
M7K'EY#3?<2>G*?TTOTEA4I:BV*)PXXU*;[4AHW4)16SC1>IHCHMDDV\/[(K'
MT/<G0M%6"_SKH7]QI$#\7];=!J0,;%7J>,V;.K2C%WMUBSR:I98PO;D?6L66
M5ZA0_=+,I:]I3W0_8U?S#;Q$%Q)=LZNMSU<_6\O%%H]42*:J6F@">&*X10M-
M(.<V*HG:KYG1?/DZLN268GG#Z7>ZV1R-AGS\7'%;*22D)5L*0D@I4;]Y@,I9
M-[UREY,]=?R:H))=;1>EAR]F*ZBZ78YG7$#W1D#F[-SQ1]R= 0&/H*4=Y_!E
M,=6V"C-8&A<^BD"\L#LU-PDJ50WF^X2HGTYQCHI,0Z9G]Y3N&PF!W7*HI3]Y
M=0_<S#<K5&H*R6 HK=!X\:$Z#A$";SI%!SV=IFEIRB5+756J6-1SB!"B6HD>
MDP?I_IBXQ-=Y/W='G>Q>AK[LB*U"JZ_FBN)(W_R2IWFS(%&J?1S&<-7/74=,
MU74!21T/@#U#VPZ*,DP6)G%2B:]ENIQ8M[" (_34+B3./!'[=U=V==C-7L>K
MUPEYED-7#\9O1N6UN=S=$V&Q[I<["MFN3WNTD-WO[:>95+0OJ]K$[-L5+3C2
M[E)NS%!&]->LI9QF^V79Z"L:T[,JVXYW95V**[<(+Y >4^?4_-8$D$/@I+2A
MZ"YD6(V@U4ICP+$=["GQKP?)6UW*=P)MMAJ4!2+:0"C9HDF<2=*];NJWJR&'
MGBV);3+D)/8]?Q_\?,29*E1N9K^.O'!OFSU QI%:9:3ZS^/,BED%O0-'E!<?
MD*$6:$LP)CCC.NSS&?\ M&X7M[GLEKNQT*ZNNS"P5-P"<%K8#4T9L&%3^%4U
M)9TTK-M8C9,5*QV,Z38LAR$J3ELT).&6#1/SZ&;[9_3=RMBB;6CTGQ[(9#;4
M[;1Q/N;R'UXA:8[J$,[(\L%8ZN]/'4#ZB###ANJXZ-1L+8L/^0"E0BV<9[@J
MM[5:A=)?E'WPH\6M65=^-,I1;K]*H?T+'[$@T@K5R9(:EA46:8Y5]B6O G&$
M'-D=1S)&_L1,)+;EYR]V<2G0"T\T116P)@IZ<L7/DXYLYS*DN@_(+;,>N&<(
MS 7#XXF=S2/YT)4Q%@AEAV;6;'-M!*-B"92@;FN O#DW%*#E8MI&]4<:8,2@
M(%)8FLD^:XKUMQYFO6:RMC9<F?(K3_:'C^0,S F"UB!$)#,X1;DAE2!0J2)P
M+C'!S) W*3"51IHB0"![ @T/>MB3Z<^5=&)6!-(=PKXB8W#;;-IA-<TEYMJ"
M83%&WQI>Y*8I(>9K/?MQMC,EC2]LC;(I%)8NVIVY68F-^%<(K>@&ZWLDP7'=
MRR[L<NZ[I#;+#RDOZ D**':ZNZ J GI5"SUZFLN<,=5455-K1RGTCN?$U-<D
MV+J76._-+BYIF("M2@K]:4664O&I5%C$DSCHC5IZYZ(:7ZT*H4V\&7'6;);'
MY/Y0MP]@B!*ASN6N+AB\(4V&%,SL"6,2*4L,-O7Y7HHM,%G4K*D=E)2-, Q2
M1D.V;^M^/C=\2GM7HL=?GF,<F=!/M.$<]\IWX[L+?7"5P;ND;8Z3(JBSIX6K
MGQ;17K%)(C X&!<S$N:E,P$J+%0*%9)Y)19.Z=L_NE6/2/LQUMZB:,GMG654
M,9EEH=#')GIP-YXE=XS*G:^JJGI=&VJ7/4(:9Q63#)6NTI&\-@E25(6M5QH@
MO9Q12T_2P!/IQ;U9"6M+Y_/.G;3IT/1+WS%#*>YI@UT,+M&T-:C<IJ\3&56H
MSRJ>25=9D:E"!76U-IJ_;2EC>E B+&H>Q#7J=%C1A"28DSC-R@+B)WG5R=1-
M_14]ELX:9/9OCEX[L"25H68Q):]3.DTF/19*D#,SJ8V*5MT;^M:C'AK3GNAJ
MI.:ZG!/./!\991>6),3QJ@S'H:\*54VO$[:M:8HKD/L"HK%BCHE.JAVY]<>8
M7CMRJ:PD;Y7Y;=$DLP@:Z,UQ/4[#)4<K4'' -.-7(5BW0#5B<LDNVW[X6SU-
M;\AFO9,3J0B\4\%CM>]I<B1-C=T"2)*W& 26T^3^S%DI86=2\-3@W%S6;IMM
MB9%]ZE.!:-0L(,+3"$()8Q)].<=+_>+@D5O=*LT3MIRW<<[G-(\A]#W/&+:L
M&O3*6CW04RI^'5#5UD)9"B42Z(;K&9'4/*)7(&*5H&]&R.3Q]T$?",U<2K0K
MQB>&MBF15VD<'>NNIY";OL24D6#Y$^#HNB%+@PIS2(X-<[!PR-<YL[0I@;8H
M9'1VA<_-;$QAI>C$:1.G$666N*,4C&^/E?W57E-ZF]026DH63<D\ED5M;R#>
M1F#S4-@*H>Y&+SX5(>F'B,,1"]NBK$<W.3R]Q(+T<24()JA6 WX@EI?_ !PC
MEBYN.D4>.RJ3= ]#<96&KO&9JFIH[:\B\ CA4.70M/$GZ(52MO%JBK4?[8HM
M&\%%1>*!9S#RU&C3VTLPP)FE.]J]3YFDEGE%2YZN.XN@V"%QV7=0.O/J>&\,
M5)T+N4Q1@J%K63V63Z36TTS*P)(7,8>\QO\ =K3B>O&PI8UMR5M3[/>Q#7'Z
M+&CT&PY22[9U1?$^H.KK&Y]Z%ZS=+C>X$ZTA7_,-D1FFF*)0<FOG-TE?.5.V
MK9C3- 2*,O,W7Q&P%4K/$W)R75"N9"%NS J##M%;*ACC+VO=:=M)DFADOCR&
M1O<86N#$Y-X9!%%#:5)6$]2A'LM:U&.C<\MZ=R)"/0RMGI3P?;K>P;UE<WBM
MQRYV&]UYQCSF#IFRJSA(?';771"6<(3:M53Z>RIR,9XZZ19ND,QKU^CQ5?T&
MT)DJA8B+;Q+S]R!!M>L&22,"A'3EC-N.K(6/]36D+C[D[KJ<2EH:XVUV,R)>
MCGA*W(6>&SREI&^R^DTMRIB%A"U5&XTH>76.6&2)&I 6G9PF@V,Q-O?J3MG=
M>,1=5MJ] 7:ZSU+9/34BYC31GG&.]91#3>R56G4 CU\3JZY%''&;;GL0?2W6
MM.=Z[B4<87%"G C,-<SEQKFM$,Y%\(LDZ9UPQU47Q=47;[X[7(E4V;K8E7C@
M\?\ 92VK5AL0W7, =[GL2\(Q)I*@CDG;6Q2ECE4%J%4C1EO#V6G(V8H"ZJ1I
M_32>-8EQQZ9KTOH*P+IK6+](RCI(R?(Z8J]D:[#@DTM9XI.7V_J+H(,Z2"TT
MTD2<Y*5\47-+ H92W!F'](0XJ2',:?XS"TY(MUBXN,;O.Y\OBT)=)EU8RYVM
M)PA#^J\:G1T-1W<]T,\6$UBF7D.JN,IUY)%"HT;1&HS*V M,:6UN(E1R=2D%
MM.:$.SP8:Q,9ZZ_V9+-%IR^I>&GM^A+^DA+C).\+LK!TL]>A;'1OJ.+VIY*+
M(KV56<J0/81L)YL19)"><E$X!&W$+MDFK &)BS2ADLEY>G[(0Z836*ZVH5S@
MOZ5M281.JNCO'#/&><D"J])8$9E-TWC*8X\UE-W9JKTB//:F.(((V2UA][6F
M7) O6M+-JTFT0=%F,9\JS(Z3A[@O[D\?SF79EA,"1&AZ+(-CS.X1A.PR YBK
M]H=SMNZ=PBR]:K4OR/WIUFBE!7_B%>J?2<S0S=DGVU@O1UKWMRWR=Q9-F>P7
MRWB+!XAM^2DTT\,$63PYO>J;YO%<-4((!J.L+;-TRW1<?^Y''ZUV<OO8*T9_
MH4: GXY\ELEM^;.'AV9=/2E[3O%DK)I+J9G-%0*Q&N=V3(N;E[H?:;RO//=1
MUHV\]/;F4GIZ6Q=>2K0E.^C3V\Y#\92H_1YGMK/+'3?+"J5R2[7R9T#0-Q6S
M/&[IIIZYH2PGR5$:J.55CNMYC$>I&-'8/-X6.&H!1]KE*>).;<4T31&N<V14
ME(.&2X$Z$L7QK$Q;-L?PG_5]SU$3->9G*RKWG%L-W55C595,CKD=$Q2S957%
M?TG65VOJFQ)E8D915:U(86DM0M(>L1-Q#RY%I4FBR3A"7F[J8F^F,,5X]V?U
M7+:3E'0:6SG%5ND?'DQ] #@$:9*X5,]GVP&V>IZR_%T\>2V500HA9,<JU(\.
MJ*/KF1"L5)0FIU:5$$99D:QQEQY_PR33*O( MC4I1Q]ZM-R@*5SIJ:-[S*K
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MJ8HVIG&.O"=!'*^B;*D*=X@XKGB*.H$[<TIR@N49=G-2J;S_ $^5&H4&&%"
M,8M[+FW=4Y93-0SUND;1.*LKN8-<Q=VF02QND\+CKZCDS\PMR!H8WQ^3.;<I
M*=GAF:FI*F2*3]&'ITZ<HLL00%AUH9LV41VYTY^?H>DKUZHVH7:!-[THDK?"
MG"MX>KBC?(E@E(U;\ACY[.-J1O"L2T[Y5)103C-'#T(6]#%ZC-5]93U2N++(
M(XOJ^O5D>EC*Q1N4,2J&1T]GD<>BR;:.,,3XVF-PD;JSQQ)O92!,> 9*,O\
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MA]'F3./2FS'#;DL);/O4]@8OA"D"J"M6@&)CN\DJWH;T)+^5.+2[>5(ZXO\
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M4=;5R71R,L\E$I(+T$7VFG$LF)<,<%/0EZ:Y+OGM0%P/!$SC,MN2!I*.-8H
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M5GR&B^J- $9OO$'6]#-55[J:KI+7&Z>D-=0E[J?;$UQ?]VCI&&9=!-1MD"C
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M#+\#<]VRSBF2=B.=RN1LFE$I;6<%%_@ZJ%M6U%O^\S&*^4P5>VN\"<ITYV)
M6I&I;'=4Y/1@1/0U)Q:1-HM(4GAI.7;A2F$R<5'.>H9"UVG+I4*8>67F&NU[
M3.&6L'EH0,,RB'(Q3X<SE(J\:5R%Z''I'IH3*]J##42) E-(^-<$Y8=3>3_Z
M_P LP>*999M[PQ'T;.KAD9ILLD5HL:CG]J9J\;Z^JO\ #$_?HBC@[D<&'&V>
MKL:#@COT[TI5O^BE#H-3[49*?1!)1GEB:1:S! (&G\GEAJ2(5$2%2;B6DWI.
MH)CC,6H3NX^A;^/$[$F@1A,*<AGDA'L\.]&[&'6_=ZZUA<WL]6%,!OWIVP(,
M>X-%Z*J\20'@F=]&B10^N*F*!);5C]UW.QQS[W(=80YMJ.#&,<&*3.K<W)T*
ME=Z@,)6)3='&'1<2=.JXK%ZTZ;H*O'J5K;#%:S[8?$,&Z*2$O$0@#2S5)8\G
MMBLJXD2^#ID94+3G5;&V:VOO32&5NZTQ."/A$J>-%'JC="<9;ZO0CE1QZ.^]
MK<8;L:;%_ [2XPM93\NN57S_ +M=]*>&)4">LDE0\X/KG ONF/2-N*4-2L25
M K/3.NR!@-TDT>96>6.FZ!/()TA+JP:[$:J>E%PMUF4MS;-^EI$B@2#G]/7C
M+&40)(DA#]<3Y>Q(%3A&G210)V2Z:(L>6ZJ$J=688,@049FR\9G?;*&+!Z!Z
M5.8NT+W8[G615BYE3<_RR 5&V0V!+8A( 2.A*BM>R(U83N_1=RF[FQ20Z7J$
MJ ;<Y-*YJ&:8?\Q_H223%DF9,;K1Z$L.T++A%G3N4WC^%&*%^3WF_G)DY^/8
M(.5%5,6AG6_/S>R /<3F+5F'VO/2S03!(J"]:;@LZQ.0%MV3H9XZ227;I^S,
M_MF['^)GIZXJZ67,SVN@J.SKS4(ZE2<_IVUJ@L$"TM7XOLN1=%I]QE+$F^3.
MQ!6D#4;IT7>XW8] 3DC-"9XSK=D.\3/,RM7IN97G)K-FBDZSN#^!;1<:S*%#
MP5PU.=I$]#.ZY*PHP1$$L3-3"XMYQB 0W8U0,2X_2LU4$*4":+RTF/.N*T^L
MIJW]&P!95DDM=VK(SL>$<@S])(T%"ME%&21U8%*>;QN(I5):+I)ZF\8=AEK?
MO0H0V?2I,H3A":B+.&72<9C7?&5B559G6<KKKER;+.E'-7)>LYETA2YK2LKV
ML28=7*EKK3I&84[/HH0W0Y/(39;"W.H&P#GIR7.36[EJE7JA*UH@)47$F9C9
MDSQ;TC8'4TGD,R4K=-<#KFIJIKF<11,VMX4Y/6ZU.Y27H%D/<AIOO<DZIB#&
M5FTE":$C2I8K^0&Q@+V&L\I)\_V8/V?W1;S>7+;"IV:6JJK:V^3N\;AIN06\
MR<]DQC[WY]B+5):VFU0Q&%)2+821!$M5C3J2YL2:)T0J$QQ@25(M?+&IQFUW
MS$N7=>W1_-KC8D$%>IDY6R6C* G+?8E@PFODQ5+RJS.GHIS_ &1-&-KB4=B;
M2LKN*Q>=ZD25N?M.8T!K+O2A:I3G&@T))>GQA-_,#<]Q[NGMJ(OUN.%Q+(Q2
M/$B<M[DB&'HITR)W)?U2ZA8)KN!1Z(196X;,5"7I#2&E ;]W+B FA-V'1YM3
ME]L]6'5J]9S2:KGLJ)2.V)'SYTYSYWL*+J+204*TQ5R14_7;DL99)2K)!"T-
MVM3$@4E*$)ITP+,^\42LE0,)1XB-F19QGK+&0/%KFM9DW8+PUF[)<FJM.4W)
MO.  HT12U#Q#6*I&8$HXLTDP0#R@[T$81!W_  ;UO7V83ET^.K'YIZ^Z1JJ@
M.=;['<I'3KU?7C\NGHR1PI5$H*W1*.3^J*,AMHL\M@NJ]8H]*4<!W)7D4>?4
M;DX.AQZEP2"3F)#PC)-J]LMLQB2LA9++^JH9+8U3]0])-G0DYOOD6V;7B4EG
M4;K%K:H!8L!<JG1QB?QM57L3:FYOJ6T0V8J1-J=[1OX$CDB1&!4K"=+R32:7
M6S&*C)HE+O;W07"!Q-V=(M$CK2^.FJMMF#6*GH-/)6RP8=1[M,':(3!77M;'
M0>4ISX^YI2TS@QJAICV1< X@TE?H1Y)=I=(M.J.L.CX]0_'/1KE=!G1S_P!&
M5C?#C,:52Q2OVMBV\59S[;-P,KE6YD/B[+,VMW8)E6"*)2$*]>Z)52^0>I:=
M&<%,2$7C,V8V5&T.D.BZ8IBOK&8NDRKL?>@>)^FKLV$^&UJ3':YF=9\ZFW1$
M;9JM-%HPUN :C;I0-)'53=(53^-0)Y:Q;6A4:/VK$G&W&-JNJ_>B^D>4P6?'
M_P!ZSG<;H[\X4Y93.^RV)5:U*JTGD[Z,B=#S=_BB1L15K$SH$S,E@EOJ1OE"
M\\M <R[TL=1)#SQ $DOEJN!QG7;+.YUS6<@DUF5=';%[%@%<0ZS[.;^8I+>#
MY43QSI;4]LJ/.C74)DNJ1M>VB=0'7W$\#;2#M)E1.CT:D*8S:J&.._7#J5]<
M/2;"XP&6RR^'>>-9?D&G7&"J&N4+K9H8I/5;&^V)#V69RE9'X@V2']\Y3I'D
MB]0XM:UL83P%;3A9B]&#,P8X])TR@=LZS[J?>79?U6SIIPU1V4\O]*V8[N<U
M1\QFUC3-DQEM4N=+MM1L4(EKY<;VFC3PW*H[)D,Q3*%*E27]2=MM-+&E$7''
M/;YIGZC6W3'X%WCS])^A9_+F\'CLDW0#5-M,-71J7QB6%$V]')E%6 Z/P!$U
M KJ6)8VCT40K2JWIL!M1HAT^0PHU.28TN.J6V:96]2MQ40W6Y:]FNW/T[:JB
MJRH)2R):6<6F06S)(K(%"^+]((2H"WV"D?)>XD)_PX[Q0*-A+*3DD. 4IXQG
MKJFEELW^-F3O9]NRFD>=9?8$*<6-A?PR&L(:3-),ATZQBMT%F6K"ZU>[2D3<
M)8@*7,M8,LK4/J@HTXM.,#?O1X@D?(+1GC,U"-A&6]#+8YKYG1],V44@NXV\
M)G([HD3#29UF'BJN+P54S4U7VT-4-=<-:J5&RE?(#3U4?<7$#3'UY2<8 [T<
MF-3&+<;,?JAMOI6_+?BM(#Z)>HI'(J@[C8I#:]?0BK-R:Y#.=[UHVMZXFS4.
M3PR60R/K415@N39) H6P3>O=VI7I*2C+$ LF+9QDSCP634<YM*W;8Y@Z E5L
M2U-)7KQI]#RZ1PID001+63]*(E85%1]S<1QU?#')Z)021V6@=5) 7/8TYZ=.
M00:6DVH(4TN)+)XJ-'KWZCE5+79:+3?BR%%<Z>/3ECH^+Q&.UQ57X>EMFR&A
M)Y9LW1S<I?#E:@%?28V')4H6MC,93D(3SAI5)6@D *&)+CQM9!V_U?8\3J/O
MR6(Y\VQU]J*WZ"C=4A5(HR:;%F>UJAY9?$[*!,N;A!?!2*:V,]EHS5I9YQQQ
MXBB1:T26 N)),Q3IAU).UG3-7I:VEUS&U/875LXY&D2J1M_/#94Y,CA=86QN
M9D50V&-YG0#C,H%95;CWMV<R53$H,3+B=D'(_IS0T[9C7?&6+59W%;/,=!0"
M1,$RD%RKF^,^7NTP-5DL\(>'5TD-$6/)E<18$+S%XA%G]M:%STD4*W(A(<$]
M2:K-*#O2<I&E3QJR6^&R7>B[YZ-YSAYB>$]0:O)ZL[C&UKP:I>^PFK#$5<SJ
MO7BFTT9LR)-\&C4=2*:4L,RT#T!;6[_>:C1Q"/:9S$+:L0ZDDO3JFV:.O7T;
MG-[4'65O2&V9.U5CS'=T>>Y&TTU$K';V.:6]:\0O&"5V[?@=KJQ,\O40K$)L
M2-DS8L3-SFJ-*6*AD"*.2D^FR6I7WTW#Q<:QNUVF>7<Y*)<_ME,QEZ%$JO\
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M(S%J&Z&<%$J;&5BCT<L%XY]ZRG-&BO!L.T8K$A:9)#(X@7+TJ=4)H2*5FQ%
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M5,?DR*7)E*I0K!M6/[J$6-&*-=O'.//S3/U"ZWC'H'W;0$HZ#F\J2E>.R3]
M,TZ31JKHM+HK*R4]M1N9Q-@,8X$0TZKN4$1U)].6K2JG]K+$HT4[".&2>GJ3
M&9<=7JG3[4N9*KKQJ<Y2^S5<DAS !1*9*"/EOKT(;:G-TJ<0Q5BC3!\P0&:!
MK:9"G"( =;%H0]B&(YW=A==_1<[KMZ\B1>IHV1UJH'BV 7568W- P%EQF5/+
M#U :\2@\YP2;$](#G:MV@'Q+-J$8#$FRP@ULTT(S<DN/._PQ2EW2_1Y47[EM
MMNZ(0LY_(##S]+H93A4*KE0U391*^9J?MF1Q2S%#A&5$R/16Y+)"XM,>VRN#
M.K0N*@>P'*@EE)"HN)I,;K^L#H^_$,)Z@Z5:;9TQ%\Z=0F4O'>8M12#*HY,H
MW&IG"(<&,RYW7,"NS1VM>B:5 <XPJ;'E B2!=F<.D*PO:C:NI)-)XS=5HS<O
M1K6OKVUY!="F31V9^1.ZN5SJE,A%?ML-3U U77=U4PY:%X;XT1/MV1&S8.@6
M;<?OC[N5IBQ)C6\1@Q*MC$VQKAEOU+9ZN.+JLJB(/]S-]IVNZ2IQBS+1312R
MN:.T8KQD)6S9Q6O?0:4^K8S&6 Z0M8E)ZC?UZA0H3ITH![-,]"2=;L\^Z,Z'
MZDZH;*\4I+V/J,A1P"Q7J]*H1 ZK?ES_ '(99MEPA$^JCI.Q3B/EP]P1PK2A
MT:VP?Q*3!EA0+DQ.AC/C5G&=.J-+<Z(NWI+DOLB;/-P--&L-<>-VLK0'!DL9
MAZR'3][Z"YDE=D3*03=REC:YS,J"JEHC8PPDL;HSJ$R]L6'&GK3?806)).4G
MF]*.D9F_5WQHQR>,#;T[PD6<O-1.WED9Y$D CDEPU'&'4LUJ?4*]L-4":'<\
M)1HB=F)C]A.)V XLL8:S->3&=FNKI!$K36^[W.>\1M1Y)I=RHGI_\#P%'"]T
MRLO^24DT&+7I-&B[!,L6-J D."=S*>2D)Q"0"50A.&8<J'%Q-O)DUTO*+?,O
M_DFGJTM%954>M9;=2^R7IFC$.D4F6L=<P]BD+0W1HV;,$E9F9P5O"L))R@Q&
MH#]"<HT$OY_@.)J3&+:P[JV^.^+O4.D[JU@D:=!*IOUQ6PFNRF_GM!0%0?NU
M,MZ#TH](5L7FBWI%UF#9:=?LJ:5I79N.*6IWI>80A0%)$HL+9QF_E\>#MI>A
MK>>7OFNC"+UM.K[)D75LLHKI(=P17GEPLZ,.!'(LPOQEA$ =(/"2Z>=@2C3>
MU/$<>24+@(Q"N&4J)&>4)"47$UN-,?NM0GJCIY_F,/YS;9+9,F=$-J]KQ);<
M].1/G$JS+*9>9WVI&6&ID[5=3Q%:<3.255;ZA/+MM+:8I5+(@I"B2H"3U(DH
M[9O\F0%/6%U+>5G(*DMJ?.',,ZJKF:@+-L.%UZSU,_R.Q+)M%YL1KEKMMXES
M7:T=3U=%#JX B"C8=&&Z<G0X!KJ()"<)A+))G>97SX]6&1,S)U(.06A.[($9
MV?T<WI=38,(UME SSUP3#VV[B$,B0ROO4!@!G$&[-2D;+!I(2F+V, R<NGR0
M'->C[[00>^NFFRVP(BZ5[#54 R<NDQ.#GQF4Q./7'%Z@+C#^[K&$^TA7%<+8
M_%R2/*T+RD0)@NS25]W*4^SQJBXFDQT3EX\HJ]1M-UV8[V-,Y[M;VO?A(-2U
M' $VD)[<](B%"Y**$P>'F#5.Y9A6E 3Q')R])BPIBDX?DT83E=ODP;F40L(A
M)T>F1W?-WQ[7^8SDUBC*^=-,!>FV!FC%R>[F/+&SQR'P\:E<G;7[:8A(K4&M
MNPH4I@D^S1K3E<:TT_\ K?W2_871W1->2]WYR;IG8MBN9W:,4I%NME@C= I;
MH35Q(^/_ .]"-A0)9F"MJ#/GJV1MJEC;W!8WA#MI-$("!6X% &;2277R_?#T
M&YL77M):1 GOQO?839Q3Y8T<3/*H-:_C!PB*"72!LK2?O33"5\XK%GG#Q!P-
MRYQ0)AJVPEU^76DX"=Z2@,7&=-GEWQRZVNWPKD_FQFO^;Q%GME3W1:C[9JR/
MT^NL%R45'?Q,?05+71CA6HX0C4R)58"V5O"EP9'ARVG;%)20:=./_P 4WRQF
MW'@A^];0F-LU59SQ/7AME<@AG$'EXIW=@L[8D96>T6JG.CN:*]:;'0M3><H:
MD!LE1,8?KRD0]H NI"KZ70$_QE@E63%T\8RSL_H^^6^'=D=&,]M?A5/R=?1E
M91?FS<4@ZN.SY@BFJ^WMBG3NZ1]990["Z#U,M#BBAH=FM*A YL_HC7;VITKK
M,DS)XQ03NO[W8Y!$8ZZSYK^/E&WIFA[F='6*,"8,BJ20W8EJ&EGI6:C;2R83
MI75LQ!9:Q2@+2:VGC1I/VISC "';/Z[+!LWK/H]JKYXM9BD;*Q269\;=/=#U
M4H>X'$'!1%&)=TQ3C3SVE6';9R'9>T-]0RU&:YHAJ-!<%BD9IN]FE)QDQ9..
MWG/[)LN*YNB:*E]GTL5=Z^8*'\GA<Z,W%-(+6R=VI;74/2,[H2RGG31&HY&(
M:^,#"AB*=9'2W=(H$C=G !2X]P3:T7E2277'BG_E:;6@?T1V?2L\NE7=4>I)
M[HE/!G)[CT#9)?&4]@UB9+7^/3-77L:B;*]/FW 1:LL[2!)L#>I3!^+0M#-.
M)<8EG5BU,KAZM4O=J2F-=!;CC:T^16"<B1&$F5G7;O&6BK;%'5,8>W]R4K&+
M4L>;&C+I/U;FQ*?O,EL+,2IR'!"X$C.T*-8X^'3*^]7]8C1^/^>WRTKIFEL-
M_6S]2U0O]51'GY+<L_AC'SU6W0KWJ3GV)'F*@V$,.:[!.3+7<3>WB4ID:4!"
M<2U0+WU,3?3&$+\P3&W.E;RY.M267G9$8?'_ )![.9GIEB26D_P^O=:KZ=IV
MI"Y,<A_ LY8#I _%D)W=P$A7*VLMT2%@;MEMAAZ95%N)+,=8L"@;2OJ&4#P'
M1D)G-\2]3<]>=%66_P [A[;S,[VT2&JWR'M3)7<6.N8,%K<UE,<)^<\.(U*1
MZD1B5L,()&60,P](6R9MN/U945Y-^ZK)L041DTRC]/6' .&ZEM!_JDU@@;U%
M9#TO84AZ4A"04YE+6GFZ]NJP:BNVIS7-L<=/K2S0@*(<=E@4 5UF]L^662?&
MEFR"91R>P:R9):+E>-2R9CC]Q1>V6^IB7N&R&0PF.RIO)C3S2D>C\#E%>R-N
M<M.;,M!HU?I.HV0LT0H)&F))RG6;//JV>XK499.=.*AF5HO-46;$^Y44(=[)
MC7/C?7>Y!S?3MDS)ED-,,\?^"]%:2-3BMCD"E3+4:AM=DAXC?:#W(A'1J<9U
MWT7G.>C^F^<X5)I"]6<&[WQ]\=5C=3)4TG@T/8F2!VY6SE5S4N4QU-!6:,N1
M]2GI[7^M5MKLJ<W).0R>H'+U/-WJF.-OKA)M.M$LC'D@41F77NIOA85P(QR$
MA\?6*!L4K0??U['$K%9Y%;L48C0X=(U31LYE#M%M41HA26-6K#HL19+]FV-5
MM7%=UX-UPW# JXG+1 E"[MWCNED4D3P.&.SHV0&SJ/B<BG@#-N+.;I_D!PCU
M FQ6Y[5[0&_ #VC2%;3"$DQF^%9A<MRZP'%XZ4K.PILNLE515\EU]&IV]L\:
M8Y0_1&04O3UNM94L20UFCD54OC"KLQ2W?5HFY 6J2)2!C)T=LT9AFXTL\&6>
M$,#69\,_^[+^8(_U)U%_'N/#K[GV<?E_#9FPY& P& P&!K,_E9O\%G4__(1T
M+_,E<X=?>^[TC9FPY&!'"RGJI<'"RW9?7$)6.=S1MLAUMN"F--)RRRXHS-;R
MQM,<G*@Q*(V3LK:S2%>E(3+-FE%)UAQ80Z"8+6RYO]':;*KK1F,93&F Q!N'
M'(%JJV#:./M9&F>M-;;1?@%N 6F"!)$/5G2?_AX-:2_^,7^A^@'T&:HT%HNF
MJQ2(4->5A!X6C;(L;!VY-'(XV-12"&'/;G)1Q-&!*G+TFCFGYY5JPH@>B<!R
M@8@@U[MX,V[JZHK*NE==@J)7!8FKJP$52P8-=*V!L50O4-0MQ+0BB_X;/3&-
M.V%(UIRTY:797P@* $.@ZUK6$S=^J,(]2'+E<OD<AT:K2GXC)G%<&QXPP-\?
MC;9('5TK).G8-SIO2!( YNCE"DL\)2#<M:,.1@=@%B,#H\.A%S:KL^I*.2+G
MNP>>X20TUM&I=5$WJQ@"PLB<#/#4<NB[M'"%;='T9S8G&G:1.FS])BS"-&>W
MVZ&#U]VA+KE3*CYDI"F8^N9X75E<,BV21AFC,^=6*$,+*.=HVEL&WB(?TZ9*
M(*MK5#5*C=HC!&)PF*SA>W8C3!#%MJH1#FKGN 16:P>$TK6,6A]D-I[+/XVR
M0MA;V>9L:EL6,HV.2H2$0"7AC S.*A(4C/T-,2E/,*+ $L8@[&;XKI25%5B!
MUKI\15U"TCS4,8=(55CJFC;22X5U$'M"QMCQ&(6K+2A.C;$YMT9;R#TJ391)
MI*(D @["6'6AFK93\W4 DF$OL!)3-:IIK/T#VV3:3)X<QDN\I128@I+)2GQ4
M6C"-P'(TQ "W PSU,6@ $)PAZ#K6AF[*)(Z;Y>G3#!)U**^IV616KHZE<:]E
M#HS1AYC,1B3*2B=$"IA<C2U#0ECK24S)U9 @"VF3B2EG ]HBPBT,V:) E<.J
MR^*_+9)A'X?:E:RY(Q2!,B=T;;)XN^)2SD4AC3ZA^4*E$IT2H)3K4*LK?N 8
M$LTH>MZ"+!K/FIDBA=*0Z&RQSE4<KZ-P-'("KEFR]\0,K9&DLFB"]IEY5E2)
M4M 2@)=HZY11$XZ<SQ:,3&H"COD#LH(M#7U4R/<X\^QF<GVG%Z:K)DL):].\
MH,G#/#F%%(Q/TD1.2&0/1#PF1 5D+Y&D>5>EYI8PB6[4F#.V,8Q"V,W;HO.
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MV<^39H@C!+:3JV0,57DZ2URRN<&CBEIA"#Z=&D$UQAN$W_1LS.<F;DY9B,@
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M$]U#7+M:C48W*&^P7"'L:N6)E;.0-*RKP/1R(:T3DR)3!%(E(A;/1E"$ D8
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MV3'ZP=%S3'V!JZZ<M@BRMA@48-CKL[NL21G&J"! ^F*^1(B"D0G&IAEN+_\
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M9H/'WNC:W=FFM27!-!$SC&D*P<91N[@!V>6]M5J &+0MCRZE 4K4PS!IU9X
M&' &((=Z&:EJ?5_![4A<DKFR8G'YU IBU*6*50^5-2-[CDA9E@=!5-CNTKRC
MD:Y$?K6O<68 0=^FL)+C6;N -;5\7/$5HEPN,@L=NA2BMT$X S(02A% %;PA
MD*F&)GD).EQ,:.?&U.K$C"/1&U!(!^WW!UO"YN,=%EG<X4*H*K\@VHH#LJJH
MT^0RN"P1MN*##(?)F<#!(8HPZ*)!]#&WIG*+(4H0_P#C' *+]P-[ #81FKG!
M#ZOBCA7Z_3%#X^YQ-B5U=6:D:=L;5;*P/A+$H606(C,^(PA&Z)X&W#&A3?\
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MXC7$FK&NU;O$DSXS1"*25N8D2V, 8RE328JA:X43:=+VHE4D+6D-Q16S >T
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M$WT2DQZBBPHA( L$7=3EAIJAN*T6B-.,$8(O8][%@S5U2JCZ@FZ0"&75O$)
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M)(<@EU#55(T-?1$NOX8B=X6R+4D?@A"8I(EAB%,<D$3^%D11!>T[>,(TI!@
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MO;9!*WG4<(JQZ8D!$JU7\2_'0VU5]\*W9P5G_2G&+ ?(-/LEDQ=-GKQA@P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!K,^&?_
M '9?S!'^I.HOX]QX=?<^SC\OX;,V'(P& P& P-9G\K-_@LZG_P"0CH7^9*YP
MZ^]]WI&S-AR,#']NY4YN:;&_>ZVTE7"*R]R-YF0IFGC#<6]&S*0;6?>\P/4:
M*]I\L5EN*@K[S&$2XL@\PH!H2QB!LO=<8Z*Y'>>J0B-COUN1:KH='K(E!KJH
MD$L9V@AO<75:^C3&/SFJ"F^-()X?S$90EZS1>E2T18=G&#WK!FXQT="2\S<_
MS"!PNL9+44&=8'7"=&EKZ-G,B<I'"$R!L$R)B(F:FT2LCY6F48D0])32M&I!
MB)'[BQ"#L9J\(S4E7PM<UN,0K^(1=6QP5NK%E,C[ W- &FO&A::XM<*;4Z!.
M0G11I N/&:4D+ $D Q;WH.L&:H%6<^4E2"A]4U%6,0KH<E^F"[EQ1I):4IQ"
M,]:J2(4J)/[4;6UI53DH,+2)2R4Q9APQ!+UL6]X+;=R8\^TG8,K-G$VK"'R:
M7*(RWPQ6_NK00H<%\5:9(1,&=A<3=^FG%M9I2G"O1EGZ,TD5"&83[!&&>X9N
MRMR6GZKF>YU^+J]B$G#9T78X3893^PMSN1-(E&5$A5QZ.R-.O(/(=6IE52MR
M-3$FA$$DQ::(/IL6]X,USUK5=>4]&_PC6<3:H='!."IV,;&H!NBU#FM"2!6X
M*CU)JA4K6'EIBP;,-,&+V%@#Z^T(=:%MN[J,=-U5&00 N/U_%F<%5E/Y%<!;
MVE*GU"B9208ED94<T6#7W8!Z3FB IT7Z?*'>];P9JR)1RCS=-&"-1>44K7SN
MQPYRE+M%4)[ E*W'ETZ=5+Y-A-*I-HA8B3S%V5F*'4@!FB'$S>MJ &>@?09J
ML2/G*B9;.HS9LBJF%.D_AZ=E1QV6FLJ8IZ0HHTN&Z1I"8K3Z)$X((XYFC4MY
M"GYBD*@P9A 2QB%O8S<8Z.P1SY2266O,[35?#B)=(9M'[*>GPEG3EJW"PHLQ
MN<:89N>$&M$?BIO8'E4DTNT#2DPDX01C%]GH,U6FNGZN9&V#L[1 HNW-5:21
MTF$ 0)&E,2EB$I>T4I;79_8"@ T%N='%!-W<DTTOT$,MQ4:W]A@O49K"ZI>"
MVF+78&XYNT4$@VS1NSXTQ1BCZB=:Z0OF[;4- 98^398_SJ:J32_NMJ-)2,S9
MI$UDJ7->L-^H//*V0:O+3$RS_C4<8H='&"(Q=K2,<9BS*U1R.LK>7\*!G8F-
M"0V-#6B)]=_$D;V]*646'_Z0 UK#"M8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M+MT<4;?I2,OV?(!/]6<3\P@?('UT'UWKW:]?X=8',6[-1RT+:4YMYKB-$!Q
M@+6IAK1MY@_C+7A2A,V>)$,?Z.C=!]F]_9K>!^%N[2=IQ$4Z-QNF<PPIVV6M
M3#TUFE%:/-+<=A-WI"841OWBT;[=A!]N_LP/AK?&5\*,/97=K>"2A: :<UN"
M1P*+'O6]Z 88D-.  6]:_@WO6\#IJ);%496CU<FCZ4@2M2WA.4/+:04)>C%H
M"Q%HPU2$&U:40M:,+]?>7O?Z6M8'8<)%'VE.F5NKZSMB5;_^9J7!S1(DZO\
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M4D>AF##ZA '>MBWK6\#B:WUD?"S#61X:G@HD6@'&-;@D<"RABUO80F#2''!
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MS->XLP:=2I*." P/VAWO7IO7\&!W4#XRN@]%MCNUN)FTI*[0$#@D6#VB4B,
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M#ND2./*FTYY3/K,H9TPAA4.I#HA.;2!%^W1@3EQ9XDI0B]C#[M"%KT]=>O\
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MV?-^AZ^_T]WV?PX%4UO6]:WK>MZWKUUO7VZWK?\ !O6_^NMX'[@,#69\,_\
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M9://,AYFBK[RS< #MZV%4IE%6I M3MO0A; ^L:S0M^HLJR:7E-K9_=]5_4]
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M>,7Q^W"[N<@M_P ?BWOJNF"7O/N,66GRK..<8X]\L6CI7O8BU:_<%;3HR\;
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M5$E&)9\0-%A/4:]PMBWK7H3-QV]"N:<HJ#3RWK<J^&PMAGMY.L;=[HF$5TG
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M6^25/9,7K*L6Q_YZ@LBK6G9%&VUJ;D]55[)4C2FDD1BA;2(AJ86!Q1,*,)Q
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M]&!UZ[Q$MLXZ;]U>J/@+L6:6'PB[%OU@2ZVZZKSISI*J.;;7G3@L>Y-8G-4
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M$_-YY#?=OD'1-_;IUD[%TH0XZLVT(Q^%":T%67H6Q@1*E+-I5J4BWINUHSX
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MNTWI:OI6ZCH&0<PD+%05 E"SG:0&)MO]4';1N!/WE"52A*6,1!NC-%'!]X!
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MGJ;PX]'U^DIB%<YZC7"?2!)U)UK)MS"$5JXJZDG[HY1Z,2O3+&]OK>0Y+33
MJM(4FS1F;%\8<MV<LYYYSG5K?G$VO".D>&>NZ9,D;S->&O!+P;T))*X9C!G:
MM^B#IE)87TC 1H]Z,^J?1U*]KGAF%[1"T\-"?7IL0@["==.VR]>2A0)'3O5T
M<XV3NB)FMJ@K^_,==EO(6QX+&NC<]KB8U]84H80N"(P>M*&UP0G)C]D"^P(M
M:UO7KKTR&LSXSC%0[601RA85YZ^.^89B_O?&M;<V\D60" ?C-\G,+YSZ0FMY
M,*&95A 7AW=7H^,HY#%VXEU6LA:G1:%2#X]%%?'L&AQUO'E?NS7J97M(T[Y!
M?*CWC5_;*<^V(QR-67*L?Y@YHF$E>DU;-T!L^J4TKG]\DP!M<VUNELF?9LHT
MV??"LI4)L+++3@V ?P[!6+;QX2\>N6!GFOF]93#H6(<.0.83NJ8EXY>.76[Z
M;_=Y"KHL@A)VPH2QHOD:O)"NKN.SES;DD:KV)*%>E;X82G$6\;$:>(6A"R->
MW+)W>-_1)G5\0XY[])\(?;9M%5T[2GNGK>G(ET0XJFC1KE,VEMH:R6N6U/,S
M0J-Z<V:(3.#A0? /[/<V W_^FG'NX]W'.T?2SCZ%R;S(==53 _'SSMTW55'T
MKX\(['&&S[2W539S5#"(K(TJ9RK!D_ ,Y!*5)K8T",$BT:V;T)I3@V<+YO4$
MZG=^.6VRVUS/'*_'UVWS^8/N'J+2*#O='7! G*O>CD<O>(!8-&GH>3H;(FYX
M@LU9WEF6MRLJ3D$'EH=&#*<5/L)$4;L>@;J9Y2<9Q\'N;XG;KLNY?';Q)-^A
MG[:J^[$YYB4JDP9 >G1S"6IB2=HT,X7-1PB5ZE1(V0")P5J-%>T1ZS8A;UL>
M'/G).5QL\RO+GQ7RC+^ZO%M+)-0U>/<DZ7[5<(-?KPN9OE6VS#V#G"=GLL<F
MIFC0Z=VEL.BS<(HD>O:$20O?_3?J;X<N4XV9VBB0U3??/GF3[6K_ (CY>K"V
M(S$>(^"H23 Y/>@J CM9PF*$6@V0Q%%QAK2S0/A D99J;:?XD>TQ:4 MF&['
M[=%TOMR\KUKSYX-9I=,H?X"XQ&Y4KK^<2Z'^=EA9)>C/.7'0B7/A$S;FF1IA
M^].)>.)/:L"DD7Z&Q_3ZWK0/7TU&N7^7AH]"_#I$HSQ?T>FX7Z,Y#::9[X5<
MU.LS.ZOAEJ.%P1/MJLHO/VINF%CO+RZK2Y5&9LKEBI(L/0/J'Z@O6S D'%$Z
M+3B>3/N?5.Z7Z<[>#%ORJ<^S+IORN='U36/+B_I*X'KQ:U4EIJ2)+5C=/ YC
MLETO.TFZ.] FS)ZD\>?$9<76F%[$4PE.#FJT7\ D^R##!!+PLG"6W$RP \@M
M92>)W3Y)R[AIXB]K'J#F'Q;UW-^[@V*X1U[XXL-^J%F@\CZ?:F!KVFLV;H7:
M6$"=UQ31\9H0( [6^THP6]&N-TF-LW3Q\GMBR477?:WE<M7FCMJ0J^C:NY9X
M(Y7?N<:\EK\\H8%:CC9B9Y17+U"IC+(](VZ83$^0,Z5M+<3A+--@5(?A$ SX
MS-5SS>/#/'2VO/Z1+F1#XX.PV]/:4Z>WSQ[>6F0UOX@K5+>5]AV:ZV8PR.$%
MU=S_ !:0+UQKK8L64OTD=XFM+-5'@VPA-,-$,#>7H$;_ ,YGKQU9L<-<H0+R
M3>/[N9OO]^=FCO;H3HNP-=7O:@A0S3CE/J.CGLQ#0$*A* 3BXKF."T&SH&E3
M'=D'B"Z(%RL6SA_5G:#6>7*\>4Q]LFB9O"JU7-UU(Y_Y)^PG2.R"\HRVNG!]
M4,4;-5*8O (MSZ_CBU[S]L+6E%A(F'0-TLBQR7'%@"(AL1I4H!?"+989-4]S
M''Z..V[";R4&.M(]H>03EI@6J6O?F&I?A1NK-&@.,)&LLI;?S)R9>A37H)FA
M@<M4V_A=U?Q?I?&5\@M>W7KHO#7C+_KG^5 X?0*)=T?Q9X\#5RQX1>)"W/*#
M8<\3*U9QYNF*O9>?4_'3@\>\6S#3E,;O@Q<C&=K^4"W^X'_;ZX7EIQO+_;'_
M )6WX;#317IX.]#..%H?B][[$/0SC!Z&(/5T=T$0]"%O0Q!U_!O?KO6L0Y[<
MOG'LGR<,6_-IY= B&/8 T?X[-A (8M@![H);/NV &]^T.Q;_ (?36O7*QR__
M %\?5$7G^B^YQ%_&S"_W8QN[ 2OR6TRPF4Y,Y'J(P^T"U]=VR4*$2F3B9I$6
MQL;[K^2/4B;UP2@_;LDS^#![=Q;\GA"^P4/]WN(<TBJ2/2>51/\ ,00Z&R#@
MN060XN%"U2CFE(R9SB_-\/O!8DE0'^K98S>C@M<P-9 6]>N4$#9TXB=A-CK+
MKG_UW;A?(?/D<@O)B>E9!RU5?+;-*"+#033GJIIM^\:O6Q),W)X1.PD<O_#$
M-^]S)<RJ0JE>ONXCX3E(ROT_9[Q5PY7/+,N6LI0;G)+39N,/!1+G ]XDO)WD
M6M5+T 2H5+A+W?C'BM85?%%N3Y[Q:&.,VHHG<-9DHQ;V$[[L,!K^#[8ZW3/N
M>,_6LEJ*YBYS[X1^7?H3NIR=WR]J>ZSZ;IR.R5XL651QWXPIJDV%(JIMSJ-.
MT/[036IA;1L4C$[$%@&[G^X1YAY>C0BOS2V\>V<=L?U8GW35L*ZL\4_A\[$Z
M=J^-SKJBYND."*3L^XI0SB#/++I9QMZ2Q8EKDZ_W$&KVJQ83\*]=H0=?6#7C
M,%O>Q^N&I>WGRXS;%33TAQ?7)OEXUSM3'CVYTZ=JVM/&?7*R,T'9UE_N6KJK
M4#ITW91[E,(FH# [#+7O2M>]*"!H])TVQ%K##/G^SXQ1)RO9FVRY3&\<=\;]
M%>4?RW).L8?&V^#4OR[PBIBL_/E+I"'.@FY54UB >Y5!YXU.C*LARMH3QQ$;
MI6 P(=_0E:,",'N *IW<IPX]N^:SA\1=L6S=7AJKJ>7'*)'/9(=7-]QZ/6/+
MC%)TJL>M8=,+&BM83E_5J_14N<W^"LZ$P:HSU,5ZUH\8AC,$,1GG)/<Q&M74
MD"NB80;P;SSG9T=0] <U>*_H'J6I8XF4J/I;1D=0W;7QS]3KV6#WC5-]MU\]
MO+!KU_[52XD6]^T.\CK;/JEVM;!G@UNZ#]*3#RE7]6CBI<X!;W<;'/(J<M 8
M0M3-[[S!1)YS4X(S!;$A=61QT<B6$?\ ZI6G,#_T]<KE[DLQ+OAXC]J]YQ51
MY(KD\A;5,[!^N\=W2E#\[4M$&"#VF[P&Q><8PHF<4\@+DJGT<B+C5*!6L?K$
M.^D$Z.R4[XX\6$(1;,*]TRZ<>/T3AXS_ .'KI^ :5\CGF"ZFJCK%RU;U*\Z\
MQ\P3CD7GAYDCRDJ6:1^[V%TDEE=$F0]J<FQLL1Y1/FT;&G6K2UA3>0, 0A 9
M\8@UC-X<)>.]NJB._.=%W]Y<U7 =]-"DSD?D;@RHYKR;R6YRZ5(ZML%XDTPD
M<<G=COK$8_ 46BMK-M9T3,D(<35Q* LP1OQ^[W#V,V<.Z?=;K75'R=SS<OEL
M=>"+IA0#^0>3^"*[L'DSE-SD\L)JI_D%C6?+VRT[0/CQK^$<Y>(.)*E:$?UA
MBLIH*/T(D!0M!%H9LX=TWM>6=[GO N+.H.6V$E[Z#YMYQ\]7.E"\T1J93A4\
ME2:O7)]B#S)>:R['E*UQ^IB,7ETB5QTA2O4* ($ZO8#1[+*T$,;GW2[6\=?Y
M6?(H+'UG(?:L16PD%%PMP\U_"=.O_CV.ESE.F'F!(RSVOXW,6]+(1K!Q]Y8.
M@D3V)WUMB !B$D"$I,(S0![T7/U3K>VZ^+U[@VJ/\=?F$F%2\QR53">4!^/>
MUNE>S*(9)8[R.J:!D]82IF,@UF-,9<'9R05A(IE&35J<]N3[1E*TP0'_  ^A
MA8M5SUY<-?NSH\T_%EV6R1?R#4-TU*IA/]3'RV27H:&],065P"VXY$ZOFR^P
M#IEP:CC,IE\49J]DGU%7MXXT5IC<5_V+PCWKT]1:C?/CGCB;<?BL:)+,);RO
MQ[Y6)@_/[XMYU\A]G>4:@W "G9Y[94_8M.699"FESDZGV[^ZV>_:O^\V4ST'
MKU>V!%H6]:,!K19KRGC,?T>S5'5+57>OD9LJA>T#%-EUGRIPGP\]\P\RRA_>
MV^LI"FMNL2WBW+X7PEM<VUOG\C9942GCP%BXM86W%^T 0@,^,0:Q;>/'/'>V
MZHDZ7Y(B<E\P2F@ZZX0HWKZNZD\8-",\3IV[[B<*TBM5Q9KO6P6)!(HV^NL+
ML]?(7A.WB^[])SM$G;3#V(2G?I[!3JO'E]&;;-6ROT)S-0G1-+"J:\ZEAME5
MPQ$H7YIA$I;].;"U/<79UJ2/KD9'N*]%+*G5&%D#_P#I"+?V97&6RYF[33B5
M#UE5W@+X0Z'J&H8<1T7<787'09O*25 XV^6\ZPSM24!@<;F<O^!T-1M>UB<A
M)]5M,?I(2+Y-E&_'H&X[YM]RR[8O]F;O2$XZ2FO>783CTO2,-Y^ER+\OAV,E
MCL7@%VF7BUNT;!8ZP\J2*I'^[ZM--+IIR-/3_1_1&BT62$WYM?)\8#,[9QG;
M?\HQT*Y[_=EX .J;74</T7S2Y3_QQT@:W]!5E;9D\L;H1"ZIH@_KW^Q8R& Q
M0R"N"\[:9W-(^\'7?UBTTKY/Y'WC-9S[DF;=5L5S#D<,BOFQ9VFHRN%P0KQ$
M,3>Z\:,=@FV$PV*XS.NIC+F_LEI=6)6&ODAJY 0*/F)6DO:I.I&;]>,"D?LV
M+KVYU^K?]D]CX?>C?"IT'-XOPK2/+5H-/+G,'3%86M3EM#L2<WW)N=D+7?26
M4SAK+K^%G0E\4Z8S3])-*G/9BA\4%[-%LGWFD[OKFN9E%X^JXZF[D0^=04@/
MW0CC=KGPZ,?WH9J,ZKA)XZD=K)3O;\WTFOEZ@2J&_P"37\*D'QZ_3^S'5>WZ
M?^?7&?U29P)R^RCZ=\=%&]"Q1LG"._O#3T[;M]0Z3DF+VR5R7IGJB"W?,&Z2
MI#C/56:G73("0?OWH8-) A^SVX3ERTMG3DC1DY YB@G!7YB6T8E2\&C5@4G>
M?D*HNJ)HUM(@/U=4ZGJZ()B:_BRG9_N;HVG3.JD(4X/3[#A:]?MPN;>7&7:R
M,F5=@]6RSI;\O0U7USQ :9@S/-I"&N)=#N@S;<=;"+UQ6])P"D44W5L"U"MC
M:0!6;UM<Y^TXS9'KOX_F,)IV\L7-_P#+:^;G-M>$H5S2X(71$,9Q0%C<K3K4
MHS4YHR%!85"8PTD0R#RQ 'K6_4(P[UOTWK>5P=[ 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# UF?#/_ +LOY@C_ %)U%_'N/#K[GV<?E_#9FPY& P& P&!K,_E9
MO\%G4_\ R$="_P R5SAU][[O2-F;#D8&**CAODQ6X/3JHHZ'FN$BZ2C_ %^]
MJA?>WR./2T51)&Z/6^?Z.>@_BAJ1(2BR_;K2;V@UZE;WA>[EX],>C@E_"7(T
M\L:Y[=E%&1%?9W0U2#HFZ9RF,>V>1V%5!@6D&X@]N+*[-QVDX2V%$$*DCX5P
M )"@A.T$L.M%[N4F,Z1^\R<+\J<=*)JX\[U&W05_L<;2*>2]?(IG/9W+2F H
M\EB1/L\L:1RV8KVIE*5&:2(QKOI4_O%L!8=[WO!>7+EN^RN%^22*'CW,)5&0
M\N@XG.$%DQVL0[=]1YIG+78)MK()(FW]Z?>'UZ:PSANH?<>(O:@6_4.P?H83
MNMN;N[TRXHY2L.17Q*YS1<$E3YT] XQ6?0"A[0*%Z6V(3"B3R(@SR]J.5":5
MYD8*4""@5Z( M2^@?C.#L /:6<N4QB[+2YC\>?''',DDDSYWI-J@TTEL?;8B
M^31QD\ZL"8'PYF/"J:8:BE-DRB7OS/#VY066,IJ1*$Z (BB]_%ZE@V$7ERY:
M6Z+5C?B\X/A5X$]%0CGUF@UIDS8VR1+H/+K&AT.56 > \!\R<:JC4Q:ZJ<Y$
M?]48(:I0RFF#&8(8M['OW8._EC%NB=D_*?/"4CHU,GJJ.%$=<&KSND"@[<MA
MMLQSA1=<KQ2;U7[]-JH02%N%]-]/KX-?9^G^EA,W^B*;<\<O%-YP>G:\LFA8
MZZ1[GR/HHI2*EC>YC!Y?5T80,J..DQV&V%!9)&Y\SLAK(W$)CTI;G\"HLD'S
M!,V'6]%G+E.NZXXYP=Q]$*IJRCXOS_ &&JJ5M&.7;6<.;$*Q*@C=O1-S5/+%
M9(E1:W3F]S)*ZK35!B]Q/5GJC1[$>(S?I@[N6<YUKDE_"G(\\LBX[@E-&1!P
MM#H*H3J%N:=)QO+3)+ J0\+469#GIR9G5O.TF^)C1 "I(^%< "4H(3M!+#K1
M.[E)C.F7SS)PMREQTJFCGSO43=!I#8VVG4[F#A(IG/IW+$[ 6>4Q-[W/+'D<
MMF*UI9BU)FDJ,2[Z5/[][ 6'>_7"WERY;I6KJ@J=J696_8==0)EBTXOV6-TY
MN.4(MK3WB?REG9$T;:'1\6+E:L8M-+$D+2I2"OB3)RM;T66'W"]26V[HDJ_@
MSD"EI)7<OJRAX;"I%4JZY'"M'!G$\A_!"GH-R0N]R_AU(H=3T+>FGSFVDGK"
M %? $P'J2 OW"]1W79%\J\4GCRFL&BE:R7EN N$$@D]L>SX7&BULM;FZ*3JW
M59*^R'^/::Y&B.:#):L("8I((&!+H6Q?&6#WB]2SGRFU9*QCF:BH;S\=RO'*
MZ:&_GY3"I372BLA*WA<RJ(3-BW@J51X]6XN2MY.1/13^L";L2K9F@GBT$0=:
M#Z$MMO=U=""\H\ZUI*V6;P6IHM'I5':$B?+S,\)2UIQR+G^#+C7*)U8$E:L4
MI#HRRK3QF%A,+&<+8MZ&8+7V8+RMW\6.BSQ.>.E=3\=H$[E&N"J=B-F/]R1>
M!(3),VL[!9TG;C&A]F#2-N?TJ]$Y.#8:(C>@':) 5OV@ '6%[^6<YU24U>/K
MBAAYZF/*,?YHJF/<\V&:4IGM71Z.%L+%-%I#FW/!;E*5+08C>'UVTY-*8S:M
M2I-4B^  =CV'7I@[N6<YU4_HGQV<8]62*+3.\:-99-.X4Q#BT8L)@D4WK:Q6
MN+&"V,<7#/ZQD\.F"J-"$(6_H#UIJ30C![T7K8Q;V)RY<=)LD^@^4.>>7_QH
M*B*P9:]4V,KBRZ=N2%8]NSQ+%4)BK?"(D:^O4B='AV</P_%&HA$ET,[82R@;
M]->X0Q");;NL>+<#<>0EDK&-12A(8QQ^E[M?NC:I9D(GH#; KKD_WYM]GL;2
M#=1DM[BXBDR_8B Z^B")69L!(=B]<&:LNZ/&)P=T-;;G?%R<X1";6\])XRD=
MIVJ=IBUO+DEAJ<I+%R%OW#)6I&H*94Y(0$Z$5O6M:^WU]=^I9SY28ET=&>^*
MWQX6I<,CORS.2ZEL"UI@_M<IE<EF;4ODB:1R)D;V]J:'=[C#NY*XBYK6YN:D
MY)0CD _8 K7I_P!?43GRDQ+HEINY%K!OZZ4]FB.>UMFD<\,_,D29%&V8$*KZ
MMD$U6SUW##FM*SD.#<\2Q[.2@<#AJS"Q)6U,4466$(_>3NO;V],I,L6B:CMJ
M4U)-K'@K/+)51$T46)43TY;6:5P6:JV%QC"B0L^DRI.3M::PNZE-O1P32_8;
MO]'W>F]$R,5%5'&+BG_0+#!6=LN6THO#H78$_3[6??4HBU?C=3(:RN.C%0T6
MDK -[5[)^,DL?\L+W"%]GH,]$+1_Q_\ &\49ZG8(Y04,9VBBVJ[V2HT2(Q\*
M! VOI$A>FO%(QF?>^SRP6,0YGA7",$8/7R[V3LO?IO1KNY>.ZG<S^.WC7C^5
MOT]Y\I1NAD[DL<1PUTF[M*Y_8DP_!C>J*6HH:VR>S)7,7MCB*56048%L0GIT
M7O)+WLK>RP>T7ERY:5/:.BJC;[N>^D$4%9D]XR2N&:HGRQP?5_?SE6T??U\I
M9HB?[E6T/W6WR!T4*@>TD)OR&[]1[UZ:T3-QCHL>2<@\SS%UZ'>Y33</?W/K
M&%QVN^C%+HG5J]6S"HC'G.*QJ/2@@Q9M,)$S1]X4IB-IP$&!";L7N]^@BT.Z
MZ:[(IN'QJ<07S'ZDCMH4*RO1%$PY/7=2/;1*9_"YQ":_2MR5H+@[98L(ED<G
MQ\1,;D191K<I<CT9VM;V86(6][V6<^4VJ\6#@_CZ*M/.[!&^?:\8V#DY_<Y;
MSNP-;:H1L=7RYX1'H'*7,S.2K VKI:J)5G"VZ+BE:\)YYIX3='&F&")W7^J3
M85SM2E<6S;=YP2O&.*6K? 8I^^&7,NUZ-181\';3&>*N$C;2UGW*K=V9J.$G
M+6Z3!5B*%L(S!:P9MF+M'?I>B:CYWB"R!4K!6>O(>X2Z83Q8PL>UFT:B7S^0
M+93,7T>URI8=]8_2!R/5'>@] T89OVA"'TUH6V[K3M'D_G*ZK6I:\K5J*)3>
MV^=G1S>J3G;TG5&/E=NCP)$-Q6,1A"H@CY#S&T@>M'EG! 87H0-!%]N"<K)B
M;5PPCD?FRM[HN/HB"T]$(S=G02%J;;EL9M3*@2&?H65.4E;4ST88K,3:+()(
M!H7P%$[-$ (C/<+6MX+RMDG2,<I7XD?')-XI4L'DW*< <(M1,7D$*J-I*<)B
MV@@D4E<@.E4B8F94U29"N^@=Y"H&K."<:;L1N_X=:UK6&N_G+G.M?4M\2GCI
MG4K89S*^7(6[2^-16NX0S2$3Y.T;DFBM3,Z&/URRG'M\L2?7IHFSMI!";:C1
MIFP ]1B&+8M[$Y\Y,2Z,C.E>2><^PHBP0/I6JF"VHG%94DG$<9W]0\)"V:7(
M6US9T;^WJF-S:ER=Q3-KRJ* /1OV!.%]GKZ;T9G*\=8@]Q\6OCX<Z/8>;E'*
M=6D4E&K#%;;1 FM$Z,B$JT!M:UE'8"MR9G5 ^NLN&T.!J82]6J/4")WH.Q;T
M 'M+W\LYSJR1H'G:E^7*[35/0D$;ZYKU&[.[ZFC+:O>G)*4[/RGZQV6Z5/[F
M[.(AK5/Z0@[.V ._L#K6OLPEMY7-W42/<G\Y1/HJ==;1RH8@T=(V7$6V!SNW
MDB10&626(M 60MO97 X2D2+Z<@N-H [&62 T84A6AC%H.M8.ZX[>B!KU\6O
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M& P-9G\K-_@LZG_Y".A?YDKG#K[WW>D;,V'(P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M/LX_+^&S-AR,!@,!@,#69_*S?X+.I_\ D(Z%_F2N<.OO?=Z1LS8<C 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M,!@:S/AG_P!V7\P1_J3J+^/<>'7W/LX_+^&S-AR,!@,!@,#69_*S?X+.I_\
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M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!K,^&?\
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MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P&!K,^&?\ W9?S!'^I.HOX]QX=?<^SC\OX;,V'(P&
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MC5_-=']%SIVY\\?4%F5V]5MEG0%DEU$3Z^^<Q3FLW<@LI5'))9$WC+2N3/\
M)7-@(0;;-:-/(3C& )&"<)W2W&MV23)_-7#.7JXIBNWJ$K[QGM=</<_=&]*2
M>0WQ455OK<PS:O$SH43"4=O21H?+\N20(F)Q>361J]I@B=D_(KTI6$$#'_/-
MSMJ]Y:XG\8M>O(':4(7[=(99,,B\^B+F(H9 G&,3%D0R)@7"(,_E"=JVIQ*,
MV 7VA]WIO[=8<K,7%7G@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,#69\,_P#NR_F"/]2=1?Q[CPZ^Y]G'Y?PV9L.1@,!@,!@:S/Y6;_!9U/\
M\A'0O\R5SAU][[O2-F;#D8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MG/$!6/7?-G/]"7)<$Y*D%'2U]D2NW:RB%9U.^SYCGJ%]9;:KIRAT)B[9!H]
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M2QW8DDA<^KB=*%QC<U(DY(2$"(2E2,@OWF&G'J3CSS3'/E>=S7HIADP& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
AP& P& P& P& P& P& P& P& P& P& P& P& P& P/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g282574g87b92.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g87b92.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ , "Q P$1  (1 0,1 ?_$ )T   ,  P$! 0
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ML$TR+)MP'VK00,!4_53.'+?JW@&_^R?:.;S#E!L7C:Y/W9=@\M#\@U85+'4
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&I$.D3__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g282574g90v60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g90v60.jpg
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M; 55M0Y5FEF!R$==@!)", PIXC,11$A(9!SCB4)QE&6,9QG'P"#X ? #X ?
M#X!.LLPZRNFH K3;9Q+*K '(IV&#DB(( BAB4RE*2<1C'".93G*,8XSG.,?
M&G?62UG6]8]O;\OK6OTFO LDJBZL0T=4A4BL+FV07>M+9T:"Z\&K.R=.9RP?
M/$C3C1BL,%(4DYYBC'KT1=:2=E%NK%5?+(#X ? #X ? &J_1MUG6]G]O:"OL
MNOTFP@K4K>ZK@WE4A;"K[FI08>J[9(;Z[$%;.M= %RO?!$;2;01,+E&4<)XB
-O'KT9="3;E3;JC__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g282574g97h93.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g97h93.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 00!& P$1  (1 0,1 ?_$ )X   (" @,!
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M$J$62R)K[HHXOR^HTWB$7C!GD!(:CUKR[*JM9CO'FPE5\-N0")+)1/=,BQ2
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;>GITQG/IC#IC#IC#IC#IC#IC#IC#IC#IC/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g282574g97o48.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g97o48.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 0 !% P$1  (1 0,1 ?_$ ),   (# 0 #
M      @)  4*!P,$!@$!  (" P$!              @)! <"!08* Q   00"
M 00! P$%"0       P($!08!!P@ $A,)$105%B(A)!<8&3%1(S,E-:?76!$
M @(!! $$ 00!! ,      0(#! 4 $08'$B$Q$P@402)""3)1@205X6(C_]H
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M0G"!H1UX;Z?\JSF<[JRE[-V);=_(XB9YI)&W9I$GK%&/I_%?)%4>*JK;* %
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M_7+%A)/LC"<L$-Y,+>:GY;;BSM$&*;_R_$-KV]?'R/MOK/%'Z'UE7^(<KO\
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M+((W1%%P-)O%E:E94G.%*QGP/-NKN ]BQA.88RO<F6,HDI!2:-22VR31E9%
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4)>6V)O[C]UPTSD'U'ASV=--?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g282574g99m98.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g282574g99m98.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1@>4&AO=&]S:&]P(#,N,  X0DE-! 0
M    & *^848X0DE-! 0       \< 5H  QLE1QP"   "/(T .$))300E
M   0S*#UTR5DX-L8&F1^OS>H9SA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$"2P
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#O_XU
M  (  CA"24T$)@      #@             _@   .$))300-       $
M>#A"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          CA"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      ,U    !@             "?@
M!$0          0                         !              1$   "
M?@                     !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "
M?@    !29VAT;&]N9P  !$0    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   GX     4F=H=&QO;F<
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M# P,# P,# P,# P,# P,_\  $0@ 70"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MDDDE*22224__T?55F=8ZY5TY
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M%*26F\DE2=GMMOM!%1V]:/>S[J)-GT+0;*ZTR_8KA9):$.SYRF8T*%#8'@
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-YQ#3#2&T<XE/.??_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
